data_2m6m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6m _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.44 149.7 1.53 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.155 1.782 . . . . 0.0 111.563 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -134.9 151.15 50.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.9 t -46.22 160.27 0.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.634 1.974 . . . . 0.0 112.999 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.13 0.47 40.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.818 2.047 . . . . 0.0 114.678 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.36 -35.23 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.345 2.258 . . . . 0.0 113.223 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.1 p -143.12 23.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 39.15 30.26 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.012 2.125 . . . . 0.0 114.965 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.81 155.98 45.45 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.93 134.32 46.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.302 1.051 . . . . 0.0 108.801 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -35.44 139.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -111.51 -168.8 1.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.702 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -104.05 15.13 29.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.442 2.297 . . . . 0.0 112.421 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.29 -27.93 0.27 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.092 1.757 . . . . 0.0 111.486 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -146.35 80.58 9.98 Favored Pre-proline 0 N--CA 1.435 -1.189 0 C-N-CA 126.465 1.906 . . . . 0.0 108.629 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.27 -143.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 125.873 4.382 . . . . 0.0 112.159 -177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -141.42 159.23 42.64 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.101 2.16 . . . . 0.0 108.916 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -165.96 161.22 17.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.919 2.087 . . . . 0.0 108.58 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -105.38 109.78 63.6 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.06 0.544 . . . . 0.0 109.726 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . 0.264 61.9 Cg_endo -78.05 -7.5 16.31 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.658 3.572 . . . . 0.0 112.994 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.2 t -150.06 176.13 11.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.937 1.695 . . . . 0.0 111.472 -167.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -110.6 36.66 3.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.382 2.273 . . . . 0.0 113.572 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.4 m -59.59 -36.71 76.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.399 0.68 . . . . 0.0 110.6 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 75.16 178.6 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.683 2.793 . . . . 0.0 113.528 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.21 -138.38 43.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.71 1.148 . . . . 0.0 113.973 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -99.6 14.7 29.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.647 1.579 . . . . 0.0 114.574 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 33.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 127.009 2.124 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -106.03 -40.49 5.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.043 1.737 . . . . 0.0 109.957 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -61.78 157.11 18.76 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.893 1.277 . . . . 0.0 112.228 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 ttm -172.48 145.88 1.68 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.127 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -71.28 154.92 41.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.95 -38.87 87.38 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.672 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.1 p -63.65 -55.31 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 111.546 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.24 -43.5 61.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.904 1.282 . . . . 0.0 112.224 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.05 -45.78 87.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.936 0.789 . . . . 0.0 111.55 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -58.88 -28.03 65.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.449 1.1 . . . . 0.0 113.161 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.99 -26.91 21.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.364 1.466 . . . . 0.0 111.919 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.68 -59.45 2.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.218 1.007 . . . . 0.0 110.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.41 -20.08 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.901 1.281 . . . . 0.0 111.604 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.42 -45.32 32.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -59.92 -29.17 68.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.008 1.323 . . . . 0.0 112.53 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.8 -3.39 12.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.669 1.988 . . . . 0.0 113.827 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.06 54.41 2.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.785 1.234 . . . . 0.0 111.948 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -140.05 132.18 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 110.812 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -88.08 97.67 11.11 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.684 0.793 . . . . 0.0 110.487 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 pt -64.7 -10.93 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.839 1.256 . . . . 0.0 113.612 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -93.53 5.61 51.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.231 . . . . 0.0 112.794 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -120.9 144.9 40.2 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.546 1.138 . . . . 0.0 113.983 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -86.12 21.53 1.07 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.798 3.665 . . . . 0.0 113.838 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.36 23.85 10.2 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.039 2.257 . . . . 0.0 111.906 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.93 166.69 20.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.298 1.439 . . . . 0.0 112.888 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.65 36.26 2.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.309 1.844 . . . . 0.0 110.405 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -36.72 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 127.36 2.264 . . . . 0.0 114.751 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 15.4 pttm -158.1 172.46 18.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.58 172.6 1.53 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.645 2.778 . . . . 0.0 116.046 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.32 -17.45 3.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.974 2.51 . . . . 0.0 112.605 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.4 -54.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.137 0.975 . . . . 0.0 109.506 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.2 p -116.2 -9.85 11.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.58 1.952 . . . . 0.0 111.45 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.307 7.3 p80 58.05 22.09 8.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.583 2.753 . . . . 0.0 116.342 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -78.92 137.48 57.6 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.733 -1.229 . . . . 0.0 112.915 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 24.5 Cg_exo -54.54 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.752 2.968 . . . . 0.0 112.303 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.5 mm -68.19 139.91 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.313 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.41 124.71 40.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 112.345 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.85 1.66 . . . . 0.0 114.309 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.474 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.72 128.64 37.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.879 0.872 . . . . 0.0 109.571 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 p -139.13 148.75 43.65 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.207 1.403 . . . . 0.0 112.103 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.48 126.65 17.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.999 1.319 . . . . 0.0 112.378 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -5.43 26.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.852 -1.155 . . . . 0.0 113.446 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.18 -43.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.004 1.321 . . . . 0.0 110.272 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.5 p -125.3 -1.58 7.59 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.318 33.9 mmt180 61.61 25.6 15.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.406 2.282 . . . . 0.0 115.455 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.24 139.64 15.75 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.97 165.28 15.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.109 0.963 . . . . 0.0 112.228 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 139.31 58.75 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 49' ' ' ASP . 50.1 p -129.92 160.47 33.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.291 1.043 . . . . 0.0 112.85 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.9 13.54 0.51 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.842 1.657 . . . . 0.0 114.662 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 47' ' ' THR . 35.7 t70 -133.66 -20.74 2.01 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.293 2.237 . . . . 0.0 110.946 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.476 HD22 ' HB3' ' A' ' 66' ' ' HIS . 28.4 t30 -158.98 72.34 3.56 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.607 1.163 . . . . 0.0 112.82 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.16 167.36 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 125.274 3.982 . . . . 0.0 116.611 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.2 mt -109.82 142.97 40.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -154.55 177.53 11.1 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.47 2.708 . . . . 0.0 107.821 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.423 ' CE1' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.74 110.16 37.21 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.29 -19.62 25.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.687 2.258 . . . . 0.0 111.209 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -145.3 154.74 42.67 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 130.38 3.472 . . . . 0.0 108.221 -173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 59' ' ' ARG . 75.6 mmtt -56.49 -39.87 73.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.672 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 28.83 10.87 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 131.182 3.793 . . . . 0.0 121.005 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 57' ' ' LYS . 17.3 tpp85 15.45 57.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 1 C-N-CA 134.514 5.126 . . . . 0.0 118.129 179.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 62' ' ' ILE . . . 170.06 -174.05 44.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.525 0.583 . . . . 0.0 114.084 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -67.6 29.39 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 127.547 2.339 . . . . 0.0 114.024 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 60' ' ' GLY . 1.9 pp -135.26 -6.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 129.215 3.006 . . . . 0.0 112.039 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' A' ' 54' ' ' HIS . 21.0 pttm -72.72 -23.02 60.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.682 1.128 . . . . 0.0 111.616 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -73.33 138.08 45.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.349 1.059 . . . . 0.0 112.067 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 84.0 mtp -157.3 140.24 15.2 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.385 1.474 . . . . 0.0 109.854 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.476 ' HB3' HD22 ' A' ' 50' ' ' ASN . 36.9 m80 -70.78 157.61 37.76 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.79 -48.13 82.03 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.75 -0.594 . . . . 0.0 109.827 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -62.22 -45.85 91.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.643 0.777 . . . . 0.0 112.127 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.13 -43.65 97.78 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.512 -0.742 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.4 -44.6 95.53 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.215 0.916 . . . . 0.0 110.198 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.62 -30.01 62.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.57 -38.71 18.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.483 1.113 . . . . 0.0 110.991 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -62.36 -48.0 81.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.427 1.091 . . . . 0.0 111.958 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -64.19 -32.87 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.569 0.748 . . . . 0.0 111.305 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.71 -35.56 79.02 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.389 0.675 . . . . 0.0 110.84 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.0 t -63.19 -19.0 64.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 0.0 112.567 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -82.55 2.99 30.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.125 1.37 . . . . 0.0 113.045 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 79.1 14.55 1.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.107 2.163 . . . . 0.0 113.715 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.94 127.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.921 1.289 . . . . 0.0 111.853 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.04 107.05 19.44 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.485 1.114 . . . . 0.0 110.062 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.0 -13.56 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.333 1.453 . . . . 0.0 114.342 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.46 -21.73 60.37 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.814 -0.554 . . . . 0.0 111.787 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -93.91 144.52 28.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.946 1.298 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.56 9.9 2.07 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.924 3.083 . . . . 0.0 115.837 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.19 -1.72 60.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.359 1.933 . . . . 0.0 113.094 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.15 141.99 57.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.115 0.958 . . . . 0.0 112.013 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.5 44.12 1.2 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.754 1.622 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.41 123.84 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.991 1.316 . . . . 0.0 111.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -145.04 143.07 30.27 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 0.0 110.647 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.4 t -62.42 163.56 8.49 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.66 -9.04 12.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.159 1.783 . . . . 0.0 111.736 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.2 -55.96 5.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 123.813 0.845 . . . . 0.0 108.793 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.0 p -109.44 -3.6 16.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.468 0.707 . . . . 0.0 112.792 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 60.78 11.44 3.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.152 1.781 . . . . 0.0 114.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -81.96 140.59 46.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 120.078 -1.639 . . . . 0.0 110.474 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.21 145.25 44.55 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.054 2.503 . . . . 0.0 111.114 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.5 mm -100.74 107.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.0 1.32 . . . . 0.0 111.045 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.52 116.06 24.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.384 1.474 . . . . 0.0 109.915 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.34 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 CA-C-O 119.321 -0.711 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.12 153.28 41.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.762 1.281 . . . . 0.0 109.67 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 p -146.87 149.15 32.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.49 128.99 38.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.379 1.472 . . . . 0.0 111.84 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -13.01 62.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.91 -43.74 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.554 1.142 . . . . 0.0 111.498 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.78 5.5 10.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 54.44 29.49 11.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.822 2.049 . . . . 0.0 113.647 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.64 147.6 16.69 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 122.726 1.181 . . . . 0.0 111.066 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.05 166.34 5.98 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.532 1.933 . . . . 0.0 114.146 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 147.04 54.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.427 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.5 p -129.39 155.65 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.577 1.18 . . . . 0.0 112.929 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.38 -10.81 1.0 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.67 1.988 . . . . 0.0 116.272 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.0 -20.7 4.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.667 1.587 . . . . 0.0 111.644 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -143.76 66.54 15.24 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.31 169.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.429 1 C-N-CA 126.167 4.578 . . . . 0.0 118.059 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.9 mt -111.97 144.92 40.53 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.781 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -150.94 168.42 24.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.712 2.805 . . . . 0.0 106.618 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -111.73 107.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.81 -13.27 21.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.355 2.704 . . . . 0.0 112.455 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t -138.17 -161.99 1.25 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.138 1.375 . . . . 0.0 112.579 -166.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.27 26.63 4.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.809 2.044 . . . . 0.0 113.388 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -8.5 0.59 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.673 1.589 . . . . 0.0 114.217 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 54.6 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.588 2.355 . . . . 0.0 115.626 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.41 -156.86 20.42 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.514 1.054 . . . . 0.0 114.635 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -82.69 5.08 22.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.018 1.327 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.73 9.2 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.563 1.545 . . . . 0.0 114.216 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -90.14 -4.7 57.13 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.181 0.993 . . . . 0.0 112.663 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -94.31 147.42 23.22 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.227 1.411 . . . . 0.0 111.201 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.1 mtp -158.85 139.89 12.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.993 0.917 . . . . 0.0 110.424 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -68.31 158.39 33.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.02 -46.75 87.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.071 -1.018 . . . . 0.0 109.015 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -54.86 -57.22 12.48 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.02 1.328 . . . . 0.0 112.988 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.68 -36.81 84.1 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.873 1.269 . . . . 0.0 111.972 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.92 -47.29 75.23 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.494 1.497 . . . . 0.0 110.694 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.63 -33.52 72.9 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.231 1.812 . . . . 0.0 112.256 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.44 -36.08 39.45 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.519 2.728 . . . . 0.0 111.898 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.3 t90 -69.4 -52.88 22.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.003 0.921 . . . . 0.0 109.806 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -58.92 -29.98 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.473 1.033 . . . . 0.0 111.204 172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.96 -39.36 76.07 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.717 -0.614 . . . . 0.0 110.498 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 m -66.03 -24.26 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.77 -1.206 . . . . 0.0 112.917 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -73.69 -5.71 42.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.954 2.102 . . . . 0.0 112.561 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.256 8.8 t30 63.15 45.27 5.24 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.321 1.449 . . . . 0.0 112.478 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.84 126.56 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.052 -1.03 . . . . 0.0 111.105 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -81.13 106.64 13.28 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.52 0.728 . . . . 0.0 111.118 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -61.54 -18.87 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 114.0 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -19.72 52.04 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.352 0.661 . . . . 0.0 112.742 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.22 141.7 43.19 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.968 -1.083 . . . . 0.0 113.545 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -84.05 6.15 5.93 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.391 3.394 . . . . 0.0 114.984 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.3 23.69 32.45 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 127.237 2.351 . . . . 0.0 112.554 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.88 163.54 30.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 112.573 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -139.34 54.17 1.71 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.147 2.179 . . . . 0.0 108.602 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.72 106.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.481 1.512 . . . . 0.0 113.294 -174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.455 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -150.58 179.26 8.32 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 178.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.8 t -66.81 173.75 3.36 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.498 1.919 . . . . 0.0 115.907 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -131.35 -6.92 3.78 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.49 2.316 . . . . 0.0 112.603 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.3 mt -81.03 -64.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.122 0.969 . . . . 0.0 108.977 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.5 p -104.26 -11.75 17.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 129.916 3.287 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 62.33 18.74 10.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.762 2.825 . . . . 0.0 114.86 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.406 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 14.4 m-85 -74.17 142.77 79.36 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.834 -1.166 . . . . 0.0 113.234 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 32.1 Cg_exo -55.81 135.48 69.77 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.306 3.337 . . . . 0.0 111.316 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.67 126.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.363 1.065 . . . . 0.0 110.511 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.89 94.45 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.384 1.873 . . . . 0.0 110.38 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 CA--C 1.546 0.812 0 C-N-CA 125.118 1.367 . . . . 0.0 112.004 -179.371 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . 0.296 . . 69.77 179.4 0.24 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.825 2.05 . . . . 0.0 112.043 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -154.36 162.86 40.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.566 1.147 . . . . 0.0 112.601 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 t -83.21 125.85 32.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.103 0.961 . . . . 0.0 111.425 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -11.67 58.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.9 1.28 . . . . 0.0 113.744 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.6 mt -102.47 -52.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.659 1.183 . . . . 0.0 109.666 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 9.4 m -98.61 -13.78 20.21 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.254 36.2 mmt180 48.35 69.02 0.59 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 123.675 1.702 . . . . 0.0 108.41 -171.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.03 139.56 10.81 Favored Glycine 0 N--CA 1.463 0.446 0 CA-C-N 110.931 -2.849 . . . . 0.0 110.206 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.19 154.58 31.0 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.498 1.119 . . . . 0.0 110.68 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.93 18.22 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.146 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -101.21 -150.84 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.378 0.671 . . . . 0.0 111.06 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.51 12.83 8.1 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.809 2.043 . . . . 0.0 111.671 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -142.6 -12.79 0.78 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.358 2.663 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -160.11 71.97 3.08 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.14 2.176 . . . . 0.0 107.82 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.57 -165.5 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.654 3.57 . . . . 0.0 110.371 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -131.6 154.14 49.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.971 1.308 . . . . 0.0 111.399 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -154.64 -179.03 7.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.297 1.439 . . . . 0.0 110.118 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -115.58 96.42 46.16 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.821 1.248 . . . . 0.0 111.601 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.14 -13.48 19.09 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.511 3.474 . . . . 0.0 113.556 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.1 t -148.61 166.98 26.65 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.858 2.863 . . . . 0.0 105.906 -171.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 59' ' ' ARG . 73.3 mmtt -75.45 -40.2 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.243 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.311 90.9 m 40.04 -17.75 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.548 1 C-N-CA 133.001 4.52 . . . . 0.0 119.719 -170.179 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 57' ' ' LYS 0.265 6.6 tpp180 45.87 58.86 4.04 Favored 'General case' 0 N--CA 1.471 0.6 1 C-N-CA 131.873 4.069 . . . . 0.0 115.99 -179.941 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.8 -178.48 48.44 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.36 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.9 p -53.49 -32.2 49.24 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.373 1.087 . . . . 0.0 112.182 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.62 -14.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 128.708 2.803 . . . . 0.0 114.642 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -62.91 -25.99 68.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.041 0.837 . . . . 0.0 112.519 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.6 136.37 36.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.388 1.089 . . . . 0.0 112.13 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 87.8 mtp -159.76 153.54 22.91 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.356 2.262 . . . . 0.0 108.278 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -77.43 166.09 23.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.924 0.783 . . . . 0.0 109.283 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.48 -41.42 76.18 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.088 -1.632 . . . . 0.0 111.772 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 m -75.4 -29.08 59.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.878 1.671 . . . . 0.0 114.486 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -78.57 -42.48 29.03 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.355 1.074 . . . . 0.0 112.113 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.274 44.6 tp -52.75 -48.78 66.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.585 1.154 . . . . 0.0 111.174 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.19 -23.87 62.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.282 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -97.83 -30.34 12.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.865 . . . . 0.0 111.585 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -65.41 -49.87 67.58 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.179 1.392 . . . . 0.0 110.802 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.27 -34.83 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.063 0.847 . . . . 0.0 111.228 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.83 79.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.25 0.548 . . . . 0.0 111.171 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 t -64.66 -16.28 62.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.55 1.14 . . . . 0.0 112.523 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -84.68 9.85 12.82 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 112.729 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 80.02 -0.71 2.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.16 2.584 . . . . 0.0 115.621 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.39 125.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.275 1.43 . . . . 0.0 112.327 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -84.48 102.54 12.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 112.787 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 pt -66.92 -15.59 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 113.798 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -69.41 -19.22 63.81 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -111.74 144.47 30.71 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.506 1.122 . . . . 0.0 112.596 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.92 10.32 2.38 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 124.197 3.265 . . . . 0.0 115.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.26 10.06 59.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.727 2.108 . . . . 0.0 113.08 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 167.47 6.3 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.564 1.546 . . . . 0.0 113.819 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -136.79 38.59 2.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.13 1.772 . . . . 0.0 110.506 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.79 78.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.471 1.909 . . . . 0.0 113.438 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -134.26 140.73 46.64 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.374 1.87 . . . . 0.0 110.677 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.39 172.78 0.79 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.493 2.317 . . . . 0.0 115.477 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.3 -9.28 6.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.351 2.26 . . . . 0.0 112.913 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.9 mt -85.3 -59.17 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p -109.35 -6.66 15.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.827 2.451 . . . . 0.0 111.829 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.0 m80 63.89 21.39 12.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.997 2.119 . . . . 0.0 114.905 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.446 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 26.9 m-85 -80.4 143.28 55.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.716 -1.24 . . . . 0.0 112.846 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.92 141.22 83.43 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.835 2.357 . . . . 0.0 110.358 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.53 129.1 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.437 1.095 . . . . 0.0 109.598 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.23 117.74 27.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.379 1.472 . . . . 0.0 109.526 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -176.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.386 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.04 138.47 47.91 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.858 1.329 . . . . 0.0 108.873 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 p -140.78 148.91 41.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.924 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.475 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.7 t -60.3 123.62 17.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.267 1.827 . . . . 0.0 111.938 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -69.83 -8.02 44.88 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.787 -1.196 . . . . 0.0 112.114 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.475 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 77.6 mt -91.13 -51.66 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.75 13.67 5.87 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 61.81 8.98 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.458 2.703 . . . . 0.0 115.805 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.45 146.68 36.19 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.65 161.01 31.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.844 0.857 . . . . 0.0 111.92 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.72 120.74 15.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.58 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -96.52 -170.99 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.301 0.572 . . . . 0.0 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -84.48 -24.05 29.61 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 3.68 5.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 112.083 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.91 60.91 4.67 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 126.911 2.084 . . . . 0.0 109.953 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.56 -164.47 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 125.527 4.151 . . . . 0.0 111.926 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.5 mt -126.65 163.04 24.35 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.703 2.001 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -165.39 -169.91 1.72 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.746 2.418 . . . . 0.0 108.177 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -126.68 101.11 27.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 119.052 0.842 . . . . 0.0 111.127 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.691 ' HG2' ' H ' ' A' ' 56' ' ' CYS . 83.3 Cg_endo -72.44 -54.44 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 N-CA-C 108.264 -1.476 . . . . 0.0 108.264 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.691 ' H ' ' HG2' ' A' ' 55' ' ' PRO . 12.5 p -102.64 169.75 8.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 131.411 3.884 . . . . 0.0 112.295 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' C ' ' H ' ' A' ' 59' ' ' ARG . 38.9 mmtt -108.16 35.3 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.436 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 11.7 m -48.11 -12.69 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 57' ' ' LYS . 56.6 ttt85 62.24 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.841 3.256 . . . . 0.0 115.335 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.0 -159.75 31.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.842 0.734 . . . . 0.0 112.234 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -64.91 -30.6 71.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.269 2.4 pp -75.4 10.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 pttm -96.4 -20.05 18.74 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.728 -0.608 . . . . 0.0 110.598 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -63.5 135.7 57.06 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.263 1.025 . . . . 0.0 108.865 171.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.6 mtp -150.89 141.36 22.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.909 1.284 . . . . 0.0 108.585 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.445 ' C ' ' H ' ' A' ' 68' ' ' SER . 4.0 m170 -64.52 139.99 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.187 0.994 . . . . 0.0 110.491 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.2 19.21 0.08 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.512 1.525 . . . . 0.0 112.629 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 66' ' ' HIS . 79.6 p -135.75 -46.63 0.67 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.352 2.661 . . . . 0.0 109.15 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.37 -37.38 85.5 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.555 1.542 . . . . 0.0 111.404 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.73 -46.94 80.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.62 1.1 . . . . 0.0 109.814 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.18 -32.2 70.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.462 1.105 . . . . 0.0 111.501 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.06 -36.45 30.47 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.254 2.622 . . . . 0.0 111.23 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -65.35 -51.9 57.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.471 1.108 . . . . 0.0 109.315 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.25 -30.34 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 119.619 1.1 . . . . 0.0 110.836 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.875 -0.516 . . . . 0.0 110.2 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 p -67.73 -8.49 35.85 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -88.95 -1.59 58.18 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.352 1.861 . . . . 0.0 113.47 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER 71.83 17.22 5.41 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.782 1.633 . . . . 0.0 114.89 178.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.69 167.91 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.429 1.892 . . . . 0.0 111.587 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -128.18 106.95 9.4 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.575 1.55 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -18.43 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 113.674 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -76.81 -8.55 57.53 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.07 143.94 78.29 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.773 -1.204 . . . . 0.0 111.586 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.17 7.07 3.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.813 3.009 . . . . 0.0 116.757 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.62 8.39 8.28 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 127.143 2.306 . . . . 0.0 112.056 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.7 142.83 57.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.896 0.848 . . . . 0.0 112.747 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -138.01 32.95 2.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.738 1.615 . . . . 0.0 110.368 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.56 118.07 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 112.741 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -146.79 176.47 9.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 176.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.01 162.29 1.97 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.025 2.53 . . . . 0.0 113.07 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -115.38 -12.0 11.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.23 -53.94 8.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 122.817 0.447 . . . . 0.0 109.811 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.3 p -106.72 -7.56 17.22 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 53.71 14.07 0.58 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.255 1.822 . . . . 0.0 115.276 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -82.5 136.34 45.75 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.118 -1.614 . . . . 0.0 110.584 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 54.5 Cg_exo -46.74 126.2 10.5 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.233 2.622 . . . . 0.0 112.276 171.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.262 0.6 OUTLIER -78.6 111.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.1 -1.864 . . . . 0.0 109.545 -173.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -80.74 73.29 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.721 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 126.161 1.784 . . . . 0.0 113.411 179.461 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.45 157.93 33.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.293 0.568 . . . . 0.0 110.625 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -156.34 165.68 35.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.793 1.237 . . . . 0.0 112.496 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.25 128.03 32.79 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 110.306 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -7.81 43.17 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.6 mt -94.05 -37.63 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.089 . . . . 0.0 110.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.43 4.17 3.66 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 61.24 19.33 10.0 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.702 2.001 . . . . 0.0 113.833 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.5 145.55 22.05 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.02 164.46 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.962 0.881 . . . . 0.0 111.472 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.83 144.43 56.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 49' ' ' ASP . 70.9 p -135.27 156.65 48.61 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.42 1.105 . . . . 0.0 113.692 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.94 8.82 0.23 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.753 2.421 . . . . 0.0 115.452 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 47' ' ' THR . 35.8 t70 -133.65 -20.07 2.05 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.13 2.172 . . . . 0.0 111.221 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -155.71 71.45 5.37 Favored Pre-proline 0 N--CA 1.445 -0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 112.125 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.42 171.36 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 125.009 3.806 . . . . 0.0 116.354 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.84 148.83 35.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.726 173.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -157.75 179.2 9.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.89 2.076 . . . . 0.0 108.393 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -120.74 112.65 33.67 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.318 0.647 . . . . 0.0 110.603 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -12.19 14.39 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.784 2.989 . . . . 0.0 112.218 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.8 t -133.36 -153.39 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.424 1.489 . . . . 0.0 112.468 -167.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 5.4 tmtt? -135.89 14.07 3.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.193 2.197 . . . . 0.0 115.028 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.9 m -46.66 -23.52 0.42 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.869 2.468 . . . . 0.0 115.222 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp-105 65.39 162.92 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.18 2.992 . . . . 0.0 114.282 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 -164.9 29.5 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.508 -0.745 . . . . 0.0 113.029 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.3 m -61.08 -34.57 75.13 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.303 -1.116 . . . . 0.0 113.185 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.76 1.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -83.21 -21.69 33.37 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.218 -0.926 . . . . 0.0 112.515 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.48 150.66 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.022 0.915 . . . . 0.0 110.636 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mtp -158.21 141.46 15.07 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.35 1.46 . . . . 0.0 109.793 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -70.53 151.4 45.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -56.28 -49.56 73.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.114 -0.366 . . . . 0.0 110.276 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -64.27 -44.32 92.11 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.46 -46.68 87.41 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.312 -0.867 . . . . 0.0 112.243 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.83 -45.44 74.45 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.179 0.9 . . . . 0.0 109.728 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.22 -25.64 65.78 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -89.78 -32.25 17.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.323 0.965 . . . . 0.0 111.868 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.83 -57.92 10.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.969 1.308 . . . . 0.0 110.618 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.95 -23.98 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.872 1.269 . . . . 0.0 111.65 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.14 58.63 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 m -93.87 5.73 50.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.918 1.287 . . . . 0.0 111.817 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -108.18 9.13 28.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.728 2.411 . . . . 0.0 113.673 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.253 10.3 t30 63.69 42.62 6.18 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.713 1.205 . . . . 0.0 112.387 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.47 152.73 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.593 1.557 . . . . 0.0 110.102 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -123.74 111.55 16.29 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.974 1.309 . . . . 0.0 110.457 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.4 pt -60.88 -19.73 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.247 1.419 . . . . 0.0 113.827 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.9 t -78.67 -14.85 59.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -93.02 143.58 27.03 Favored Pre-proline 0 N--CA 1.478 0.942 0 O-C-N 121.177 -0.952 . . . . 0.0 112.629 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.11 5.09 6.47 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.849 3.033 . . . . 0.0 115.638 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.62 10.75 38.68 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.955 2.217 . . . . 0.0 112.727 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.37 156.47 29.11 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.034 0.934 . . . . 0.0 113.145 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.04 45.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.409 1.484 . . . . 0.0 110.746 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.93 102.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.743 1.217 . . . . 0.0 112.575 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.9 tttm -143.66 142.1 30.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.362 1.465 . . . . 0.0 112.378 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.82 178.33 0.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.447 2.699 . . . . 0.0 115.174 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -132.19 -12.08 3.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.755 2.422 . . . . 0.0 112.727 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -78.33 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 122.119 0.961 . . . . 0.0 109.213 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.75 -8.6 17.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.916 2.886 . . . . 0.0 111.264 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.439 ' O ' ' HE2' ' A' ' 89' ' ' LYS 0.364 0.0 OUTLIER 63.34 18.97 11.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.643 3.177 . . . . 0.0 115.366 -175.883 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.424 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 16.8 m-85 -75.7 145.8 79.05 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 120.477 -1.389 . . . . 0.0 114.329 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -61.74 141.61 91.12 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.214 1.943 . . . . 0.0 109.813 170.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -86.42 117.92 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 125.17 1.388 . . . . 0.0 108.143 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -114.38 94.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.427 1.491 . . . . 0.0 111.845 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 126.037 1.735 . . . . 0.0 112.807 178.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.528 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 158.62 36.06 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.7 p -121.11 163.9 17.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.8 t -80.62 133.31 35.73 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 120.835 -1.166 . . . . 0.0 108.093 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -21.77 66.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.49 1.041 . . . . 0.0 113.021 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.72 -49.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.749 1.22 . . . . 0.0 110.216 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -88.23 -23.73 23.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 58.91 36.91 24.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.376 1.47 . . . . 0.0 108.893 -167.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.0 134.49 10.83 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.931 1.253 . . . . 0.0 112.974 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -71.58 142.62 50.01 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.18 148.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.625 1.57 . . . . 0.0 114.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -128.22 179.61 5.52 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.202 1.001 . . . . 0.0 111.214 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.84 -32.02 68.92 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.98 -31.37 13.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.644 1.978 . . . . 0.0 110.704 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -123.62 65.56 33.84 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.63 167.16 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.261 1.974 . . . . 0.0 112.186 162.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.9 mt -117.83 146.62 43.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.759 -2.019 . . . . 0.0 112.153 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -149.39 163.53 37.49 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.406 3.082 . . . . 0.0 105.712 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -114.02 104.33 54.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.54 -24.72 35.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.282 1.988 . . . . 0.0 113.174 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.258 0.5 OUTLIER -139.96 150.53 44.6 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 127.262 2.225 . . . . 0.0 107.779 -168.876 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.22 -46.7 62.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 117.112 -1.423 . . . . 0.0 111.734 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 68.2 m 32.73 -12.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 1 C-N-CA 133.195 4.598 . . . . 0.0 120.901 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 72.14 149.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 131.002 3.721 . . . . 0.0 113.941 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.41 -142.55 48.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.74 1.162 . . . . 0.0 114.679 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -95.92 -7.05 37.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 112.891 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.0 24.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 111.931 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -105.82 -26.21 11.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.513 1.525 . . . . 0.0 112.374 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -77.48 152.45 34.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.139 1.376 . . . . 0.0 112.226 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 90.3 mtp -158.74 144.75 16.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.328 0.651 . . . . 0.0 112.294 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -70.8 152.45 43.74 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -56.16 -49.19 74.69 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.204 -0.935 . . . . 0.0 110.874 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -54.71 -50.04 69.27 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.411 1.084 . . . . 0.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.53 -44.16 93.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.72 -48.0 73.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.06 0.845 . . . . 0.0 111.44 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -55.7 -30.86 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.603 1.961 . . . . 0.0 112.949 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -91.99 -38.84 12.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.088 1.755 . . . . 0.0 112.156 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 80.2 t90 -58.62 -45.19 89.74 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 123.819 0.848 . . . . 0.0 111.015 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.36 -26.08 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.176 0.898 . . . . 0.0 112.213 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.63 62.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.788 -1.195 . . . . 0.0 111.43 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.7 p -84.5 11.18 9.14 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.527 -0.733 . . . . 0.0 112.502 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -115.03 8.39 15.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.701 1.6 . . . . 0.0 112.894 -174.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.32 0.0 OUTLIER 79.36 38.03 0.13 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.911 2.084 . . . . 0.0 112.67 178.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.58 145.28 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.437 1.095 . . . . 0.0 113.54 -171.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -139.54 102.84 4.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 110.024 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -12.26 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.258 1.423 . . . . 0.0 114.485 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -75.59 -16.34 60.25 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.726 -0.609 . . . . 0.0 111.972 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -106.56 142.21 24.46 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.103 1.361 . . . . 0.0 111.6 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.97 29.27 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.548 3.499 . . . . 0.0 114.626 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.15 20.19 6.32 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.882 2.182 . . . . 0.0 111.724 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.09 163.69 24.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 122.353 1.073 . . . . 0.0 113.637 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -143.92 41.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.85 2.06 . . . . 0.0 109.099 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.285 11.1 p -68.36 65.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.685 2.394 . . . . 0.0 115.447 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -133.53 144.88 49.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.401 2.281 . . . . 0.0 110.64 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -67.95 173.65 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.656 2.383 . . . . 0.0 115.256 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -129.12 -10.69 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.862 2.465 . . . . 0.0 112.978 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -78.76 -55.76 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.903 0.858 . . . . 0.0 109.434 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.9 p -115.45 -7.46 12.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 129.06 2.944 . . . . 0.0 111.85 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 66.9 20.7 10.51 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.078 2.551 . . . . 0.0 114.861 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.414 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.8 m-85 -85.14 145.81 43.91 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 113.487 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.24 135.96 49.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.53 2.154 . . . . 0.0 109.796 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -77.76 141.74 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.507 1.123 . . . . 0.0 109.817 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -133.56 120.58 20.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.243 1.417 . . . . 0.0 111.456 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -178.824 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 CA-C-O 119.452 -0.638 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.69 46.69 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.477 1.139 . . . . 0.0 109.749 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -143.36 149.34 37.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.125 1.37 . . . . 0.0 113.01 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -57.51 129.25 40.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.663 1.585 . . . . 0.0 112.214 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -7.97 53.51 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.455 -1.403 . . . . 0.0 113.827 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.6 mt -96.17 -44.09 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 117.724 -1.132 . . . . 0.0 109.627 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.3 p -128.07 9.67 6.3 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 55.17 19.58 2.94 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.652 2.381 . . . . 0.0 114.499 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.2 149.28 29.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.72 163.63 24.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.124 0.962 . . . . 0.0 111.175 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 129.44 41.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -99.02 -146.67 0.33 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.335 0.588 . . . . 0.0 112.046 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -130.7 13.49 5.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.561 2.344 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -145.25 -18.01 0.49 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.207 2.603 . . . . 0.0 111.591 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.405 HD22 ' HB3' ' A' ' 66' ' ' HIS . 47.3 t30 -153.84 68.59 6.22 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 125.043 1.337 . . . . 0.0 111.883 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.67 179.51 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.43 1 C-N-CA 125.466 4.111 . . . . 0.0 116.263 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.52 154.01 32.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.459 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.17 -177.62 6.4 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.813 3.245 . . . . 0.0 106.311 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -128.96 117.62 19.3 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.585 0.63 . . . . 0.0 109.794 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -82.74 -9.93 10.82 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.815 3.01 . . . . 0.0 113.015 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 2.0 t -141.01 -162.87 1.43 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.769 1.228 . . . . 0.0 111.327 -166.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -129.21 24.38 5.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.258 1.823 . . . . 0.0 113.352 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -48.25 -21.53 0.52 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.849 2.06 . . . . 0.0 113.816 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 63.05 152.85 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 129.391 3.077 . . . . 0.0 115.549 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.4 -164.89 40.68 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.653 1.121 . . . . 0.0 114.752 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.7 m -59.02 6.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.88 7.15 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 126.491 1.916 . . . . 0.0 112.386 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -82.19 -23.09 35.68 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.894 . . . . 0.0 111.977 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -78.07 145.75 35.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.058 1.343 . . . . 0.0 111.289 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 91.6 mtp -155.9 139.22 15.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.47 1.108 . . . . 0.0 109.353 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.405 ' HB3' HD22 ' A' ' 50' ' ' ASN . 37.5 m80 -70.1 157.51 37.43 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.99 -50.59 72.78 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.391 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.3 t -58.69 -36.92 74.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.303 1.041 . . . . 0.0 113.074 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.51 -44.77 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.439 -0.788 . . . . 0.0 112.106 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.41 -41.75 85.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.712 1.596 . . . . 0.0 109.839 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.36 -33.52 72.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.906 1.682 . . . . 0.0 113.401 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.86 -27.4 26.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.533 0.733 . . . . 0.0 111.819 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.91 -57.58 4.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.687 1.595 . . . . 0.0 111.095 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -55.47 -23.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.288 0.635 . . . . 0.0 111.105 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.51 30.77 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.812 0.445 . . . . 0.0 112.066 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -72.12 -23.85 61.38 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.356 -1.465 . . . . 0.0 111.399 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -77.61 -2.63 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.519 2.728 . . . . 0.0 112.389 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.42 47.11 7.0 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.363 1.465 . . . . 0.0 113.487 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.08 118.81 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.558 -1.339 . . . . 0.0 111.741 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -78.44 97.26 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.019 0.928 . . . . 0.0 111.477 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.66 -16.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.289 1.436 . . . . 0.0 113.68 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -75.97 -14.21 60.24 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -81.34 139.46 48.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 O-C-N 120.978 -1.076 . . . . 0.0 112.036 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.88 4.41 7.06 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.894 3.062 . . . . 0.0 115.949 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.39 18.27 5.79 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 127.789 2.614 . . . . 0.0 111.615 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.09 158.71 10.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.948 0.899 . . . . 0.0 113.31 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -120.23 37.17 4.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.5 1.52 . . . . 0.0 111.89 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.64 101.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.418 1.487 . . . . 0.0 110.734 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -147.95 143.73 27.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.673 1.189 . . . . 0.0 112.796 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.6 t -66.37 177.42 1.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.439 2.696 . . . . 0.0 115.169 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -131.32 -10.63 3.67 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.426 2.29 . . . . 0.0 112.65 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.36 -61.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.245 -0.909 . . . . 0.0 109.236 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.7 p -106.45 -9.7 16.58 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.348 2.659 . . . . 0.0 111.194 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.4 t60 63.74 23.53 13.5 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.939 2.495 . . . . 0.0 114.516 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.464 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 16.7 m-85 -79.41 145.04 62.92 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.413 -1.429 . . . . 0.0 113.132 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.28 135.86 56.56 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.012 2.475 . . . . 0.0 110.49 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.9 mm -79.29 113.77 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.892 2.077 . . . . 0.0 108.514 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -126.19 97.56 5.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.753 2.021 . . . . 0.0 110.924 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 130.317 3.447 . . . . 0.0 117.835 -177.051 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.272 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.21 168.3 19.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.119 0.968 . . . . 0.0 110.959 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.7 p -150.81 153.53 35.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.755 1.222 . . . . 0.0 113.485 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.94 133.09 54.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.145 1.378 . . . . 0.0 110.084 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -71.09 -13.25 61.9 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.185 -0.947 . . . . 0.0 113.032 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.01 -41.57 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.296 1.039 . . . . 0.0 111.046 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.26 13.01 4.22 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 55.15 17.46 1.98 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.932 2.093 . . . . 0.0 114.353 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.46 154.6 42.47 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.59 164.58 19.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.393 1.096 . . . . 0.0 110.111 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.82 25.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -92.01 -138.11 0.17 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.657 0.265 . . . . 0.0 111.49 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -130.71 5.38 4.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.776 2.03 . . . . 0.0 111.334 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.34 -10.01 0.96 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.694 3.198 . . . . 0.0 110.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -140.86 61.98 16.2 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 127.271 2.228 . . . . 0.0 114.162 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.1 159.97 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.893 2.395 . . . . 0.0 114.171 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.61 143.0 36.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 112.452 -2.158 . . . . 0.0 110.492 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -156.16 176.93 12.03 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.48 3.112 . . . . 0.0 106.612 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -124.04 117.85 26.96 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 118.253 0.479 . . . . 0.0 110.057 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -81.47 -7.58 12.71 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.72 3.614 . . . . 0.0 112.549 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 30.3 p -152.49 159.25 43.35 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.172 1.789 . . . . 0.0 113.055 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 95' ' ' TYR . 6.2 mtmm -77.12 30.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.264 1.826 . . . . 0.0 113.868 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.32 -14.9 1.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 27.09 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 130.559 3.544 . . . . 0.0 115.826 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.73 30.19 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.853 1.692 . . . . 0.0 112.147 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -62.61 6.43 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.75 6.07 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.549 2.34 . . . . 0.0 112.392 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -78.19 -22.5 48.51 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.081 -1.012 . . . . 0.0 112.002 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -80.29 145.99 31.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.172 1.389 . . . . 0.0 112.26 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.7 mtp -154.77 139.19 16.77 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.041 0.936 . . . . 0.0 110.485 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -66.2 148.07 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.76 -35.3 77.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 122.011 -0.431 . . . . 0.0 110.837 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -79.21 -28.83 42.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.0 m -81.07 -39.78 25.19 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.119 0.967 . . . . 0.0 111.219 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.21 -44.18 92.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.966 1.257 . . . . 0.0 109.277 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.16 -33.91 65.68 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.635 1.174 . . . . 0.0 113.597 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -88.99 -32.7 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.063 0.545 . . . . 0.0 112.244 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -62.24 -49.3 76.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.859 0.864 . . . . 0.0 110.097 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.62 -32.42 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.784 0.72 . . . . 0.0 112.199 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.98 -17.74 62.64 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.557 -0.714 . . . . 0.0 111.747 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -86.26 2.26 47.84 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.247 -0.908 . . . . 0.0 111.891 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -105.0 4.74 31.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.583 1.953 . . . . 0.0 114.046 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 62.98 44.85 5.71 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.566 1.146 . . . . 0.0 112.298 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.72 121.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.64 1.176 . . . . 0.0 110.697 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -80.13 106.91 12.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.283 0.633 . . . . 0.0 109.926 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.9 pt -60.85 -18.02 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.965 1.306 . . . . 0.0 113.907 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -82.09 -13.5 57.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -88.63 141.02 29.87 Favored Pre-proline 0 N--CA 1.481 1.083 0 O-C-N 121.027 -1.046 . . . . 0.0 112.682 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.08 0.83 9.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.03 3.153 . . . . 0.0 116.177 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.49 8.53 34.96 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.957 2.218 . . . . 0.0 112.736 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 168.3 15.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.775 1.23 . . . . 0.0 113.555 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -134.2 52.46 2.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.006 1.723 . . . . 0.0 109.979 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.36 76.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.135 1.774 . . . . 0.0 111.477 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . 0.269 18.5 ttmt -131.04 151.1 51.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.832 2.053 . . . . 0.0 111.631 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 15.3 t -63.98 165.78 8.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 0.0 113.731 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -120.7 3.58 10.63 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.396 1.878 . . . . 0.0 111.911 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -106.87 -55.58 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.513 1.525 . . . . 0.0 108.82 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 16.6 p -105.1 -4.82 21.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 60.77 10.43 2.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.326 2.25 . . . . 0.0 116.027 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 75.2 m-85 -92.44 146.32 32.23 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.464 -1.397 . . . . 0.0 111.611 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -45.33 142.98 5.81 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.853 3.036 . . . . 0.0 113.208 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -104.56 122.77 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.68 1.592 . . . . 0.0 110.596 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.72 122.87 44.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 126.235 1.814 . . . . 0.0 113.977 179.848 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.489 0 N-CA-C 114.141 0.416 . . . . 0.0 114.141 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.61 134.94 40.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.954 0.877 . . . . 0.0 110.059 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.4 p -144.16 153.53 42.21 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 111.488 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.0 t -63.72 127.1 29.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.504 1.122 . . . . 0.0 112.005 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -4.8 22.64 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.0 mt -103.57 -45.24 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.123 1.369 . . . . 0.0 110.226 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -123.69 5.08 8.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.32 31.5 mmt180 50.73 32.41 6.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.17 2.188 . . . . 0.0 115.632 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.3 148.1 18.86 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.29 168.4 18.4 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.834 1.653 . . . . 0.0 112.407 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.67 150.03 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.664 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.4 p -139.18 172.13 13.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.502 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -61.83 -21.93 65.05 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -119.63 -20.94 7.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.428 1.491 . . . . 0.0 112.281 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.97 66.51 47.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.193 1.797 . . . . 0.0 110.499 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.03 -167.93 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 1 C-N-CA 125.435 4.09 . . . . 0.0 111.113 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.7 mt -132.77 155.57 48.67 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.724 1.61 . . . . 0.0 111.868 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -153.92 -179.61 8.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.786 2.434 . . . . 0.0 108.122 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -129.24 110.42 18.03 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.579 0.752 . . . . 0.0 111.146 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.63 -17.42 12.61 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.577 2.851 . . . . 0.0 113.57 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 4.1 t -133.55 -161.55 1.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 112.067 -165.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -123.14 12.79 9.62 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.734 1.614 . . . . 0.0 114.717 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -44.62 -25.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.222 2.609 . . . . 0.0 116.703 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 65.18 159.36 0.11 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.933 3.293 . . . . 0.0 115.599 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.47 -157.63 19.34 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.09 0.852 . . . . 0.0 113.599 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.1 p -59.48 -18.41 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.5 pt -84.79 -7.57 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.755 1.161 . . . . 0.0 113.601 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -76.06 -18.74 59.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.154 1.343 . . . . 0.0 113.535 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -84.53 143.34 29.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.359 1.064 . . . . 0.0 112.285 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 81.6 mtp -156.62 143.03 18.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.363 1.465 . . . . 0.0 109.793 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -76.35 154.51 34.92 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.14 -46.45 82.69 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.272 -0.892 . . . . 0.0 111.911 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -64.36 -42.97 95.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.002 0.921 . . . . 0.0 111.949 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.3 m -61.79 -43.88 97.97 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.173 -0.955 . . . . 0.0 111.751 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.71 -47.88 83.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.88 0.764 . . . . 0.0 109.811 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.08 -29.49 60.65 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.97 -38.33 18.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.415 1.086 . . . . 0.0 111.577 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.78 -48.19 77.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.199 1.0 . . . . 0.0 111.731 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.89 -28.96 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.656 -0.653 . . . . 0.0 111.691 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.52 71.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.013 0.525 . . . . 0.0 111.429 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 p -66.91 -14.24 62.57 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.744 -1.223 . . . . 0.0 113.305 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.31 3.66 20.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.689 1.596 . . . . 0.0 112.796 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.254 10.2 t30 64.47 42.73 4.88 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.35 147.48 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.069 1.348 . . . . 0.0 110.547 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -125.89 111.57 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.269 1.428 . . . . 0.0 111.083 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.98 -18.75 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.014 1.326 . . . . 0.0 113.777 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -77.28 -7.62 56.27 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.67 150.94 44.81 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.64 1.576 . . . . 0.0 112.397 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.9 14.96 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.128 3.219 . . . . 0.0 115.89 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.95 4.3 38.87 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.511 2.005 . . . . 0.0 112.757 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 145.45 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.352 1.061 . . . . 0.0 113.18 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.03 40.94 0.73 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.309 1.844 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -66.26 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.568 1.547 . . . . 0.0 113.169 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.5 tttm -145.74 146.62 31.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.292 1.837 . . . . 0.0 111.378 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -63.4 175.72 0.95 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.599 2.36 . . . . 0.0 115.903 -174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -130.42 -4.06 4.29 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.599 2.36 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.6 -66.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.011 -1.055 . . . . 0.0 108.437 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.27 -8.84 21.76 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.206 2.602 . . . . 0.0 110.947 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' HE2' ' A' ' 89' ' ' LYS . 72.3 m80 64.07 24.0 13.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.162 2.185 . . . . 0.0 114.38 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 18.7 m-85 -79.72 145.75 63.17 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -61.03 142.28 96.9 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.853 2.369 . . . . 0.0 110.045 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.48 130.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 124.662 1.185 . . . . 0.0 111.306 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -119.05 107.92 14.09 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.024 1.729 . . . . 0.0 111.49 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.548 0.895 0 C-N-CA 126.527 1.931 . . . . 0.0 113.611 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.015 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.26 57.76 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.63 2.215 . . . . 0.0 111.18 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.9 p -145.42 152.31 39.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.395 0.678 . . . . 0.0 112.739 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.74 131.84 35.52 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.635 1.174 . . . . 0.0 110.62 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.11 64.7 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.739 -1.226 . . . . 0.0 111.503 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -92.49 -42.01 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.339 1.055 . . . . 0.0 110.57 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . 0.257 29.2 p -124.79 9.26 8.23 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 50.53 29.01 3.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.284 2.233 . . . . 0.0 112.888 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.43 140.22 14.88 Favored Glycine 0 N--CA 1.467 0.74 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.269 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.1 171.0 0.78 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.16 1.384 . . . . 0.0 114.718 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 141.15 57.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.69 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 p -130.08 155.36 46.3 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.065 0.936 . . . . 0.0 112.695 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.03 -11.79 0.1 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -128.28 -15.98 4.54 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.537 1.535 . . . . 0.0 112.921 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.45 HD22 ' CG ' ' A' ' 66' ' ' HIS . 36.3 t30 -150.69 74.62 8.66 Favored Pre-proline 0 N--CA 1.44 -0.93 0 C-N-CA 125.511 1.524 . . . . 0.0 109.483 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.22 -158.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.312 4.008 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mt -129.8 156.67 43.96 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 123.037 1.398 . . . . 0.0 111.532 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -154.04 177.14 11.39 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 129.463 3.105 . . . . 0.0 107.739 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -124.63 98.1 37.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.724 0.809 . . . . 0.0 108.86 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.25 -15.45 20.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.806 2.338 . . . . 0.0 112.732 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 0.4 OUTLIER -151.85 157.39 41.83 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 124.262 1.025 . . . . 0.0 112.433 -169.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -85.28 20.99 1.82 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.4 m -47.97 -14.39 0.05 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 126.582 1.953 . . . . 0.0 114.785 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttp-105 58.25 173.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.231 3.412 . . . . 0.0 115.26 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.63 -161.59 26.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.775 -1.203 . . . . 0.0 112.981 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.7 p -65.04 -24.15 67.4 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.494 -1.003 . . . . 0.0 113.194 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 pt -74.9 -3.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -74.17 -20.07 60.34 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.486 1.039 . . . . 0.0 112.684 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -90.3 139.93 30.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.433 1.093 . . . . 0.0 113.661 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 mtt -151.83 142.94 23.21 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.563 0.745 . . . . 0.0 111.973 -174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.45 ' CG ' HD22 ' A' ' 50' ' ' ASN . 23.5 m170 -70.1 149.5 47.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.177 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.53 -33.98 77.17 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.719 -0.613 . . . . 0.0 110.681 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.1 m -73.82 -42.94 60.17 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.758 -0.589 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.0 m -64.59 -43.5 93.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.916 1.287 . . . . 0.0 112.524 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.14 -44.05 97.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.386 0.994 . . . . 0.0 110.088 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.02 -28.84 59.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.257 1.023 . . . . 0.0 113.531 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -91.05 -37.0 13.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.281 1.432 . . . . 0.0 111.166 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.449 ' CE2' ' HE3' ' A' ' 77' ' ' LYS . 88.8 t90 -60.55 -51.74 68.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.49 -34.14 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.422 -0.799 . . . . 0.0 111.437 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.51 78.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.983 -0.448 . . . . 0.0 111.408 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -71.02 -30.87 67.21 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.967 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.449 ' HE3' ' CE2' ' A' ' 73' ' ' TRP . 56.1 mmtt -81.05 8.38 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.496 2.718 . . . . 0.0 113.736 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER 75.68 16.51 2.48 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.4 2.28 . . . . 0.0 115.528 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.73 139.46 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.079 1.352 . . . . 0.0 111.41 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -130.08 112.97 13.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 0.0 112.998 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.2 pt -67.49 -17.87 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 113.94 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -71.77 -13.04 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.12 143.66 27.19 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.698 1.199 . . . . 0.0 111.53 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.68 16.77 1.23 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.049 3.166 . . . . 0.0 116.272 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.25 7.03 25.0 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.536 2.017 . . . . 0.0 112.805 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.8 55.81 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.286 1.034 . . . . 0.0 113.286 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.5 41.08 1.59 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.392 1.877 . . . . 0.0 110.141 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.67 107.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.712 2.405 . . . . 0.0 114.13 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -148.38 144.95 27.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.147 1.779 . . . . 0.0 110.949 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 43.1 t -66.56 170.87 5.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.548 2.339 . . . . 0.0 114.715 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.79 -17.8 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.193 2.597 . . . . 0.0 111.808 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.2 -55.69 11.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.105 . . . . 0.0 109.578 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.9 p -115.85 -7.07 12.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.977 0.511 . . . . 0.0 111.894 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 68.89 18.03 8.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.518 2.327 . . . . 0.0 114.678 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.8 m-85 -82.75 145.31 50.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 120.817 -1.177 . . . . 0.0 111.966 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.37 132.19 39.86 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.577 2.185 . . . . 0.0 109.85 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -85.22 116.02 27.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 126.255 1.822 . . . . 0.0 108.854 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -114.26 111.94 22.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -170.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 126.994 2.118 . . . . 0.0 111.915 176.047 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.494 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.92 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.4 147.93 30.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.309 1.555 . . . . 0.0 109.962 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 57.1 p -141.49 145.36 35.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.033 1.333 . . . . 0.0 112.652 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 69' ' ' CYS . 18.8 t -58.33 140.17 53.95 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.941 1.296 . . . . 0.0 114.246 174.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.1 mt -99.22 -48.16 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 110.502 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.4 m -107.38 -4.64 18.37 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 49.34 31.23 3.67 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.234 2.214 . . . . 0.0 112.385 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.64 141.59 16.18 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.297 0.951 . . . . 0.0 112.627 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.76 160.43 11.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.922 1.289 . . . . 0.0 113.554 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.48 144.26 51.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.519 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.7 p -128.35 157.69 40.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.313 1.054 . . . . 0.0 112.636 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -57.72 -11.59 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.63 -21.77 5.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.432 1.493 . . . . 0.0 111.475 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.464 HD22 ' HB3' ' A' ' 66' ' ' HIS . 35.6 t30 -141.02 67.48 27.14 Favored Pre-proline 0 N--CA 1.444 -0.747 0 C-N-CA 124.118 0.967 . . . . 0.0 113.49 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -49.75 167.74 0.18 Allowed 'Trans proline' 0 C--O 1.235 0.371 1 C-N-CA 125.5 4.133 . . . . 0.0 116.928 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.62 142.33 44.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.177 173.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -152.75 -177.49 6.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.671 1.988 . . . . 0.0 108.765 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -114.99 108.23 48.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.841 0.856 . . . . 0.0 110.354 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.85 -18.82 16.67 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.622 2.881 . . . . 0.0 112.764 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.281 5.1 t -141.15 -161.33 1.2 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 129.678 3.191 . . . . 0.0 106.889 -167.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 59' ' ' ARG . 70.5 mmtt -95.11 -41.58 9.03 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.255 169.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.321 6.2 m 40.97 -5.47 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 1 C-N-CA 132.309 4.244 . . . . 0.0 119.298 -173.26 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 57' ' ' LYS . 25.8 tpt180 45.52 67.9 0.66 Allowed 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 131.78 4.032 . . . . 0.0 117.743 173.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.93 -174.19 31.01 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 125.942 1.734 . . . . 0.0 111.844 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -55.83 -23.92 33.34 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.215 1.008 . . . . 0.0 111.854 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -61.98 -14.62 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 113.498 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -70.36 -5.91 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.768 -1.207 . . . . 0.0 114.02 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -97.48 138.95 34.12 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.727 1.211 . . . . 0.0 110.724 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 83.3 mtp -158.35 145.89 18.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.606 1.562 . . . . 0.0 109.684 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.464 ' HB3' HD22 ' A' ' 50' ' ' ASN . 44.5 m80 -69.99 151.53 45.47 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.26 -38.88 77.81 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.749 -0.594 . . . . 0.0 110.712 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -81.32 -31.62 33.44 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -76.03 -41.05 52.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.411 1.101 . . . . 0.0 112.245 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.86 -49.85 74.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.708 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 mt -55.14 -35.39 64.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.423 1.089 . . . . 0.0 112.748 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.49 -37.67 27.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.216 0.462 . . . . 0.0 112.096 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -62.91 -51.02 68.56 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.681 -0.637 . . . . 0.0 110.715 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.78 -31.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.938 0.79 . . . . 0.0 112.331 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.66 -20.21 61.29 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.088 -0.382 . . . . 0.0 111.868 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -80.57 -5.02 56.16 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.804 -1.185 . . . . 0.0 111.867 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -92.11 9.85 31.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.611 1.964 . . . . 0.0 114.049 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 79.61 9.3 1.56 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.816 2.046 . . . . 0.0 113.844 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mt -109.89 124.22 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 111.342 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -87.4 82.33 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.174 0.988 . . . . 0.0 111.099 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -9.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 113.818 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.7 t -65.9 -25.77 67.32 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.15 -0.344 . . . . 0.0 110.977 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -92.52 143.55 27.4 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.521 1.128 . . . . 0.0 110.545 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.47 9.24 2.62 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.687 2.925 . . . . 0.0 116.624 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.3 -9.44 69.88 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.524 1.535 . . . . 0.0 113.32 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.59 150.2 49.1 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.203 1.001 . . . . 0.0 112.741 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.57 49.7 1.22 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.137 1.775 . . . . 0.0 109.839 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.01 131.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 126.234 1.814 . . . . 0.0 111.982 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -142.87 144.16 32.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.962 1.705 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 17.5 t -59.04 169.54 1.04 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.974 2.109 . . . . 0.0 115.743 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -127.76 -8.09 5.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.541 2.736 . . . . 0.0 112.041 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.3 mt -89.91 -56.28 5.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 124.022 0.929 . . . . 0.0 108.784 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.03 -1.76 11.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.017 0.927 . . . . 0.0 111.708 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 70.6 m80 61.31 16.74 7.64 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.896 2.078 . . . . 0.0 115.164 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.9 m-85 -77.03 144.24 71.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 120.848 -1.157 . . . . 0.0 111.297 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -57.67 148.82 71.8 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.402 2.068 . . . . 0.0 109.988 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.45 135.55 56.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 124.078 0.951 . . . . 0.0 110.78 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -121.96 125.59 46.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.216 1.006 . . . . 0.0 110.842 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -173.032 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 112.855 -0.098 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.13 162.93 27.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.482 0.713 . . . . 0.0 112.071 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -149.87 160.78 43.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.033 1.333 . . . . 0.0 113.55 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.1 t -69.12 125.16 25.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.18 1.792 . . . . 0.0 112.822 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -10.32 56.06 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.259 -0.901 . . . . 0.0 113.136 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 mt -91.77 -46.18 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 125.097 1.359 . . . . 0.0 109.668 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -125.73 3.22 7.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 59.25 31.27 21.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.736 2.015 . . . . 0.0 113.815 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 144.89 17.14 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.87 169.32 10.01 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.159 0.981 . . . . 0.0 111.685 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.74 53.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.8 p -114.94 168.56 9.8 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.112 0.958 . . . . 0.0 111.797 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.56 -19.31 37.0 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -121.49 -17.85 7.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 110.92 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.57 58.0 16.1 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.15 145.31 26.45 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.506 2.137 . . . . 0.0 111.919 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.38 175.58 9.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.136 -2.302 . . . . 0.0 109.92 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.4 175.47 2.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.215 2.206 . . . . 0.0 109.035 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -112.16 95.46 30.36 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.507 1.123 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.08 -30.4 16.35 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.689 2.26 . . . . 0.0 111.688 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.9 t -135.37 -178.99 5.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.836 2.854 . . . . 0.0 110.446 -171.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.62 36.13 4.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.639 1.976 . . . . 0.0 113.419 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.5 m -51.6 -8.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.634 2.374 . . . . 0.0 116.519 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 65.64 175.5 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.875 2.07 . . . . 0.0 114.493 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.12 -150.5 1.01 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.478 1.513 . . . . 0.0 115.538 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -75.47 -1.79 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.788 1.235 . . . . 0.0 113.872 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.7 pt -97.78 -0.61 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.915 1.286 . . . . 0.0 113.91 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -83.61 5.57 23.86 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.47 143.24 45.26 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.673 1.589 . . . . 0.0 109.281 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.7 mtp -154.32 140.3 18.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.641 1.176 . . . . 0.0 111.084 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -70.22 144.57 51.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.049 0.94 . . . . 0.0 110.091 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.98 12.95 1.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 113.545 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -129.84 -40.38 1.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.129 1.372 . . . . 0.0 109.048 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.7 m -59.69 -47.85 83.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.641 1.176 . . . . 0.0 111.332 172.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -56.0 -44.33 78.54 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.275 0.63 . . . . 0.0 110.381 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.17 -22.62 61.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.856 1.262 . . . . 0.0 112.869 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.63 -39.89 8.87 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.828 1.651 . . . . 0.0 111.321 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.4 ' CZ2' ' HE2' ' A' ' 77' ' ' LYS . 91.9 t90 -56.38 -47.55 78.71 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.099 1.36 . . . . 0.0 111.416 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.9 m -66.7 -25.34 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 119.141 0.882 . . . . 0.0 111.817 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.77 -38.42 76.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.115 -0.366 . . . . 0.0 110.591 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 p -69.06 -18.64 64.03 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.068 -1.02 . . . . 0.0 113.605 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HE2' ' CZ2' ' A' ' 73' ' ' TRP . 35.7 mmtm -75.32 6.15 4.81 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.063 2.145 . . . . 0.0 113.619 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.262 9.3 t30 66.07 43.96 2.78 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.599 1.56 . . . . 0.0 111.601 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -138.48 140.79 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 109.312 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -117.9 99.58 7.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.411 1.085 . . . . 0.0 111.703 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.2 pt -63.51 -15.9 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.365 1.466 . . . . 0.0 113.881 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -68.75 -23.79 64.37 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.236 0.614 . . . . 0.0 112.084 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -107.18 148.78 37.71 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 125.333 1.453 . . . . 0.0 112.381 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.1 27.7 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.633 3.556 . . . . 0.0 114.673 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.83 -1.86 30.4 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.462 1.982 . . . . 0.0 112.314 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.79 43.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.172 0.989 . . . . 0.0 112.672 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -150.78 46.69 0.86 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.061 1.744 . . . . 0.0 109.741 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.72 109.34 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.999 1.32 . . . . 0.0 113.009 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -143.11 140.21 30.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.383 1.873 . . . . 0.0 110.003 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.6 168.11 2.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.058 2.143 . . . . 0.0 115.19 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -122.97 -7.99 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.543 2.337 . . . . 0.0 111.919 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -88.16 -57.29 4.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.659 1.184 . . . . 0.0 108.46 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.4 p -110.99 -6.88 14.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.104 0.562 . . . . 0.0 111.749 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.254 73.9 m80 64.44 19.25 11.73 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.706 2.002 . . . . 0.0 114.305 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.446 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.5 m-85 -82.11 145.02 51.87 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.056 -1.027 . . . . 0.0 111.413 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.53 153.0 69.64 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.811 1.674 . . . . 0.0 109.256 168.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.15 141.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.902 0.858 . . . . 0.0 110.092 -173.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -113.89 121.84 45.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.819 1.248 . . . . 0.0 111.101 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -176.296 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.601 0 CA-C-O 119.607 -0.552 . . . . 0.0 114.293 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.02 161.99 30.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.667 1.234 . . . . 0.0 108.481 172.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.7 p -148.3 148.7 30.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.073 0.949 . . . . 0.0 113.225 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.43 127.93 34.15 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.461 1.904 . . . . 0.0 110.751 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -14.85 62.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.4 mt -96.64 -52.8 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.513 1.125 . . . . 0.0 110.346 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.53 -16.66 36.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 54.95 38.71 30.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.454 1.502 . . . . 0.0 110.445 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.36 156.25 22.31 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 122.802 1.223 . . . . 0.0 111.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -63.44 166.87 6.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 126.669 1.988 . . . . 0.0 115.932 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 158.41 28.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.721 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.6 p -137.27 160.09 40.03 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.281 1.039 . . . . 0.0 113.113 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.92 -9.27 3.95 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.85 -27.55 4.26 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.632 1.573 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -138.07 67.05 47.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.0 176.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 126.82 5.013 . . . . 0.0 117.75 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.01 145.49 43.64 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.92 172.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -156.39 -176.49 5.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.536 2.334 . . . . 0.0 109.632 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -119.49 102.4 47.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.302 1.041 . . . . 0.0 113.571 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.63 -33.52 1.25 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.102 1.201 . . . . 0.0 113.082 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 12.0 p -147.18 150.31 34.67 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.638 1.975 . . . . 0.0 110.165 -170.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 12.1 mptt -84.05 28.27 0.62 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.456 -1.247 . . . . 0.0 114.169 -174.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.46 87.91 5.06 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 161.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.433 ' H ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -175.81 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 3 C-N-CA 141.81 8.044 . . . . 0.0 112.122 1.415 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.6 -139.43 6.11 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.067 1.794 . . . . 0.0 109.624 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -54.01 -29.1 42.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 119.563 1.682 . . . . 0.0 111.775 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 pt -62.59 -9.1 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.121 1.768 . . . . 0.0 113.316 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 59' ' ' ARG . 16.5 pttt -82.13 0.33 41.3 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.339 -0.851 . . . . 0.0 112.012 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.61 139.18 31.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.36 1.464 . . . . 0.0 108.751 171.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.5 ttp -161.6 145.45 12.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.828 0.851 . . . . 0.0 110.438 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -67.84 154.89 40.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.372 0.533 . . . . 0.0 110.787 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.79 -45.42 92.38 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.277 -0.889 . . . . 0.0 109.638 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 p -54.98 -54.34 44.13 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.982 0.913 . . . . 0.0 112.375 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.6 -36.99 84.53 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.376 1.47 . . . . 0.0 112.747 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.2 tp -66.3 -47.02 74.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.13 1.332 . . . . 0.0 110.723 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.57 -32.74 70.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.187 1.795 . . . . 0.0 111.92 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -79.6 -41.09 27.84 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 128.076 2.55 . . . . 0.0 111.199 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -62.28 -50.77 70.36 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.998 -1.064 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.46 -32.13 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.794 0.724 . . . . 0.0 110.605 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.09 93.13 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.593 -0.692 . . . . 0.0 109.983 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -61.65 -16.27 47.17 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.594 -1.316 . . . . 0.0 113.462 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.84 3.75 50.12 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.142 1.777 . . . . 0.0 112.586 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.252 10.1 t30 64.62 44.09 4.06 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.114 1.365 . . . . 0.0 112.375 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -135.61 142.22 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.762 1.225 . . . . 0.0 110.424 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -108.77 100.43 9.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.811 1.244 . . . . 0.0 109.422 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.27 -11.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 t -76.99 -21.42 54.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.179 0.592 . . . . 0.0 112.048 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.89 144.34 90.39 Favored Pre-proline 0 N--CA 1.475 0.821 0 O-C-N 120.985 -1.072 . . . . 0.0 111.558 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.38 7.03 3.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.642 2.894 . . . . 0.0 116.768 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.02 -3.08 34.02 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.451 1.977 . . . . 0.0 112.519 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.42 127.83 34.41 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.285 1.042 . . . . 0.0 111.755 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.36 40.92 1.61 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.219 1.808 . . . . 0.0 109.8 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.18 124.78 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.341 2.256 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -139.16 131.35 28.18 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.468 1.507 . . . . 0.0 110.625 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.9 t -66.47 126.91 30.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.49 -21.53 41.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.13 -66.69 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.625 1.17 . . . . 0.0 111.338 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 30.0 p -83.39 -18.99 36.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 111.423 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 21.7 t60 79.79 1.43 2.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.332 3.053 . . . . 0.0 112.609 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 57' ' ' LYS . 53.6 m-85 -83.89 131.2 52.36 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.402 -1.436 . . . . 0.0 112.098 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.46 145.83 66.31 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.314 3.343 . . . . 0.0 111.44 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 mm -74.12 107.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 122.233 1.016 . . . . 0.0 109.39 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -99.89 85.82 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 113.198 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 125.086 1.354 . . . . 0.0 111.019 176.89 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 CA-C-O 119.946 -0.363 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.94 -175.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 111.525 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 p -160.53 172.96 16.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 112.016 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -84.89 127.25 34.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.769 1.228 . . . . 0.0 107.698 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -20.63 66.47 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.157 1.344 . . . . 0.0 112.945 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.2 mt -79.94 -43.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 117.542 -1.218 . . . . 0.0 109.503 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.36 -2.18 8.54 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.322 38.8 mmt180 52.3 45.86 27.7 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.2 1.8 . . . . 0.0 111.413 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.43 134.23 12.04 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 111.643 -2.526 . . . . 0.0 110.422 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.36 155.07 41.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.874 0.845 . . . . 0.0 110.955 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.9 156.36 2.91 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -128.65 173.36 10.36 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.36 1.076 . . . . 0.0 113.042 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.42 5.01 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.853 1.798 . . . . 0.0 115.853 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -145.98 -28.85 0.42 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.367 1.467 . . . . 0.0 111.636 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -127.69 67.84 73.48 Favored Pre-proline 0 N--CA 1.44 -0.941 0 C-N-CA 125.657 1.583 . . . . 0.0 110.231 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.34 -171.42 1.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.074 3.849 . . . . 0.0 112.109 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.72 142.09 46.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 110.87 -2.877 . . . . 0.0 109.359 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -158.0 -166.65 2.02 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 128.359 2.664 . . . . 0.0 107.738 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.54 107.79 14.48 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.247 1.019 . . . . 0.0 112.5 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.15 -18.6 9.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.878 3.052 . . . . 0.0 113.743 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 9.8 t -143.43 171.68 13.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.269 2.228 . . . . 0.0 110.142 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -83.28 20.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 129.681 3.193 . . . . 0.0 113.784 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -12.26 0.18 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 55.23 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 130.534 3.534 . . . . 0.0 120.068 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 62' ' ' ILE . . . -86.35 -175.91 49.69 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.342 1.428 . . . . 0.0 113.52 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -69.12 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.409 ' H ' ' C ' ' A' ' 60' ' ' GLY . 2.1 pp -118.73 -28.1 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.748 2.419 . . . . 0.0 108.704 171.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -54.05 -29.11 42.74 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.263 1.392 . . . . 0.0 113.585 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.34 134.17 49.88 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.707 1.241 . . . . 0.0 111.839 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.4 mtt -157.69 143.81 17.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.214 1.405 . . . . 0.0 109.706 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -69.0 155.38 40.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.567 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.97 -52.27 66.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.483 -0.76 . . . . 0.0 110.564 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -60.31 -45.46 93.32 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.562 -0.711 . . . . 0.0 112.313 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.1 -44.77 91.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.731 0.696 . . . . 0.0 112.07 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.05 -47.06 87.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.964 0.802 . . . . 0.0 110.141 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.64 -28.03 66.87 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.965 0.906 . . . . 0.0 112.787 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -85.65 -34.02 21.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.865 0.866 . . . . 0.0 111.723 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -58.81 -59.05 6.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 109.951 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.84 -23.52 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 111.811 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.0 -0.44 55.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.2 m -113.5 -5.4 13.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.99 1.716 . . . . 0.0 111.811 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -80.28 6.0 13.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.701 2.8 . . . . 0.0 114.691 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.318 0.0 OUTLIER 76.34 32.15 0.59 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.684 1.593 . . . . 0.0 111.518 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -142.08 159.77 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.748 2.019 . . . . 0.0 109.795 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -132.83 112.98 12.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.534 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.8 pt -61.23 -17.68 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.231 1.412 . . . . 0.0 114.452 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -74.36 -26.78 60.34 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.204 0.456 . . . . 0.0 111.873 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.83 145.31 83.95 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 121.263 -0.898 . . . . 0.0 112.734 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -79.86 27.42 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.54 3.493 . . . . 0.0 114.948 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.47 20.99 3.66 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.167 2.318 . . . . 0.0 111.188 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.81 131.8 38.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.755 0.822 . . . . 0.0 112.743 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -145.62 55.78 1.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.575 1.95 . . . . 0.0 108.6 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -71.55 37.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.818 2.047 . . . . 0.0 116.024 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -58.44 141.91 50.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.699 2.8 . . . . 0.0 113.005 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 46.9 t -60.33 116.51 4.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.556 1.942 . . . . 0.0 110.759 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -78.11 13.97 1.3 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.65 -47.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.86 1.264 . . . . 0.0 110.502 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -116.44 -9.31 11.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.187 1.795 . . . . 0.0 111.816 -174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.277 78.4 m-70 65.4 31.31 10.45 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.972 2.109 . . . . 0.0 115.823 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.507 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.6 m-85 -106.96 138.19 19.74 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.868 1.267 . . . . 0.0 112.552 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.94 135.55 71.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.394 2.063 . . . . 0.0 110.31 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.1 mm -74.93 136.98 23.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.029 0.932 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -123.98 88.2 2.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.597 1.189 . . . . 0.0 113.503 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 C-N-CA 126.223 1.809 . . . . 0.0 110.137 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.558 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.86 152.67 45.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.884 1.274 . . . . 0.0 110.244 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 79.0 p -143.91 153.1 41.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.738 1.215 . . . . 0.0 112.333 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 t -59.91 127.19 30.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.482 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -14.0 61.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 112.899 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.08 -46.28 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.3 p -113.8 -7.33 13.24 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.315 31.2 mmt180 57.22 44.72 21.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.063 1.345 . . . . 0.0 112.552 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.96 16.49 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 172.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.0 172.43 4.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.45 1.1 . . . . 0.0 111.764 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.84 161.81 23.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.538 0.685 . . . . 0.0 109.637 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.4 p -136.93 166.78 22.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.208 0.603 . . . . 0.0 111.108 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.43 -22.25 64.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.71 -27.77 10.1 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.078 1.751 . . . . 0.0 111.376 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.444 HD22 ' HB3' ' A' ' 66' ' ' HIS . 58.1 t30 -137.27 66.9 53.51 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.51 173.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.546 4.164 . . . . 0.0 116.364 172.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.3 mt -110.24 146.01 36.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.105 -1.861 . . . . 0.0 110.49 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.46 -177.9 6.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.074 2.149 . . . . 0.0 108.827 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -126.12 118.01 23.67 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.929 0.892 . . . . 0.0 109.201 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.68 -26.41 7.01 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.108 2.538 . . . . 0.0 111.575 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.58 -152.71 0.51 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 128.326 2.65 . . . . 0.0 110.962 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 6.1 mmtt -119.66 13.35 12.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.549 1.939 . . . . 0.0 113.69 -174.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 m -44.35 -17.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -174.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? 38.99 34.55 0.1 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 129.11 2.964 . . . . 0.0 118.435 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.33 28.36 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.602 1.096 . . . . 0.0 114.642 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.5 p -64.19 9.42 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.475 1.51 . . . . 0.0 114.437 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.02 12.33 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.559 2.343 . . . . 0.0 110.22 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -90.26 -21.87 21.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 113.214 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -79.85 140.36 36.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.967 1.307 . . . . 0.0 111.597 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.0 mtp -154.61 143.04 20.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.671 1.188 . . . . 0.0 110.527 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.444 ' HB3' HD22 ' A' ' 50' ' ' ASN . 42.8 m80 -76.11 158.45 31.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.2 -46.91 88.52 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.243 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 m -65.1 -48.55 73.28 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.654 0.782 . . . . 0.0 111.613 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.62 -39.44 88.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.955 -1.09 . . . . 0.0 111.603 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.03 -49.89 75.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.043 1.747 . . . . 0.0 109.815 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.9 -30.7 68.0 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 113.447 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.46 -34.65 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.001 2.52 . . . . 0.0 112.225 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -70.6 -52.84 18.7 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.449 1.1 . . . . 0.0 109.156 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.4 m -58.88 -30.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.989 0.813 . . . . 0.0 110.573 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.18 75.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.34 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 t -60.92 -30.96 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.709 -1.244 . . . . 0.0 111.591 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.63 8.67 7.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.721 2.808 . . . . 0.0 114.025 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.286 0.0 OUTLIER 74.7 18.99 2.65 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.907 2.083 . . . . 0.0 115.531 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.92 141.69 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -129.79 113.39 14.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.027 1.331 . . . . 0.0 111.533 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -21.07 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.592 1.557 . . . . 0.0 114.003 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -75.3 -16.98 60.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.795 0.838 . . . . 0.0 112.888 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.89 142.15 51.92 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 120.928 -1.108 . . . . 0.0 113.252 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.48 17.74 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.571 3.514 . . . . 0.0 115.314 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.98 16.15 5.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.369 2.414 . . . . 0.0 111.541 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.14 147.89 42.51 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.525 0.73 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.19 39.93 0.93 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.853 1.661 . . . . 0.0 110.366 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -53.77 116.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.284 1.834 . . . . 0.0 113.084 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -148.75 147.21 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.843 1.657 . . . . 0.0 111.473 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.8 t -64.03 172.18 2.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.53 1.532 . . . . 0.0 113.76 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -129.74 0.49 4.89 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.764 2.025 . . . . 0.0 112.673 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -105.04 -65.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.1 p -92.74 -9.37 40.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.612 1.965 . . . . 0.0 111.078 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.343 4.3 p-80 58.7 16.72 4.58 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.163 2.585 . . . . 0.0 115.905 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.475 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 28.7 m-85 -81.59 143.78 51.64 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 120.018 1.281 . . . . 0.0 113.232 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.02 136.03 29.49 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.895 3.063 . . . . 0.0 111.772 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -82.79 124.33 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.894 1.278 . . . . 0.0 109.988 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.86 93.22 4.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.323 1.449 . . . . 0.0 112.159 -175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.475 1.11 . . . . 0.0 111.226 176.203 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 170.85 6.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.665 1.186 . . . . 0.0 111.892 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.3 p -150.34 165.82 31.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.99 1.316 . . . . 0.0 112.135 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.41 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 39.1 t -75.62 120.97 21.75 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 114.336 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -9.17 13.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.57 1.148 . . . . 0.0 113.186 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.41 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 57.5 mt -99.26 -42.05 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.109 1.364 . . . . 0.0 110.831 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.77 12.42 4.03 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 53.75 19.39 1.84 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.681 2.793 . . . . 0.0 115.488 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.52 144.94 25.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.56 173.85 8.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 110.404 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.06 157.41 22.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.416 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.3 p -127.05 165.23 19.88 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.48 1.133 . . . . 0.0 112.407 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -61.51 -15.7 40.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.01 -24.28 2.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.129 0.972 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -136.59 71.72 58.09 Favored Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 124.753 1.221 . . . . 0.0 111.324 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.92 -160.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 124.499 3.466 . . . . 0.0 109.291 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mt -120.05 141.86 49.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.093 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -144.76 173.85 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 110.877 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -113.98 101.87 54.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.552 1.141 . . . . 0.0 112.381 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.68 -36.1 8.91 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.97 1.78 . . . . 0.0 111.443 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.9 t -119.7 -164.26 1.05 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 129.07 2.948 . . . . 0.0 112.294 -166.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -116.11 1.44 13.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.98 2.512 . . . . 0.0 115.247 -172.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 m -34.15 -48.69 0.33 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.598 2.359 . . . . 0.0 114.944 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 109.5 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 1 C-N-CA 132.925 4.49 . . . . 0.0 112.052 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 18.72 -109.98 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 129.213 3.292 . . . . 0.0 117.643 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -55.51 -5.26 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -174.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.94 19.41 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.85 1.659 . . . . 0.0 111.165 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -100.28 -53.56 3.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.705 1.202 . . . . 0.0 109.72 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -46.48 142.3 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.591 1.956 . . . . 0.0 112.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.1 mtt -159.64 150.57 19.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.474 1.51 . . . . 0.0 111.55 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -74.82 150.94 39.11 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -56.47 -42.32 78.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.822 1.192 . . . . 0.0 111.328 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.0 p -61.22 -46.29 91.05 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.372 1.469 . . . . 0.0 112.631 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.4 m -64.78 -40.13 94.75 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 112.292 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.58 -47.72 84.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.65 1.114 . . . . 0.0 110.289 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.45 -31.05 63.6 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.186 2.194 . . . . 0.0 113.268 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -92.46 -35.48 13.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.912 1.285 . . . . 0.0 112.143 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -62.97 -48.25 79.68 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.651 0.78 . . . . 0.0 111.04 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.87 -27.22 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.986 0.812 . . . . 0.0 111.585 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.39 90.25 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.76 -0.587 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.7 p -67.72 -1.66 5.68 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.92 8.63 44.8 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.037 1.29 . . . . 0.0 111.676 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 80.9 30.1 0.17 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.658 2.383 . . . . 0.0 113.296 178.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.25 145.94 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.494 1.118 . . . . 0.0 112.807 -170.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -139.43 111.31 7.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.093 1.357 . . . . 0.0 110.564 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 pt -63.91 -16.54 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.498 1.119 . . . . 0.0 113.321 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -82.11 0.18 41.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.462 1.105 . . . . 0.0 113.462 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -126.77 151.03 72.96 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.697 1.599 . . . . 0.0 112.418 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.38 27.69 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.75 3.633 . . . . 0.0 115.268 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.41 5.54 11.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.952 2.215 . . . . 0.0 112.084 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 144.7 53.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.432 1.093 . . . . 0.0 113.17 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.66 38.41 0.68 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.898 1.679 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.77 99.08 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 126.212 1.805 . . . . 0.0 114.246 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -150.88 142.84 23.94 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.399 2.279 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.5 t -67.15 177.78 1.68 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.231 2.612 . . . . 0.0 116.063 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -132.52 -3.8 3.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.762 2.425 . . . . 0.0 112.769 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mt -86.31 -71.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.788 -1.195 . . . . 0.0 107.854 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 7.9 p -88.03 -15.37 36.53 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.844 2.458 . . . . 0.0 110.574 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.4 m80 69.66 17.5 7.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.907 2.483 . . . . 0.0 113.11 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.422 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 10.3 m-85 -76.19 146.65 78.65 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.46 149.21 76.28 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.228 2.619 . . . . 0.0 111.276 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.63 140.76 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.665 1.186 . . . . 0.0 109.906 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -135.64 137.2 41.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.144 0.974 . . . . 0.0 112.877 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.871 1.269 . . . . 0.0 113.287 179.829 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 93.54 129.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 131.43 3.892 . . . . 0.0 112.854 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.3 p -136.01 150.39 49.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.832 2.853 . . . . 0.0 114.393 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.439 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 51.2 t -61.88 132.62 53.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.66 1.584 . . . . 0.0 111.122 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -20.1 63.56 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.644 -1.285 . . . . 0.0 112.72 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.439 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 96.8 mt -83.25 -39.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 110.34 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.39 -10.87 12.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.253 22.0 mmt85 62.22 40.33 11.69 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.318 2.247 . . . . 0.0 112.567 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.76 152.83 21.12 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 125.325 1.44 . . . . 0.0 114.315 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -156.0 -34.44 0.09 Allowed 'General case' 0 CA--C 1.481 -1.675 1 C-N-CA 133.324 4.65 . . . . 0.0 116.296 -1.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.5 -176.01 5.06 Favored 'General case' 0 C--N 1.305 -1.355 1 C-N-CA 141.687 7.995 . . . . 0.0 112.174 -4.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 p -125.35 148.54 48.71 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.751 -1.218 . . . . 0.0 113.124 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.49 -7.07 1.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.04 -20.52 8.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.577 1.951 . . . . 0.0 111.052 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 66' ' ' HIS . 44.0 t30 -145.75 72.8 13.86 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 125.284 1.434 . . . . 0.0 113.912 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -46.23 173.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.08 4.52 . . . . 0.0 117.014 173.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -116.71 155.58 28.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.512 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -157.04 -171.01 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.065 2.546 . . . . 0.0 107.74 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -125.4 115.56 25.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.926 0.89 . . . . 0.0 109.628 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -78.31 -19.41 11.88 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.833 3.022 . . . . 0.0 112.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.3 p -151.03 151.98 32.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.29 2.636 . . . . 0.0 110.969 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.2 39.86 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.467 1.507 . . . . 0.0 114.519 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.87 -3.73 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 175.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? 23.37 92.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 129.678 3.191 . . . . 0.0 115.867 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.4 23.16 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.924 1.726 . . . . 0.0 112.006 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.9 p -54.03 -37.13 63.78 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.28 1.69 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -80.75 -14.37 58.15 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.376 -0.827 . . . . 0.0 112.923 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.76 140.06 29.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.546 0.738 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.3 mtp -153.86 144.64 22.59 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.115 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 68' ' ' SER . 7.4 m170 -70.26 135.36 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -75.6 32.68 0.11 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.297 1.439 . . . . 0.0 113.4 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 66' ' ' HIS . 33.3 t -145.66 -43.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.304 2.242 . . . . 0.0 108.469 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -59.19 -48.34 81.97 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.785 1.234 . . . . 0.0 112.948 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.0 tp -58.03 -46.94 84.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 123.853 0.861 . . . . 0.0 110.682 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -22.6 63.54 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.232 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -92.56 -40.16 10.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 110.353 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -56.69 -49.33 75.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.568 1.147 . . . . 0.0 112.172 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.23 -33.44 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.475 0.71 . . . . 0.0 111.956 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.9 81.87 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.741 -0.599 . . . . 0.0 111.24 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.2 m -63.82 -15.52 59.02 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.843 -1.16 . . . . 0.0 113.395 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -75.05 -7.84 54.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.808 1.243 . . . . 0.0 113.14 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 62.91 52.58 2.61 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.836 1.303 . . . . 0.0 112.368 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.4 150.51 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.872 -1.143 . . . . 0.0 111.246 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.16 117.45 9.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.041 0.536 . . . . 0.0 112.096 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.85 0.51 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -96.14 5.55 50.82 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 122.347 1.07 . . . . 0.0 110.249 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? 30.32 80.94 0.23 Allowed Pre-proline 0 CA--C 1.539 0.545 1 C-N-CA 133.049 4.54 . . . . 0.0 119.162 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -84.18 46.96 2.1 Favored 'Trans proline' 0 CA--C 1.544 0.995 1 C-N-CA 126.336 4.691 . . . . 0.0 109.902 172.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.98 -11.55 22.59 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.601 2.048 . . . . 0.0 112.015 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 162.87 13.88 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.019 0.909 . . . . 0.0 113.103 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.11 45.17 1.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.519 1.528 . . . . 0.0 110.619 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.9 t -52.65 114.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.817 1.647 . . . . 0.0 113.74 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -148.28 -177.82 5.97 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.3 t -62.79 164.54 7.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.861 2.064 . . . . 0.0 114.329 -174.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -125.51 13.08 8.12 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.679 1.992 . . . . 0.0 111.784 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 mt -113.43 -55.3 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.82 1.648 . . . . 0.0 108.297 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.48 -10.74 14.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 t60 55.42 19.56 3.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.016 1.726 . . . . 0.0 114.718 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -78.21 139.47 60.51 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.737 -1.227 . . . . 0.0 108.988 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 43.1 Cg_exo -49.68 129.16 23.0 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.058 3.172 . . . . 0.0 112.439 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -89.76 129.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.151 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -118.17 136.6 53.53 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.318 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 126.425 1.89 . . . . 0.0 111.26 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 168.85 2.56 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.976 1.31 . . . . 0.0 112.104 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.3 p -139.16 157.03 46.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -62.1 134.72 56.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.38 1.472 . . . . 0.0 113.162 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -5.67 43.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.27 -41.66 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.826 1.25 . . . . 0.0 110.112 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.48 6.49 5.24 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 54.45 27.83 8.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.608 1.563 . . . . 0.0 114.467 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.46 140.98 15.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -72.57 162.89 28.89 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.266 1.026 . . . . 0.0 112.681 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.53 140.52 34.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.217 1.407 . . . . 0.0 113.094 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.2 p -114.98 -149.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.607 1.963 . . . . 0.0 110.217 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -109.88 -5.28 15.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.562 1.545 . . . . 0.0 112.284 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.68 -18.22 5.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.362 2.265 . . . . 0.0 110.939 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -141.53 69.79 26.06 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 128.33 2.652 . . . . 0.0 108.408 174.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.15 4.21 6.02 Favored 'Trans proline' 0 N--CA 1.501 1.945 1 C-N-CA 129.397 6.732 . . . . 0.0 118.276 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt 60.08 144.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 1 C-N-CA 136.599 5.959 . . . . 0.0 113.636 -170.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.11 179.83 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.241 1.816 . . . . 0.0 109.483 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -122.65 103.48 37.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.922 1.289 . . . . 0.0 109.829 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.49 -17.92 20.53 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.464 2.109 . . . . 0.0 111.425 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.5 t -134.92 -168.11 2.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.703 2.401 . . . . 0.0 111.428 -168.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -125.14 33.25 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.455 1.502 . . . . 0.0 113.626 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 93' ' ' CYS . 2.3 m -53.72 -10.39 0.29 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.286 1.434 . . . . 0.0 114.091 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 30.36 69.55 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.851 2.86 . . . . 0.0 116.561 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.4 -169.8 42.83 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.44 -1.255 . . . . 0.0 114.013 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -64.04 8.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.822 1.649 . . . . 0.0 114.495 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.87 12.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 127.741 2.416 . . . . 0.0 111.442 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 pttt -90.86 -17.01 27.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.639 1.576 . . . . 0.0 113.08 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.412 ' CE2' ' HE2' ' A' ' 63' ' ' LYS . 45.4 m-85 -90.15 144.32 25.98 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.116 1.766 . . . . 0.0 111.091 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.4 mtp -157.8 143.07 16.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.124 0.97 . . . . 0.0 110.956 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -75.97 144.53 40.92 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.31 -40.72 78.48 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.956 -1.09 . . . . 0.0 110.954 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -59.62 -47.02 87.23 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.525 1.93 . . . . 0.0 112.09 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.3 m -63.17 -46.37 87.45 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.857 1.263 . . . . 0.0 111.122 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.12 -48.85 80.08 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 122.911 0.485 . . . . 0.0 112.059 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.02 -20.85 60.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.635 1.574 . . . . 0.0 112.522 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -96.41 -31.89 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.959 1.704 . . . . 0.0 112.057 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.426 ' CZ2' ' HE3' ' A' ' 77' ' ' LYS . 15.8 t90 -64.05 -57.19 10.4 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.01 1.724 . . . . 0.0 111.746 178.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 m -55.75 -22.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.456 1.502 . . . . 0.0 111.225 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.03 -33.94 22.42 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.036 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 t -70.55 -26.4 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.254 1.422 . . . . 0.0 110.817 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.426 ' HE3' ' CZ2' ' A' ' 73' ' ' TRP . 65.8 mmtt -74.35 7.31 2.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.875 2.87 . . . . 0.0 113.747 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 75.16 6.48 4.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.478 2.311 . . . . 0.0 115.531 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.81 152.05 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.37 1.468 . . . . 0.0 111.382 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -134.49 110.33 9.31 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.095 1.358 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -18.46 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.985 1.314 . . . . 0.0 113.702 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -82.59 -5.38 58.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.902 0.881 . . . . 0.0 113.266 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.97 150.06 44.4 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 112.924 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -77.94 23.27 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.494 3.463 . . . . 0.0 115.182 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.88 8.27 16.7 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.691 2.091 . . . . 0.0 112.182 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.61 145.5 51.95 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 113.224 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.16 44.1 0.71 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.335 1.854 . . . . 0.0 109.871 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.79 88.07 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.924 1.69 . . . . 0.0 113.566 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -141.42 139.55 33.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.712 1.605 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.3 t -64.58 176.49 1.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.121 2.568 . . . . 0.0 115.739 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.26 -10.24 4.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.518 2.327 . . . . 0.0 112.591 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -79.44 -64.59 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 122.576 1.179 . . . . 0.0 108.932 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 58' ' ' CYS . 26.5 p -101.4 -11.93 18.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 130.268 3.427 . . . . 0.0 111.222 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.0 m80 70.69 14.95 7.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.439 2.696 . . . . 0.0 114.064 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 17.9 m-85 -78.42 145.84 68.86 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.61 143.13 99.39 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.65 2.233 . . . . 0.0 109.631 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -91.85 132.83 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -127.72 120.34 27.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.285 1.034 . . . . 0.0 111.012 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 126.38 1.872 . . . . 0.0 114.573 -177.823 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.81 18.62 1.64 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -81.25 -24.25 37.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.185 0.994 . . . . 0.0 113.304 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.0 174.43 3.79 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.495 1.518 . . . . 0.0 113.319 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.47 11.21 6.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.382 1.473 . . . . 0.0 113.542 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 t -159.14 161.71 36.32 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.176 1.791 . . . . 0.0 110.502 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -161.52 160.84 29.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.62 1.568 . . . . 0.0 111.106 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.8 m -57.68 140.44 51.29 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.297 1.439 . . . . 0.0 111.825 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.61 173.05 14.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.538 1.535 . . . . 0.0 111.874 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.0 m -135.48 138.71 43.42 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.991 1.316 . . . . 0.0 110.16 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -143.32 131.55 21.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.311 1.445 . . . . 0.0 110.25 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -156.25 171.65 19.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.298 1.439 . . . . 0.0 112.913 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -116.07 23.96 11.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.434 1.493 . . . . 0.0 113.192 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.95 170.32 20.83 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.495 3.118 . . . . 0.0 108.365 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.94 102.75 0.32 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.079 2.152 . . . . 0.0 113.324 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -65.3 148.58 88.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.628 2.218 . . . . 0.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.1 m -81.54 -13.34 58.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.47 46.14 0.82 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 126.43 1.967 . . . . 0.0 112.045 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.44 149.7 1.53 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.155 1.782 . . . . 0.0 111.563 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -134.9 151.15 50.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.9 t -46.22 160.27 0.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.634 1.974 . . . . 0.0 112.999 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.13 0.47 40.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.818 2.047 . . . . 0.0 114.678 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.36 -35.23 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.345 2.258 . . . . 0.0 113.223 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.1 p -143.12 23.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 39.15 30.26 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.012 2.125 . . . . 0.0 114.965 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.81 155.98 45.45 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.93 134.32 46.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.302 1.051 . . . . 0.0 108.801 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -35.44 139.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -111.51 -168.8 1.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.702 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -104.05 15.13 29.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.442 2.297 . . . . 0.0 112.421 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.29 -27.93 0.27 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.092 1.757 . . . . 0.0 111.486 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -146.35 80.58 9.98 Favored Pre-proline 0 N--CA 1.435 -1.189 0 C-N-CA 126.465 1.906 . . . . 0.0 108.629 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.27 -143.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 125.873 4.382 . . . . 0.0 112.159 -177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -141.42 159.23 42.64 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.101 2.16 . . . . 0.0 108.916 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -165.96 161.22 17.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.919 2.087 . . . . 0.0 108.58 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -105.38 109.78 63.6 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.06 0.544 . . . . 0.0 109.726 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . 0.264 61.9 Cg_endo -78.05 -7.5 16.31 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.658 3.572 . . . . 0.0 112.994 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.2 t -150.06 176.13 11.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.937 1.695 . . . . 0.0 111.472 -167.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -110.6 36.66 3.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.382 2.273 . . . . 0.0 113.572 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.4 m -59.59 -36.71 76.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.399 0.68 . . . . 0.0 110.6 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 75.16 178.6 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.683 2.793 . . . . 0.0 113.528 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.21 -138.38 43.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.71 1.148 . . . . 0.0 113.973 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -99.6 14.7 29.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.647 1.579 . . . . 0.0 114.574 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 33.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 127.009 2.124 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -106.03 -40.49 5.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.043 1.737 . . . . 0.0 109.957 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -61.78 157.11 18.76 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.893 1.277 . . . . 0.0 112.228 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 ttm -172.48 145.88 1.68 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.127 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -71.28 154.92 41.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.95 -38.87 87.38 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.672 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.1 p -63.65 -55.31 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 111.546 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.24 -43.5 61.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.904 1.282 . . . . 0.0 112.224 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.05 -45.78 87.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.936 0.789 . . . . 0.0 111.55 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -58.88 -28.03 65.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.449 1.1 . . . . 0.0 113.161 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.99 -26.91 21.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.364 1.466 . . . . 0.0 111.919 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.68 -59.45 2.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.218 1.007 . . . . 0.0 110.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.41 -20.08 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.901 1.281 . . . . 0.0 111.604 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.42 -45.32 32.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -59.92 -29.17 68.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.008 1.323 . . . . 0.0 112.53 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.8 -3.39 12.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.669 1.988 . . . . 0.0 113.827 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.06 54.41 2.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.785 1.234 . . . . 0.0 111.948 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -140.05 132.18 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 110.812 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -88.08 97.67 11.11 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.684 0.793 . . . . 0.0 110.487 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 pt -64.7 -10.93 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.839 1.256 . . . . 0.0 113.612 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -93.53 5.61 51.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.231 . . . . 0.0 112.794 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -120.9 144.9 40.2 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.546 1.138 . . . . 0.0 113.983 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -86.12 21.53 1.07 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.798 3.665 . . . . 0.0 113.838 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.36 23.85 10.2 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.039 2.257 . . . . 0.0 111.906 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.93 166.69 20.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.298 1.439 . . . . 0.0 112.888 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.65 36.26 2.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.309 1.844 . . . . 0.0 110.405 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -36.72 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 127.36 2.264 . . . . 0.0 114.751 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 15.4 pttm -158.1 172.46 18.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.58 172.6 1.53 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.645 2.778 . . . . 0.0 116.046 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.32 -17.45 3.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.974 2.51 . . . . 0.0 112.605 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.4 -54.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.137 0.975 . . . . 0.0 109.506 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.2 p -116.2 -9.85 11.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.58 1.952 . . . . 0.0 111.45 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.307 7.3 p80 58.05 22.09 8.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.583 2.753 . . . . 0.0 116.342 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -78.92 137.48 57.6 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.733 -1.229 . . . . 0.0 112.915 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 24.5 Cg_exo -54.54 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.752 2.968 . . . . 0.0 112.303 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.5 mm -68.19 139.91 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.313 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.41 124.71 40.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 112.345 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.08 11.33 4.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.85 1.66 . . . . 0.0 114.309 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -160.56 151.91 19.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.065 2.146 . . . . 0.0 110.932 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.115 1.766 . . . . 0.0 111.637 179.274 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 110.715 -0.106 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.03 26.71 1.84 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.863 1.265 . . . . 0.0 113.086 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.99 153.16 39.73 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.976 1.71 . . . . 0.0 111.433 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.86 -1.34 2.01 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -120.71 0.17 10.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.62 1.568 . . . . 0.0 113.117 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -75.68 -7.32 54.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 73.23 154.8 0.15 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 128.356 2.662 . . . . 0.0 113.664 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.0 p -138.57 13.65 2.75 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.652 1.981 . . . . 0.0 113.414 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.91 164.62 32.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -107.86 2.72 23.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.45 1.5 . . . . 0.0 114.658 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 t80 48.06 58.1 5.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.997 2.119 . . . . 0.0 112.146 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -82.46 -174.92 5.45 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.111 1.765 . . . . 0.0 112.997 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.9 -173.39 3.79 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.305 2.242 . . . . 0.0 108.113 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.75 -38.11 79.88 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.754 -1.216 . . . . 0.0 112.129 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.31 144.16 36.18 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.798 2.439 . . . . 0.0 113.11 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.76 165.34 0.78 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 125.162 3.908 . . . . 0.0 115.061 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -102.62 19.78 18.43 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.398 1.879 . . . . 0.0 110.837 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.24 28.46 0.29 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 126.479 1.99 . . . . 0.0 114.548 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.72 128.64 37.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.879 0.872 . . . . 0.0 109.571 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 p -139.13 148.75 43.65 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.207 1.403 . . . . 0.0 112.103 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.48 126.65 17.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.999 1.319 . . . . 0.0 112.378 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -5.43 26.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.852 -1.155 . . . . 0.0 113.446 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.18 -43.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.004 1.321 . . . . 0.0 110.272 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.5 p -125.3 -1.58 7.59 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.318 33.9 mmt180 61.61 25.6 15.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.406 2.282 . . . . 0.0 115.455 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.24 139.64 15.75 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.97 165.28 15.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.109 0.963 . . . . 0.0 112.228 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 139.31 58.75 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 49' ' ' ASP . 50.1 p -129.92 160.47 33.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.291 1.043 . . . . 0.0 112.85 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.9 13.54 0.51 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.842 1.657 . . . . 0.0 114.662 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 47' ' ' THR . 35.7 t70 -133.66 -20.74 2.01 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.293 2.237 . . . . 0.0 110.946 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.476 HD22 ' HB3' ' A' ' 66' ' ' HIS . 28.4 t30 -158.98 72.34 3.56 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.607 1.163 . . . . 0.0 112.82 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.16 167.36 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 125.274 3.982 . . . . 0.0 116.611 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.2 mt -109.82 142.97 40.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -154.55 177.53 11.1 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.47 2.708 . . . . 0.0 107.821 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.423 ' CE1' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.74 110.16 37.21 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.29 -19.62 25.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.687 2.258 . . . . 0.0 111.209 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -145.3 154.74 42.67 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 130.38 3.472 . . . . 0.0 108.221 -173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 59' ' ' ARG . 75.6 mmtt -56.49 -39.87 73.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.672 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 28.83 10.87 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 131.182 3.793 . . . . 0.0 121.005 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 57' ' ' LYS . 17.3 tpp85 15.45 57.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 1 C-N-CA 134.514 5.126 . . . . 0.0 118.129 179.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 62' ' ' ILE . . . 170.06 -174.05 44.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.525 0.583 . . . . 0.0 114.084 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -67.6 29.39 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 127.547 2.339 . . . . 0.0 114.024 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 60' ' ' GLY . 1.9 pp -135.26 -6.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 129.215 3.006 . . . . 0.0 112.039 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HE2' ' CE1' ' A' ' 54' ' ' HIS . 21.0 pttm -72.72 -23.02 60.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.682 1.128 . . . . 0.0 111.616 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -73.33 138.08 45.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.349 1.059 . . . . 0.0 112.067 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 84.0 mtp -157.3 140.24 15.2 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.385 1.474 . . . . 0.0 109.854 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.476 ' HB3' HD22 ' A' ' 50' ' ' ASN . 36.9 m80 -70.78 157.61 37.76 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.79 -48.13 82.03 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.75 -0.594 . . . . 0.0 109.827 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -62.22 -45.85 91.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.643 0.777 . . . . 0.0 112.127 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.13 -43.65 97.78 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.512 -0.742 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.4 -44.6 95.53 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.215 0.916 . . . . 0.0 110.198 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.62 -30.01 62.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.57 -38.71 18.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.483 1.113 . . . . 0.0 110.991 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -62.36 -48.0 81.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.427 1.091 . . . . 0.0 111.958 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -64.19 -32.87 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.569 0.748 . . . . 0.0 111.305 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.71 -35.56 79.02 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.389 0.675 . . . . 0.0 110.84 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.0 t -63.19 -19.0 64.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 0.0 112.567 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -82.55 2.99 30.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.125 1.37 . . . . 0.0 113.045 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 79.1 14.55 1.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.107 2.163 . . . . 0.0 113.715 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.94 127.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.921 1.289 . . . . 0.0 111.853 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.04 107.05 19.44 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.485 1.114 . . . . 0.0 110.062 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.0 -13.56 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.333 1.453 . . . . 0.0 114.342 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.46 -21.73 60.37 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.814 -0.554 . . . . 0.0 111.787 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -93.91 144.52 28.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.946 1.298 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.56 9.9 2.07 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.924 3.083 . . . . 0.0 115.837 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.19 -1.72 60.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.359 1.933 . . . . 0.0 113.094 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.15 141.99 57.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.115 0.958 . . . . 0.0 112.013 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.5 44.12 1.2 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.754 1.622 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.41 123.84 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.991 1.316 . . . . 0.0 111.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -145.04 143.07 30.27 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 0.0 110.647 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.4 t -62.42 163.56 8.49 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.66 -9.04 12.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.159 1.783 . . . . 0.0 111.736 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.2 -55.96 5.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 123.813 0.845 . . . . 0.0 108.793 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.0 p -109.44 -3.6 16.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.468 0.707 . . . . 0.0 112.792 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 60.78 11.44 3.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.152 1.781 . . . . 0.0 114.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -81.96 140.59 46.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 120.078 -1.639 . . . . 0.0 110.474 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.21 145.25 44.55 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.054 2.503 . . . . 0.0 111.114 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.5 mm -100.74 107.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.0 1.32 . . . . 0.0 111.045 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.52 116.06 24.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.384 1.474 . . . . 0.0 109.915 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -64.26 4.48 0.34 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -159.89 160.42 33.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.13 2.172 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 128.561 2.744 . . . . 0.0 113.917 178.3 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 110.714 -0.106 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.03 -171.13 3.39 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.732 1.213 . . . . 0.0 111.921 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -131.8 7.13 4.38 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.029 1.732 . . . . 0.0 113.192 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -149.72 150.95 32.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.048 2.939 . . . . 0.0 109.622 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -151.33 26.29 0.69 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.02 0.928 . . . . 0.0 112.598 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.0 p -129.86 6.03 5.05 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.39 169.49 0.43 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.648 1.979 . . . . 0.0 115.616 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.7 m -142.66 143.2 32.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.158 2.183 . . . . 0.0 109.241 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.71 162.1 40.61 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 m -147.8 142.37 26.53 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.811 2.044 . . . . 0.0 108.836 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -143.08 148.7 37.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.548 1.139 . . . . 0.0 113.247 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -153.94 140.82 19.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.69 1.596 . . . . 0.0 111.012 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -156.21 175.19 14.31 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.096 1.758 . . . . 0.0 110.503 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.23 -3.3 10.28 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.05 132.87 10.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.192 2.197 . . . . 0.0 110.888 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -50.85 151.63 10.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.851 3.034 . . . . 0.0 114.552 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -58.76 -25.86 63.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.189 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.59 26.98 6.12 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 126.224 1.869 . . . . 0.0 114.401 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.12 153.28 41.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.762 1.281 . . . . 0.0 109.67 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 p -146.87 149.15 32.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.49 128.99 38.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.379 1.472 . . . . 0.0 111.84 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -13.01 62.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.91 -43.74 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.554 1.142 . . . . 0.0 111.498 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.78 5.5 10.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 54.44 29.49 11.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.822 2.049 . . . . 0.0 113.647 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.64 147.6 16.69 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 122.726 1.181 . . . . 0.0 111.066 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.05 166.34 5.98 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.532 1.933 . . . . 0.0 114.146 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 147.04 54.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.427 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.5 p -129.39 155.65 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.577 1.18 . . . . 0.0 112.929 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.38 -10.81 1.0 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.67 1.988 . . . . 0.0 116.272 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.0 -20.7 4.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.667 1.587 . . . . 0.0 111.644 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -143.76 66.54 15.24 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.31 169.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.429 1 C-N-CA 126.167 4.578 . . . . 0.0 118.059 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.9 mt -111.97 144.92 40.53 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.781 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -150.94 168.42 24.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.712 2.805 . . . . 0.0 106.618 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -111.73 107.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.81 -13.27 21.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.355 2.704 . . . . 0.0 112.455 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t -138.17 -161.99 1.25 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.138 1.375 . . . . 0.0 112.579 -166.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.27 26.63 4.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.809 2.044 . . . . 0.0 113.388 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -8.5 0.59 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.673 1.589 . . . . 0.0 114.217 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 54.6 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.588 2.355 . . . . 0.0 115.626 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.41 -156.86 20.42 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.514 1.054 . . . . 0.0 114.635 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -82.69 5.08 22.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.018 1.327 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.73 9.2 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.563 1.545 . . . . 0.0 114.216 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -90.14 -4.7 57.13 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.181 0.993 . . . . 0.0 112.663 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -94.31 147.42 23.22 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.227 1.411 . . . . 0.0 111.201 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.1 mtp -158.85 139.89 12.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.993 0.917 . . . . 0.0 110.424 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -68.31 158.39 33.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.02 -46.75 87.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.071 -1.018 . . . . 0.0 109.015 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -54.86 -57.22 12.48 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.02 1.328 . . . . 0.0 112.988 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.68 -36.81 84.1 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.873 1.269 . . . . 0.0 111.972 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.92 -47.29 75.23 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.494 1.497 . . . . 0.0 110.694 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.63 -33.52 72.9 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.231 1.812 . . . . 0.0 112.256 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.44 -36.08 39.45 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.519 2.728 . . . . 0.0 111.898 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.3 t90 -69.4 -52.88 22.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.003 0.921 . . . . 0.0 109.806 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -58.92 -29.98 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.473 1.033 . . . . 0.0 111.204 172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.96 -39.36 76.07 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.717 -0.614 . . . . 0.0 110.498 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 m -66.03 -24.26 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.77 -1.206 . . . . 0.0 112.917 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -73.69 -5.71 42.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.954 2.102 . . . . 0.0 112.561 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.256 8.8 t30 63.15 45.27 5.24 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.321 1.449 . . . . 0.0 112.478 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.84 126.56 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.052 -1.03 . . . . 0.0 111.105 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -81.13 106.64 13.28 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.52 0.728 . . . . 0.0 111.118 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -61.54 -18.87 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 114.0 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -19.72 52.04 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.352 0.661 . . . . 0.0 112.742 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.22 141.7 43.19 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.968 -1.083 . . . . 0.0 113.545 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -84.05 6.15 5.93 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.391 3.394 . . . . 0.0 114.984 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.3 23.69 32.45 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 127.237 2.351 . . . . 0.0 112.554 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.88 163.54 30.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 112.573 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -139.34 54.17 1.71 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.147 2.179 . . . . 0.0 108.602 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.72 106.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.481 1.512 . . . . 0.0 113.294 -174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.455 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -150.58 179.26 8.32 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 178.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.8 t -66.81 173.75 3.36 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.498 1.919 . . . . 0.0 115.907 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -131.35 -6.92 3.78 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.49 2.316 . . . . 0.0 112.603 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.3 mt -81.03 -64.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.122 0.969 . . . . 0.0 108.977 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.5 p -104.26 -11.75 17.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 129.916 3.287 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 62.33 18.74 10.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.762 2.825 . . . . 0.0 114.86 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.406 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 14.4 m-85 -74.17 142.77 79.36 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.834 -1.166 . . . . 0.0 113.234 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 32.1 Cg_exo -55.81 135.48 69.77 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.306 3.337 . . . . 0.0 111.316 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.67 126.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.363 1.065 . . . . 0.0 110.511 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.89 94.45 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.384 1.873 . . . . 0.0 110.38 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -57.27 132.45 53.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.118 1.367 . . . . 0.0 112.004 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HG3' ' H ' ' A' ' 101' ' ' THR . 24.2 tptt 57.97 -169.02 0.12 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.522 1.929 . . . . 0.0 113.823 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.465 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 13.2 t . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.842 2.057 . . . . 0.0 111.223 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.1 169.12 23.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.973 1.309 . . . . 0.0 112.51 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -149.55 157.61 43.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.175 1.79 . . . . 0.0 110.479 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -141.38 162.21 36.04 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.508 1.123 . . . . 0.0 112.971 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.33 -28.98 0.19 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.721 1.609 . . . . 0.0 113.274 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 p -69.78 -173.09 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.835 2.454 . . . . 0.0 114.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.78 159.17 43.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.308 1.843 . . . . 0.0 111.838 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -148.42 -25.55 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.74 133.79 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.717 1.607 . . . . 0.0 113.342 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.6 m -145.21 136.75 25.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.898 2.079 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -159.06 165.36 34.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.93 1.292 . . . . 0.0 111.633 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -150.83 -70.35 0.18 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.511 1.524 . . . . 0.0 109.927 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -142.45 148.58 37.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.04 1.336 . . . . 0.0 111.93 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.75 161.5 16.75 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.19 86.31 4.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.606 2.362 . . . . 0.0 109.674 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.87 149.58 91.01 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.756 2.304 . . . . 0.0 115.136 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -64.27 69.11 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.55 -46.61 1.12 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.818 3.104 . . . . 0.0 109.728 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . 0.296 . . 69.77 179.4 0.24 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.825 2.05 . . . . 0.0 112.043 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -154.36 162.86 40.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.566 1.147 . . . . 0.0 112.601 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 t -83.21 125.85 32.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.103 0.961 . . . . 0.0 111.425 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -11.67 58.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.9 1.28 . . . . 0.0 113.744 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.6 mt -102.47 -52.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.659 1.183 . . . . 0.0 109.666 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 9.4 m -98.61 -13.78 20.21 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.254 36.2 mmt180 48.35 69.02 0.59 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 123.675 1.702 . . . . 0.0 108.41 -171.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.03 139.56 10.81 Favored Glycine 0 N--CA 1.463 0.446 0 CA-C-N 110.931 -2.849 . . . . 0.0 110.206 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.19 154.58 31.0 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.498 1.119 . . . . 0.0 110.68 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.93 18.22 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.146 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -101.21 -150.84 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.378 0.671 . . . . 0.0 111.06 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.51 12.83 8.1 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.809 2.043 . . . . 0.0 111.671 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -142.6 -12.79 0.78 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.358 2.663 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -160.11 71.97 3.08 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.14 2.176 . . . . 0.0 107.82 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.57 -165.5 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.654 3.57 . . . . 0.0 110.371 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -131.6 154.14 49.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.971 1.308 . . . . 0.0 111.399 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -154.64 -179.03 7.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.297 1.439 . . . . 0.0 110.118 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -115.58 96.42 46.16 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.821 1.248 . . . . 0.0 111.601 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.14 -13.48 19.09 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.511 3.474 . . . . 0.0 113.556 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.1 t -148.61 166.98 26.65 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.858 2.863 . . . . 0.0 105.906 -171.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 59' ' ' ARG . 73.3 mmtt -75.45 -40.2 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.243 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.311 90.9 m 40.04 -17.75 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.548 1 C-N-CA 133.001 4.52 . . . . 0.0 119.719 -170.179 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 57' ' ' LYS 0.265 6.6 tpp180 45.87 58.86 4.04 Favored 'General case' 0 N--CA 1.471 0.6 1 C-N-CA 131.873 4.069 . . . . 0.0 115.99 -179.941 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.8 -178.48 48.44 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.36 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.9 p -53.49 -32.2 49.24 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.373 1.087 . . . . 0.0 112.182 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.62 -14.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 128.708 2.803 . . . . 0.0 114.642 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -62.91 -25.99 68.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.041 0.837 . . . . 0.0 112.519 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.6 136.37 36.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.388 1.089 . . . . 0.0 112.13 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 87.8 mtp -159.76 153.54 22.91 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.356 2.262 . . . . 0.0 108.278 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -77.43 166.09 23.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.924 0.783 . . . . 0.0 109.283 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.48 -41.42 76.18 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.088 -1.632 . . . . 0.0 111.772 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 m -75.4 -29.08 59.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.878 1.671 . . . . 0.0 114.486 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -78.57 -42.48 29.03 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.355 1.074 . . . . 0.0 112.113 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.274 44.6 tp -52.75 -48.78 66.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.585 1.154 . . . . 0.0 111.174 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.19 -23.87 62.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.282 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -97.83 -30.34 12.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.865 . . . . 0.0 111.585 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -65.41 -49.87 67.58 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.179 1.392 . . . . 0.0 110.802 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.27 -34.83 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.063 0.847 . . . . 0.0 111.228 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.83 79.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.25 0.548 . . . . 0.0 111.171 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 t -64.66 -16.28 62.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.55 1.14 . . . . 0.0 112.523 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -84.68 9.85 12.82 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 112.729 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 80.02 -0.71 2.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.16 2.584 . . . . 0.0 115.621 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.39 125.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.275 1.43 . . . . 0.0 112.327 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -84.48 102.54 12.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 112.787 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 pt -66.92 -15.59 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 113.798 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -69.41 -19.22 63.81 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -111.74 144.47 30.71 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.506 1.122 . . . . 0.0 112.596 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.92 10.32 2.38 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 124.197 3.265 . . . . 0.0 115.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.26 10.06 59.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.727 2.108 . . . . 0.0 113.08 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 167.47 6.3 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.564 1.546 . . . . 0.0 113.819 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -136.79 38.59 2.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.13 1.772 . . . . 0.0 110.506 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.79 78.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.471 1.909 . . . . 0.0 113.438 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -134.26 140.73 46.64 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.374 1.87 . . . . 0.0 110.677 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.39 172.78 0.79 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.493 2.317 . . . . 0.0 115.477 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.3 -9.28 6.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.351 2.26 . . . . 0.0 112.913 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.9 mt -85.3 -59.17 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p -109.35 -6.66 15.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.827 2.451 . . . . 0.0 111.829 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.0 m80 63.89 21.39 12.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.997 2.119 . . . . 0.0 114.905 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.446 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 26.9 m-85 -80.4 143.28 55.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.716 -1.24 . . . . 0.0 112.846 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.92 141.22 83.43 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.835 2.357 . . . . 0.0 110.358 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -86.53 129.1 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.437 1.095 . . . . 0.0 109.598 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.23 117.74 27.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.379 1.472 . . . . 0.0 109.526 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.7 8.13 3.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -161.75 153.08 18.49 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.634 2.373 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.282 2.233 . . . . 0.0 111.592 178.13 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.3 19.55 1.38 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.415 1.086 . . . . 0.0 113.89 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -60.31 -36.73 78.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -144.97 156.81 44.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.66 8.08 5.32 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.31 -1.768 . . . . 0.0 114.064 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.6 p -140.52 175.38 9.65 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.759 1.623 . . . . 0.0 111.558 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.33 -4.65 0.67 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.716 2.406 . . . . 0.0 117.249 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -50.98 -32.43 21.04 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.635 1.574 . . . . 0.0 114.858 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.71 40.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.612 2.365 . . . . 0.0 113.223 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -142.53 55.73 1.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.866 2.066 . . . . 0.0 110.244 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -106.39 8.33 31.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.065 1.746 . . . . 0.0 114.767 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.92 154.54 34.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.248 1.419 . . . . 0.0 112.987 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.37 165.44 23.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.652 1.181 . . . . 0.0 111.599 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -148.87 26.28 0.91 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.193 2.197 . . . . 0.0 112.313 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.11 172.22 6.06 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 127.741 2.416 . . . . 0.0 112.22 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.18 -178.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 1 C-N-CA 125.363 4.042 . . . . 0.0 115.686 174.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.2 p -94.91 -2.33 50.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.472 1.509 . . . . 0.0 113.624 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.27 15.36 1.88 Allowed Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.774 1.654 . . . . 0.0 114.302 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.04 138.47 47.91 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.858 1.329 . . . . 0.0 108.873 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 p -140.78 148.91 41.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.924 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.475 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.7 t -60.3 123.62 17.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.267 1.827 . . . . 0.0 111.938 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -69.83 -8.02 44.88 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.787 -1.196 . . . . 0.0 112.114 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.475 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 77.6 mt -91.13 -51.66 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.75 13.67 5.87 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 61.81 8.98 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.458 2.703 . . . . 0.0 115.805 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.45 146.68 36.19 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.65 161.01 31.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.844 0.857 . . . . 0.0 111.92 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.72 120.74 15.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.58 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -96.52 -170.99 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.301 0.572 . . . . 0.0 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -84.48 -24.05 29.61 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 3.68 5.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 112.083 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.91 60.91 4.67 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 126.911 2.084 . . . . 0.0 109.953 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.56 -164.47 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 125.527 4.151 . . . . 0.0 111.926 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.5 mt -126.65 163.04 24.35 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.703 2.001 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -165.39 -169.91 1.72 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.746 2.418 . . . . 0.0 108.177 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -126.68 101.11 27.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 119.052 0.842 . . . . 0.0 111.127 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.691 ' HG2' ' H ' ' A' ' 56' ' ' CYS . 83.3 Cg_endo -72.44 -54.44 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 N-CA-C 108.264 -1.476 . . . . 0.0 108.264 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.691 ' H ' ' HG2' ' A' ' 55' ' ' PRO . 12.5 p -102.64 169.75 8.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 131.411 3.884 . . . . 0.0 112.295 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' C ' ' H ' ' A' ' 59' ' ' ARG . 38.9 mmtt -108.16 35.3 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.436 -174.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 11.7 m -48.11 -12.69 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 57' ' ' LYS . 56.6 ttt85 62.24 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.841 3.256 . . . . 0.0 115.335 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.0 -159.75 31.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.842 0.734 . . . . 0.0 112.234 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -64.91 -30.6 71.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.269 2.4 pp -75.4 10.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 pttm -96.4 -20.05 18.74 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.728 -0.608 . . . . 0.0 110.598 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -63.5 135.7 57.06 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.263 1.025 . . . . 0.0 108.865 171.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.6 mtp -150.89 141.36 22.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.909 1.284 . . . . 0.0 108.585 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' C ' ' H ' ' A' ' 68' ' ' SER . 4.0 m170 -64.52 139.99 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.187 0.994 . . . . 0.0 110.491 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.2 19.21 0.08 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.512 1.525 . . . . 0.0 112.629 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 66' ' ' HIS . 79.6 p -135.75 -46.63 0.67 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.352 2.661 . . . . 0.0 109.15 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.37 -37.38 85.5 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.555 1.542 . . . . 0.0 111.404 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.73 -46.94 80.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.62 1.1 . . . . 0.0 109.814 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.18 -32.2 70.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.462 1.105 . . . . 0.0 111.501 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.06 -36.45 30.47 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.254 2.622 . . . . 0.0 111.23 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -65.35 -51.9 57.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.471 1.108 . . . . 0.0 109.315 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.25 -30.34 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 119.619 1.1 . . . . 0.0 110.836 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.875 -0.516 . . . . 0.0 110.2 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 p -67.73 -8.49 35.85 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -88.95 -1.59 58.18 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.352 1.861 . . . . 0.0 113.47 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER 71.83 17.22 5.41 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.782 1.633 . . . . 0.0 114.89 178.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.69 167.91 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.429 1.892 . . . . 0.0 111.587 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -128.18 106.95 9.4 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.575 1.55 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -18.43 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 113.674 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -76.81 -8.55 57.53 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.07 143.94 78.29 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.773 -1.204 . . . . 0.0 111.586 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.17 7.07 3.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.813 3.009 . . . . 0.0 116.757 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.62 8.39 8.28 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 127.143 2.306 . . . . 0.0 112.056 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.7 142.83 57.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.896 0.848 . . . . 0.0 112.747 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -138.01 32.95 2.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.738 1.615 . . . . 0.0 110.368 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.56 118.07 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 112.741 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -146.79 176.47 9.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 176.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.01 162.29 1.97 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.025 2.53 . . . . 0.0 113.07 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -115.38 -12.0 11.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.23 -53.94 8.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 122.817 0.447 . . . . 0.0 109.811 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.3 p -106.72 -7.56 17.22 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 53.71 14.07 0.58 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.255 1.822 . . . . 0.0 115.276 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -82.5 136.34 45.75 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.118 -1.614 . . . . 0.0 110.584 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 54.5 Cg_exo -46.74 126.2 10.5 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.233 2.622 . . . . 0.0 112.276 171.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . 0.262 0.6 OUTLIER -78.6 111.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.1 -1.864 . . . . 0.0 109.545 -173.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -80.74 73.29 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.721 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.03 143.16 3.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.161 1.784 . . . . 0.0 113.411 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.65 123.77 19.09 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.427 1.491 . . . . 0.0 109.44 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.501 1.521 . . . . 0.0 109.543 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.13 22.67 3.26 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.0 1.32 . . . . 0.0 113.272 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -140.58 156.7 46.21 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.776 1.63 . . . . 0.0 111.887 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.55 147.88 21.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.196 1.798 . . . . 0.0 113.904 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.35 56.33 3.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.427 1.891 . . . . 0.0 111.541 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p 51.28 -163.75 0.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.197 2.199 . . . . 0.0 115.357 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -152.37 139.28 19.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.842 1.657 . . . . 0.0 110.38 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.8 t -160.91 159.78 30.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.972 1.309 . . . . 0.0 111.653 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.92 161.21 41.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.23 1.412 . . . . 0.0 112.429 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 p -94.85 26.28 3.67 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.789 2.036 . . . . 0.0 112.761 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -139.55 144.0 37.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.889 2.475 . . . . 0.0 111.903 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.08 65.23 0.77 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.836 1.254 . . . . 0.0 112.496 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.86 36.94 0.79 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.8 1.24 . . . . 0.0 111.271 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 60.44 -58.23 0.08 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 130.892 3.677 . . . . 0.0 118.644 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 5.62 86.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 130.573 3.549 . . . . 0.0 115.964 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -57.07 146.98 78.0 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.33 2.02 . . . . 0.0 114.281 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 m -80.73 31.73 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.588 1.155 . . . . 0.0 112.667 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.38 38.23 0.04 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.013 2.244 . . . . 0.0 112.273 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.45 157.93 33.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.293 0.568 . . . . 0.0 110.625 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -156.34 165.68 35.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.793 1.237 . . . . 0.0 112.496 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.25 128.03 32.79 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 110.306 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -7.81 43.17 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.6 mt -94.05 -37.63 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.089 . . . . 0.0 110.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.43 4.17 3.66 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 61.24 19.33 10.0 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.702 2.001 . . . . 0.0 113.833 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.5 145.55 22.05 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.02 164.46 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.962 0.881 . . . . 0.0 111.472 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.83 144.43 56.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 49' ' ' ASP . 70.9 p -135.27 156.65 48.61 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.42 1.105 . . . . 0.0 113.692 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.94 8.82 0.23 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.753 2.421 . . . . 0.0 115.452 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 47' ' ' THR . 35.8 t70 -133.65 -20.07 2.05 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.13 2.172 . . . . 0.0 111.221 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -155.71 71.45 5.37 Favored Pre-proline 0 N--CA 1.445 -0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 112.125 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.42 171.36 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 125.009 3.806 . . . . 0.0 116.354 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.84 148.83 35.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.726 173.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -157.75 179.2 9.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.89 2.076 . . . . 0.0 108.393 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -120.74 112.65 33.67 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.318 0.647 . . . . 0.0 110.603 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -12.19 14.39 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.784 2.989 . . . . 0.0 112.218 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.8 t -133.36 -153.39 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.424 1.489 . . . . 0.0 112.468 -167.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 5.4 tmtt? -135.89 14.07 3.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.193 2.197 . . . . 0.0 115.028 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.9 m -46.66 -23.52 0.42 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.869 2.468 . . . . 0.0 115.222 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp-105 65.39 162.92 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.18 2.992 . . . . 0.0 114.282 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 -164.9 29.5 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.508 -0.745 . . . . 0.0 113.029 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.3 m -61.08 -34.57 75.13 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.303 -1.116 . . . . 0.0 113.185 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.76 1.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -83.21 -21.69 33.37 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.218 -0.926 . . . . 0.0 112.515 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.48 150.66 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.022 0.915 . . . . 0.0 110.636 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mtp -158.21 141.46 15.07 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.35 1.46 . . . . 0.0 109.793 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -70.53 151.4 45.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -56.28 -49.56 73.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.114 -0.366 . . . . 0.0 110.276 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -64.27 -44.32 92.11 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.46 -46.68 87.41 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.312 -0.867 . . . . 0.0 112.243 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.83 -45.44 74.45 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.179 0.9 . . . . 0.0 109.728 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.22 -25.64 65.78 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -89.78 -32.25 17.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.323 0.965 . . . . 0.0 111.868 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.83 -57.92 10.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.969 1.308 . . . . 0.0 110.618 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.95 -23.98 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.872 1.269 . . . . 0.0 111.65 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.14 58.63 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 m -93.87 5.73 50.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.918 1.287 . . . . 0.0 111.817 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -108.18 9.13 28.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.728 2.411 . . . . 0.0 113.673 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.253 10.3 t30 63.69 42.62 6.18 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.713 1.205 . . . . 0.0 112.387 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.47 152.73 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.593 1.557 . . . . 0.0 110.102 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -123.74 111.55 16.29 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.974 1.309 . . . . 0.0 110.457 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.4 pt -60.88 -19.73 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.247 1.419 . . . . 0.0 113.827 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.9 t -78.67 -14.85 59.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -93.02 143.58 27.03 Favored Pre-proline 0 N--CA 1.478 0.942 0 O-C-N 121.177 -0.952 . . . . 0.0 112.629 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.11 5.09 6.47 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.849 3.033 . . . . 0.0 115.638 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.62 10.75 38.68 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.955 2.217 . . . . 0.0 112.727 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.37 156.47 29.11 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.034 0.934 . . . . 0.0 113.145 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.04 45.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.409 1.484 . . . . 0.0 110.746 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.93 102.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.743 1.217 . . . . 0.0 112.575 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.9 tttm -143.66 142.1 30.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.362 1.465 . . . . 0.0 112.378 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.82 178.33 0.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.447 2.699 . . . . 0.0 115.174 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -132.19 -12.08 3.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.755 2.422 . . . . 0.0 112.727 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -78.33 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 122.119 0.961 . . . . 0.0 109.213 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.75 -8.6 17.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.916 2.886 . . . . 0.0 111.264 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.439 ' O ' ' HE2' ' A' ' 89' ' ' LYS 0.364 0.0 OUTLIER 63.34 18.97 11.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.643 3.177 . . . . 0.0 115.366 -175.883 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.424 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 16.8 m-85 -75.7 145.8 79.05 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 120.477 -1.389 . . . . 0.0 114.329 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -61.74 141.61 91.12 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.214 1.943 . . . . 0.0 109.813 170.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -86.42 117.92 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 125.17 1.388 . . . . 0.0 108.143 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -114.38 94.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.427 1.491 . . . . 0.0 111.845 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.01 157.35 10.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.037 1.735 . . . . 0.0 112.807 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.9 158.74 18.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 113.258 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.288 1.835 . . . . 0.0 110.73 178.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.091 0.472 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.53 167.08 29.46 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.482 1.913 . . . . 0.0 110.205 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -37.72 -8.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 120.814 3.635 . . . . 0.0 120.814 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -110.82 -15.45 13.8 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 0.0 113.168 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.46 4.51 43.77 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.496 2.318 . . . . 0.0 113.265 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -82.06 60.02 4.67 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.182 1.793 . . . . 0.0 111.253 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.68 20.68 15.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.339 1.855 . . . . 0.0 113.97 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.4 p -79.05 49.05 0.9 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 127.213 2.205 . . . . 0.0 111.981 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.59 151.07 6.25 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -144.89 162.88 35.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.88 2.472 . . . . 0.0 110.972 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.32 154.94 44.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.513 1.525 . . . . 0.0 112.138 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -149.99 152.86 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.183 1.393 . . . . 0.0 113.529 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -73.74 47.2 0.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.834 2.054 . . . . 0.0 114.03 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -81.57 48.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.683 1.993 . . . . 0.0 112.258 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.85 92.44 34.06 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.196 2.198 . . . . 0.0 114.068 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.91 146.96 92.12 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.632 2.222 . . . . 0.0 112.333 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 m -78.04 -7.75 57.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.141 -0.974 . . . . 0.0 112.571 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.75 -1.38 49.38 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.291 1.901 . . . . 0.0 113.448 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 158.62 36.06 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.7 p -121.11 163.9 17.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.8 t -80.62 133.31 35.73 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 120.835 -1.166 . . . . 0.0 108.093 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -21.77 66.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.49 1.041 . . . . 0.0 113.021 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.72 -49.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.749 1.22 . . . . 0.0 110.216 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -88.23 -23.73 23.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 58.91 36.91 24.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.376 1.47 . . . . 0.0 108.893 -167.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.0 134.49 10.83 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.931 1.253 . . . . 0.0 112.974 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -71.58 142.62 50.01 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.18 148.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.625 1.57 . . . . 0.0 114.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -128.22 179.61 5.52 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.202 1.001 . . . . 0.0 111.214 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.84 -32.02 68.92 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.98 -31.37 13.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.644 1.978 . . . . 0.0 110.704 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -123.62 65.56 33.84 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.63 167.16 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.261 1.974 . . . . 0.0 112.186 162.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.9 mt -117.83 146.62 43.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.759 -2.019 . . . . 0.0 112.153 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -149.39 163.53 37.49 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.406 3.082 . . . . 0.0 105.712 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -114.02 104.33 54.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.54 -24.72 35.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.282 1.988 . . . . 0.0 113.174 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.258 0.5 OUTLIER -139.96 150.53 44.6 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 127.262 2.225 . . . . 0.0 107.779 -168.876 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.22 -46.7 62.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 117.112 -1.423 . . . . 0.0 111.734 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 68.2 m 32.73 -12.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 1 C-N-CA 133.195 4.598 . . . . 0.0 120.901 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 72.14 149.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 131.002 3.721 . . . . 0.0 113.941 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.41 -142.55 48.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.74 1.162 . . . . 0.0 114.679 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -95.92 -7.05 37.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 112.891 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.0 24.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 111.931 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -105.82 -26.21 11.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.513 1.525 . . . . 0.0 112.374 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -77.48 152.45 34.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.139 1.376 . . . . 0.0 112.226 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 90.3 mtp -158.74 144.75 16.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.328 0.651 . . . . 0.0 112.294 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -70.8 152.45 43.74 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -56.16 -49.19 74.69 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.204 -0.935 . . . . 0.0 110.874 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -54.71 -50.04 69.27 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.411 1.084 . . . . 0.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.53 -44.16 93.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.72 -48.0 73.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.06 0.845 . . . . 0.0 111.44 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -55.7 -30.86 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.603 1.961 . . . . 0.0 112.949 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -91.99 -38.84 12.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.088 1.755 . . . . 0.0 112.156 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 80.2 t90 -58.62 -45.19 89.74 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 123.819 0.848 . . . . 0.0 111.015 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.36 -26.08 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.176 0.898 . . . . 0.0 112.213 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.63 62.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.788 -1.195 . . . . 0.0 111.43 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.7 p -84.5 11.18 9.14 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.527 -0.733 . . . . 0.0 112.502 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -115.03 8.39 15.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.701 1.6 . . . . 0.0 112.894 -174.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.32 0.0 OUTLIER 79.36 38.03 0.13 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.911 2.084 . . . . 0.0 112.67 178.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.58 145.28 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.437 1.095 . . . . 0.0 113.54 -171.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -139.54 102.84 4.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 110.024 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -12.26 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.258 1.423 . . . . 0.0 114.485 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -75.59 -16.34 60.25 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.726 -0.609 . . . . 0.0 111.972 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -106.56 142.21 24.46 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.103 1.361 . . . . 0.0 111.6 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.97 29.27 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.548 3.499 . . . . 0.0 114.626 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.15 20.19 6.32 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.882 2.182 . . . . 0.0 111.724 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.09 163.69 24.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 122.353 1.073 . . . . 0.0 113.637 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -143.92 41.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.85 2.06 . . . . 0.0 109.099 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.285 11.1 p -68.36 65.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.685 2.394 . . . . 0.0 115.447 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -133.53 144.88 49.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.401 2.281 . . . . 0.0 110.64 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -67.95 173.65 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.656 2.383 . . . . 0.0 115.256 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -129.12 -10.69 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.862 2.465 . . . . 0.0 112.978 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -78.76 -55.76 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.903 0.858 . . . . 0.0 109.434 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.9 p -115.45 -7.46 12.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 129.06 2.944 . . . . 0.0 111.85 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 66.9 20.7 10.51 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.078 2.551 . . . . 0.0 114.861 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.414 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.8 m-85 -85.14 145.81 43.91 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 113.487 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.24 135.96 49.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.53 2.154 . . . . 0.0 109.796 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.4 mm -77.76 141.74 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.507 1.123 . . . . 0.0 109.817 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -133.56 120.58 20.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.243 1.417 . . . . 0.0 111.456 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -78.43 18.27 0.57 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -159.76 151.76 20.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.642 2.377 . . . . 0.0 110.448 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 126.416 1.886 . . . . 0.0 113.202 178.695 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.87 166.75 26.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 112.737 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.45 2.47 28.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.251 1.421 . . . . 0.0 113.612 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -146.09 157.73 43.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.273 1.829 . . . . 0.0 111.414 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 56.08 12.9 1.03 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.684 1.994 . . . . 0.0 116.222 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -156.24 175.16 14.36 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.417 -1.427 . . . . 0.0 112.176 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.94 147.85 27.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.922 1.689 . . . . 0.0 111.991 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.2 p -141.07 32.83 1.74 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.549 1.54 . . . . 0.0 113.08 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.92 50.93 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.028 -1.045 . . . . 0.0 113.776 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.2 p -74.31 154.97 38.68 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 113.015 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -48.68 159.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.181 2.192 . . . . 0.0 115.615 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.09 171.66 13.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.866 1.667 . . . . 0.0 112.112 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -140.47 172.86 12.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.274 1.83 . . . . 0.0 111.527 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -150.0 142.27 24.18 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.48 1.112 . . . . 0.0 113.618 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.04 159.89 60.12 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.87 2.068 . . . . 0.0 111.629 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.66 161.51 1.28 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.945 3.097 . . . . 0.0 114.72 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 m -76.71 -6.89 54.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.64 23.09 1.83 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 114.02 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.69 46.69 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.477 1.139 . . . . 0.0 109.749 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -143.36 149.34 37.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.125 1.37 . . . . 0.0 113.01 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -57.51 129.25 40.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.663 1.585 . . . . 0.0 112.214 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -7.97 53.51 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.455 -1.403 . . . . 0.0 113.827 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.6 mt -96.17 -44.09 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 117.724 -1.132 . . . . 0.0 109.627 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.3 p -128.07 9.67 6.3 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 55.17 19.58 2.94 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.652 2.381 . . . . 0.0 114.499 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.2 149.28 29.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.72 163.63 24.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.124 0.962 . . . . 0.0 111.175 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 129.44 41.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -99.02 -146.67 0.33 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.335 0.588 . . . . 0.0 112.046 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -130.7 13.49 5.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.561 2.344 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -145.25 -18.01 0.49 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.207 2.603 . . . . 0.0 111.591 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.405 HD22 ' HB3' ' A' ' 66' ' ' HIS . 47.3 t30 -153.84 68.59 6.22 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 125.043 1.337 . . . . 0.0 111.883 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.67 179.51 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.43 1 C-N-CA 125.466 4.111 . . . . 0.0 116.263 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.52 154.01 32.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.459 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.17 -177.62 6.4 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.813 3.245 . . . . 0.0 106.311 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -128.96 117.62 19.3 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.585 0.63 . . . . 0.0 109.794 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -82.74 -9.93 10.82 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.815 3.01 . . . . 0.0 113.015 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 2.0 t -141.01 -162.87 1.43 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.769 1.228 . . . . 0.0 111.327 -166.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -129.21 24.38 5.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.258 1.823 . . . . 0.0 113.352 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -48.25 -21.53 0.52 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.849 2.06 . . . . 0.0 113.816 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 63.05 152.85 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 129.391 3.077 . . . . 0.0 115.549 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.4 -164.89 40.68 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.653 1.121 . . . . 0.0 114.752 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.7 m -59.02 6.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.88 7.15 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 126.491 1.916 . . . . 0.0 112.386 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -82.19 -23.09 35.68 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.894 . . . . 0.0 111.977 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -78.07 145.75 35.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.058 1.343 . . . . 0.0 111.289 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 91.6 mtp -155.9 139.22 15.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.47 1.108 . . . . 0.0 109.353 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.405 ' HB3' HD22 ' A' ' 50' ' ' ASN . 37.5 m80 -70.1 157.51 37.43 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.99 -50.59 72.78 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.391 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.3 t -58.69 -36.92 74.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.303 1.041 . . . . 0.0 113.074 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.51 -44.77 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.439 -0.788 . . . . 0.0 112.106 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.41 -41.75 85.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.712 1.596 . . . . 0.0 109.839 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.36 -33.52 72.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.906 1.682 . . . . 0.0 113.401 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.86 -27.4 26.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.533 0.733 . . . . 0.0 111.819 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.91 -57.58 4.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.687 1.595 . . . . 0.0 111.095 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 m -55.47 -23.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.288 0.635 . . . . 0.0 111.105 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.51 30.77 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.812 0.445 . . . . 0.0 112.066 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -72.12 -23.85 61.38 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.356 -1.465 . . . . 0.0 111.399 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -77.61 -2.63 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.519 2.728 . . . . 0.0 112.389 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.42 47.11 7.0 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.363 1.465 . . . . 0.0 113.487 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.08 118.81 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.558 -1.339 . . . . 0.0 111.741 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -78.44 97.26 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.019 0.928 . . . . 0.0 111.477 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.66 -16.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.289 1.436 . . . . 0.0 113.68 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -75.97 -14.21 60.24 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -81.34 139.46 48.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 O-C-N 120.978 -1.076 . . . . 0.0 112.036 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.88 4.41 7.06 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.894 3.062 . . . . 0.0 115.949 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.39 18.27 5.79 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 127.789 2.614 . . . . 0.0 111.615 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.09 158.71 10.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.948 0.899 . . . . 0.0 113.31 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -120.23 37.17 4.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.5 1.52 . . . . 0.0 111.89 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.64 101.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.418 1.487 . . . . 0.0 110.734 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -147.95 143.73 27.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.673 1.189 . . . . 0.0 112.796 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.6 t -66.37 177.42 1.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.439 2.696 . . . . 0.0 115.169 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -131.32 -10.63 3.67 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.426 2.29 . . . . 0.0 112.65 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.36 -61.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.245 -0.909 . . . . 0.0 109.236 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.7 p -106.45 -9.7 16.58 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.348 2.659 . . . . 0.0 111.194 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.4 t60 63.74 23.53 13.5 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.939 2.495 . . . . 0.0 114.516 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.464 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 16.7 m-85 -79.41 145.04 62.92 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.413 -1.429 . . . . 0.0 113.132 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.28 135.86 56.56 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.012 2.475 . . . . 0.0 110.49 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.9 mm -79.29 113.77 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.892 2.077 . . . . 0.0 108.514 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -126.19 97.56 5.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.753 2.021 . . . . 0.0 110.924 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -59.11 29.26 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 130.317 3.447 . . . . 0.0 117.835 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.3 mttm 42.89 46.12 4.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 128.494 2.718 . . . . 0.0 114.284 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.254 1.312 0 C-N-CA 126.859 2.064 . . . . 0.0 113.718 178.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.64 39.11 0.12 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.688 1.995 . . . . 0.0 113.381 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.92 4.9 0.48 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.778 2.031 . . . . 0.0 112.005 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.53 -5.32 0.56 Allowed 'General case' 0 CA--C 1.554 1.134 0 O-C-N 120.402 -1.436 . . . . 0.0 113.067 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -129.16 21.87 5.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.322 2.649 . . . . 0.0 110.013 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 p -156.24 160.48 39.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.123 2.569 . . . . 0.0 110.929 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.24 125.3 19.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.631 1.172 . . . . 0.0 110.445 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -156.37 22.85 0.35 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.584 1.553 . . . . 0.0 112.518 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.79 143.3 13.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.122 1.369 . . . . 0.0 114.254 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.5 p -72.17 -3.69 24.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.434 1.894 . . . . 0.0 115.237 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -74.3 44.26 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.284 2.634 . . . . 0.0 112.776 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -135.04 -9.39 2.31 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.397 1.879 . . . . 0.0 113.185 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -149.26 166.14 29.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.044 2.138 . . . . 0.0 108.776 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -139.43 145.6 39.07 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.334 1.054 . . . . 0.0 112.349 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.46 162.19 27.17 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.648 2.779 . . . . 0.0 106.505 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -42.16 -36.61 4.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.81 3.674 . . . . 0.0 120.403 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 t 56.87 36.42 27.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.433 1.893 . . . . 0.0 111.31 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.14 41.62 0.02 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 128.675 3.036 . . . . 0.0 111.287 -176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.21 168.3 19.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.119 0.968 . . . . 0.0 110.959 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.7 p -150.81 153.53 35.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.755 1.222 . . . . 0.0 113.485 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.94 133.09 54.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.145 1.378 . . . . 0.0 110.084 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -71.09 -13.25 61.9 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.185 -0.947 . . . . 0.0 113.032 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.01 -41.57 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.296 1.039 . . . . 0.0 111.046 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.26 13.01 4.22 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 55.15 17.46 1.98 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.932 2.093 . . . . 0.0 114.353 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.46 154.6 42.47 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.59 164.58 19.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.393 1.096 . . . . 0.0 110.111 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.82 25.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -92.01 -138.11 0.17 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.657 0.265 . . . . 0.0 111.49 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -130.71 5.38 4.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.776 2.03 . . . . 0.0 111.334 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.34 -10.01 0.96 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.694 3.198 . . . . 0.0 110.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -140.86 61.98 16.2 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 127.271 2.228 . . . . 0.0 114.162 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.1 159.97 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.893 2.395 . . . . 0.0 114.171 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.61 143.0 36.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 112.452 -2.158 . . . . 0.0 110.492 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -156.16 176.93 12.03 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.48 3.112 . . . . 0.0 106.612 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -124.04 117.85 26.96 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 118.253 0.479 . . . . 0.0 110.057 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -81.47 -7.58 12.71 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.72 3.614 . . . . 0.0 112.549 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 30.3 p -152.49 159.25 43.35 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.172 1.789 . . . . 0.0 113.055 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 95' ' ' TYR . 6.2 mtmm -77.12 30.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.264 1.826 . . . . 0.0 113.868 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.32 -14.9 1.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 27.09 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 130.559 3.544 . . . . 0.0 115.826 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.73 30.19 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.853 1.692 . . . . 0.0 112.147 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -62.61 6.43 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.75 6.07 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.549 2.34 . . . . 0.0 112.392 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -78.19 -22.5 48.51 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.081 -1.012 . . . . 0.0 112.002 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -80.29 145.99 31.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.172 1.389 . . . . 0.0 112.26 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.7 mtp -154.77 139.19 16.77 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.041 0.936 . . . . 0.0 110.485 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -66.2 148.07 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.76 -35.3 77.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 122.011 -0.431 . . . . 0.0 110.837 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -79.21 -28.83 42.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.0 m -81.07 -39.78 25.19 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.119 0.967 . . . . 0.0 111.219 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.21 -44.18 92.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.966 1.257 . . . . 0.0 109.277 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.16 -33.91 65.68 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.635 1.174 . . . . 0.0 113.597 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -88.99 -32.7 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.063 0.545 . . . . 0.0 112.244 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -62.24 -49.3 76.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.859 0.864 . . . . 0.0 110.097 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.62 -32.42 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.784 0.72 . . . . 0.0 112.199 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.98 -17.74 62.64 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.557 -0.714 . . . . 0.0 111.747 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -86.26 2.26 47.84 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.247 -0.908 . . . . 0.0 111.891 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -105.0 4.74 31.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.583 1.953 . . . . 0.0 114.046 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 62.98 44.85 5.71 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.566 1.146 . . . . 0.0 112.298 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.72 121.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.64 1.176 . . . . 0.0 110.697 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -80.13 106.91 12.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.283 0.633 . . . . 0.0 109.926 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.9 pt -60.85 -18.02 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.965 1.306 . . . . 0.0 113.907 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -82.09 -13.5 57.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -88.63 141.02 29.87 Favored Pre-proline 0 N--CA 1.481 1.083 0 O-C-N 121.027 -1.046 . . . . 0.0 112.682 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.08 0.83 9.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.03 3.153 . . . . 0.0 116.177 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.49 8.53 34.96 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.957 2.218 . . . . 0.0 112.736 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 168.3 15.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.775 1.23 . . . . 0.0 113.555 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -134.2 52.46 2.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.006 1.723 . . . . 0.0 109.979 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.36 76.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.135 1.774 . . . . 0.0 111.477 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . 0.269 18.5 ttmt -131.04 151.1 51.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.832 2.053 . . . . 0.0 111.631 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 15.3 t -63.98 165.78 8.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 0.0 113.731 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -120.7 3.58 10.63 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.396 1.878 . . . . 0.0 111.911 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -106.87 -55.58 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.513 1.525 . . . . 0.0 108.82 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 16.6 p -105.1 -4.82 21.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 60.77 10.43 2.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.326 2.25 . . . . 0.0 116.027 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 75.2 m-85 -92.44 146.32 32.23 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.464 -1.397 . . . . 0.0 111.611 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -45.33 142.98 5.81 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.853 3.036 . . . . 0.0 113.208 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -104.56 122.77 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.68 1.592 . . . . 0.0 110.596 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.72 122.87 44.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -66.24 175.42 2.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.235 1.814 . . . . 0.0 113.977 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -127.04 148.55 50.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.36 1.864 . . . . 0.0 111.244 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 128.348 2.659 . . . . 0.0 109.735 179.805 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 111.196 0.072 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.86 38.21 1.98 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.145 1.378 . . . . 0.0 111.994 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -55.61 140.1 42.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.21 1.404 . . . . 0.0 112.996 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.35 153.49 30.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.959 0.904 . . . . 0.0 113.373 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 60.3 -25.63 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.091 2.956 . . . . 0.0 117.467 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -97.68 15.03 24.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.255 1.822 . . . . 0.0 113.518 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -146.08 153.74 41.05 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.251 1.821 . . . . 0.0 111.494 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.19 135.4 32.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.467 1.507 . . . . 0.0 110.366 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.98 169.98 15.4 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.787 1.235 . . . . 0.0 113.086 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 p -148.65 149.58 31.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.893 2.077 . . . . 0.0 110.179 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -143.94 -4.68 0.82 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.584 1.554 . . . . 0.0 114.778 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -135.88 21.38 3.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.017 1.727 . . . . 0.0 113.244 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.26 40.37 0.1 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.51 1.924 . . . . 0.0 114.295 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -63.06 20.85 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.93 3.292 . . . . 0.0 117.048 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.09 150.75 73.83 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.339 1.856 . . . . 0.0 113.646 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -50.33 155.44 4.87 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.581 3.52 . . . . 0.0 115.782 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -62.09 -15.0 42.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.513 1.525 . . . . 0.0 114.551 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.29 11.64 7.2 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.453 1.978 . . . . 0.0 114.141 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.61 134.94 40.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.954 0.877 . . . . 0.0 110.059 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.4 p -144.16 153.53 42.21 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 111.488 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.0 t -63.72 127.1 29.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.504 1.122 . . . . 0.0 112.005 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -4.8 22.64 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.0 mt -103.57 -45.24 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.123 1.369 . . . . 0.0 110.226 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -123.69 5.08 8.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.32 31.5 mmt180 50.73 32.41 6.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.17 2.188 . . . . 0.0 115.632 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.3 148.1 18.86 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.29 168.4 18.4 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.834 1.653 . . . . 0.0 112.407 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.67 150.03 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.664 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.4 p -139.18 172.13 13.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.502 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -61.83 -21.93 65.05 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -119.63 -20.94 7.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.428 1.491 . . . . 0.0 112.281 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.97 66.51 47.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.193 1.797 . . . . 0.0 110.499 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.03 -167.93 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 1 C-N-CA 125.435 4.09 . . . . 0.0 111.113 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.7 mt -132.77 155.57 48.67 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.724 1.61 . . . . 0.0 111.868 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -153.92 -179.61 8.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.786 2.434 . . . . 0.0 108.122 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -129.24 110.42 18.03 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.579 0.752 . . . . 0.0 111.146 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.63 -17.42 12.61 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.577 2.851 . . . . 0.0 113.57 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 4.1 t -133.55 -161.55 1.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 112.067 -165.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -123.14 12.79 9.62 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.734 1.614 . . . . 0.0 114.717 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -44.62 -25.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.222 2.609 . . . . 0.0 116.703 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 65.18 159.36 0.11 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.933 3.293 . . . . 0.0 115.599 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.47 -157.63 19.34 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.09 0.852 . . . . 0.0 113.599 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.1 p -59.48 -18.41 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.5 pt -84.79 -7.57 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.755 1.161 . . . . 0.0 113.601 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -76.06 -18.74 59.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.154 1.343 . . . . 0.0 113.535 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -84.53 143.34 29.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.359 1.064 . . . . 0.0 112.285 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 81.6 mtp -156.62 143.03 18.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.363 1.465 . . . . 0.0 109.793 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -76.35 154.51 34.92 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.14 -46.45 82.69 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.272 -0.892 . . . . 0.0 111.911 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -64.36 -42.97 95.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.002 0.921 . . . . 0.0 111.949 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.3 m -61.79 -43.88 97.97 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.173 -0.955 . . . . 0.0 111.751 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.71 -47.88 83.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.88 0.764 . . . . 0.0 109.811 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.08 -29.49 60.65 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.97 -38.33 18.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.415 1.086 . . . . 0.0 111.577 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.78 -48.19 77.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.199 1.0 . . . . 0.0 111.731 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.89 -28.96 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.656 -0.653 . . . . 0.0 111.691 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.52 71.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.013 0.525 . . . . 0.0 111.429 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 p -66.91 -14.24 62.57 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.744 -1.223 . . . . 0.0 113.305 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.31 3.66 20.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.689 1.596 . . . . 0.0 112.796 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.254 10.2 t30 64.47 42.73 4.88 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.35 147.48 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.069 1.348 . . . . 0.0 110.547 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -125.89 111.57 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.269 1.428 . . . . 0.0 111.083 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.98 -18.75 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.014 1.326 . . . . 0.0 113.777 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -77.28 -7.62 56.27 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.67 150.94 44.81 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.64 1.576 . . . . 0.0 112.397 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.9 14.96 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.128 3.219 . . . . 0.0 115.89 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.95 4.3 38.87 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.511 2.005 . . . . 0.0 112.757 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 145.45 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.352 1.061 . . . . 0.0 113.18 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.03 40.94 0.73 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.309 1.844 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -66.26 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.568 1.547 . . . . 0.0 113.169 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.5 tttm -145.74 146.62 31.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.292 1.837 . . . . 0.0 111.378 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -63.4 175.72 0.95 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.599 2.36 . . . . 0.0 115.903 -174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -130.42 -4.06 4.29 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.599 2.36 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.6 -66.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.011 -1.055 . . . . 0.0 108.437 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.27 -8.84 21.76 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.206 2.602 . . . . 0.0 110.947 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.444 ' O ' ' HE2' ' A' ' 89' ' ' LYS . 72.3 m80 64.07 24.0 13.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.162 2.185 . . . . 0.0 114.38 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 18.7 m-85 -79.72 145.75 63.17 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -61.03 142.28 96.9 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.853 2.369 . . . . 0.0 110.045 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.48 130.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 124.662 1.185 . . . . 0.0 111.306 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -119.05 107.92 14.09 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.024 1.729 . . . . 0.0 111.49 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -69.63 70.04 0.29 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.527 1.931 . . . . 0.0 113.611 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? 55.56 -154.49 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.896 2.078 . . . . 0.0 112.576 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.329 2.252 . . . . 0.0 112.447 -175.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.18 154.57 0.57 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.667 1.587 . . . . 0.0 114.166 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -51.46 -21.49 2.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -137.13 129.68 30.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.646 1.178 . . . . 0.0 111.354 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -89.88 0.68 56.91 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.166 1.386 . . . . 0.0 113.928 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -74.93 31.68 0.09 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.13 2.172 . . . . 0.0 114.617 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.02 162.4 29.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.988 1.715 . . . . 0.0 112.818 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.6 p -149.73 156.75 42.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.034 1.734 . . . . 0.0 112.237 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.74 156.62 36.68 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.391 1.477 . . . . 0.0 111.76 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -154.82 160.22 41.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.779 1.232 . . . . 0.0 112.013 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -45.85 111.69 0.38 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.639 1.976 . . . . 0.0 113.411 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -63.93 1.82 0.61 Allowed 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.4 t0 103.02 155.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 131.046 3.739 . . . . 0.0 111.378 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -73.44 120.17 18.68 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.74 159.06 20.36 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.54 2.336 . . . . 0.0 113.761 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.25 149.59 16.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.615 2.877 . . . . 0.0 111.829 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.3 m -74.58 38.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.04 -11.14 0.02 OUTLIER Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.735 2.112 . . . . 0.0 113.807 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.26 57.76 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.63 2.215 . . . . 0.0 111.18 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.9 p -145.42 152.31 39.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.395 0.678 . . . . 0.0 112.739 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.74 131.84 35.52 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.635 1.174 . . . . 0.0 110.62 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.11 64.7 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.739 -1.226 . . . . 0.0 111.503 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -92.49 -42.01 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.339 1.055 . . . . 0.0 110.57 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . 0.257 29.2 p -124.79 9.26 8.23 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 50.53 29.01 3.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.284 2.233 . . . . 0.0 112.888 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.43 140.22 14.88 Favored Glycine 0 N--CA 1.467 0.74 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.269 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.1 171.0 0.78 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.16 1.384 . . . . 0.0 114.718 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 141.15 57.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.69 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 p -130.08 155.36 46.3 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.065 0.936 . . . . 0.0 112.695 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.03 -11.79 0.1 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -128.28 -15.98 4.54 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.537 1.535 . . . . 0.0 112.921 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.45 HD22 ' CG ' ' A' ' 66' ' ' HIS . 36.3 t30 -150.69 74.62 8.66 Favored Pre-proline 0 N--CA 1.44 -0.93 0 C-N-CA 125.511 1.524 . . . . 0.0 109.483 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.22 -158.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.312 4.008 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mt -129.8 156.67 43.96 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 123.037 1.398 . . . . 0.0 111.532 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -154.04 177.14 11.39 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 129.463 3.105 . . . . 0.0 107.739 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -124.63 98.1 37.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.724 0.809 . . . . 0.0 108.86 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.25 -15.45 20.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.806 2.338 . . . . 0.0 112.732 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 0.4 OUTLIER -151.85 157.39 41.83 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 124.262 1.025 . . . . 0.0 112.433 -169.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -85.28 20.99 1.82 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.4 m -47.97 -14.39 0.05 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 126.582 1.953 . . . . 0.0 114.785 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttp-105 58.25 173.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.231 3.412 . . . . 0.0 115.26 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.63 -161.59 26.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.775 -1.203 . . . . 0.0 112.981 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.7 p -65.04 -24.15 67.4 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.494 -1.003 . . . . 0.0 113.194 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 pt -74.9 -3.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -74.17 -20.07 60.34 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.486 1.039 . . . . 0.0 112.684 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -90.3 139.93 30.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.433 1.093 . . . . 0.0 113.661 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 mtt -151.83 142.94 23.21 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.563 0.745 . . . . 0.0 111.973 -174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.45 ' CG ' HD22 ' A' ' 50' ' ' ASN . 23.5 m170 -70.1 149.5 47.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.177 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.53 -33.98 77.17 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.719 -0.613 . . . . 0.0 110.681 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.1 m -73.82 -42.94 60.17 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.758 -0.589 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.0 m -64.59 -43.5 93.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.916 1.287 . . . . 0.0 112.524 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.14 -44.05 97.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.386 0.994 . . . . 0.0 110.088 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.02 -28.84 59.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.257 1.023 . . . . 0.0 113.531 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -91.05 -37.0 13.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.281 1.432 . . . . 0.0 111.166 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.449 ' CE2' ' HE3' ' A' ' 77' ' ' LYS . 88.8 t90 -60.55 -51.74 68.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.49 -34.14 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.422 -0.799 . . . . 0.0 111.437 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.51 78.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.983 -0.448 . . . . 0.0 111.408 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -71.02 -30.87 67.21 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.967 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' HE3' ' CE2' ' A' ' 73' ' ' TRP . 56.1 mmtt -81.05 8.38 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.496 2.718 . . . . 0.0 113.736 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER 75.68 16.51 2.48 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.4 2.28 . . . . 0.0 115.528 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.73 139.46 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.079 1.352 . . . . 0.0 111.41 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -130.08 112.97 13.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 0.0 112.998 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.2 pt -67.49 -17.87 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 113.94 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -71.77 -13.04 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.12 143.66 27.19 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.698 1.199 . . . . 0.0 111.53 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.68 16.77 1.23 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.049 3.166 . . . . 0.0 116.272 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.25 7.03 25.0 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.536 2.017 . . . . 0.0 112.805 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.8 55.81 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.286 1.034 . . . . 0.0 113.286 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.5 41.08 1.59 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.392 1.877 . . . . 0.0 110.141 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.67 107.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.712 2.405 . . . . 0.0 114.13 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -148.38 144.95 27.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.147 1.779 . . . . 0.0 110.949 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 43.1 t -66.56 170.87 5.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.548 2.339 . . . . 0.0 114.715 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.79 -17.8 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.193 2.597 . . . . 0.0 111.808 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.2 -55.69 11.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.105 . . . . 0.0 109.578 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.9 p -115.85 -7.07 12.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.977 0.511 . . . . 0.0 111.894 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 68.89 18.03 8.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.518 2.327 . . . . 0.0 114.678 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.436 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.8 m-85 -82.75 145.31 50.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 120.817 -1.177 . . . . 0.0 111.966 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.37 132.19 39.86 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.577 2.185 . . . . 0.0 109.85 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -85.22 116.02 27.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 126.255 1.822 . . . . 0.0 108.854 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -114.26 111.94 22.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -170.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -73.47 48.37 0.25 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.994 2.118 . . . . 0.0 111.915 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.7 126.7 16.35 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.585 2.754 . . . . 0.0 113.451 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.251 1.155 0 C-N-CA 127.111 2.164 . . . . 0.0 111.188 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.48 166.68 10.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 113.499 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -149.18 -12.84 0.31 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -158.41 -24.91 0.08 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.336 1.454 . . . . 0.0 114.056 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -47.88 -45.58 30.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.182 2.193 . . . . 0.0 112.958 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -67.23 -0.06 3.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.863 2.065 . . . . 0.0 115.515 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.92 18.73 15.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.656 1.982 . . . . 0.0 112.711 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -71.2 164.08 26.37 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.197 1.399 . . . . 0.0 111.685 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.72 23.09 3.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.748 1.219 . . . . 0.0 114.032 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m 50.58 54.22 11.56 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.06 1.744 . . . . 0.0 111.854 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -50.5 153.24 1.65 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.4 2.28 . . . . 0.0 114.57 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -165.93 174.58 9.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.702 2.001 . . . . 0.0 111.074 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -132.81 144.34 50.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.994 1.318 . . . . 0.0 111.139 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -75.11 79.51 2.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.0 149.41 71.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.33 2.252 . . . . 0.0 110.67 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.18 155.85 8.55 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.921 3.081 . . . . 0.0 113.872 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.6 p -97.83 10.55 39.88 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.44 1.496 . . . . 0.0 113.185 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.97 7.45 0.56 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.4 147.93 30.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.309 1.555 . . . . 0.0 109.962 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 57.1 p -141.49 145.36 35.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.033 1.333 . . . . 0.0 112.652 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.8 t -58.33 140.17 53.95 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.941 1.296 . . . . 0.0 114.246 174.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.1 mt -99.22 -48.16 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 110.502 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.4 m -107.38 -4.64 18.37 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 49.34 31.23 3.67 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.234 2.214 . . . . 0.0 112.385 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.64 141.59 16.18 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.297 0.951 . . . . 0.0 112.627 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.76 160.43 11.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.922 1.289 . . . . 0.0 113.554 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.48 144.26 51.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.519 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.7 p -128.35 157.69 40.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.313 1.054 . . . . 0.0 112.636 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -57.72 -11.59 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.63 -21.77 5.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.432 1.493 . . . . 0.0 111.475 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.464 HD22 ' HB3' ' A' ' 66' ' ' HIS . 35.6 t30 -141.02 67.48 27.14 Favored Pre-proline 0 N--CA 1.444 -0.747 0 C-N-CA 124.118 0.967 . . . . 0.0 113.49 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -49.75 167.74 0.18 Allowed 'Trans proline' 0 C--O 1.235 0.371 1 C-N-CA 125.5 4.133 . . . . 0.0 116.928 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.62 142.33 44.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.177 173.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -152.75 -177.49 6.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.671 1.988 . . . . 0.0 108.765 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -114.99 108.23 48.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.841 0.856 . . . . 0.0 110.354 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.85 -18.82 16.67 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.622 2.881 . . . . 0.0 112.764 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.281 5.1 t -141.15 -161.33 1.2 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 129.678 3.191 . . . . 0.0 106.889 -167.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 59' ' ' ARG . 70.5 mmtt -95.11 -41.58 9.03 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.255 169.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.321 6.2 m 40.97 -5.47 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 1 C-N-CA 132.309 4.244 . . . . 0.0 119.298 -173.26 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 57' ' ' LYS . 25.8 tpt180 45.52 67.9 0.66 Allowed 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 131.78 4.032 . . . . 0.0 117.743 173.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.93 -174.19 31.01 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 125.942 1.734 . . . . 0.0 111.844 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -55.83 -23.92 33.34 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.215 1.008 . . . . 0.0 111.854 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -61.98 -14.62 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 113.498 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -70.36 -5.91 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.768 -1.207 . . . . 0.0 114.02 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -97.48 138.95 34.12 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.727 1.211 . . . . 0.0 110.724 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 83.3 mtp -158.35 145.89 18.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.606 1.562 . . . . 0.0 109.684 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.464 ' HB3' HD22 ' A' ' 50' ' ' ASN . 44.5 m80 -69.99 151.53 45.47 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.26 -38.88 77.81 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.749 -0.594 . . . . 0.0 110.712 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -81.32 -31.62 33.44 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -76.03 -41.05 52.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.411 1.101 . . . . 0.0 112.245 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.86 -49.85 74.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.708 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 mt -55.14 -35.39 64.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.423 1.089 . . . . 0.0 112.748 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -81.49 -37.67 27.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.216 0.462 . . . . 0.0 112.096 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -62.91 -51.02 68.56 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.681 -0.637 . . . . 0.0 110.715 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.78 -31.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.938 0.79 . . . . 0.0 112.331 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.66 -20.21 61.29 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.088 -0.382 . . . . 0.0 111.868 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -80.57 -5.02 56.16 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.804 -1.185 . . . . 0.0 111.867 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -92.11 9.85 31.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.611 1.964 . . . . 0.0 114.049 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 79.61 9.3 1.56 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.816 2.046 . . . . 0.0 113.844 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mt -109.89 124.22 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 111.342 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -87.4 82.33 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.174 0.988 . . . . 0.0 111.099 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -9.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 113.818 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.7 t -65.9 -25.77 67.32 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.15 -0.344 . . . . 0.0 110.977 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -92.52 143.55 27.4 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.521 1.128 . . . . 0.0 110.545 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.47 9.24 2.62 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.687 2.925 . . . . 0.0 116.624 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.3 -9.44 69.88 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.524 1.535 . . . . 0.0 113.32 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.59 150.2 49.1 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.203 1.001 . . . . 0.0 112.741 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.57 49.7 1.22 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.137 1.775 . . . . 0.0 109.839 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.01 131.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 126.234 1.814 . . . . 0.0 111.982 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -142.87 144.16 32.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.962 1.705 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 17.5 t -59.04 169.54 1.04 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.974 2.109 . . . . 0.0 115.743 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -127.76 -8.09 5.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.541 2.736 . . . . 0.0 112.041 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.3 mt -89.91 -56.28 5.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 124.022 0.929 . . . . 0.0 108.784 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.03 -1.76 11.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.017 0.927 . . . . 0.0 111.708 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 70.6 m80 61.31 16.74 7.64 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.896 2.078 . . . . 0.0 115.164 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.9 m-85 -77.03 144.24 71.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 120.848 -1.157 . . . . 0.0 111.297 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -57.67 148.82 71.8 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.402 2.068 . . . . 0.0 109.988 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.45 135.55 56.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 124.078 0.951 . . . . 0.0 110.78 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -121.96 125.59 46.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.216 1.006 . . . . 0.0 110.842 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -68.36 -1.37 6.25 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -160.87 161.98 32.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.601 2.36 . . . . 0.0 110.489 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.251 1.177 0 C-N-CA 127.012 2.125 . . . . 0.0 113.776 176.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.06 59.08 1.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.897 1.679 . . . . 0.0 110.258 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -133.25 22.4 4.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.854 1.661 . . . . 0.0 113.488 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -71.3 170.94 12.04 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 111.73 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.65 -4.6 4.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 p -142.78 137.65 29.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.805 1.242 . . . . 0.0 112.549 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -111.41 -135.17 0.36 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 0.0 110.115 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -138.38 138.17 38.0 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 109.881 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.02 173.17 14.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.81 1.244 . . . . 0.0 112.656 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -140.55 160.21 40.51 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.943 1.697 . . . . 0.0 111.072 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -125.98 169.93 12.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.706 1.202 . . . . 0.0 112.879 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.68 3.66 3.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.253 1.421 . . . . 0.0 113.523 -176.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -152.73 145.38 24.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.825 2.05 . . . . 0.0 108.505 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 67.94 -31.65 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.081 2.552 . . . . 0.0 116.486 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.56 153.94 32.71 Favored Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 128.979 2.912 . . . . 0.0 111.353 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -89.59 -137.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.867 3.711 . . . . 0.0 111.409 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.6 m -72.63 53.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.36 35.05 83.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.495 1.045 . . . . 0.0 112.855 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.13 162.93 27.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.482 0.713 . . . . 0.0 112.071 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -149.87 160.78 43.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.033 1.333 . . . . 0.0 113.55 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.1 t -69.12 125.16 25.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.18 1.792 . . . . 0.0 112.822 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -10.32 56.06 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.259 -0.901 . . . . 0.0 113.136 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 mt -91.77 -46.18 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 125.097 1.359 . . . . 0.0 109.668 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -125.73 3.22 7.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 59.25 31.27 21.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.736 2.015 . . . . 0.0 113.815 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 144.89 17.14 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.87 169.32 10.01 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.159 0.981 . . . . 0.0 111.685 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.74 53.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.8 p -114.94 168.56 9.8 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.112 0.958 . . . . 0.0 111.797 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.56 -19.31 37.0 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -121.49 -17.85 7.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 110.92 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.57 58.0 16.1 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.15 145.31 26.45 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.506 2.137 . . . . 0.0 111.919 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.38 175.58 9.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.136 -2.302 . . . . 0.0 109.92 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.4 175.47 2.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.215 2.206 . . . . 0.0 109.035 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -112.16 95.46 30.36 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.507 1.123 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.08 -30.4 16.35 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.689 2.26 . . . . 0.0 111.688 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.9 t -135.37 -178.99 5.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.836 2.854 . . . . 0.0 110.446 -171.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.62 36.13 4.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.639 1.976 . . . . 0.0 113.419 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.5 m -51.6 -8.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.634 2.374 . . . . 0.0 116.519 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 65.64 175.5 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.875 2.07 . . . . 0.0 114.493 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.12 -150.5 1.01 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.478 1.513 . . . . 0.0 115.538 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -75.47 -1.79 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.788 1.235 . . . . 0.0 113.872 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.7 pt -97.78 -0.61 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.915 1.286 . . . . 0.0 113.91 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -83.61 5.57 23.86 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.47 143.24 45.26 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.673 1.589 . . . . 0.0 109.281 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.7 mtp -154.32 140.3 18.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.641 1.176 . . . . 0.0 111.084 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -70.22 144.57 51.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.049 0.94 . . . . 0.0 110.091 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.98 12.95 1.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 113.545 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -129.84 -40.38 1.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.129 1.372 . . . . 0.0 109.048 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.7 m -59.69 -47.85 83.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.641 1.176 . . . . 0.0 111.332 172.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -56.0 -44.33 78.54 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.275 0.63 . . . . 0.0 110.381 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.17 -22.62 61.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.856 1.262 . . . . 0.0 112.869 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.63 -39.89 8.87 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.828 1.651 . . . . 0.0 111.321 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.4 ' CZ2' ' HE2' ' A' ' 77' ' ' LYS . 91.9 t90 -56.38 -47.55 78.71 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.099 1.36 . . . . 0.0 111.416 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.9 m -66.7 -25.34 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 119.141 0.882 . . . . 0.0 111.817 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.77 -38.42 76.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.115 -0.366 . . . . 0.0 110.591 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 p -69.06 -18.64 64.03 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.068 -1.02 . . . . 0.0 113.605 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HE2' ' CZ2' ' A' ' 73' ' ' TRP . 35.7 mmtm -75.32 6.15 4.81 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.063 2.145 . . . . 0.0 113.619 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.262 9.3 t30 66.07 43.96 2.78 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.599 1.56 . . . . 0.0 111.601 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -138.48 140.79 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 109.312 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -117.9 99.58 7.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.411 1.085 . . . . 0.0 111.703 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.2 pt -63.51 -15.9 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.365 1.466 . . . . 0.0 113.881 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -68.75 -23.79 64.37 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.236 0.614 . . . . 0.0 112.084 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -107.18 148.78 37.71 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 125.333 1.453 . . . . 0.0 112.381 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.1 27.7 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.633 3.556 . . . . 0.0 114.673 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.83 -1.86 30.4 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.462 1.982 . . . . 0.0 112.314 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.79 43.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.172 0.989 . . . . 0.0 112.672 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -150.78 46.69 0.86 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.061 1.744 . . . . 0.0 109.741 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.72 109.34 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.999 1.32 . . . . 0.0 113.009 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -143.11 140.21 30.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.383 1.873 . . . . 0.0 110.003 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.6 168.11 2.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.058 2.143 . . . . 0.0 115.19 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -122.97 -7.99 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.543 2.337 . . . . 0.0 111.919 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -88.16 -57.29 4.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.659 1.184 . . . . 0.0 108.46 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.4 p -110.99 -6.88 14.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.104 0.562 . . . . 0.0 111.749 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.254 73.9 m80 64.44 19.25 11.73 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.706 2.002 . . . . 0.0 114.305 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.446 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.5 m-85 -82.11 145.02 51.87 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.056 -1.027 . . . . 0.0 111.413 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.53 153.0 69.64 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.811 1.674 . . . . 0.0 109.256 168.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.15 141.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.902 0.858 . . . . 0.0 110.092 -173.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -113.89 121.84 45.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.819 1.248 . . . . 0.0 111.101 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.3 -4.35 53.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -163.72 152.81 14.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.684 2.794 . . . . 0.0 109.685 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.006 1.722 . . . . 0.0 112.698 178.387 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 110.91 -0.033 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.63 18.93 1.67 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -145.89 151.83 38.49 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.785 1.634 . . . . 0.0 111.101 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.48 -42.47 99.51 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -48.74 2.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 130.429 3.491 . . . . 0.0 119.031 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.2 p -127.93 -3.62 5.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.345 1.458 . . . . 0.0 113.448 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.23 -11.94 8.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.14 1.776 . . . . 0.0 113.788 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 t -155.06 158.56 39.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.156 2.182 . . . . 0.0 110.493 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.87 43.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.236 1.015 . . . . 0.0 113.661 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.1 p -56.25 -7.42 0.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 118.281 2.697 . . . . 0.0 118.281 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.45 140.85 49.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.79 1.636 . . . . 0.0 112.566 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -141.6 123.12 15.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.754 2.021 . . . . 0.0 109.865 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.97 166.23 22.61 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.286 1.435 . . . . 0.0 114.155 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -63.74 179.66 0.47 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.65 160.52 53.15 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.622 2.369 . . . . 0.0 111.096 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -45.38 -2.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 2 C-N-CA 128.512 6.141 . . . . 0.0 125.202 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m 45.53 10.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.823 2.449 . . . . 0.0 117.48 -170.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.34 -2.2 0.34 Allowed Glycine 0 CA--C 1.54 1.601 0 C-N-CA 127.594 2.521 . . . . 0.0 114.293 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.02 161.99 30.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.667 1.234 . . . . 0.0 108.481 172.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.7 p -148.3 148.7 30.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.073 0.949 . . . . 0.0 113.225 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.43 127.93 34.15 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.461 1.904 . . . . 0.0 110.751 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -14.85 62.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.4 mt -96.64 -52.8 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.513 1.125 . . . . 0.0 110.346 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.53 -16.66 36.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 54.95 38.71 30.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.454 1.502 . . . . 0.0 110.445 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.36 156.25 22.31 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 122.802 1.223 . . . . 0.0 111.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -63.44 166.87 6.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 126.669 1.988 . . . . 0.0 115.932 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 158.41 28.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.721 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.6 p -137.27 160.09 40.03 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.281 1.039 . . . . 0.0 113.113 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.92 -9.27 3.95 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.85 -27.55 4.26 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.632 1.573 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -138.07 67.05 47.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.0 176.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 126.82 5.013 . . . . 0.0 117.75 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.01 145.49 43.64 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.92 172.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -156.39 -176.49 5.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.536 2.334 . . . . 0.0 109.632 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -119.49 102.4 47.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.302 1.041 . . . . 0.0 113.571 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.63 -33.52 1.25 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.102 1.201 . . . . 0.0 113.082 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 12.0 p -147.18 150.31 34.67 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.638 1.975 . . . . 0.0 110.165 -170.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 12.1 mptt -84.05 28.27 0.62 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.456 -1.247 . . . . 0.0 114.169 -174.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.46 87.91 5.06 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 161.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.433 ' H ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -175.81 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 3 C-N-CA 141.81 8.044 . . . . 0.0 112.122 1.415 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.6 -139.43 6.11 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.067 1.794 . . . . 0.0 109.624 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -54.01 -29.1 42.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 119.563 1.682 . . . . 0.0 111.775 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 pt -62.59 -9.1 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.121 1.768 . . . . 0.0 113.316 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 59' ' ' ARG . 16.5 pttt -82.13 0.33 41.3 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.339 -0.851 . . . . 0.0 112.012 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.61 139.18 31.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.36 1.464 . . . . 0.0 108.751 171.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.5 ttp -161.6 145.45 12.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.828 0.851 . . . . 0.0 110.438 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -67.84 154.89 40.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.372 0.533 . . . . 0.0 110.787 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.79 -45.42 92.38 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.277 -0.889 . . . . 0.0 109.638 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 p -54.98 -54.34 44.13 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.982 0.913 . . . . 0.0 112.375 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.6 -36.99 84.53 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.376 1.47 . . . . 0.0 112.747 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.2 tp -66.3 -47.02 74.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.13 1.332 . . . . 0.0 110.723 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.57 -32.74 70.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.187 1.795 . . . . 0.0 111.92 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -79.6 -41.09 27.84 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 128.076 2.55 . . . . 0.0 111.199 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -62.28 -50.77 70.36 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.998 -1.064 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.46 -32.13 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.794 0.724 . . . . 0.0 110.605 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.09 93.13 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.593 -0.692 . . . . 0.0 109.983 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -61.65 -16.27 47.17 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.594 -1.316 . . . . 0.0 113.462 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.84 3.75 50.12 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.142 1.777 . . . . 0.0 112.586 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.252 10.1 t30 64.62 44.09 4.06 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.114 1.365 . . . . 0.0 112.375 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -135.61 142.22 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.762 1.225 . . . . 0.0 110.424 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -108.77 100.43 9.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.811 1.244 . . . . 0.0 109.422 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.27 -11.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 t -76.99 -21.42 54.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.179 0.592 . . . . 0.0 112.048 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.89 144.34 90.39 Favored Pre-proline 0 N--CA 1.475 0.821 0 O-C-N 120.985 -1.072 . . . . 0.0 111.558 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.38 7.03 3.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.642 2.894 . . . . 0.0 116.768 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.02 -3.08 34.02 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.451 1.977 . . . . 0.0 112.519 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.42 127.83 34.41 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.285 1.042 . . . . 0.0 111.755 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.36 40.92 1.61 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.219 1.808 . . . . 0.0 109.8 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.18 124.78 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.341 2.256 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -139.16 131.35 28.18 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.468 1.507 . . . . 0.0 110.625 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.9 t -66.47 126.91 30.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.49 -21.53 41.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.13 -66.69 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.625 1.17 . . . . 0.0 111.338 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 30.0 p -83.39 -18.99 36.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 111.423 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 21.7 t60 79.79 1.43 2.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.332 3.053 . . . . 0.0 112.609 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 57' ' ' LYS . 53.6 m-85 -83.89 131.2 52.36 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.402 -1.436 . . . . 0.0 112.098 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.46 145.83 66.31 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.314 3.343 . . . . 0.0 111.44 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 mm -74.12 107.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 122.233 1.016 . . . . 0.0 109.39 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -99.89 85.82 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 113.198 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -58.98 128.49 37.51 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.086 1.354 . . . . 0.0 111.019 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -69.55 145.81 52.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.442 1.097 . . . . 0.0 113.174 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 125.571 1.548 . . . . 0.0 109.312 173.397 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.8 161.29 34.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.72 1.208 . . . . 0.0 112.739 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -121.82 178.53 4.83 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.339 1.856 . . . . 0.0 112.826 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -145.77 165.06 29.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.637 1.975 . . . . 0.0 109.787 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.14 12.71 1.73 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.771 1.229 . . . . 0.0 114.025 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 p -76.57 163.93 26.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.626 1.57 . . . . 0.0 112.824 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.52 142.86 23.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.997 1.319 . . . . 0.0 111.417 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.1 p -137.59 9.37 2.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 113.704 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.22 145.73 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -146.01 151.42 37.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.661 2.385 . . . . 0.0 109.744 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -52.09 143.18 14.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.625 1.17 . . . . 0.0 113.34 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -141.61 170.65 15.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.636 1.974 . . . . 0.0 111.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.93 132.26 30.06 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.054 1.342 . . . . 0.0 111.886 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -76.3 166.67 23.12 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 40.62 68.3 2.41 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 127.519 2.328 . . . . 0.0 115.168 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.49 142.71 98.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.656 2.237 . . . . 0.0 114.426 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -92.92 54.96 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.437 1.113 . . . . 0.0 108.22 169.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.56 48.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.019 1.771 . . . . 0.0 112.412 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.94 -175.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 111.525 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 p -160.53 172.96 16.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 112.016 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -84.89 127.25 34.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.769 1.228 . . . . 0.0 107.698 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -20.63 66.47 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.157 1.344 . . . . 0.0 112.945 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.2 mt -79.94 -43.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 117.542 -1.218 . . . . 0.0 109.503 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.36 -2.18 8.54 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.322 38.8 mmt180 52.3 45.86 27.7 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.2 1.8 . . . . 0.0 111.413 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.43 134.23 12.04 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 111.643 -2.526 . . . . 0.0 110.422 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.36 155.07 41.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.874 0.845 . . . . 0.0 110.955 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.9 156.36 2.91 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -128.65 173.36 10.36 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.36 1.076 . . . . 0.0 113.042 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.42 5.01 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.853 1.798 . . . . 0.0 115.853 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -145.98 -28.85 0.42 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.367 1.467 . . . . 0.0 111.636 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -127.69 67.84 73.48 Favored Pre-proline 0 N--CA 1.44 -0.941 0 C-N-CA 125.657 1.583 . . . . 0.0 110.231 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.34 -171.42 1.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.074 3.849 . . . . 0.0 112.109 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.72 142.09 46.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 110.87 -2.877 . . . . 0.0 109.359 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -158.0 -166.65 2.02 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 128.359 2.664 . . . . 0.0 107.738 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.54 107.79 14.48 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.247 1.019 . . . . 0.0 112.5 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.15 -18.6 9.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.878 3.052 . . . . 0.0 113.743 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 9.8 t -143.43 171.68 13.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.269 2.228 . . . . 0.0 110.142 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -83.28 20.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 129.681 3.193 . . . . 0.0 113.784 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -12.26 0.18 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 55.23 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 130.534 3.534 . . . . 0.0 120.068 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 62' ' ' ILE . . . -86.35 -175.91 49.69 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.342 1.428 . . . . 0.0 113.52 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -69.12 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.409 ' H ' ' C ' ' A' ' 60' ' ' GLY . 2.1 pp -118.73 -28.1 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.748 2.419 . . . . 0.0 108.704 171.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -54.05 -29.11 42.74 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.263 1.392 . . . . 0.0 113.585 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.34 134.17 49.88 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.707 1.241 . . . . 0.0 111.839 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.4 mtt -157.69 143.81 17.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.214 1.405 . . . . 0.0 109.706 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -69.0 155.38 40.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.567 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.97 -52.27 66.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.483 -0.76 . . . . 0.0 110.564 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -60.31 -45.46 93.32 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.562 -0.711 . . . . 0.0 112.313 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.1 -44.77 91.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.731 0.696 . . . . 0.0 112.07 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.05 -47.06 87.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.964 0.802 . . . . 0.0 110.141 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.64 -28.03 66.87 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.965 0.906 . . . . 0.0 112.787 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -85.65 -34.02 21.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.865 0.866 . . . . 0.0 111.723 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -58.81 -59.05 6.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 109.951 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.84 -23.52 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 111.811 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.0 -0.44 55.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.2 m -113.5 -5.4 13.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.99 1.716 . . . . 0.0 111.811 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -80.28 6.0 13.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.701 2.8 . . . . 0.0 114.691 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.318 0.0 OUTLIER 76.34 32.15 0.59 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.684 1.593 . . . . 0.0 111.518 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -142.08 159.77 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.748 2.019 . . . . 0.0 109.795 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -132.83 112.98 12.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.534 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.8 pt -61.23 -17.68 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.231 1.412 . . . . 0.0 114.452 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -74.36 -26.78 60.34 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.204 0.456 . . . . 0.0 111.873 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.83 145.31 83.95 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 121.263 -0.898 . . . . 0.0 112.734 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -79.86 27.42 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.54 3.493 . . . . 0.0 114.948 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.47 20.99 3.66 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.167 2.318 . . . . 0.0 111.188 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.81 131.8 38.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.755 0.822 . . . . 0.0 112.743 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -145.62 55.78 1.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.575 1.95 . . . . 0.0 108.6 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -71.55 37.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.818 2.047 . . . . 0.0 116.024 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -58.44 141.91 50.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.699 2.8 . . . . 0.0 113.005 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 46.9 t -60.33 116.51 4.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.556 1.942 . . . . 0.0 110.759 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -78.11 13.97 1.3 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.65 -47.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.86 1.264 . . . . 0.0 110.502 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -116.44 -9.31 11.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.187 1.795 . . . . 0.0 111.816 -174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.277 78.4 m-70 65.4 31.31 10.45 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.972 2.109 . . . . 0.0 115.823 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.507 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.6 m-85 -106.96 138.19 19.74 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.868 1.267 . . . . 0.0 112.552 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.94 135.55 71.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.394 2.063 . . . . 0.0 110.31 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.1 mm -74.93 136.98 23.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.029 0.932 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -123.98 88.2 2.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.597 1.189 . . . . 0.0 113.503 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.56 64.14 7.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.223 1.809 . . . . 0.0 110.137 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.68 149.81 20.99 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.999 1.32 . . . . 0.0 113.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.489 1.916 . . . . 0.0 111.59 179.524 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.711 -0.185 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.54 11.9 2.97 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -52.53 156.46 1.82 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.628 1.571 . . . . 0.0 113.75 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.17 -34.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.036 2.934 . . . . 0.0 109.303 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -45.13 -32.18 1.71 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.054 2.541 . . . . 0.0 115.079 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -62.82 -12.87 27.43 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.99 144.1 54.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.925 1.29 . . . . 0.0 111.479 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -137.64 38.41 2.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.57 126.94 21.2 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.852 -1.155 . . . . 0.0 111.057 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.2 m -145.28 143.73 30.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.937 1.695 . . . . 0.0 110.133 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -134.59 145.03 48.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.434 1.494 . . . . 0.0 111.132 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -124.26 5.31 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.8 28.35 0.11 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -127.49 15.3 7.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.114 2.566 . . . . 0.0 112.528 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.6 161.34 71.38 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 127.507 2.323 . . . . 0.0 113.439 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -39.01 127.33 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 125.175 3.917 . . . . 0.0 117.826 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -142.66 42.12 1.59 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.957 2.503 . . . . 0.0 109.917 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.13 19.03 7.84 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.942 1.734 . . . . 0.0 111.556 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.86 152.67 45.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.884 1.274 . . . . 0.0 110.244 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 79.0 p -143.91 153.1 41.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.738 1.215 . . . . 0.0 112.333 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 t -59.91 127.19 30.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.482 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -14.0 61.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 112.899 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.08 -46.28 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.3 p -113.8 -7.33 13.24 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.315 31.2 mmt180 57.22 44.72 21.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.063 1.345 . . . . 0.0 112.552 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.96 16.49 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 172.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.0 172.43 4.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.45 1.1 . . . . 0.0 111.764 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.84 161.81 23.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.538 0.685 . . . . 0.0 109.637 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.4 p -136.93 166.78 22.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.208 0.603 . . . . 0.0 111.108 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.43 -22.25 64.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.71 -27.77 10.1 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.078 1.751 . . . . 0.0 111.376 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.444 HD22 ' HB3' ' A' ' 66' ' ' HIS . 58.1 t30 -137.27 66.9 53.51 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.51 173.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.546 4.164 . . . . 0.0 116.364 172.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.3 mt -110.24 146.01 36.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.105 -1.861 . . . . 0.0 110.49 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.46 -177.9 6.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.074 2.149 . . . . 0.0 108.827 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -126.12 118.01 23.67 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.929 0.892 . . . . 0.0 109.201 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.68 -26.41 7.01 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.108 2.538 . . . . 0.0 111.575 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.58 -152.71 0.51 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 128.326 2.65 . . . . 0.0 110.962 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 6.1 mmtt -119.66 13.35 12.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.549 1.939 . . . . 0.0 113.69 -174.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 m -44.35 -17.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -174.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? 38.99 34.55 0.1 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 129.11 2.964 . . . . 0.0 118.435 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.33 28.36 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.602 1.096 . . . . 0.0 114.642 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.5 p -64.19 9.42 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.475 1.51 . . . . 0.0 114.437 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.02 12.33 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.559 2.343 . . . . 0.0 110.22 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -90.26 -21.87 21.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 113.214 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -79.85 140.36 36.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.967 1.307 . . . . 0.0 111.597 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.0 mtp -154.61 143.04 20.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.671 1.188 . . . . 0.0 110.527 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.444 ' HB3' HD22 ' A' ' 50' ' ' ASN . 42.8 m80 -76.11 158.45 31.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.2 -46.91 88.52 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.243 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 m -65.1 -48.55 73.28 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.654 0.782 . . . . 0.0 111.613 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.62 -39.44 88.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.955 -1.09 . . . . 0.0 111.603 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.03 -49.89 75.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.043 1.747 . . . . 0.0 109.815 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.9 -30.7 68.0 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 113.447 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.46 -34.65 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.001 2.52 . . . . 0.0 112.225 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -70.6 -52.84 18.7 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.449 1.1 . . . . 0.0 109.156 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.4 m -58.88 -30.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.989 0.813 . . . . 0.0 110.573 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.18 75.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.34 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 t -60.92 -30.96 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.709 -1.244 . . . . 0.0 111.591 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.63 8.67 7.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.721 2.808 . . . . 0.0 114.025 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.286 0.0 OUTLIER 74.7 18.99 2.65 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.907 2.083 . . . . 0.0 115.531 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.92 141.69 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -129.79 113.39 14.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.027 1.331 . . . . 0.0 111.533 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -21.07 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.592 1.557 . . . . 0.0 114.003 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -75.3 -16.98 60.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.795 0.838 . . . . 0.0 112.888 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.89 142.15 51.92 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 120.928 -1.108 . . . . 0.0 113.252 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.48 17.74 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.571 3.514 . . . . 0.0 115.314 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.98 16.15 5.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.369 2.414 . . . . 0.0 111.541 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.14 147.89 42.51 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.525 0.73 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.19 39.93 0.93 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.853 1.661 . . . . 0.0 110.366 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -53.77 116.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.284 1.834 . . . . 0.0 113.084 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -148.75 147.21 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.843 1.657 . . . . 0.0 111.473 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.8 t -64.03 172.18 2.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.53 1.532 . . . . 0.0 113.76 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -129.74 0.49 4.89 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.764 2.025 . . . . 0.0 112.673 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -105.04 -65.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.1 p -92.74 -9.37 40.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.612 1.965 . . . . 0.0 111.078 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.343 4.3 p-80 58.7 16.72 4.58 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.163 2.585 . . . . 0.0 115.905 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.475 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 28.7 m-85 -81.59 143.78 51.64 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 120.018 1.281 . . . . 0.0 113.232 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.02 136.03 29.49 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.895 3.063 . . . . 0.0 111.772 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -82.79 124.33 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.894 1.278 . . . . 0.0 109.988 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.86 93.22 4.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.323 1.449 . . . . 0.0 112.159 -175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -62.08 158.33 16.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.475 1.11 . . . . 0.0 111.226 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.5 162.79 14.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.397 1.079 . . . . 0.0 112.964 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.543 1.937 . . . . 0.0 112.858 -179.239 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.62 40.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.98 1.312 . . . . 0.0 111.702 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -102.11 158.14 16.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.122 1.369 . . . . 0.0 113.495 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -142.27 145.08 33.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.083 2.153 . . . . 0.0 109.879 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -165.58 -36.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.791 1.637 . . . . 0.0 113.055 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 p -60.74 -14.59 22.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 119.517 3.155 . . . . 0.0 119.517 -170.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -60.83 167.37 2.84 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.8 t -115.17 -136.63 0.36 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.378 1.871 . . . . 0.0 109.645 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.02 164.43 31.19 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.818 1.644 . . . . 0.0 112.074 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -141.6 148.71 39.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.754 1.622 . . . . 0.0 110.503 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -154.03 155.25 35.15 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.216 1.406 . . . . 0.0 111.218 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -141.39 152.87 44.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.825 1.65 . . . . 0.0 111.432 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.0 p-10 -146.13 149.9 34.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.488 1.115 . . . . 0.0 113.288 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 68.88 -24.93 0.14 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 128.895 2.878 . . . . 0.0 115.237 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 31' ' ' ASP . . . -125.86 80.04 67.73 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.379 2.672 . . . . 0.0 112.373 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -64.96 153.48 78.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.626 2.217 . . . . 0.0 113.171 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.0 m -97.8 18.24 16.21 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.859 1.264 . . . . 0.0 111.924 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.79 52.2 0.2 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 128.122 2.772 . . . . 0.0 109.989 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 170.85 6.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.665 1.186 . . . . 0.0 111.892 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.3 p -150.34 165.82 31.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.99 1.316 . . . . 0.0 112.135 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.41 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 39.1 t -75.62 120.97 21.75 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 114.336 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -9.17 13.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.57 1.148 . . . . 0.0 113.186 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.41 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 57.5 mt -99.26 -42.05 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.109 1.364 . . . . 0.0 110.831 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.77 12.42 4.03 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 53.75 19.39 1.84 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.681 2.793 . . . . 0.0 115.488 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.52 144.94 25.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.56 173.85 8.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 110.404 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.06 157.41 22.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.416 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.3 p -127.05 165.23 19.88 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.48 1.133 . . . . 0.0 112.407 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -61.51 -15.7 40.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.01 -24.28 2.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.129 0.972 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -136.59 71.72 58.09 Favored Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 124.753 1.221 . . . . 0.0 111.324 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.92 -160.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 124.499 3.466 . . . . 0.0 109.291 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mt -120.05 141.86 49.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.093 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -144.76 173.85 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 110.877 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -113.98 101.87 54.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.552 1.141 . . . . 0.0 112.381 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.68 -36.1 8.91 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.97 1.78 . . . . 0.0 111.443 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.9 t -119.7 -164.26 1.05 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 129.07 2.948 . . . . 0.0 112.294 -166.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -116.11 1.44 13.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.98 2.512 . . . . 0.0 115.247 -172.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 m -34.15 -48.69 0.33 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.598 2.359 . . . . 0.0 114.944 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 109.5 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 1 C-N-CA 132.925 4.49 . . . . 0.0 112.052 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 18.72 -109.98 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 129.213 3.292 . . . . 0.0 117.643 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -55.51 -5.26 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -174.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.94 19.41 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.85 1.659 . . . . 0.0 111.165 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -100.28 -53.56 3.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.705 1.202 . . . . 0.0 109.72 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -46.48 142.3 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.591 1.956 . . . . 0.0 112.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.1 mtt -159.64 150.57 19.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.474 1.51 . . . . 0.0 111.55 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -74.82 150.94 39.11 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -56.47 -42.32 78.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.822 1.192 . . . . 0.0 111.328 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.0 p -61.22 -46.29 91.05 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.372 1.469 . . . . 0.0 112.631 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.4 m -64.78 -40.13 94.75 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 112.292 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.58 -47.72 84.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.65 1.114 . . . . 0.0 110.289 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.45 -31.05 63.6 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.186 2.194 . . . . 0.0 113.268 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -92.46 -35.48 13.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.912 1.285 . . . . 0.0 112.143 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -62.97 -48.25 79.68 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.651 0.78 . . . . 0.0 111.04 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.87 -27.22 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.986 0.812 . . . . 0.0 111.585 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.39 90.25 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.76 -0.587 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.7 p -67.72 -1.66 5.68 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.92 8.63 44.8 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.037 1.29 . . . . 0.0 111.676 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 80.9 30.1 0.17 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.658 2.383 . . . . 0.0 113.296 178.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.25 145.94 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.494 1.118 . . . . 0.0 112.807 -170.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -139.43 111.31 7.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.093 1.357 . . . . 0.0 110.564 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 pt -63.91 -16.54 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.498 1.119 . . . . 0.0 113.321 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -82.11 0.18 41.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.462 1.105 . . . . 0.0 113.462 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -126.77 151.03 72.96 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.697 1.599 . . . . 0.0 112.418 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.38 27.69 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.75 3.633 . . . . 0.0 115.268 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.41 5.54 11.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.952 2.215 . . . . 0.0 112.084 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 144.7 53.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.432 1.093 . . . . 0.0 113.17 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.66 38.41 0.68 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.898 1.679 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.77 99.08 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 126.212 1.805 . . . . 0.0 114.246 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -150.88 142.84 23.94 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.399 2.279 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.5 t -67.15 177.78 1.68 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.231 2.612 . . . . 0.0 116.063 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -132.52 -3.8 3.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.762 2.425 . . . . 0.0 112.769 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mt -86.31 -71.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.788 -1.195 . . . . 0.0 107.854 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 7.9 p -88.03 -15.37 36.53 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.844 2.458 . . . . 0.0 110.574 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.4 m80 69.66 17.5 7.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.907 2.483 . . . . 0.0 113.11 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.422 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 10.3 m-85 -76.19 146.65 78.65 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.46 149.21 76.28 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.228 2.619 . . . . 0.0 111.276 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.63 140.76 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.665 1.186 . . . . 0.0 109.906 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -135.64 137.2 41.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.144 0.974 . . . . 0.0 112.877 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -97.51 17.17 18.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.871 1.269 . . . . 0.0 113.287 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -152.98 139.46 18.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.304 2.242 . . . . 0.0 110.36 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.707 2.003 . . . . 0.0 113.975 -178.208 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.57 163.68 38.09 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.204 1.402 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -69.67 -8.36 47.01 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.86 17.13 2.66 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.032 1.733 . . . . 0.0 113.259 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -42.94 -43.65 4.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.475 1.91 . . . . 0.0 114.586 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.8 p -136.38 128.1 29.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.458 1.503 . . . . 0.0 111.167 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -156.71 154.58 30.28 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.568 1.547 . . . . 0.0 111.096 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.2 p -147.27 145.37 29.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.533 1.533 . . . . 0.0 111.288 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.33 22.53 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 p -111.79 122.93 49.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.514 1.525 . . . . 0.0 111.881 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -139.86 130.26 25.45 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.673 1.589 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -89.7 -15.09 33.34 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.647 1.179 . . . . 0.0 113.265 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -147.12 164.74 32.14 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.469 1.908 . . . . 0.0 110.359 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -147.58 10.88 0.97 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.161 1.385 . . . . 0.0 113.771 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.17 120.66 81.42 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.768 1.627 . . . . 0.0 112.81 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -61.25 -178.73 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.948 3.099 . . . . 0.0 113.716 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -71.72 32.64 0.05 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.977 2.511 . . . . 0.0 116.463 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.01 -38.06 1.92 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.961 2.696 . . . . 0.0 109.309 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 93.54 129.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 131.43 3.892 . . . . 0.0 112.854 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.3 p -136.01 150.39 49.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.832 2.853 . . . . 0.0 114.393 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.439 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 51.2 t -61.88 132.62 53.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.66 1.584 . . . . 0.0 111.122 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -20.1 63.56 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.644 -1.285 . . . . 0.0 112.72 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.439 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 96.8 mt -83.25 -39.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 110.34 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.39 -10.87 12.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.253 22.0 mmt85 62.22 40.33 11.69 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.318 2.247 . . . . 0.0 112.567 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.76 152.83 21.12 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 125.325 1.44 . . . . 0.0 114.315 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -156.0 -34.44 0.09 Allowed 'General case' 0 CA--C 1.481 -1.675 1 C-N-CA 133.324 4.65 . . . . 0.0 116.296 -1.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.5 -176.01 5.06 Favored 'General case' 0 C--N 1.305 -1.355 1 C-N-CA 141.687 7.995 . . . . 0.0 112.174 -4.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 p -125.35 148.54 48.71 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.751 -1.218 . . . . 0.0 113.124 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.49 -7.07 1.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.04 -20.52 8.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.577 1.951 . . . . 0.0 111.052 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 66' ' ' HIS . 44.0 t30 -145.75 72.8 13.86 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 125.284 1.434 . . . . 0.0 113.912 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -46.23 173.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.08 4.52 . . . . 0.0 117.014 173.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -116.71 155.58 28.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.512 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -157.04 -171.01 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.065 2.546 . . . . 0.0 107.74 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -125.4 115.56 25.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.926 0.89 . . . . 0.0 109.628 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -78.31 -19.41 11.88 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.833 3.022 . . . . 0.0 112.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.3 p -151.03 151.98 32.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.29 2.636 . . . . 0.0 110.969 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.2 39.86 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.467 1.507 . . . . 0.0 114.519 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.87 -3.73 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 175.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? 23.37 92.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 129.678 3.191 . . . . 0.0 115.867 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.4 23.16 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.924 1.726 . . . . 0.0 112.006 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.9 p -54.03 -37.13 63.78 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.28 1.69 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -80.75 -14.37 58.15 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.376 -0.827 . . . . 0.0 112.923 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.76 140.06 29.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.546 0.738 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.3 mtp -153.86 144.64 22.59 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.115 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 68' ' ' SER . 7.4 m170 -70.26 135.36 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -75.6 32.68 0.11 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.297 1.439 . . . . 0.0 113.4 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 66' ' ' HIS . 33.3 t -145.66 -43.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.304 2.242 . . . . 0.0 108.469 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.0 m -59.19 -48.34 81.97 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.785 1.234 . . . . 0.0 112.948 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.0 tp -58.03 -46.94 84.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 123.853 0.861 . . . . 0.0 110.682 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -22.6 63.54 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.232 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -92.56 -40.16 10.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 110.353 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -56.69 -49.33 75.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.568 1.147 . . . . 0.0 112.172 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.23 -33.44 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.475 0.71 . . . . 0.0 111.956 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.9 81.87 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.741 -0.599 . . . . 0.0 111.24 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.2 m -63.82 -15.52 59.02 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.843 -1.16 . . . . 0.0 113.395 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -75.05 -7.84 54.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.808 1.243 . . . . 0.0 113.14 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 62.91 52.58 2.61 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.836 1.303 . . . . 0.0 112.368 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.4 150.51 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.872 -1.143 . . . . 0.0 111.246 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.16 117.45 9.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.041 0.536 . . . . 0.0 112.096 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.85 0.51 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -96.14 5.55 50.82 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 122.347 1.07 . . . . 0.0 110.249 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? 30.32 80.94 0.23 Allowed Pre-proline 0 CA--C 1.539 0.545 1 C-N-CA 133.049 4.54 . . . . 0.0 119.162 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -84.18 46.96 2.1 Favored 'Trans proline' 0 CA--C 1.544 0.995 1 C-N-CA 126.336 4.691 . . . . 0.0 109.902 172.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.98 -11.55 22.59 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.601 2.048 . . . . 0.0 112.015 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 162.87 13.88 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.019 0.909 . . . . 0.0 113.103 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.11 45.17 1.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.519 1.528 . . . . 0.0 110.619 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.9 t -52.65 114.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.817 1.647 . . . . 0.0 113.74 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -148.28 -177.82 5.97 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.3 t -62.79 164.54 7.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.861 2.064 . . . . 0.0 114.329 -174.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -125.51 13.08 8.12 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.679 1.992 . . . . 0.0 111.784 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 mt -113.43 -55.3 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.82 1.648 . . . . 0.0 108.297 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.48 -10.74 14.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 t60 55.42 19.56 3.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.016 1.726 . . . . 0.0 114.718 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -78.21 139.47 60.51 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.737 -1.227 . . . . 0.0 108.988 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 43.1 Cg_exo -49.68 129.16 23.0 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.058 3.172 . . . . 0.0 112.439 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -89.76 129.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.151 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -118.17 136.6 53.53 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.318 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.72 35.33 4.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.425 1.89 . . . . 0.0 111.26 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -154.35 159.77 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.627 3.171 . . . . 0.0 109.785 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.228 1.811 . . . . 0.0 110.594 178.75 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 111.269 0.1 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.11 163.59 18.69 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.129 0.972 . . . . 0.0 112.042 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -118.1 -8.59 10.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.552 1.141 . . . . 0.0 114.077 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.48 168.81 19.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.395 1.078 . . . . 0.0 112.684 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.96 150.7 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.383 1.873 . . . . 0.0 109.723 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -161.32 179.94 7.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.645 1.978 . . . . 0.0 110.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.97 136.59 58.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.374 1.07 . . . . 0.0 111.289 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 m -145.84 142.7 29.08 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.753 1.221 . . . . 0.0 110.93 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.94 -175.11 1.35 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.122 1.369 . . . . 0.0 112.63 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -140.8 140.92 34.8 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 111.255 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -158.95 162.81 36.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.426 1.891 . . . . 0.0 111.504 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -137.2 63.22 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.113 1.365 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -145.45 143.32 29.96 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.27 24.02 0.05 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.926 2.89 . . . . 0.0 114.374 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -162.86 79.19 1.76 Allowed Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.664 1.586 . . . . 0.0 113.499 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -63.92 151.07 86.82 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.15 1.9 . . . . 0.0 111.628 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -95.57 13.33 26.52 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.51 44.67 0.25 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.989 1.757 . . . . 0.0 112.225 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 168.85 2.56 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.976 1.31 . . . . 0.0 112.104 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.3 p -139.16 157.03 46.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -62.1 134.72 56.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.38 1.472 . . . . 0.0 113.162 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -5.67 43.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.27 -41.66 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.826 1.25 . . . . 0.0 110.112 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.48 6.49 5.24 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 54.45 27.83 8.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.608 1.563 . . . . 0.0 114.467 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.46 140.98 15.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -72.57 162.89 28.89 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.266 1.026 . . . . 0.0 112.681 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.53 140.52 34.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.217 1.407 . . . . 0.0 113.094 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.2 p -114.98 -149.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.607 1.963 . . . . 0.0 110.217 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -109.88 -5.28 15.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.562 1.545 . . . . 0.0 112.284 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.68 -18.22 5.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.362 2.265 . . . . 0.0 110.939 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -141.53 69.79 26.06 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 128.33 2.652 . . . . 0.0 108.408 174.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.15 4.21 6.02 Favored 'Trans proline' 0 N--CA 1.501 1.945 1 C-N-CA 129.397 6.732 . . . . 0.0 118.276 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt 60.08 144.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 1 C-N-CA 136.599 5.959 . . . . 0.0 113.636 -170.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.11 179.83 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.241 1.816 . . . . 0.0 109.483 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -122.65 103.48 37.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.922 1.289 . . . . 0.0 109.829 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.49 -17.92 20.53 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.464 2.109 . . . . 0.0 111.425 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.5 t -134.92 -168.11 2.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.703 2.401 . . . . 0.0 111.428 -168.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -125.14 33.25 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.455 1.502 . . . . 0.0 113.626 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 93' ' ' CYS . 2.3 m -53.72 -10.39 0.29 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.286 1.434 . . . . 0.0 114.091 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 30.36 69.55 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.851 2.86 . . . . 0.0 116.561 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.4 -169.8 42.83 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.44 -1.255 . . . . 0.0 114.013 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -64.04 8.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.822 1.649 . . . . 0.0 114.495 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.87 12.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 127.741 2.416 . . . . 0.0 111.442 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 pttt -90.86 -17.01 27.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.639 1.576 . . . . 0.0 113.08 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.412 ' CE2' ' HE2' ' A' ' 63' ' ' LYS . 45.4 m-85 -90.15 144.32 25.98 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.116 1.766 . . . . 0.0 111.091 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.4 mtp -157.8 143.07 16.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.124 0.97 . . . . 0.0 110.956 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -75.97 144.53 40.92 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.31 -40.72 78.48 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.956 -1.09 . . . . 0.0 110.954 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -59.62 -47.02 87.23 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.525 1.93 . . . . 0.0 112.09 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.3 m -63.17 -46.37 87.45 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.857 1.263 . . . . 0.0 111.122 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.12 -48.85 80.08 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 122.911 0.485 . . . . 0.0 112.059 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.02 -20.85 60.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.635 1.574 . . . . 0.0 112.522 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -96.41 -31.89 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.959 1.704 . . . . 0.0 112.057 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.426 ' CZ2' ' HE3' ' A' ' 77' ' ' LYS . 15.8 t90 -64.05 -57.19 10.4 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.01 1.724 . . . . 0.0 111.746 178.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 m -55.75 -22.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.456 1.502 . . . . 0.0 111.225 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.03 -33.94 22.42 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.036 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 t -70.55 -26.4 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.254 1.422 . . . . 0.0 110.817 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' HE3' ' CZ2' ' A' ' 73' ' ' TRP . 65.8 mmtt -74.35 7.31 2.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.875 2.87 . . . . 0.0 113.747 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 75.16 6.48 4.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.478 2.311 . . . . 0.0 115.531 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.81 152.05 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.37 1.468 . . . . 0.0 111.382 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -134.49 110.33 9.31 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.095 1.358 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -18.46 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.985 1.314 . . . . 0.0 113.702 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -82.59 -5.38 58.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.902 0.881 . . . . 0.0 113.266 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.97 150.06 44.4 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 112.924 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -77.94 23.27 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.494 3.463 . . . . 0.0 115.182 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.88 8.27 16.7 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.691 2.091 . . . . 0.0 112.182 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.61 145.5 51.95 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 113.224 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.16 44.1 0.71 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.335 1.854 . . . . 0.0 109.871 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.79 88.07 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.924 1.69 . . . . 0.0 113.566 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -141.42 139.55 33.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.712 1.605 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.3 t -64.58 176.49 1.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.121 2.568 . . . . 0.0 115.739 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.26 -10.24 4.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.518 2.327 . . . . 0.0 112.591 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -79.44 -64.59 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 122.576 1.179 . . . . 0.0 108.932 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 58' ' ' CYS . 26.5 p -101.4 -11.93 18.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 130.268 3.427 . . . . 0.0 111.222 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.0 m80 70.69 14.95 7.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.439 2.696 . . . . 0.0 114.064 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 17.9 m-85 -78.42 145.84 68.86 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.61 143.13 99.39 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.65 2.233 . . . . 0.0 109.631 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -91.85 132.83 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -127.72 120.34 27.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.285 1.034 . . . . 0.0 111.012 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -73.84 38.51 0.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.38 1.872 . . . . 0.0 114.573 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -157.61 136.04 11.19 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.244 2.218 . . . . 0.0 110.957 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.256 1.399 0 C-N-CA 126.062 1.745 . . . . 0.0 111.981 177.039 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.44 149.7 1.53 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.155 1.782 . . . . 0.0 111.563 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -134.9 151.15 50.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.9 t -46.22 160.27 0.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.634 1.974 . . . . 0.0 112.999 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.13 0.47 40.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.818 2.047 . . . . 0.0 114.678 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.36 -35.23 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.345 2.258 . . . . 0.0 113.223 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.1 p -143.12 23.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 39.15 30.26 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.012 2.125 . . . . 0.0 114.965 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.81 155.98 45.45 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.93 134.32 46.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.302 1.051 . . . . 0.0 108.801 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -35.44 139.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -111.51 -168.8 1.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.702 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -104.05 15.13 29.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.442 2.297 . . . . 0.0 112.421 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.29 -27.93 0.27 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.092 1.757 . . . . 0.0 111.486 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 65.2 t30 -146.35 80.58 9.98 Favored Pre-proline 0 N--CA 1.435 -1.189 0 C-N-CA 126.465 1.906 . . . . 0.0 108.629 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.27 -143.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 125.873 4.382 . . . . 0.0 112.159 -177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -141.42 159.23 42.64 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.101 2.16 . . . . 0.0 108.916 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -165.96 161.22 17.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.919 2.087 . . . . 0.0 108.58 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 8.3 p80 -105.38 109.78 63.6 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.06 0.544 . . . . 0.0 109.726 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 54' ' ' HIS 0.264 61.9 Cg_endo -78.05 -7.5 16.31 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.658 3.572 . . . . 0.0 112.994 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.435 ' HB2' HD13 ' A' ' 97' ' ' ILE . 2.2 t -150.06 176.13 11.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.937 1.695 . . . . 0.0 111.472 -167.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -110.6 36.66 3.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.382 2.273 . . . . 0.0 113.572 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.4 m -59.59 -36.71 76.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.399 0.68 . . . . 0.0 110.6 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 75.16 178.6 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.683 2.793 . . . . 0.0 113.528 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.21 -138.38 43.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.71 1.148 . . . . 0.0 113.973 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -99.6 14.7 29.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.647 1.579 . . . . 0.0 114.574 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 33.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 127.009 2.124 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -106.03 -40.49 5.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.043 1.737 . . . . 0.0 109.957 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -61.78 157.11 18.76 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.893 1.277 . . . . 0.0 112.228 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 ttm -172.48 145.88 1.68 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.127 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.2 m80 -71.28 154.92 41.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.95 -38.87 87.38 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.672 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.1 p -63.65 -55.31 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 111.546 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.24 -43.5 61.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.904 1.282 . . . . 0.0 112.224 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.05 -45.78 87.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.936 0.789 . . . . 0.0 111.55 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -58.88 -28.03 65.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.449 1.1 . . . . 0.0 113.161 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.99 -26.91 21.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.364 1.466 . . . . 0.0 111.919 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.68 -59.45 2.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.218 1.007 . . . . 0.0 110.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.41 -20.08 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.901 1.281 . . . . 0.0 111.604 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.42 -45.32 32.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -59.92 -29.17 68.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.008 1.323 . . . . 0.0 112.53 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.8 -3.39 12.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.669 1.988 . . . . 0.0 113.827 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.06 54.41 2.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.785 1.234 . . . . 0.0 111.948 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -140.05 132.18 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 110.812 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -88.08 97.67 11.11 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.684 0.793 . . . . 0.0 110.487 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 pt -64.7 -10.93 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.839 1.256 . . . . 0.0 113.612 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -93.53 5.61 51.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.231 . . . . 0.0 112.794 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -120.9 144.9 40.2 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.546 1.138 . . . . 0.0 113.983 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -86.12 21.53 1.07 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.798 3.665 . . . . 0.0 113.838 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.36 23.85 10.2 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.039 2.257 . . . . 0.0 111.906 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.93 166.69 20.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.298 1.439 . . . . 0.0 112.888 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.65 36.26 2.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.309 1.844 . . . . 0.0 110.405 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -36.72 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 127.36 2.264 . . . . 0.0 114.751 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 15.4 pttm -158.1 172.46 18.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.58 172.6 1.53 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.645 2.778 . . . . 0.0 116.046 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.32 -17.45 3.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.974 2.51 . . . . 0.0 112.605 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.4 -54.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.137 0.975 . . . . 0.0 109.506 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.2 p -116.2 -9.85 11.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.58 1.952 . . . . 0.0 111.45 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.307 7.3 p80 58.05 22.09 8.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.583 2.753 . . . . 0.0 116.342 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -78.92 137.48 57.6 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.733 -1.229 . . . . 0.0 112.915 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 24.5 Cg_exo -54.54 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.752 2.968 . . . . 0.0 112.303 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' A' ' 56' ' ' CYS . 10.5 mm -68.19 139.91 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.313 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.41 124.71 40.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 112.345 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.85 1.66 . . . . 0.0 114.309 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.474 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.72 128.64 37.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.879 0.872 . . . . 0.0 109.571 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 p -139.13 148.75 43.65 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.207 1.403 . . . . 0.0 112.103 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.48 126.65 17.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.999 1.319 . . . . 0.0 112.378 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -5.43 26.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.852 -1.155 . . . . 0.0 113.446 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.18 -43.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.004 1.321 . . . . 0.0 110.272 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.5 p -125.3 -1.58 7.59 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.318 33.9 mmt180 61.61 25.6 15.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.406 2.282 . . . . 0.0 115.455 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.24 139.64 15.75 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.97 165.28 15.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.109 0.963 . . . . 0.0 112.228 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 139.31 58.75 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.1 p -129.92 160.47 33.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.291 1.043 . . . . 0.0 112.85 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.9 13.54 0.51 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.842 1.657 . . . . 0.0 114.662 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.66 -20.74 2.01 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.293 2.237 . . . . 0.0 110.946 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -158.98 72.34 3.56 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.607 1.163 . . . . 0.0 112.82 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.16 167.36 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 125.274 3.982 . . . . 0.0 116.611 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.2 mt -109.82 142.97 40.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -154.55 177.53 11.1 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.47 2.708 . . . . 0.0 107.821 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CE1' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.74 110.16 37.21 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.29 -19.62 25.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.687 2.258 . . . . 0.0 111.209 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -145.3 154.74 42.67 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 130.38 3.472 . . . . 0.0 108.221 -173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -56.49 -39.87 73.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.672 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 28.83 10.87 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 131.182 3.793 . . . . 0.0 121.005 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 15.45 57.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 1 C-N-CA 134.514 5.126 . . . . 0.0 118.129 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.06 -174.05 44.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.525 0.583 . . . . 0.0 114.084 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -67.6 29.39 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 127.547 2.339 . . . . 0.0 114.024 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.26 -6.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 129.215 3.006 . . . . 0.0 112.039 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 54' ' ' HIS . 21.0 pttm -72.72 -23.02 60.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.682 1.128 . . . . 0.0 111.616 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -73.33 138.08 45.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.349 1.059 . . . . 0.0 112.067 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 84.0 mtp -157.3 140.24 15.2 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.385 1.474 . . . . 0.0 109.854 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.78 157.61 37.76 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.79 -48.13 82.03 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.75 -0.594 . . . . 0.0 109.827 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -62.22 -45.85 91.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.643 0.777 . . . . 0.0 112.127 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.13 -43.65 97.78 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.512 -0.742 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.4 -44.6 95.53 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.215 0.916 . . . . 0.0 110.198 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.62 -30.01 62.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.57 -38.71 18.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.483 1.113 . . . . 0.0 110.991 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -62.36 -48.0 81.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.427 1.091 . . . . 0.0 111.958 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -64.19 -32.87 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.569 0.748 . . . . 0.0 111.305 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.71 -35.56 79.02 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.389 0.675 . . . . 0.0 110.84 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.0 t -63.19 -19.0 64.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 0.0 112.567 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -82.55 2.99 30.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.125 1.37 . . . . 0.0 113.045 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 79.1 14.55 1.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.107 2.163 . . . . 0.0 113.715 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.94 127.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.921 1.289 . . . . 0.0 111.853 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.04 107.05 19.44 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.485 1.114 . . . . 0.0 110.062 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.0 -13.56 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.333 1.453 . . . . 0.0 114.342 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.46 -21.73 60.37 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.814 -0.554 . . . . 0.0 111.787 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -93.91 144.52 28.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.946 1.298 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.56 9.9 2.07 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.924 3.083 . . . . 0.0 115.837 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.19 -1.72 60.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.359 1.933 . . . . 0.0 113.094 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.15 141.99 57.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.115 0.958 . . . . 0.0 112.013 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.5 44.12 1.2 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.754 1.622 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.41 123.84 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.991 1.316 . . . . 0.0 111.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -145.04 143.07 30.27 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 0.0 110.647 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.4 t -62.42 163.56 8.49 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.66 -9.04 12.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.159 1.783 . . . . 0.0 111.736 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.2 -55.96 5.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 123.813 0.845 . . . . 0.0 108.793 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.0 p -109.44 -3.6 16.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.468 0.707 . . . . 0.0 112.792 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 60.78 11.44 3.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.152 1.781 . . . . 0.0 114.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -81.96 140.59 46.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 120.078 -1.639 . . . . 0.0 110.474 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.21 145.25 44.55 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.054 2.503 . . . . 0.0 111.114 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.5 mm -100.74 107.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.0 1.32 . . . . 0.0 111.045 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.52 116.06 24.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.384 1.474 . . . . 0.0 109.915 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.34 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 CA-C-O 119.321 -0.711 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.12 153.28 41.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.762 1.281 . . . . 0.0 109.67 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 p -146.87 149.15 32.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.49 128.99 38.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.379 1.472 . . . . 0.0 111.84 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -13.01 62.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.91 -43.74 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.554 1.142 . . . . 0.0 111.498 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.78 5.5 10.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 54.44 29.49 11.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.822 2.049 . . . . 0.0 113.647 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.64 147.6 16.69 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 122.726 1.181 . . . . 0.0 111.066 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.05 166.34 5.98 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.532 1.933 . . . . 0.0 114.146 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 147.04 54.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.427 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.5 p -129.39 155.65 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.577 1.18 . . . . 0.0 112.929 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.38 -10.81 1.0 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.67 1.988 . . . . 0.0 116.272 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.0 -20.7 4.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.667 1.587 . . . . 0.0 111.644 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 66' ' ' HIS . 45.5 t30 -143.76 66.54 15.24 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.31 169.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.429 1 C-N-CA 126.167 4.578 . . . . 0.0 118.059 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.9 mt -111.97 144.92 40.53 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.781 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -150.94 168.42 24.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.712 2.805 . . . . 0.0 106.618 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -111.73 107.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.81 -13.27 21.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.355 2.704 . . . . 0.0 112.455 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t -138.17 -161.99 1.25 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.138 1.375 . . . . 0.0 112.579 -166.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 55.6 mmtt -131.27 26.63 4.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.809 2.044 . . . . 0.0 113.388 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -8.5 0.59 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.673 1.589 . . . . 0.0 114.217 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 54.6 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.588 2.355 . . . . 0.0 115.626 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.41 -156.86 20.42 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.514 1.054 . . . . 0.0 114.635 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -82.69 5.08 22.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.018 1.327 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.73 9.2 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.563 1.545 . . . . 0.0 114.216 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -90.14 -4.7 57.13 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.181 0.993 . . . . 0.0 112.663 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -94.31 147.42 23.22 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.227 1.411 . . . . 0.0 111.201 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.1 mtp -158.85 139.89 12.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.993 0.917 . . . . 0.0 110.424 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HB3' HD21 ' A' ' 50' ' ' ASN . 41.6 m80 -68.31 158.39 33.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.02 -46.75 87.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.071 -1.018 . . . . 0.0 109.015 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -54.86 -57.22 12.48 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.02 1.328 . . . . 0.0 112.988 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.68 -36.81 84.1 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.873 1.269 . . . . 0.0 111.972 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.92 -47.29 75.23 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.494 1.497 . . . . 0.0 110.694 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.63 -33.52 72.9 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.231 1.812 . . . . 0.0 112.256 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.44 -36.08 39.45 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.519 2.728 . . . . 0.0 111.898 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.3 t90 -69.4 -52.88 22.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.003 0.921 . . . . 0.0 109.806 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -58.92 -29.98 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.473 1.033 . . . . 0.0 111.204 172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.96 -39.36 76.07 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.717 -0.614 . . . . 0.0 110.498 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 m -66.03 -24.26 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.77 -1.206 . . . . 0.0 112.917 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -73.69 -5.71 42.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.954 2.102 . . . . 0.0 112.561 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.256 8.8 t30 63.15 45.27 5.24 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.321 1.449 . . . . 0.0 112.478 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.84 126.56 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.052 -1.03 . . . . 0.0 111.105 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -81.13 106.64 13.28 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.52 0.728 . . . . 0.0 111.118 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -61.54 -18.87 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 114.0 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -19.72 52.04 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.352 0.661 . . . . 0.0 112.742 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.22 141.7 43.19 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.968 -1.083 . . . . 0.0 113.545 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -84.05 6.15 5.93 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.391 3.394 . . . . 0.0 114.984 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.3 23.69 32.45 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 127.237 2.351 . . . . 0.0 112.554 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.88 163.54 30.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 112.573 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -139.34 54.17 1.71 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.147 2.179 . . . . 0.0 108.602 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.72 106.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.481 1.512 . . . . 0.0 113.294 -174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -150.58 179.26 8.32 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 178.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.8 t -66.81 173.75 3.36 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.498 1.919 . . . . 0.0 115.907 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -131.35 -6.92 3.78 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.49 2.316 . . . . 0.0 112.603 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.3 mt -81.03 -64.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.122 0.969 . . . . 0.0 108.977 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.5 p -104.26 -11.75 17.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 129.916 3.287 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 62.33 18.74 10.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.762 2.825 . . . . 0.0 114.86 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 14.4 m-85 -74.17 142.77 79.36 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.834 -1.166 . . . . 0.0 113.234 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 32.1 Cg_exo -55.81 135.48 69.77 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.306 3.337 . . . . 0.0 111.316 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.67 126.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.363 1.065 . . . . 0.0 110.511 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.89 94.45 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.384 1.873 . . . . 0.0 110.38 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 CA--C 1.546 0.812 0 C-N-CA 125.118 1.367 . . . . 0.0 112.004 -179.371 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . 0.296 . . 69.77 179.4 0.24 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.825 2.05 . . . . 0.0 112.043 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -154.36 162.86 40.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.566 1.147 . . . . 0.0 112.601 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 t -83.21 125.85 32.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.103 0.961 . . . . 0.0 111.425 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -11.67 58.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.9 1.28 . . . . 0.0 113.744 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE ' ' A' ' 65' ' ' MET . 67.6 mt -102.47 -52.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.659 1.183 . . . . 0.0 109.666 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 9.4 m -98.61 -13.78 20.21 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.254 36.2 mmt180 48.35 69.02 0.59 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 123.675 1.702 . . . . 0.0 108.41 -171.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.03 139.56 10.81 Favored Glycine 0 N--CA 1.463 0.446 0 CA-C-N 110.931 -2.849 . . . . 0.0 110.206 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.19 154.58 31.0 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.498 1.119 . . . . 0.0 110.68 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.93 18.22 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.146 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -101.21 -150.84 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.378 0.671 . . . . 0.0 111.06 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.51 12.83 8.1 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.809 2.043 . . . . 0.0 111.671 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -142.6 -12.79 0.78 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.358 2.663 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -160.11 71.97 3.08 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.14 2.176 . . . . 0.0 107.82 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.57 -165.5 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.654 3.57 . . . . 0.0 110.371 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -131.6 154.14 49.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.971 1.308 . . . . 0.0 111.399 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -154.64 -179.03 7.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.297 1.439 . . . . 0.0 110.118 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 5.9 p80 -115.58 96.42 46.16 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.821 1.248 . . . . 0.0 111.601 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 54' ' ' HIS . 72.8 Cg_endo -76.14 -13.48 19.09 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.511 3.474 . . . . 0.0 113.556 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.1 t -148.61 166.98 26.65 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.858 2.863 . . . . 0.0 105.906 -171.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -75.45 -40.2 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.243 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.311 90.9 m 40.04 -17.75 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.548 1 C-N-CA 133.001 4.52 . . . . 0.0 119.719 -170.179 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.265 6.6 tpp180 45.87 58.86 4.04 Favored 'General case' 0 N--CA 1.471 0.6 1 C-N-CA 131.873 4.069 . . . . 0.0 115.99 -179.941 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.8 -178.48 48.44 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.36 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.9 p -53.49 -32.2 49.24 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.373 1.087 . . . . 0.0 112.182 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.62 -14.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 128.708 2.803 . . . . 0.0 114.642 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -62.91 -25.99 68.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.041 0.837 . . . . 0.0 112.519 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.6 136.37 36.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.388 1.089 . . . . 0.0 112.13 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.407 ' CE ' HD11 ' A' ' 41' ' ' ILE . 87.8 mtp -159.76 153.54 22.91 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.356 2.262 . . . . 0.0 108.278 -173.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -77.43 166.09 23.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.924 0.783 . . . . 0.0 109.283 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.48 -41.42 76.18 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.088 -1.632 . . . . 0.0 111.772 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 m -75.4 -29.08 59.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.878 1.671 . . . . 0.0 114.486 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 14.0 p -78.57 -42.48 29.03 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.355 1.074 . . . . 0.0 112.113 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' CG2' ' A' ' 97' ' ' ILE 0.274 44.6 tp -52.75 -48.78 66.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.585 1.154 . . . . 0.0 111.174 169.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.19 -23.87 62.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.282 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 3.9 pt-20 -97.83 -30.34 12.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.865 . . . . 0.0 111.585 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -65.41 -49.87 67.58 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.179 1.392 . . . . 0.0 110.802 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.27 -34.83 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.063 0.847 . . . . 0.0 111.228 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.83 79.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.25 0.548 . . . . 0.0 111.171 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 t -64.66 -16.28 62.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.55 1.14 . . . . 0.0 112.523 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -84.68 9.85 12.82 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 112.729 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 80.02 -0.71 2.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.16 2.584 . . . . 0.0 115.621 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.39 125.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.275 1.43 . . . . 0.0 112.327 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -84.48 102.54 12.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 112.787 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 pt -66.92 -15.59 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 113.798 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -69.41 -19.22 63.81 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -111.74 144.47 30.71 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.506 1.122 . . . . 0.0 112.596 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.92 10.32 2.38 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 124.197 3.265 . . . . 0.0 115.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.26 10.06 59.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.727 2.108 . . . . 0.0 113.08 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 167.47 6.3 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.564 1.546 . . . . 0.0 113.819 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -136.79 38.59 2.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.13 1.772 . . . . 0.0 110.506 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.79 78.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.471 1.909 . . . . 0.0 113.438 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -134.26 140.73 46.64 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.374 1.87 . . . . 0.0 110.677 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.39 172.78 0.79 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.493 2.317 . . . . 0.0 115.477 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.3 -9.28 6.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.351 2.26 . . . . 0.0 112.913 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.9 mt -85.3 -59.17 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p -109.35 -6.66 15.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.827 2.451 . . . . 0.0 111.829 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.0 m80 63.89 21.39 12.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.997 2.119 . . . . 0.0 114.905 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.47 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 26.9 m-85 -80.4 143.28 55.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.716 -1.24 . . . . 0.0 112.846 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.92 141.22 83.43 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.835 2.357 . . . . 0.0 110.358 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.481 ' CG2' HD11 ' A' ' 70' ' ' LEU . 5.4 mm -86.53 129.1 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.437 1.095 . . . . 0.0 109.598 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.23 117.74 27.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.379 1.472 . . . . 0.0 109.526 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -176.93 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.386 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.04 138.47 47.91 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.858 1.329 . . . . 0.0 108.873 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 p -140.78 148.91 41.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.924 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.7 t -60.3 123.62 17.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.267 1.827 . . . . 0.0 111.938 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -69.83 -8.02 44.88 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.787 -1.196 . . . . 0.0 112.114 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 77.6 mt -91.13 -51.66 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.75 13.67 5.87 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 61.81 8.98 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.458 2.703 . . . . 0.0 115.805 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.45 146.68 36.19 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.65 161.01 31.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.844 0.857 . . . . 0.0 111.92 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' A' ' 52' ' ' LEU . . . -68.72 120.74 15.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.58 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -96.52 -170.99 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.301 0.572 . . . . 0.0 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -84.48 -24.05 29.61 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 3.68 5.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 112.083 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.91 60.91 4.67 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 126.911 2.084 . . . . 0.0 109.953 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.56 -164.47 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 125.527 4.151 . . . . 0.0 111.926 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 46' ' ' ALA . 14.5 mt -126.65 163.04 24.35 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.703 2.001 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -165.39 -169.91 1.72 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.746 2.418 . . . . 0.0 108.177 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -126.68 101.11 27.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 119.052 0.842 . . . . 0.0 111.127 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.57 ' HG2' ' H ' ' A' ' 56' ' ' CYS . 83.3 Cg_endo -72.44 -54.44 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 N-CA-C 108.264 -1.476 . . . . 0.0 108.264 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.57 ' H ' ' HG2' ' A' ' 55' ' ' PRO . 12.5 p -102.64 169.75 8.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 131.411 3.884 . . . . 0.0 112.295 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -108.16 35.3 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.436 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 11.7 m -48.11 -12.69 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 62.24 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.841 3.256 . . . . 0.0 115.335 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.0 -159.75 31.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.842 0.734 . . . . 0.0 112.234 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -64.91 -30.6 71.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.269 2.4 pp -75.4 10.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 pttm -96.4 -20.05 18.74 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.728 -0.608 . . . . 0.0 110.598 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -63.5 135.7 57.06 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.263 1.025 . . . . 0.0 108.865 171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.6 mtp -150.89 141.36 22.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.909 1.284 . . . . 0.0 108.585 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 4.0 m170 -64.52 139.99 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.187 0.994 . . . . 0.0 110.491 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.2 19.21 0.08 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.512 1.525 . . . . 0.0 112.629 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.6 p -135.75 -46.63 0.67 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.352 2.661 . . . . 0.0 109.15 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 74.1 m -62.37 -37.38 85.5 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.555 1.542 . . . . 0.0 111.404 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.73 -46.94 80.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.62 1.1 . . . . 0.0 109.814 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.18 -32.2 70.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.462 1.105 . . . . 0.0 111.501 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.06 -36.45 30.47 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.254 2.622 . . . . 0.0 111.23 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -65.35 -51.9 57.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.471 1.108 . . . . 0.0 109.315 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.25 -30.34 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 119.619 1.1 . . . . 0.0 110.836 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.875 -0.516 . . . . 0.0 110.2 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 p -67.73 -8.49 35.85 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -88.95 -1.59 58.18 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.352 1.861 . . . . 0.0 113.47 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER 71.83 17.22 5.41 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.782 1.633 . . . . 0.0 114.89 178.082 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.69 167.91 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.429 1.892 . . . . 0.0 111.587 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -128.18 106.95 9.4 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.575 1.55 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -18.43 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 113.674 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -76.81 -8.55 57.53 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.07 143.94 78.29 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.773 -1.204 . . . . 0.0 111.586 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.17 7.07 3.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.813 3.009 . . . . 0.0 116.757 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.62 8.39 8.28 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 127.143 2.306 . . . . 0.0 112.056 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.7 142.83 57.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.896 0.848 . . . . 0.0 112.747 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -138.01 32.95 2.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.738 1.615 . . . . 0.0 110.368 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.56 118.07 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 112.741 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -146.79 176.47 9.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 176.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.01 162.29 1.97 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.025 2.53 . . . . 0.0 113.07 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -115.38 -12.0 11.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.23 -53.94 8.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 122.817 0.447 . . . . 0.0 109.811 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.3 p -106.72 -7.56 17.22 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 53.71 14.07 0.58 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.255 1.822 . . . . 0.0 115.276 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -82.5 136.34 45.75 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.118 -1.614 . . . . 0.0 110.584 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 54.5 Cg_exo -46.74 126.2 10.5 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.233 2.622 . . . . 0.0 112.276 171.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 55' ' ' PRO 0.262 0.6 OUTLIER -78.6 111.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.1 -1.864 . . . . 0.0 109.545 -173.521 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -80.74 73.29 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.721 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 126.161 1.784 . . . . 0.0 113.411 179.461 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.45 157.93 33.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.293 0.568 . . . . 0.0 110.625 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -156.34 165.68 35.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.793 1.237 . . . . 0.0 112.496 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.25 128.03 32.79 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 110.306 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -7.81 43.17 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.6 mt -94.05 -37.63 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.089 . . . . 0.0 110.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.43 4.17 3.66 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 61.24 19.33 10.0 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.702 2.001 . . . . 0.0 113.833 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.5 145.55 22.05 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.02 164.46 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.962 0.881 . . . . 0.0 111.472 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.83 144.43 56.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.9 p -135.27 156.65 48.61 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.42 1.105 . . . . 0.0 113.692 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.94 8.82 0.23 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.753 2.421 . . . . 0.0 115.452 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -133.65 -20.07 2.05 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.13 2.172 . . . . 0.0 111.221 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -155.71 71.45 5.37 Favored Pre-proline 0 N--CA 1.445 -0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 112.125 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.42 171.36 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 125.009 3.806 . . . . 0.0 116.354 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.84 148.83 35.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.726 173.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -157.75 179.2 9.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.89 2.076 . . . . 0.0 108.393 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -120.74 112.65 33.67 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.318 0.647 . . . . 0.0 110.603 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -12.19 14.39 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.784 2.989 . . . . 0.0 112.218 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.8 t -133.36 -153.39 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.424 1.489 . . . . 0.0 112.468 -167.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 5.4 tmtt? -135.89 14.07 3.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.193 2.197 . . . . 0.0 115.028 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.9 m -46.66 -23.52 0.42 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.869 2.468 . . . . 0.0 115.222 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp-105 65.39 162.92 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.18 2.992 . . . . 0.0 114.282 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 -164.9 29.5 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.508 -0.745 . . . . 0.0 113.029 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.3 m -61.08 -34.57 75.13 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.303 -1.116 . . . . 0.0 113.185 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.76 1.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -83.21 -21.69 33.37 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.218 -0.926 . . . . 0.0 112.515 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.48 150.66 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.022 0.915 . . . . 0.0 110.636 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mtp -158.21 141.46 15.07 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.35 1.46 . . . . 0.0 109.793 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -70.53 151.4 45.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -56.28 -49.56 73.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.114 -0.366 . . . . 0.0 110.276 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -64.27 -44.32 92.11 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.46 -46.68 87.41 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.312 -0.867 . . . . 0.0 112.243 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.83 -45.44 74.45 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.179 0.9 . . . . 0.0 109.728 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.22 -25.64 65.78 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -89.78 -32.25 17.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.323 0.965 . . . . 0.0 111.868 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.83 -57.92 10.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.969 1.308 . . . . 0.0 110.618 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.95 -23.98 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.872 1.269 . . . . 0.0 111.65 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.14 58.63 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 m -93.87 5.73 50.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.918 1.287 . . . . 0.0 111.817 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -108.18 9.13 28.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.728 2.411 . . . . 0.0 113.673 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.253 10.3 t30 63.69 42.62 6.18 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.713 1.205 . . . . 0.0 112.387 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.47 152.73 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.593 1.557 . . . . 0.0 110.102 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -123.74 111.55 16.29 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.974 1.309 . . . . 0.0 110.457 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.4 pt -60.88 -19.73 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.247 1.419 . . . . 0.0 113.827 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.9 t -78.67 -14.85 59.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -93.02 143.58 27.03 Favored Pre-proline 0 N--CA 1.478 0.942 0 O-C-N 121.177 -0.952 . . . . 0.0 112.629 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.11 5.09 6.47 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.849 3.033 . . . . 0.0 115.638 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.62 10.75 38.68 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.955 2.217 . . . . 0.0 112.727 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.37 156.47 29.11 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.034 0.934 . . . . 0.0 113.145 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.04 45.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.409 1.484 . . . . 0.0 110.746 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.93 102.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.743 1.217 . . . . 0.0 112.575 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.9 tttm -143.66 142.1 30.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.362 1.465 . . . . 0.0 112.378 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.82 178.33 0.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.447 2.699 . . . . 0.0 115.174 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -132.19 -12.08 3.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.755 2.422 . . . . 0.0 112.727 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -78.33 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 122.119 0.961 . . . . 0.0 109.213 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.75 -8.6 17.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.916 2.886 . . . . 0.0 111.264 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.448 ' O ' ' HE2' ' A' ' 89' ' ' LYS 0.364 0.0 OUTLIER 63.34 18.97 11.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.643 3.177 . . . . 0.0 115.366 -175.883 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 16.8 m-85 -75.7 145.8 79.05 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 120.477 -1.389 . . . . 0.0 114.329 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -61.74 141.61 91.12 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.214 1.943 . . . . 0.0 109.813 170.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -86.42 117.92 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 125.17 1.388 . . . . 0.0 108.143 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -114.38 94.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.427 1.491 . . . . 0.0 111.845 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 126.037 1.735 . . . . 0.0 112.807 178.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.528 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 158.62 36.06 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.7 p -121.11 163.9 17.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.8 t -80.62 133.31 35.73 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 120.835 -1.166 . . . . 0.0 108.093 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -21.77 66.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.49 1.041 . . . . 0.0 113.021 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.72 -49.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.749 1.22 . . . . 0.0 110.216 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -88.23 -23.73 23.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 58.91 36.91 24.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.376 1.47 . . . . 0.0 108.893 -167.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.0 134.49 10.83 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.931 1.253 . . . . 0.0 112.974 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -71.58 142.62 50.01 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.18 148.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.625 1.57 . . . . 0.0 114.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -128.22 179.61 5.52 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.202 1.001 . . . . 0.0 111.214 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.84 -32.02 68.92 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.98 -31.37 13.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.644 1.978 . . . . 0.0 110.704 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -123.62 65.56 33.84 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.63 167.16 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.261 1.974 . . . . 0.0 112.186 162.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.9 mt -117.83 146.62 43.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.759 -2.019 . . . . 0.0 112.153 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -149.39 163.53 37.49 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.406 3.082 . . . . 0.0 105.712 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -114.02 104.33 54.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.54 -24.72 35.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.282 1.988 . . . . 0.0 113.174 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' HB2' HD13 ' A' ' 97' ' ' ILE 0.258 0.5 OUTLIER -139.96 150.53 44.6 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 127.262 2.225 . . . . 0.0 107.779 -168.876 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.22 -46.7 62.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 117.112 -1.423 . . . . 0.0 111.734 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 68.2 m 32.73 -12.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 1 C-N-CA 133.195 4.598 . . . . 0.0 120.901 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 72.14 149.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 131.002 3.721 . . . . 0.0 113.941 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.41 -142.55 48.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.74 1.162 . . . . 0.0 114.679 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -95.92 -7.05 37.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 112.891 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.0 24.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 111.931 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -105.82 -26.21 11.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.513 1.525 . . . . 0.0 112.374 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -77.48 152.45 34.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.139 1.376 . . . . 0.0 112.226 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 90.3 mtp -158.74 144.75 16.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.328 0.651 . . . . 0.0 112.294 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -70.8 152.45 43.74 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -56.16 -49.19 74.69 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.204 -0.935 . . . . 0.0 110.874 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -54.71 -50.04 69.27 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.411 1.084 . . . . 0.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.53 -44.16 93.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.72 -48.0 73.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.06 0.845 . . . . 0.0 111.44 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -55.7 -30.86 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.603 1.961 . . . . 0.0 112.949 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -91.99 -38.84 12.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.088 1.755 . . . . 0.0 112.156 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 80.2 t90 -58.62 -45.19 89.74 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 123.819 0.848 . . . . 0.0 111.015 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.36 -26.08 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.176 0.898 . . . . 0.0 112.213 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.63 62.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.788 -1.195 . . . . 0.0 111.43 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.7 p -84.5 11.18 9.14 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.527 -0.733 . . . . 0.0 112.502 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -115.03 8.39 15.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.701 1.6 . . . . 0.0 112.894 -174.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.32 0.0 OUTLIER 79.36 38.03 0.13 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.911 2.084 . . . . 0.0 112.67 178.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.58 145.28 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.437 1.095 . . . . 0.0 113.54 -171.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -139.54 102.84 4.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 110.024 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -12.26 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.258 1.423 . . . . 0.0 114.485 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -75.59 -16.34 60.25 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.726 -0.609 . . . . 0.0 111.972 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -106.56 142.21 24.46 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.103 1.361 . . . . 0.0 111.6 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.97 29.27 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.548 3.499 . . . . 0.0 114.626 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.15 20.19 6.32 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.882 2.182 . . . . 0.0 111.724 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.09 163.69 24.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 122.353 1.073 . . . . 0.0 113.637 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -143.92 41.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.85 2.06 . . . . 0.0 109.099 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.285 11.1 p -68.36 65.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.685 2.394 . . . . 0.0 115.447 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -133.53 144.88 49.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.401 2.281 . . . . 0.0 110.64 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -67.95 173.65 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.656 2.383 . . . . 0.0 115.256 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -129.12 -10.69 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.862 2.465 . . . . 0.0 112.978 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -78.76 -55.76 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.903 0.858 . . . . 0.0 109.434 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.9 p -115.45 -7.46 12.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 129.06 2.944 . . . . 0.0 111.85 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 66.9 20.7 10.51 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.078 2.551 . . . . 0.0 114.861 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.8 m-85 -85.14 145.81 43.91 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 113.487 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.24 135.96 49.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.53 2.154 . . . . 0.0 109.796 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 56' ' ' CYS . 11.4 mm -77.76 141.74 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.507 1.123 . . . . 0.0 109.817 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -133.56 120.58 20.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.243 1.417 . . . . 0.0 111.456 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -178.824 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 CA-C-O 119.452 -0.638 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.69 46.69 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.477 1.139 . . . . 0.0 109.749 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -143.36 149.34 37.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.125 1.37 . . . . 0.0 113.01 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -57.51 129.25 40.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.663 1.585 . . . . 0.0 112.214 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -7.97 53.51 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.455 -1.403 . . . . 0.0 113.827 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.6 mt -96.17 -44.09 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 117.724 -1.132 . . . . 0.0 109.627 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.3 p -128.07 9.67 6.3 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 55.17 19.58 2.94 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.652 2.381 . . . . 0.0 114.499 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.2 149.28 29.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.72 163.63 24.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.124 0.962 . . . . 0.0 111.175 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 129.44 41.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -99.02 -146.67 0.33 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.335 0.588 . . . . 0.0 112.046 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -130.7 13.49 5.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.561 2.344 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -145.25 -18.01 0.49 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.207 2.603 . . . . 0.0 111.591 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 66' ' ' HIS . 47.3 t30 -153.84 68.59 6.22 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 125.043 1.337 . . . . 0.0 111.883 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.67 179.51 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.43 1 C-N-CA 125.466 4.111 . . . . 0.0 116.263 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.52 154.01 32.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.459 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.17 -177.62 6.4 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.813 3.245 . . . . 0.0 106.311 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -128.96 117.62 19.3 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.585 0.63 . . . . 0.0 109.794 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 56' ' ' CYS . 33.0 Cg_endo -82.74 -9.93 10.82 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.815 3.01 . . . . 0.0 113.015 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 2.0 t -141.01 -162.87 1.43 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.769 1.228 . . . . 0.0 111.327 -166.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -129.21 24.38 5.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.258 1.823 . . . . 0.0 113.352 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -48.25 -21.53 0.52 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.849 2.06 . . . . 0.0 113.816 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 63.05 152.85 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 129.391 3.077 . . . . 0.0 115.549 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.4 -164.89 40.68 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.653 1.121 . . . . 0.0 114.752 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.7 m -59.02 6.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.88 7.15 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 126.491 1.916 . . . . 0.0 112.386 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -82.19 -23.09 35.68 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.894 . . . . 0.0 111.977 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -78.07 145.75 35.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.058 1.343 . . . . 0.0 111.289 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 91.6 mtp -155.9 139.22 15.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.47 1.108 . . . . 0.0 109.353 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.423 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.5 m80 -70.1 157.51 37.43 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.99 -50.59 72.78 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.391 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.3 t -58.69 -36.92 74.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.303 1.041 . . . . 0.0 113.074 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.51 -44.77 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.439 -0.788 . . . . 0.0 112.106 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.41 -41.75 85.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.712 1.596 . . . . 0.0 109.839 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.36 -33.52 72.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.906 1.682 . . . . 0.0 113.401 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.86 -27.4 26.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.533 0.733 . . . . 0.0 111.819 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.91 -57.58 4.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.687 1.595 . . . . 0.0 111.095 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 81' ' ' ILE . 33.3 m -55.47 -23.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.288 0.635 . . . . 0.0 111.105 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.51 30.77 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.812 0.445 . . . . 0.0 112.066 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -72.12 -23.85 61.38 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.356 -1.465 . . . . 0.0 111.399 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -77.61 -2.63 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.519 2.728 . . . . 0.0 112.389 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.42 47.11 7.0 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.363 1.465 . . . . 0.0 113.487 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.08 118.81 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.558 -1.339 . . . . 0.0 111.741 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -78.44 97.26 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.019 0.928 . . . . 0.0 111.477 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 74' ' ' VAL . 19.8 pt -63.66 -16.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.289 1.436 . . . . 0.0 113.68 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -75.97 -14.21 60.24 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -81.34 139.46 48.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 O-C-N 120.978 -1.076 . . . . 0.0 112.036 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.88 4.41 7.06 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.894 3.062 . . . . 0.0 115.949 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.39 18.27 5.79 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 127.789 2.614 . . . . 0.0 111.615 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.09 158.71 10.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.948 0.899 . . . . 0.0 113.31 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -120.23 37.17 4.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.5 1.52 . . . . 0.0 111.89 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.64 101.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.418 1.487 . . . . 0.0 110.734 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -147.95 143.73 27.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.673 1.189 . . . . 0.0 112.796 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.6 t -66.37 177.42 1.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.439 2.696 . . . . 0.0 115.169 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -131.32 -10.63 3.67 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.426 2.29 . . . . 0.0 112.65 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.36 -61.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.245 -0.909 . . . . 0.0 109.236 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.7 p -106.45 -9.7 16.58 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.348 2.659 . . . . 0.0 111.194 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.4 t60 63.74 23.53 13.5 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.939 2.495 . . . . 0.0 114.516 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 16.7 m-85 -79.41 145.04 62.92 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.413 -1.429 . . . . 0.0 113.132 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.28 135.86 56.56 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.012 2.475 . . . . 0.0 110.49 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.9 mm -79.29 113.77 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.892 2.077 . . . . 0.0 108.514 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -126.19 97.56 5.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.753 2.021 . . . . 0.0 110.924 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 130.317 3.447 . . . . 0.0 117.835 -177.051 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.272 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.21 168.3 19.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.119 0.968 . . . . 0.0 110.959 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.7 p -150.81 153.53 35.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.755 1.222 . . . . 0.0 113.485 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.94 133.09 54.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.145 1.378 . . . . 0.0 110.084 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -71.09 -13.25 61.9 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.185 -0.947 . . . . 0.0 113.032 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 69' ' ' CYS . 73.5 mt -94.01 -41.57 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.296 1.039 . . . . 0.0 111.046 -175.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.26 13.01 4.22 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 55.15 17.46 1.98 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.932 2.093 . . . . 0.0 114.353 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.46 154.6 42.47 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.59 164.58 19.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.393 1.096 . . . . 0.0 110.111 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.82 25.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -92.01 -138.11 0.17 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.657 0.265 . . . . 0.0 111.49 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -130.71 5.38 4.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.776 2.03 . . . . 0.0 111.334 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.34 -10.01 0.96 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.694 3.198 . . . . 0.0 110.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -140.86 61.98 16.2 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 127.271 2.228 . . . . 0.0 114.162 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.1 159.97 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.893 2.395 . . . . 0.0 114.171 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.61 143.0 36.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 112.452 -2.158 . . . . 0.0 110.492 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -156.16 176.93 12.03 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.48 3.112 . . . . 0.0 106.612 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -124.04 117.85 26.96 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 118.253 0.479 . . . . 0.0 110.057 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -81.47 -7.58 12.71 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.72 3.614 . . . . 0.0 112.549 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 30.3 p -152.49 159.25 43.35 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.172 1.789 . . . . 0.0 113.055 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HB2' ' CD2' ' A' ' 95' ' ' TYR . 6.2 mtmm -77.12 30.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.264 1.826 . . . . 0.0 113.868 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.32 -14.9 1.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 27.09 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 130.559 3.544 . . . . 0.0 115.826 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.73 30.19 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.853 1.692 . . . . 0.0 112.147 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -62.61 6.43 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.75 6.07 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.549 2.34 . . . . 0.0 112.392 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -78.19 -22.5 48.51 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.081 -1.012 . . . . 0.0 112.002 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -80.29 145.99 31.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.172 1.389 . . . . 0.0 112.26 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.7 mtp -154.77 139.19 16.77 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.041 0.936 . . . . 0.0 110.485 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 15.7 m170 -66.2 148.07 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.76 -35.3 77.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 122.011 -0.431 . . . . 0.0 110.837 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -79.21 -28.83 42.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 88.0 m -81.07 -39.78 25.19 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.119 0.967 . . . . 0.0 111.219 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.21 -44.18 92.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.966 1.257 . . . . 0.0 109.277 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.16 -33.91 65.68 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.635 1.174 . . . . 0.0 113.597 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.5 pt-20 -88.99 -32.7 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.063 0.545 . . . . 0.0 112.244 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -62.24 -49.3 76.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.859 0.864 . . . . 0.0 110.097 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.62 -32.42 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.784 0.72 . . . . 0.0 112.199 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.98 -17.74 62.64 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.557 -0.714 . . . . 0.0 111.747 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -86.26 2.26 47.84 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.247 -0.908 . . . . 0.0 111.891 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -105.0 4.74 31.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.583 1.953 . . . . 0.0 114.046 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 62.98 44.85 5.71 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.566 1.146 . . . . 0.0 112.298 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.72 121.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.64 1.176 . . . . 0.0 110.697 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -80.13 106.91 12.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.283 0.633 . . . . 0.0 109.926 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.9 pt -60.85 -18.02 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.965 1.306 . . . . 0.0 113.907 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -82.09 -13.5 57.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -88.63 141.02 29.87 Favored Pre-proline 0 N--CA 1.481 1.083 0 O-C-N 121.027 -1.046 . . . . 0.0 112.682 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.08 0.83 9.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.03 3.153 . . . . 0.0 116.177 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.49 8.53 34.96 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.957 2.218 . . . . 0.0 112.736 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 168.3 15.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.775 1.23 . . . . 0.0 113.555 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -134.2 52.46 2.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.006 1.723 . . . . 0.0 109.979 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.36 76.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.135 1.774 . . . . 0.0 111.477 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . 0.269 18.5 ttmt -131.04 151.1 51.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.832 2.053 . . . . 0.0 111.631 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 15.3 t -63.98 165.78 8.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 0.0 113.731 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -120.7 3.58 10.63 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.396 1.878 . . . . 0.0 111.911 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -106.87 -55.58 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.513 1.525 . . . . 0.0 108.82 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 16.6 p -105.1 -4.82 21.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 60.77 10.43 2.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.326 2.25 . . . . 0.0 116.027 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 75.2 m-85 -92.44 146.32 32.23 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.464 -1.397 . . . . 0.0 111.611 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -45.33 142.98 5.81 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.853 3.036 . . . . 0.0 113.208 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -104.56 122.77 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.68 1.592 . . . . 0.0 110.596 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.72 122.87 44.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 126.235 1.814 . . . . 0.0 113.977 179.848 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.489 0 N-CA-C 114.141 0.416 . . . . 0.0 114.141 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.61 134.94 40.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.954 0.877 . . . . 0.0 110.059 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.4 p -144.16 153.53 42.21 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 111.488 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.0 t -63.72 127.1 29.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.504 1.122 . . . . 0.0 112.005 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -4.8 22.64 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.0 mt -103.57 -45.24 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.123 1.369 . . . . 0.0 110.226 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -123.69 5.08 8.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.32 31.5 mmt180 50.73 32.41 6.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.17 2.188 . . . . 0.0 115.632 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.3 148.1 18.86 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.29 168.4 18.4 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.834 1.653 . . . . 0.0 112.407 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.67 150.03 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.664 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.4 p -139.18 172.13 13.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.502 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -61.83 -21.93 65.05 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -119.63 -20.94 7.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.428 1.491 . . . . 0.0 112.281 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.97 66.51 47.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.193 1.797 . . . . 0.0 110.499 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.03 -167.93 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 1 C-N-CA 125.435 4.09 . . . . 0.0 111.113 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.7 mt -132.77 155.57 48.67 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.724 1.61 . . . . 0.0 111.868 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -153.92 -179.61 8.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.786 2.434 . . . . 0.0 108.122 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -129.24 110.42 18.03 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.579 0.752 . . . . 0.0 111.146 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.63 -17.42 12.61 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.577 2.851 . . . . 0.0 113.57 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 4.1 t -133.55 -161.55 1.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 112.067 -165.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 4.3 mptp? -123.14 12.79 9.62 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.734 1.614 . . . . 0.0 114.717 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -44.62 -25.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.222 2.609 . . . . 0.0 116.703 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 65.18 159.36 0.11 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.933 3.293 . . . . 0.0 115.599 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.47 -157.63 19.34 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.09 0.852 . . . . 0.0 113.599 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.1 p -59.48 -18.41 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.5 pt -84.79 -7.57 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.755 1.161 . . . . 0.0 113.601 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -76.06 -18.74 59.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.154 1.343 . . . . 0.0 113.535 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -84.53 143.34 29.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.359 1.064 . . . . 0.0 112.285 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 81.6 mtp -156.62 143.03 18.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.363 1.465 . . . . 0.0 109.793 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -76.35 154.51 34.92 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.14 -46.45 82.69 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.272 -0.892 . . . . 0.0 111.911 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -64.36 -42.97 95.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.002 0.921 . . . . 0.0 111.949 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.3 m -61.79 -43.88 97.97 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.173 -0.955 . . . . 0.0 111.751 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.71 -47.88 83.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.88 0.764 . . . . 0.0 109.811 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.08 -29.49 60.65 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.97 -38.33 18.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.415 1.086 . . . . 0.0 111.577 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.78 -48.19 77.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.199 1.0 . . . . 0.0 111.731 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.89 -28.96 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.656 -0.653 . . . . 0.0 111.691 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.52 71.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.013 0.525 . . . . 0.0 111.429 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 p -66.91 -14.24 62.57 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.744 -1.223 . . . . 0.0 113.305 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.31 3.66 20.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.689 1.596 . . . . 0.0 112.796 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.254 10.2 t30 64.47 42.73 4.88 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.35 147.48 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.069 1.348 . . . . 0.0 110.547 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -125.89 111.57 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.269 1.428 . . . . 0.0 111.083 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.98 -18.75 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.014 1.326 . . . . 0.0 113.777 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -77.28 -7.62 56.27 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.67 150.94 44.81 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.64 1.576 . . . . 0.0 112.397 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.9 14.96 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.128 3.219 . . . . 0.0 115.89 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.95 4.3 38.87 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.511 2.005 . . . . 0.0 112.757 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 145.45 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.352 1.061 . . . . 0.0 113.18 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.03 40.94 0.73 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.309 1.844 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -66.26 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.568 1.547 . . . . 0.0 113.169 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.5 tttm -145.74 146.62 31.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.292 1.837 . . . . 0.0 111.378 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -63.4 175.72 0.95 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.599 2.36 . . . . 0.0 115.903 -174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -130.42 -4.06 4.29 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.599 2.36 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.6 -66.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.011 -1.055 . . . . 0.0 108.437 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.27 -8.84 21.76 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.206 2.602 . . . . 0.0 110.947 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.456 ' O ' ' HE2' ' A' ' 89' ' ' LYS . 72.3 m80 64.07 24.0 13.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.162 2.185 . . . . 0.0 114.38 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 18.7 m-85 -79.72 145.75 63.17 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -61.03 142.28 96.9 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.853 2.369 . . . . 0.0 110.045 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 56' ' ' CYS . 6.9 mm -90.48 130.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 124.662 1.185 . . . . 0.0 111.306 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -119.05 107.92 14.09 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.024 1.729 . . . . 0.0 111.49 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.548 0.895 0 C-N-CA 126.527 1.931 . . . . 0.0 113.611 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.015 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.26 57.76 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.63 2.215 . . . . 0.0 111.18 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.9 p -145.42 152.31 39.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.395 0.678 . . . . 0.0 112.739 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.74 131.84 35.52 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.635 1.174 . . . . 0.0 110.62 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.11 64.7 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.739 -1.226 . . . . 0.0 111.503 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -92.49 -42.01 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.339 1.055 . . . . 0.0 110.57 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . 0.257 29.2 p -124.79 9.26 8.23 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 50.53 29.01 3.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.284 2.233 . . . . 0.0 112.888 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.43 140.22 14.88 Favored Glycine 0 N--CA 1.467 0.74 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.269 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.1 171.0 0.78 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.16 1.384 . . . . 0.0 114.718 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 141.15 57.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.69 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 p -130.08 155.36 46.3 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.065 0.936 . . . . 0.0 112.695 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.03 -11.79 0.1 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -128.28 -15.98 4.54 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.537 1.535 . . . . 0.0 112.921 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.54 HD22 ' HB3' ' A' ' 66' ' ' HIS . 10.3 t-20 -150.69 74.62 8.66 Favored Pre-proline 0 N--CA 1.44 -0.93 0 C-N-CA 125.511 1.524 . . . . 0.0 109.483 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.22 -158.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.312 4.008 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mt -129.8 156.67 43.96 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 123.037 1.398 . . . . 0.0 111.532 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -154.04 177.14 11.39 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 129.463 3.105 . . . . 0.0 107.739 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -124.63 98.1 37.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.724 0.809 . . . . 0.0 108.86 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.25 -15.45 20.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.806 2.338 . . . . 0.0 112.732 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 0.4 OUTLIER -151.85 157.39 41.83 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 124.262 1.025 . . . . 0.0 112.433 -169.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -85.28 20.99 1.82 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.4 m -47.97 -14.39 0.05 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 126.582 1.953 . . . . 0.0 114.785 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttp-105 58.25 173.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.231 3.412 . . . . 0.0 115.26 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.63 -161.59 26.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.775 -1.203 . . . . 0.0 112.981 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.7 p -65.04 -24.15 67.4 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.494 -1.003 . . . . 0.0 113.194 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 pt -74.9 -3.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -74.17 -20.07 60.34 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.486 1.039 . . . . 0.0 112.684 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -90.3 139.93 30.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.433 1.093 . . . . 0.0 113.661 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 mtt -151.83 142.94 23.21 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.563 0.745 . . . . 0.0 111.973 -174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.54 ' HB3' HD22 ' A' ' 50' ' ' ASN . 23.5 m170 -70.1 149.5 47.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.177 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.53 -33.98 77.17 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.719 -0.613 . . . . 0.0 110.681 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.1 m -73.82 -42.94 60.17 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.758 -0.589 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 84.0 m -64.59 -43.5 93.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.916 1.287 . . . . 0.0 112.524 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.14 -44.05 97.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.386 0.994 . . . . 0.0 110.088 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.02 -28.84 59.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.257 1.023 . . . . 0.0 113.531 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -91.05 -37.0 13.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.281 1.432 . . . . 0.0 111.166 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.451 ' CE2' ' HE3' ' A' ' 77' ' ' LYS . 88.8 t90 -60.55 -51.74 68.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.49 -34.14 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.422 -0.799 . . . . 0.0 111.437 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.51 78.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.983 -0.448 . . . . 0.0 111.408 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -71.02 -30.87 67.21 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.967 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HE3' ' CE2' ' A' ' 73' ' ' TRP . 56.1 mmtt -81.05 8.38 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.496 2.718 . . . . 0.0 113.736 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER 75.68 16.51 2.48 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.4 2.28 . . . . 0.0 115.528 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.73 139.46 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.079 1.352 . . . . 0.0 111.41 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -130.08 112.97 13.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 0.0 112.998 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.2 pt -67.49 -17.87 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 113.94 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -71.77 -13.04 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.12 143.66 27.19 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.698 1.199 . . . . 0.0 111.53 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.68 16.77 1.23 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.049 3.166 . . . . 0.0 116.272 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.25 7.03 25.0 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.536 2.017 . . . . 0.0 112.805 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.8 55.81 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.286 1.034 . . . . 0.0 113.286 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.5 41.08 1.59 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.392 1.877 . . . . 0.0 110.141 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 88' ' ' VAL . 2.0 t -49.67 107.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.712 2.405 . . . . 0.0 114.13 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -148.38 144.95 27.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.147 1.779 . . . . 0.0 110.949 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 43.1 t -66.56 170.87 5.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.548 2.339 . . . . 0.0 114.715 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.79 -17.8 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.193 2.597 . . . . 0.0 111.808 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.2 -55.69 11.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.105 . . . . 0.0 109.578 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.9 p -115.85 -7.07 12.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.977 0.511 . . . . 0.0 111.894 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 68.89 18.03 8.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.518 2.327 . . . . 0.0 114.678 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.8 m-85 -82.75 145.31 50.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 120.817 -1.177 . . . . 0.0 111.966 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.37 132.19 39.86 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.577 2.185 . . . . 0.0 109.85 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -85.22 116.02 27.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 126.255 1.822 . . . . 0.0 108.854 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -114.26 111.94 22.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -170.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 126.994 2.118 . . . . 0.0 111.915 176.047 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.494 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.92 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.4 147.93 30.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.309 1.555 . . . . 0.0 109.962 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 57.1 p -141.49 145.36 35.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.033 1.333 . . . . 0.0 112.652 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.551 ' HG ' ' HG ' ' A' ' 69' ' ' CYS . 18.8 t -58.33 140.17 53.95 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.941 1.296 . . . . 0.0 114.246 174.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.1 mt -99.22 -48.16 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 110.502 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.4 m -107.38 -4.64 18.37 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 49.34 31.23 3.67 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.234 2.214 . . . . 0.0 112.385 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.64 141.59 16.18 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.297 0.951 . . . . 0.0 112.627 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.76 160.43 11.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.922 1.289 . . . . 0.0 113.554 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.48 144.26 51.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.519 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.7 p -128.35 157.69 40.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.313 1.054 . . . . 0.0 112.636 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -57.72 -11.59 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.63 -21.77 5.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.432 1.493 . . . . 0.0 111.475 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.602 HD21 ' HB3' ' A' ' 66' ' ' HIS . 35.6 t30 -141.02 67.48 27.14 Favored Pre-proline 0 N--CA 1.444 -0.747 0 C-N-CA 124.118 0.967 . . . . 0.0 113.49 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -49.75 167.74 0.18 Allowed 'Trans proline' 0 C--O 1.235 0.371 1 C-N-CA 125.5 4.133 . . . . 0.0 116.928 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.62 142.33 44.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.177 173.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -152.75 -177.49 6.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.671 1.988 . . . . 0.0 108.765 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -114.99 108.23 48.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.841 0.856 . . . . 0.0 110.354 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 97' ' ' ILE . 87.4 Cg_endo -75.85 -18.82 16.67 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.622 2.881 . . . . 0.0 112.764 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.281 5.1 t -141.15 -161.33 1.2 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 129.678 3.191 . . . . 0.0 106.889 -167.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -95.11 -41.58 9.03 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.255 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.321 6.2 m 40.97 -5.47 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 1 C-N-CA 132.309 4.244 . . . . 0.0 119.298 -173.26 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 45.52 67.9 0.66 Allowed 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 131.78 4.032 . . . . 0.0 117.743 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.93 -174.19 31.01 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 125.942 1.734 . . . . 0.0 111.844 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -55.83 -23.92 33.34 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.215 1.008 . . . . 0.0 111.854 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -61.98 -14.62 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 113.498 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -70.36 -5.91 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.768 -1.207 . . . . 0.0 114.02 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -97.48 138.95 34.12 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.727 1.211 . . . . 0.0 110.724 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 83.3 mtp -158.35 145.89 18.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.606 1.562 . . . . 0.0 109.684 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.602 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.5 m80 -69.99 151.53 45.47 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.26 -38.88 77.81 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.749 -0.594 . . . . 0.0 110.712 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -81.32 -31.62 33.44 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.551 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -76.03 -41.05 52.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.411 1.101 . . . . 0.0 112.245 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.86 -49.85 74.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.708 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 mt -55.14 -35.39 64.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.423 1.089 . . . . 0.0 112.748 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.2 pt-20 -81.49 -37.67 27.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.216 0.462 . . . . 0.0 112.096 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -62.91 -51.02 68.56 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.681 -0.637 . . . . 0.0 110.715 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.78 -31.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.938 0.79 . . . . 0.0 112.331 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.66 -20.21 61.29 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.088 -0.382 . . . . 0.0 111.868 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -80.57 -5.02 56.16 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.804 -1.185 . . . . 0.0 111.867 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -92.11 9.85 31.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.611 1.964 . . . . 0.0 114.049 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 79.61 9.3 1.56 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.816 2.046 . . . . 0.0 113.844 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mt -109.89 124.22 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 111.342 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -87.4 82.33 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.174 0.988 . . . . 0.0 111.099 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -9.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 113.818 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.7 t -65.9 -25.77 67.32 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.15 -0.344 . . . . 0.0 110.977 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -92.52 143.55 27.4 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.521 1.128 . . . . 0.0 110.545 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.47 9.24 2.62 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.687 2.925 . . . . 0.0 116.624 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.3 -9.44 69.88 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.524 1.535 . . . . 0.0 113.32 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.59 150.2 49.1 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.203 1.001 . . . . 0.0 112.741 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.57 49.7 1.22 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.137 1.775 . . . . 0.0 109.839 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.01 131.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 126.234 1.814 . . . . 0.0 111.982 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -142.87 144.16 32.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.962 1.705 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 17.5 t -59.04 169.54 1.04 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.974 2.109 . . . . 0.0 115.743 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -127.76 -8.09 5.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.541 2.736 . . . . 0.0 112.041 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.3 mt -89.91 -56.28 5.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 124.022 0.929 . . . . 0.0 108.784 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.03 -1.76 11.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.017 0.927 . . . . 0.0 111.708 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 70.6 m80 61.31 16.74 7.64 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.896 2.078 . . . . 0.0 115.164 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.514 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.9 m-85 -77.03 144.24 71.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 120.848 -1.157 . . . . 0.0 111.297 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -57.67 148.82 71.8 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.402 2.068 . . . . 0.0 109.988 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 55' ' ' PRO . 2.4 mt -116.45 135.55 56.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 124.078 0.951 . . . . 0.0 110.78 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -121.96 125.59 46.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.216 1.006 . . . . 0.0 110.842 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -173.032 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 112.855 -0.098 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.13 162.93 27.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.482 0.713 . . . . 0.0 112.071 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -149.87 160.78 43.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.033 1.333 . . . . 0.0 113.55 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.1 t -69.12 125.16 25.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.18 1.792 . . . . 0.0 112.822 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -10.32 56.06 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.259 -0.901 . . . . 0.0 113.136 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 mt -91.77 -46.18 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 125.097 1.359 . . . . 0.0 109.668 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -125.73 3.22 7.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 59.25 31.27 21.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.736 2.015 . . . . 0.0 113.815 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 144.89 17.14 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.87 169.32 10.01 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.159 0.981 . . . . 0.0 111.685 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.74 53.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.8 p -114.94 168.56 9.8 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.112 0.958 . . . . 0.0 111.797 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.56 -19.31 37.0 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -121.49 -17.85 7.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 110.92 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.57 58.0 16.1 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.15 145.31 26.45 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.506 2.137 . . . . 0.0 111.919 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.38 175.58 9.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.136 -2.302 . . . . 0.0 109.92 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.4 175.47 2.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.215 2.206 . . . . 0.0 109.035 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -112.16 95.46 30.36 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.507 1.123 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.446 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.4 Cg_endo -71.08 -30.4 16.35 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.689 2.26 . . . . 0.0 111.688 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.9 t -135.37 -178.99 5.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.836 2.854 . . . . 0.0 110.446 -171.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.62 36.13 4.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.639 1.976 . . . . 0.0 113.419 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.5 m -51.6 -8.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.634 2.374 . . . . 0.0 116.519 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 65.64 175.5 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.875 2.07 . . . . 0.0 114.493 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.12 -150.5 1.01 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.478 1.513 . . . . 0.0 115.538 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -75.47 -1.79 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.788 1.235 . . . . 0.0 113.872 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.7 pt -97.78 -0.61 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.915 1.286 . . . . 0.0 113.91 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -83.61 5.57 23.86 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.47 143.24 45.26 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.673 1.589 . . . . 0.0 109.281 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.7 mtp -154.32 140.3 18.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.641 1.176 . . . . 0.0 111.084 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 7.2 m170 -70.22 144.57 51.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.049 0.94 . . . . 0.0 110.091 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.98 12.95 1.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 113.545 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -129.84 -40.38 1.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.129 1.372 . . . . 0.0 109.048 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 83.7 m -59.69 -47.85 83.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.641 1.176 . . . . 0.0 111.332 172.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -56.0 -44.33 78.54 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.275 0.63 . . . . 0.0 110.381 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.17 -22.62 61.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.856 1.262 . . . . 0.0 112.869 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.63 -39.89 8.87 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.828 1.651 . . . . 0.0 111.321 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.407 ' CZ2' ' HE2' ' A' ' 77' ' ' LYS . 91.9 t90 -56.38 -47.55 78.71 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.099 1.36 . . . . 0.0 111.416 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.9 m -66.7 -25.34 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 119.141 0.882 . . . . 0.0 111.817 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.77 -38.42 76.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.115 -0.366 . . . . 0.0 110.591 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 p -69.06 -18.64 64.03 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.068 -1.02 . . . . 0.0 113.605 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HE2' ' CZ2' ' A' ' 73' ' ' TRP . 35.7 mmtm -75.32 6.15 4.81 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.063 2.145 . . . . 0.0 113.619 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.262 9.3 t30 66.07 43.96 2.78 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.599 1.56 . . . . 0.0 111.601 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -138.48 140.79 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 109.312 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -117.9 99.58 7.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.411 1.085 . . . . 0.0 111.703 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.2 pt -63.51 -15.9 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.365 1.466 . . . . 0.0 113.881 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -68.75 -23.79 64.37 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.236 0.614 . . . . 0.0 112.084 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -107.18 148.78 37.71 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 125.333 1.453 . . . . 0.0 112.381 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.1 27.7 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.633 3.556 . . . . 0.0 114.673 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.83 -1.86 30.4 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.462 1.982 . . . . 0.0 112.314 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.79 43.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.172 0.989 . . . . 0.0 112.672 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -150.78 46.69 0.86 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.061 1.744 . . . . 0.0 109.741 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.72 109.34 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.999 1.32 . . . . 0.0 113.009 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -143.11 140.21 30.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.383 1.873 . . . . 0.0 110.003 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.6 168.11 2.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.058 2.143 . . . . 0.0 115.19 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -122.97 -7.99 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.543 2.337 . . . . 0.0 111.919 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -88.16 -57.29 4.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.659 1.184 . . . . 0.0 108.46 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.4 p -110.99 -6.88 14.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.104 0.562 . . . . 0.0 111.749 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.254 73.9 m80 64.44 19.25 11.73 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.706 2.002 . . . . 0.0 114.305 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.455 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.5 m-85 -82.11 145.02 51.87 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.056 -1.027 . . . . 0.0 111.413 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.53 153.0 69.64 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.811 1.674 . . . . 0.0 109.256 168.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -112.15 141.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.902 0.858 . . . . 0.0 110.092 -173.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -113.89 121.84 45.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.819 1.248 . . . . 0.0 111.101 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -176.296 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.601 0 CA-C-O 119.607 -0.552 . . . . 0.0 114.293 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.02 161.99 30.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.667 1.234 . . . . 0.0 108.481 172.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.7 p -148.3 148.7 30.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.073 0.949 . . . . 0.0 113.225 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.43 127.93 34.15 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.461 1.904 . . . . 0.0 110.751 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -14.85 62.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 69' ' ' CYS . 67.4 mt -96.64 -52.8 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.513 1.125 . . . . 0.0 110.346 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.53 -16.66 36.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 54.95 38.71 30.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.454 1.502 . . . . 0.0 110.445 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.36 156.25 22.31 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 122.802 1.223 . . . . 0.0 111.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -63.44 166.87 6.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 126.669 1.988 . . . . 0.0 115.932 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 158.41 28.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.721 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.6 p -137.27 160.09 40.03 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.281 1.039 . . . . 0.0 113.113 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.92 -9.27 3.95 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.85 -27.55 4.26 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.632 1.573 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 56.5 t30 -138.07 67.05 47.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.0 176.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 126.82 5.013 . . . . 0.0 117.75 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.01 145.49 43.64 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.92 172.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -156.39 -176.49 5.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.536 2.334 . . . . 0.0 109.632 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 8.6 m170 -119.49 102.4 47.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.302 1.041 . . . . 0.0 113.571 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.63 -33.52 1.25 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.102 1.201 . . . . 0.0 113.082 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.0 p -147.18 150.31 34.67 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.638 1.975 . . . . 0.0 110.165 -170.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 12.1 mptt -84.05 28.27 0.62 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.456 -1.247 . . . . 0.0 114.169 -174.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.46 87.91 5.06 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 161.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.81 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 3 C-N-CA 141.81 8.044 . . . . 0.0 112.122 1.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.6 -139.43 6.11 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.067 1.794 . . . . 0.0 109.624 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -54.01 -29.1 42.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 119.563 1.682 . . . . 0.0 111.775 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 pt -62.59 -9.1 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.121 1.768 . . . . 0.0 113.316 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG3' ' CD2' ' A' ' 54' ' ' HIS . 16.5 pttt -82.13 0.33 41.3 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.339 -0.851 . . . . 0.0 112.012 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.61 139.18 31.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.36 1.464 . . . . 0.0 108.751 171.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.5 ttp -161.6 145.45 12.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.828 0.851 . . . . 0.0 110.438 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.8 m80 -67.84 154.89 40.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.372 0.533 . . . . 0.0 110.787 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.79 -45.42 92.38 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.277 -0.889 . . . . 0.0 109.638 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 p -54.98 -54.34 44.13 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.982 0.913 . . . . 0.0 112.375 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 41' ' ' ILE . 82.1 m -62.6 -36.99 84.53 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.376 1.47 . . . . 0.0 112.747 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.2 tp -66.3 -47.02 74.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.13 1.332 . . . . 0.0 110.723 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.57 -32.74 70.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.187 1.795 . . . . 0.0 111.92 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -79.6 -41.09 27.84 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 128.076 2.55 . . . . 0.0 111.199 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -62.28 -50.77 70.36 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.998 -1.064 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.46 -32.13 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.794 0.724 . . . . 0.0 110.605 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.09 93.13 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.593 -0.692 . . . . 0.0 109.983 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -61.65 -16.27 47.17 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.594 -1.316 . . . . 0.0 113.462 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.84 3.75 50.12 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.142 1.777 . . . . 0.0 112.586 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.252 10.1 t30 64.62 44.09 4.06 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.114 1.365 . . . . 0.0 112.375 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -135.61 142.22 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.762 1.225 . . . . 0.0 110.424 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -108.77 100.43 9.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.811 1.244 . . . . 0.0 109.422 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.27 -11.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 t -76.99 -21.42 54.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.179 0.592 . . . . 0.0 112.048 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.89 144.34 90.39 Favored Pre-proline 0 N--CA 1.475 0.821 0 O-C-N 120.985 -1.072 . . . . 0.0 111.558 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.38 7.03 3.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.642 2.894 . . . . 0.0 116.768 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.02 -3.08 34.02 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.451 1.977 . . . . 0.0 112.519 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.42 127.83 34.41 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.285 1.042 . . . . 0.0 111.755 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.36 40.92 1.61 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.219 1.808 . . . . 0.0 109.8 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.18 124.78 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.341 2.256 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -139.16 131.35 28.18 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.468 1.507 . . . . 0.0 110.625 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.9 t -66.47 126.91 30.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.49 -21.53 41.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.13 -66.69 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.625 1.17 . . . . 0.0 111.338 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.0 p -83.39 -18.99 36.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 111.423 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 21.7 t60 79.79 1.43 2.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.332 3.053 . . . . 0.0 112.609 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 57' ' ' LYS . 53.6 m-85 -83.89 131.2 52.36 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.402 -1.436 . . . . 0.0 112.098 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 95' ' ' TYR . 31.6 Cg_exo -55.46 145.83 66.31 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.314 3.343 . . . . 0.0 111.44 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 mm -74.12 107.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 122.233 1.016 . . . . 0.0 109.39 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -99.89 85.82 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 113.198 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 125.086 1.354 . . . . 0.0 111.019 176.89 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 CA-C-O 119.946 -0.363 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 38' ' ' THR . . . -65.94 -175.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 111.525 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 37' ' ' ALA . 11.5 p -160.53 172.96 16.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 112.016 174.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -84.89 127.25 34.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.769 1.228 . . . . 0.0 107.698 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -20.63 66.47 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.157 1.344 . . . . 0.0 112.945 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.2 mt -79.94 -43.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 117.542 -1.218 . . . . 0.0 109.503 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.36 -2.18 8.54 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.322 38.8 mmt180 52.3 45.86 27.7 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.2 1.8 . . . . 0.0 111.413 -173.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.43 134.23 12.04 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 111.643 -2.526 . . . . 0.0 110.422 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.36 155.07 41.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.874 0.845 . . . . 0.0 110.955 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.9 156.36 2.91 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -128.65 173.36 10.36 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.36 1.076 . . . . 0.0 113.042 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.42 5.01 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.853 1.798 . . . . 0.0 115.853 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -145.98 -28.85 0.42 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.367 1.467 . . . . 0.0 111.636 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -127.69 67.84 73.48 Favored Pre-proline 0 N--CA 1.44 -0.941 0 C-N-CA 125.657 1.583 . . . . 0.0 110.231 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.34 -171.42 1.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.074 3.849 . . . . 0.0 112.109 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.72 142.09 46.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 110.87 -2.877 . . . . 0.0 109.359 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -158.0 -166.65 2.02 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 128.359 2.664 . . . . 0.0 107.738 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.54 107.79 14.48 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.247 1.019 . . . . 0.0 112.5 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.15 -18.6 9.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.878 3.052 . . . . 0.0 113.743 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 9.8 t -143.43 171.68 13.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.269 2.228 . . . . 0.0 110.142 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -83.28 20.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 129.681 3.193 . . . . 0.0 113.784 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -12.26 0.18 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 55.23 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 130.534 3.534 . . . . 0.0 120.068 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.35 -175.91 49.69 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.342 1.428 . . . . 0.0 113.52 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -69.12 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.73 -28.1 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.748 2.419 . . . . 0.0 108.704 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -54.05 -29.11 42.74 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.263 1.392 . . . . 0.0 113.585 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.34 134.17 49.88 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.707 1.241 . . . . 0.0 111.839 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.4 mtt -157.69 143.81 17.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.214 1.405 . . . . 0.0 109.706 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -69.0 155.38 40.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.567 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.97 -52.27 66.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.483 -0.76 . . . . 0.0 110.564 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -60.31 -45.46 93.32 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.562 -0.711 . . . . 0.0 112.313 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.1 -44.77 91.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.731 0.696 . . . . 0.0 112.07 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.05 -47.06 87.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.964 0.802 . . . . 0.0 110.141 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.64 -28.03 66.87 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.965 0.906 . . . . 0.0 112.787 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -85.65 -34.02 21.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.865 0.866 . . . . 0.0 111.723 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -58.81 -59.05 6.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 109.951 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.84 -23.52 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 111.811 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.0 -0.44 55.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.2 m -113.5 -5.4 13.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.99 1.716 . . . . 0.0 111.811 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -80.28 6.0 13.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.701 2.8 . . . . 0.0 114.691 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.318 0.0 OUTLIER 76.34 32.15 0.59 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.684 1.593 . . . . 0.0 111.518 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -142.08 159.77 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.748 2.019 . . . . 0.0 109.795 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -132.83 112.98 12.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.534 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.8 pt -61.23 -17.68 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.231 1.412 . . . . 0.0 114.452 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -74.36 -26.78 60.34 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.204 0.456 . . . . 0.0 111.873 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.83 145.31 83.95 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 121.263 -0.898 . . . . 0.0 112.734 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -79.86 27.42 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.54 3.493 . . . . 0.0 114.948 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.47 20.99 3.66 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.167 2.318 . . . . 0.0 111.188 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.81 131.8 38.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.755 0.822 . . . . 0.0 112.743 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -145.62 55.78 1.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.575 1.95 . . . . 0.0 108.6 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -71.55 37.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.818 2.047 . . . . 0.0 116.024 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -58.44 141.91 50.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.699 2.8 . . . . 0.0 113.005 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 46.9 t -60.33 116.51 4.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.556 1.942 . . . . 0.0 110.759 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -78.11 13.97 1.3 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.65 -47.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.86 1.264 . . . . 0.0 110.502 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -116.44 -9.31 11.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.187 1.795 . . . . 0.0 111.816 -174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.277 78.4 m-70 65.4 31.31 10.45 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.972 2.109 . . . . 0.0 115.823 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.6 m-85 -106.96 138.19 19.74 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.868 1.267 . . . . 0.0 112.552 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.94 135.55 71.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.394 2.063 . . . . 0.0 110.31 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.1 mm -74.93 136.98 23.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.029 0.932 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -123.98 88.2 2.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.597 1.189 . . . . 0.0 113.503 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 C-N-CA 126.223 1.809 . . . . 0.0 110.137 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.558 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.86 152.67 45.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.884 1.274 . . . . 0.0 110.244 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 79.0 p -143.91 153.1 41.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.738 1.215 . . . . 0.0 112.333 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 t -59.91 127.19 30.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.482 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -14.0 61.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 112.899 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.08 -46.28 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.3 p -113.8 -7.33 13.24 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.315 31.2 mmt180 57.22 44.72 21.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.063 1.345 . . . . 0.0 112.552 -175.274 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.96 16.49 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 172.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.0 172.43 4.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.45 1.1 . . . . 0.0 111.764 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.84 161.81 23.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.538 0.685 . . . . 0.0 109.637 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.4 p -136.93 166.78 22.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.208 0.603 . . . . 0.0 111.108 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.43 -22.25 64.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.71 -27.77 10.1 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.078 1.751 . . . . 0.0 111.376 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -137.27 66.9 53.51 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.51 173.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.546 4.164 . . . . 0.0 116.364 172.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.3 mt -110.24 146.01 36.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.105 -1.861 . . . . 0.0 110.49 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.46 -177.9 6.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.074 2.149 . . . . 0.0 108.827 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -126.12 118.01 23.67 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.929 0.892 . . . . 0.0 109.201 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.68 -26.41 7.01 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.108 2.538 . . . . 0.0 111.575 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.58 -152.71 0.51 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 128.326 2.65 . . . . 0.0 110.962 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 6.1 mmtt -119.66 13.35 12.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.549 1.939 . . . . 0.0 113.69 -174.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 m -44.35 -17.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -174.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? 38.99 34.55 0.1 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 129.11 2.964 . . . . 0.0 118.435 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.33 28.36 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.602 1.096 . . . . 0.0 114.642 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.5 p -64.19 9.42 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.475 1.51 . . . . 0.0 114.437 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.02 12.33 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.559 2.343 . . . . 0.0 110.22 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -90.26 -21.87 21.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 113.214 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -79.85 140.36 36.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.967 1.307 . . . . 0.0 111.597 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.0 mtp -154.61 143.04 20.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.671 1.188 . . . . 0.0 110.527 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -76.11 158.45 31.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.2 -46.91 88.52 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.243 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 m -65.1 -48.55 73.28 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.654 0.782 . . . . 0.0 111.613 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.62 -39.44 88.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.955 -1.09 . . . . 0.0 111.603 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.03 -49.89 75.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.043 1.747 . . . . 0.0 109.815 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.9 -30.7 68.0 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 113.447 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.46 -34.65 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.001 2.52 . . . . 0.0 112.225 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -70.6 -52.84 18.7 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.449 1.1 . . . . 0.0 109.156 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.4 m -58.88 -30.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.989 0.813 . . . . 0.0 110.573 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.18 75.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.34 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 t -60.92 -30.96 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.709 -1.244 . . . . 0.0 111.591 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.63 8.67 7.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.721 2.808 . . . . 0.0 114.025 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.286 0.0 OUTLIER 74.7 18.99 2.65 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.907 2.083 . . . . 0.0 115.531 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.92 141.69 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -129.79 113.39 14.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.027 1.331 . . . . 0.0 111.533 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -21.07 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.592 1.557 . . . . 0.0 114.003 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -75.3 -16.98 60.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.795 0.838 . . . . 0.0 112.888 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.89 142.15 51.92 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 120.928 -1.108 . . . . 0.0 113.252 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.48 17.74 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.571 3.514 . . . . 0.0 115.314 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.98 16.15 5.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.369 2.414 . . . . 0.0 111.541 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.14 147.89 42.51 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.525 0.73 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.19 39.93 0.93 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.853 1.661 . . . . 0.0 110.366 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -53.77 116.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.284 1.834 . . . . 0.0 113.084 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -148.75 147.21 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.843 1.657 . . . . 0.0 111.473 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.8 t -64.03 172.18 2.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.53 1.532 . . . . 0.0 113.76 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -129.74 0.49 4.89 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.764 2.025 . . . . 0.0 112.673 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -105.04 -65.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.1 p -92.74 -9.37 40.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.612 1.965 . . . . 0.0 111.078 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.343 4.3 p-80 58.7 16.72 4.58 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.163 2.585 . . . . 0.0 115.905 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 28.7 m-85 -81.59 143.78 51.64 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 120.018 1.281 . . . . 0.0 113.232 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.02 136.03 29.49 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.895 3.063 . . . . 0.0 111.772 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -82.79 124.33 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.894 1.278 . . . . 0.0 109.988 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.86 93.22 4.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.323 1.449 . . . . 0.0 112.159 -175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.475 1.11 . . . . 0.0 111.226 176.203 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 170.85 6.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.665 1.186 . . . . 0.0 111.892 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.3 p -150.34 165.82 31.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.99 1.316 . . . . 0.0 112.135 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 39.1 t -75.62 120.97 21.75 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 114.336 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -9.17 13.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.57 1.148 . . . . 0.0 113.186 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.424 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 57.5 mt -99.26 -42.05 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.109 1.364 . . . . 0.0 110.831 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.77 12.42 4.03 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 53.75 19.39 1.84 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.681 2.793 . . . . 0.0 115.488 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.52 144.94 25.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.56 173.85 8.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 110.404 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.06 157.41 22.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.416 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.3 p -127.05 165.23 19.88 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.48 1.133 . . . . 0.0 112.407 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -61.51 -15.7 40.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.01 -24.28 2.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.129 0.972 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -136.59 71.72 58.09 Favored Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 124.753 1.221 . . . . 0.0 111.324 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.92 -160.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 124.499 3.466 . . . . 0.0 109.291 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mt -120.05 141.86 49.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.093 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -144.76 173.85 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 110.877 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -113.98 101.87 54.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.552 1.141 . . . . 0.0 112.381 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.68 -36.1 8.91 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.97 1.78 . . . . 0.0 111.443 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.9 t -119.7 -164.26 1.05 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 129.07 2.948 . . . . 0.0 112.294 -166.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -116.11 1.44 13.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.98 2.512 . . . . 0.0 115.247 -172.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 m -34.15 -48.69 0.33 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.598 2.359 . . . . 0.0 114.944 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 109.5 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 1 C-N-CA 132.925 4.49 . . . . 0.0 112.052 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 18.72 -109.98 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 129.213 3.292 . . . . 0.0 117.643 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -55.51 -5.26 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -174.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.94 19.41 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.85 1.659 . . . . 0.0 111.165 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -100.28 -53.56 3.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.705 1.202 . . . . 0.0 109.72 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -46.48 142.3 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.591 1.956 . . . . 0.0 112.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.1 mtt -159.64 150.57 19.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.474 1.51 . . . . 0.0 111.55 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -74.82 150.94 39.11 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -56.47 -42.32 78.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.822 1.192 . . . . 0.0 111.328 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.0 p -61.22 -46.29 91.05 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.372 1.469 . . . . 0.0 112.631 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.4 m -64.78 -40.13 94.75 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 112.292 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.58 -47.72 84.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.65 1.114 . . . . 0.0 110.289 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.45 -31.05 63.6 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.186 2.194 . . . . 0.0 113.268 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -92.46 -35.48 13.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.912 1.285 . . . . 0.0 112.143 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -62.97 -48.25 79.68 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.651 0.78 . . . . 0.0 111.04 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.87 -27.22 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.986 0.812 . . . . 0.0 111.585 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.39 90.25 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.76 -0.587 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.7 p -67.72 -1.66 5.68 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.92 8.63 44.8 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.037 1.29 . . . . 0.0 111.676 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 80.9 30.1 0.17 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.658 2.383 . . . . 0.0 113.296 178.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.25 145.94 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.494 1.118 . . . . 0.0 112.807 -170.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -139.43 111.31 7.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.093 1.357 . . . . 0.0 110.564 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 pt -63.91 -16.54 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.498 1.119 . . . . 0.0 113.321 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -82.11 0.18 41.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.462 1.105 . . . . 0.0 113.462 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -126.77 151.03 72.96 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.697 1.599 . . . . 0.0 112.418 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.38 27.69 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.75 3.633 . . . . 0.0 115.268 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.41 5.54 11.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.952 2.215 . . . . 0.0 112.084 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 144.7 53.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.432 1.093 . . . . 0.0 113.17 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.66 38.41 0.68 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.898 1.679 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.77 99.08 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 126.212 1.805 . . . . 0.0 114.246 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -150.88 142.84 23.94 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.399 2.279 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.5 t -67.15 177.78 1.68 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.231 2.612 . . . . 0.0 116.063 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -132.52 -3.8 3.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.762 2.425 . . . . 0.0 112.769 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mt -86.31 -71.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.788 -1.195 . . . . 0.0 107.854 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 7.9 p -88.03 -15.37 36.53 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.844 2.458 . . . . 0.0 110.574 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.4 m80 69.66 17.5 7.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.907 2.483 . . . . 0.0 113.11 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -76.19 146.65 78.65 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.46 149.21 76.28 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.228 2.619 . . . . 0.0 111.276 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 56' ' ' CYS . 5.2 mm -100.63 140.76 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.665 1.186 . . . . 0.0 109.906 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -135.64 137.2 41.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.144 0.974 . . . . 0.0 112.877 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.871 1.269 . . . . 0.0 113.287 179.829 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 93.54 129.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 131.43 3.892 . . . . 0.0 112.854 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 45' ' ' GLU . 77.3 p -136.01 150.39 49.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.832 2.853 . . . . 0.0 114.393 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 51.2 t -61.88 132.62 53.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.66 1.584 . . . . 0.0 111.122 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -20.1 63.56 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.644 -1.285 . . . . 0.0 112.72 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 96.8 mt -83.25 -39.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 110.34 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.39 -10.87 12.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.253 22.0 mmt85 62.22 40.33 11.69 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.318 2.247 . . . . 0.0 112.567 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.76 152.83 21.12 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 125.325 1.44 . . . . 0.0 114.315 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.866 ' HA ' HG22 ' A' ' 38' ' ' THR . 3.4 mt-10 -156.0 -34.44 0.09 Allowed 'General case' 0 CA--C 1.481 -1.675 1 C-N-CA 133.324 4.65 . . . . 0.0 116.296 -1.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' H ' ' A' ' 45' ' ' GLU . . . -79.5 -176.01 5.06 Favored 'General case' 0 C--N 1.305 -1.355 1 C-N-CA 141.687 7.995 . . . . 0.0 112.174 -4.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 p -125.35 148.54 48.71 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.751 -1.218 . . . . 0.0 113.124 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.49 -7.07 1.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.04 -20.52 8.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.577 1.951 . . . . 0.0 111.052 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -145.75 72.8 13.86 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 125.284 1.434 . . . . 0.0 113.912 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -46.23 173.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.08 4.52 . . . . 0.0 117.014 173.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -116.71 155.58 28.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.512 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -157.04 -171.01 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.065 2.546 . . . . 0.0 107.74 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -125.4 115.56 25.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.926 0.89 . . . . 0.0 109.628 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -78.31 -19.41 11.88 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.833 3.022 . . . . 0.0 112.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.3 p -151.03 151.98 32.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.29 2.636 . . . . 0.0 110.969 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.2 39.86 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.467 1.507 . . . . 0.0 114.519 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.87 -3.73 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 175.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? 23.37 92.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 129.678 3.191 . . . . 0.0 115.867 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.4 23.16 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.924 1.726 . . . . 0.0 112.006 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.9 p -54.03 -37.13 63.78 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.28 1.69 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -80.75 -14.37 58.15 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.376 -0.827 . . . . 0.0 112.923 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.76 140.06 29.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.546 0.738 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.3 mtp -153.86 144.64 22.59 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.115 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 7.4 m170 -70.26 135.36 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -75.6 32.68 0.11 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.297 1.439 . . . . 0.0 113.4 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.3 t -145.66 -43.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.304 2.242 . . . . 0.0 108.469 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 86.0 m -59.19 -48.34 81.97 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.785 1.234 . . . . 0.0 112.948 174.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.0 tp -58.03 -46.94 84.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 123.853 0.861 . . . . 0.0 110.682 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -22.6 63.54 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.232 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -92.56 -40.16 10.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 110.353 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -56.69 -49.33 75.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.568 1.147 . . . . 0.0 112.172 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.23 -33.44 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.475 0.71 . . . . 0.0 111.956 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.9 81.87 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.741 -0.599 . . . . 0.0 111.24 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.2 m -63.82 -15.52 59.02 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.843 -1.16 . . . . 0.0 113.395 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -75.05 -7.84 54.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.808 1.243 . . . . 0.0 113.14 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 62.91 52.58 2.61 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.836 1.303 . . . . 0.0 112.368 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.4 150.51 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.872 -1.143 . . . . 0.0 111.246 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.16 117.45 9.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.041 0.536 . . . . 0.0 112.096 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.85 0.51 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -96.14 5.55 50.82 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 122.347 1.07 . . . . 0.0 110.249 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? 30.32 80.94 0.23 Allowed Pre-proline 0 CA--C 1.539 0.545 1 C-N-CA 133.049 4.54 . . . . 0.0 119.162 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -84.18 46.96 2.1 Favored 'Trans proline' 0 CA--C 1.544 0.995 1 C-N-CA 126.336 4.691 . . . . 0.0 109.902 172.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.98 -11.55 22.59 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.601 2.048 . . . . 0.0 112.015 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 162.87 13.88 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.019 0.909 . . . . 0.0 113.103 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.11 45.17 1.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.519 1.528 . . . . 0.0 110.619 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.9 t -52.65 114.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.817 1.647 . . . . 0.0 113.74 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -148.28 -177.82 5.97 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.3 t -62.79 164.54 7.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.861 2.064 . . . . 0.0 114.329 -174.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -125.51 13.08 8.12 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.679 1.992 . . . . 0.0 111.784 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 mt -113.43 -55.3 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.82 1.648 . . . . 0.0 108.297 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.48 -10.74 14.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 t60 55.42 19.56 3.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.016 1.726 . . . . 0.0 114.718 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -78.21 139.47 60.51 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.737 -1.227 . . . . 0.0 108.988 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 43.1 Cg_exo -49.68 129.16 23.0 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.058 3.172 . . . . 0.0 112.439 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -89.76 129.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.151 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -118.17 136.6 53.53 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.318 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 126.425 1.89 . . . . 0.0 111.26 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 168.85 2.56 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.976 1.31 . . . . 0.0 112.104 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.3 p -139.16 157.03 46.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -62.1 134.72 56.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.38 1.472 . . . . 0.0 113.162 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -5.67 43.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.27 -41.66 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.826 1.25 . . . . 0.0 110.112 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.48 6.49 5.24 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 54.45 27.83 8.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.608 1.563 . . . . 0.0 114.467 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.46 140.98 15.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -72.57 162.89 28.89 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.266 1.026 . . . . 0.0 112.681 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 51' ' ' PRO . . . -54.53 140.52 34.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.217 1.407 . . . . 0.0 113.094 173.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.2 p -114.98 -149.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.607 1.963 . . . . 0.0 110.217 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -109.88 -5.28 15.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.562 1.545 . . . . 0.0 112.284 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.68 -18.22 5.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.362 2.265 . . . . 0.0 110.939 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -141.53 69.79 26.06 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 128.33 2.652 . . . . 0.0 108.408 174.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 51.6 Cg_endo -77.15 4.21 6.02 Favored 'Trans proline' 0 N--CA 1.501 1.945 1 C-N-CA 129.397 6.732 . . . . 0.0 118.276 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt 60.08 144.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 1 C-N-CA 136.599 5.959 . . . . 0.0 113.636 -170.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.11 179.83 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.241 1.816 . . . . 0.0 109.483 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -122.65 103.48 37.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.922 1.289 . . . . 0.0 109.829 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.49 -17.92 20.53 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.464 2.109 . . . . 0.0 111.425 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.5 t -134.92 -168.11 2.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.703 2.401 . . . . 0.0 111.428 -168.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -125.14 33.25 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.455 1.502 . . . . 0.0 113.626 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 93' ' ' CYS . 2.3 m -53.72 -10.39 0.29 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.286 1.434 . . . . 0.0 114.091 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 30.36 69.55 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.851 2.86 . . . . 0.0 116.561 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.4 -169.8 42.83 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.44 -1.255 . . . . 0.0 114.013 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -64.04 8.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.822 1.649 . . . . 0.0 114.495 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.87 12.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 127.741 2.416 . . . . 0.0 111.442 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 pttt -90.86 -17.01 27.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.639 1.576 . . . . 0.0 113.08 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 63' ' ' LYS . 45.4 m-85 -90.15 144.32 25.98 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.116 1.766 . . . . 0.0 111.091 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.4 mtp -157.8 143.07 16.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.124 0.97 . . . . 0.0 110.956 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -75.97 144.53 40.92 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.31 -40.72 78.48 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.956 -1.09 . . . . 0.0 110.954 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -59.62 -47.02 87.23 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.525 1.93 . . . . 0.0 112.09 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.3 m -63.17 -46.37 87.45 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.857 1.263 . . . . 0.0 111.122 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.12 -48.85 80.08 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 122.911 0.485 . . . . 0.0 112.059 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.02 -20.85 60.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.635 1.574 . . . . 0.0 112.522 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -96.41 -31.89 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.959 1.704 . . . . 0.0 112.057 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.438 ' CZ2' ' HE3' ' A' ' 77' ' ' LYS . 15.8 t90 -64.05 -57.19 10.4 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.01 1.724 . . . . 0.0 111.746 178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 m -55.75 -22.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.456 1.502 . . . . 0.0 111.225 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.03 -33.94 22.42 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.036 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 t -70.55 -26.4 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.254 1.422 . . . . 0.0 110.817 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE3' ' CZ2' ' A' ' 73' ' ' TRP . 65.8 mmtt -74.35 7.31 2.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.875 2.87 . . . . 0.0 113.747 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 75.16 6.48 4.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.478 2.311 . . . . 0.0 115.531 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.81 152.05 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.37 1.468 . . . . 0.0 111.382 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -134.49 110.33 9.31 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.095 1.358 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -18.46 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.985 1.314 . . . . 0.0 113.702 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -82.59 -5.38 58.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.902 0.881 . . . . 0.0 113.266 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.97 150.06 44.4 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 112.924 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -77.94 23.27 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.494 3.463 . . . . 0.0 115.182 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.88 8.27 16.7 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.691 2.091 . . . . 0.0 112.182 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.61 145.5 51.95 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 113.224 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.16 44.1 0.71 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.335 1.854 . . . . 0.0 109.871 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.79 88.07 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.924 1.69 . . . . 0.0 113.566 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -141.42 139.55 33.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.712 1.605 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.3 t -64.58 176.49 1.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.121 2.568 . . . . 0.0 115.739 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.26 -10.24 4.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.518 2.327 . . . . 0.0 112.591 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -79.44 -64.59 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 122.576 1.179 . . . . 0.0 108.932 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 58' ' ' CYS . 26.5 p -101.4 -11.93 18.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 130.268 3.427 . . . . 0.0 111.222 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.0 m80 70.69 14.95 7.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.439 2.696 . . . . 0.0 114.064 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 17.9 m-85 -78.42 145.84 68.86 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.61 143.13 99.39 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.65 2.233 . . . . 0.0 109.631 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -91.85 132.83 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -127.72 120.34 27.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.285 1.034 . . . . 0.0 111.012 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 126.38 1.872 . . . . 0.0 114.573 -177.823 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.81 18.62 1.64 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -81.25 -24.25 37.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.185 0.994 . . . . 0.0 113.304 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.0 174.43 3.79 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.495 1.518 . . . . 0.0 113.319 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.47 11.21 6.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.382 1.473 . . . . 0.0 113.542 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 t -159.14 161.71 36.32 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.176 1.791 . . . . 0.0 110.502 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -161.52 160.84 29.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.62 1.568 . . . . 0.0 111.106 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.8 m -57.68 140.44 51.29 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.297 1.439 . . . . 0.0 111.825 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.61 173.05 14.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.538 1.535 . . . . 0.0 111.874 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.0 m -135.48 138.71 43.42 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.991 1.316 . . . . 0.0 110.16 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -143.32 131.55 21.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.311 1.445 . . . . 0.0 110.25 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -156.25 171.65 19.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.298 1.439 . . . . 0.0 112.913 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -116.07 23.96 11.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.434 1.493 . . . . 0.0 113.192 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.95 170.32 20.83 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.495 3.118 . . . . 0.0 108.365 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.94 102.75 0.32 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.079 2.152 . . . . 0.0 113.324 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -65.3 148.58 88.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.628 2.218 . . . . 0.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.1 m -81.54 -13.34 58.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.47 46.14 0.82 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 126.43 1.967 . . . . 0.0 112.045 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.44 149.7 1.53 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.155 1.782 . . . . 0.0 111.563 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -134.9 151.15 50.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.9 t -46.22 160.27 0.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.634 1.974 . . . . 0.0 112.999 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.13 0.47 40.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.818 2.047 . . . . 0.0 114.678 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.36 -35.23 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.345 2.258 . . . . 0.0 113.223 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.1 p -143.12 23.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 39.15 30.26 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.012 2.125 . . . . 0.0 114.965 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.81 155.98 45.45 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.93 134.32 46.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.302 1.051 . . . . 0.0 108.801 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -35.44 139.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -111.51 -168.8 1.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.702 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -104.05 15.13 29.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.442 2.297 . . . . 0.0 112.421 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.29 -27.93 0.27 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.092 1.757 . . . . 0.0 111.486 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 65.2 t30 -146.35 80.58 9.98 Favored Pre-proline 0 N--CA 1.435 -1.189 0 C-N-CA 126.465 1.906 . . . . 0.0 108.629 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.27 -143.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 125.873 4.382 . . . . 0.0 112.159 -177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -141.42 159.23 42.64 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.101 2.16 . . . . 0.0 108.916 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -165.96 161.22 17.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.919 2.087 . . . . 0.0 108.58 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 8.3 p80 -105.38 109.78 63.6 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.06 0.544 . . . . 0.0 109.726 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 54' ' ' HIS 0.264 61.9 Cg_endo -78.05 -7.5 16.31 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.658 3.572 . . . . 0.0 112.994 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.435 ' HB2' HD13 ' A' ' 97' ' ' ILE . 2.2 t -150.06 176.13 11.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.937 1.695 . . . . 0.0 111.472 -167.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -110.6 36.66 3.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.382 2.273 . . . . 0.0 113.572 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.4 m -59.59 -36.71 76.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.399 0.68 . . . . 0.0 110.6 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 75.16 178.6 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.683 2.793 . . . . 0.0 113.528 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.21 -138.38 43.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.71 1.148 . . . . 0.0 113.973 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -99.6 14.7 29.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.647 1.579 . . . . 0.0 114.574 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 33.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 127.009 2.124 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -106.03 -40.49 5.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.043 1.737 . . . . 0.0 109.957 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -61.78 157.11 18.76 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.893 1.277 . . . . 0.0 112.228 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 ttm -172.48 145.88 1.68 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.127 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.2 m80 -71.28 154.92 41.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.95 -38.87 87.38 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.672 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.1 p -63.65 -55.31 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 111.546 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.24 -43.5 61.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.904 1.282 . . . . 0.0 112.224 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.05 -45.78 87.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.936 0.789 . . . . 0.0 111.55 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -58.88 -28.03 65.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.449 1.1 . . . . 0.0 113.161 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.99 -26.91 21.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.364 1.466 . . . . 0.0 111.919 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.68 -59.45 2.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.218 1.007 . . . . 0.0 110.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.41 -20.08 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.901 1.281 . . . . 0.0 111.604 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.42 -45.32 32.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -59.92 -29.17 68.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.008 1.323 . . . . 0.0 112.53 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.8 -3.39 12.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.669 1.988 . . . . 0.0 113.827 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.06 54.41 2.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.785 1.234 . . . . 0.0 111.948 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -140.05 132.18 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 110.812 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -88.08 97.67 11.11 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.684 0.793 . . . . 0.0 110.487 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 pt -64.7 -10.93 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.839 1.256 . . . . 0.0 113.612 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -93.53 5.61 51.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.231 . . . . 0.0 112.794 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -120.9 144.9 40.2 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.546 1.138 . . . . 0.0 113.983 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -86.12 21.53 1.07 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.798 3.665 . . . . 0.0 113.838 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.36 23.85 10.2 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.039 2.257 . . . . 0.0 111.906 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.93 166.69 20.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.298 1.439 . . . . 0.0 112.888 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.65 36.26 2.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.309 1.844 . . . . 0.0 110.405 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -36.72 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 127.36 2.264 . . . . 0.0 114.751 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 15.4 pttm -158.1 172.46 18.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.58 172.6 1.53 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.645 2.778 . . . . 0.0 116.046 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.32 -17.45 3.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.974 2.51 . . . . 0.0 112.605 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.4 -54.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.137 0.975 . . . . 0.0 109.506 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.2 p -116.2 -9.85 11.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.58 1.952 . . . . 0.0 111.45 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.307 7.3 p80 58.05 22.09 8.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.583 2.753 . . . . 0.0 116.342 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -78.92 137.48 57.6 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.733 -1.229 . . . . 0.0 112.915 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 24.5 Cg_exo -54.54 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.752 2.968 . . . . 0.0 112.303 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' A' ' 56' ' ' CYS . 10.5 mm -68.19 139.91 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.313 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.41 124.71 40.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 112.345 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.08 11.33 4.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.85 1.66 . . . . 0.0 114.309 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -160.56 151.91 19.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.065 2.146 . . . . 0.0 110.932 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.115 1.766 . . . . 0.0 111.637 179.274 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 110.715 -0.106 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.03 26.71 1.84 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.863 1.265 . . . . 0.0 113.086 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.99 153.16 39.73 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.976 1.71 . . . . 0.0 111.433 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.86 -1.34 2.01 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -120.71 0.17 10.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.62 1.568 . . . . 0.0 113.117 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -75.68 -7.32 54.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 73.23 154.8 0.15 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 128.356 2.662 . . . . 0.0 113.664 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.0 p -138.57 13.65 2.75 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.652 1.981 . . . . 0.0 113.414 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.91 164.62 32.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -107.86 2.72 23.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.45 1.5 . . . . 0.0 114.658 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 t80 48.06 58.1 5.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.997 2.119 . . . . 0.0 112.146 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -82.46 -174.92 5.45 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.111 1.765 . . . . 0.0 112.997 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.9 -173.39 3.79 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.305 2.242 . . . . 0.0 108.113 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.75 -38.11 79.88 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.754 -1.216 . . . . 0.0 112.129 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.31 144.16 36.18 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.798 2.439 . . . . 0.0 113.11 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.76 165.34 0.78 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 125.162 3.908 . . . . 0.0 115.061 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -102.62 19.78 18.43 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.398 1.879 . . . . 0.0 110.837 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.24 28.46 0.29 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 126.479 1.99 . . . . 0.0 114.548 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.72 128.64 37.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.879 0.872 . . . . 0.0 109.571 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 p -139.13 148.75 43.65 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.207 1.403 . . . . 0.0 112.103 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.48 126.65 17.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.999 1.319 . . . . 0.0 112.378 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -5.43 26.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.852 -1.155 . . . . 0.0 113.446 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.18 -43.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.004 1.321 . . . . 0.0 110.272 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.5 p -125.3 -1.58 7.59 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.318 33.9 mmt180 61.61 25.6 15.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.406 2.282 . . . . 0.0 115.455 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.24 139.64 15.75 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.97 165.28 15.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.109 0.963 . . . . 0.0 112.228 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 139.31 58.75 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.1 p -129.92 160.47 33.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.291 1.043 . . . . 0.0 112.85 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.9 13.54 0.51 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.842 1.657 . . . . 0.0 114.662 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.66 -20.74 2.01 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.293 2.237 . . . . 0.0 110.946 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -158.98 72.34 3.56 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.607 1.163 . . . . 0.0 112.82 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.16 167.36 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 125.274 3.982 . . . . 0.0 116.611 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.2 mt -109.82 142.97 40.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -154.55 177.53 11.1 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.47 2.708 . . . . 0.0 107.821 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CE1' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.74 110.16 37.21 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.29 -19.62 25.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.687 2.258 . . . . 0.0 111.209 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -145.3 154.74 42.67 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 130.38 3.472 . . . . 0.0 108.221 -173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -56.49 -39.87 73.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.672 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 28.83 10.87 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 131.182 3.793 . . . . 0.0 121.005 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 15.45 57.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 1 C-N-CA 134.514 5.126 . . . . 0.0 118.129 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.06 -174.05 44.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.525 0.583 . . . . 0.0 114.084 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -67.6 29.39 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 127.547 2.339 . . . . 0.0 114.024 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.26 -6.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 129.215 3.006 . . . . 0.0 112.039 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 54' ' ' HIS . 21.0 pttm -72.72 -23.02 60.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.682 1.128 . . . . 0.0 111.616 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -73.33 138.08 45.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.349 1.059 . . . . 0.0 112.067 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 84.0 mtp -157.3 140.24 15.2 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.385 1.474 . . . . 0.0 109.854 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.78 157.61 37.76 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.79 -48.13 82.03 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.75 -0.594 . . . . 0.0 109.827 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -62.22 -45.85 91.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.643 0.777 . . . . 0.0 112.127 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.13 -43.65 97.78 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.512 -0.742 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.4 -44.6 95.53 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.215 0.916 . . . . 0.0 110.198 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.62 -30.01 62.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.57 -38.71 18.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.483 1.113 . . . . 0.0 110.991 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -62.36 -48.0 81.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.427 1.091 . . . . 0.0 111.958 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -64.19 -32.87 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.569 0.748 . . . . 0.0 111.305 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.71 -35.56 79.02 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.389 0.675 . . . . 0.0 110.84 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.0 t -63.19 -19.0 64.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 0.0 112.567 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -82.55 2.99 30.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.125 1.37 . . . . 0.0 113.045 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 79.1 14.55 1.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.107 2.163 . . . . 0.0 113.715 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.94 127.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.921 1.289 . . . . 0.0 111.853 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.04 107.05 19.44 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.485 1.114 . . . . 0.0 110.062 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.0 -13.56 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.333 1.453 . . . . 0.0 114.342 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.46 -21.73 60.37 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.814 -0.554 . . . . 0.0 111.787 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -93.91 144.52 28.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.946 1.298 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.56 9.9 2.07 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.924 3.083 . . . . 0.0 115.837 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.19 -1.72 60.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.359 1.933 . . . . 0.0 113.094 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.15 141.99 57.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.115 0.958 . . . . 0.0 112.013 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.5 44.12 1.2 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.754 1.622 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.41 123.84 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.991 1.316 . . . . 0.0 111.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -145.04 143.07 30.27 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 0.0 110.647 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.4 t -62.42 163.56 8.49 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.66 -9.04 12.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.159 1.783 . . . . 0.0 111.736 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.2 -55.96 5.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 123.813 0.845 . . . . 0.0 108.793 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.0 p -109.44 -3.6 16.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.468 0.707 . . . . 0.0 112.792 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 60.78 11.44 3.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.152 1.781 . . . . 0.0 114.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -81.96 140.59 46.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 120.078 -1.639 . . . . 0.0 110.474 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.21 145.25 44.55 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.054 2.503 . . . . 0.0 111.114 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.5 mm -100.74 107.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.0 1.32 . . . . 0.0 111.045 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.52 116.06 24.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.384 1.474 . . . . 0.0 109.915 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -64.26 4.48 0.34 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -159.89 160.42 33.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.13 2.172 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 128.561 2.744 . . . . 0.0 113.917 178.3 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 110.714 -0.106 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.03 -171.13 3.39 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.732 1.213 . . . . 0.0 111.921 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -131.8 7.13 4.38 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.029 1.732 . . . . 0.0 113.192 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -149.72 150.95 32.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.048 2.939 . . . . 0.0 109.622 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -151.33 26.29 0.69 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.02 0.928 . . . . 0.0 112.598 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.0 p -129.86 6.03 5.05 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.39 169.49 0.43 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.648 1.979 . . . . 0.0 115.616 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.7 m -142.66 143.2 32.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.158 2.183 . . . . 0.0 109.241 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.71 162.1 40.61 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 m -147.8 142.37 26.53 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.811 2.044 . . . . 0.0 108.836 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -143.08 148.7 37.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.548 1.139 . . . . 0.0 113.247 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -153.94 140.82 19.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.69 1.596 . . . . 0.0 111.012 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -156.21 175.19 14.31 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.096 1.758 . . . . 0.0 110.503 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.23 -3.3 10.28 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.05 132.87 10.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.192 2.197 . . . . 0.0 110.888 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -50.85 151.63 10.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.851 3.034 . . . . 0.0 114.552 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -58.76 -25.86 63.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.189 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.59 26.98 6.12 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 126.224 1.869 . . . . 0.0 114.401 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.12 153.28 41.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.762 1.281 . . . . 0.0 109.67 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 p -146.87 149.15 32.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.49 128.99 38.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.379 1.472 . . . . 0.0 111.84 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -13.01 62.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.91 -43.74 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.554 1.142 . . . . 0.0 111.498 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.78 5.5 10.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 54.44 29.49 11.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.822 2.049 . . . . 0.0 113.647 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.64 147.6 16.69 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 122.726 1.181 . . . . 0.0 111.066 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.05 166.34 5.98 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.532 1.933 . . . . 0.0 114.146 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 147.04 54.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.427 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.5 p -129.39 155.65 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.577 1.18 . . . . 0.0 112.929 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.38 -10.81 1.0 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.67 1.988 . . . . 0.0 116.272 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.0 -20.7 4.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.667 1.587 . . . . 0.0 111.644 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 66' ' ' HIS . 45.5 t30 -143.76 66.54 15.24 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.31 169.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.429 1 C-N-CA 126.167 4.578 . . . . 0.0 118.059 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.9 mt -111.97 144.92 40.53 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.781 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -150.94 168.42 24.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.712 2.805 . . . . 0.0 106.618 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -111.73 107.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.81 -13.27 21.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.355 2.704 . . . . 0.0 112.455 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t -138.17 -161.99 1.25 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.138 1.375 . . . . 0.0 112.579 -166.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 55.6 mmtt -131.27 26.63 4.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.809 2.044 . . . . 0.0 113.388 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -8.5 0.59 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.673 1.589 . . . . 0.0 114.217 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 54.6 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.588 2.355 . . . . 0.0 115.626 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.41 -156.86 20.42 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.514 1.054 . . . . 0.0 114.635 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -82.69 5.08 22.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.018 1.327 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.73 9.2 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.563 1.545 . . . . 0.0 114.216 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -90.14 -4.7 57.13 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.181 0.993 . . . . 0.0 112.663 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -94.31 147.42 23.22 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.227 1.411 . . . . 0.0 111.201 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.1 mtp -158.85 139.89 12.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.993 0.917 . . . . 0.0 110.424 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HB3' HD21 ' A' ' 50' ' ' ASN . 41.6 m80 -68.31 158.39 33.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.02 -46.75 87.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.071 -1.018 . . . . 0.0 109.015 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -54.86 -57.22 12.48 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.02 1.328 . . . . 0.0 112.988 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.68 -36.81 84.1 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.873 1.269 . . . . 0.0 111.972 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.92 -47.29 75.23 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.494 1.497 . . . . 0.0 110.694 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.63 -33.52 72.9 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.231 1.812 . . . . 0.0 112.256 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.44 -36.08 39.45 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.519 2.728 . . . . 0.0 111.898 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.3 t90 -69.4 -52.88 22.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.003 0.921 . . . . 0.0 109.806 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -58.92 -29.98 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.473 1.033 . . . . 0.0 111.204 172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.96 -39.36 76.07 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.717 -0.614 . . . . 0.0 110.498 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 m -66.03 -24.26 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.77 -1.206 . . . . 0.0 112.917 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -73.69 -5.71 42.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.954 2.102 . . . . 0.0 112.561 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.256 8.8 t30 63.15 45.27 5.24 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.321 1.449 . . . . 0.0 112.478 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.84 126.56 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.052 -1.03 . . . . 0.0 111.105 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -81.13 106.64 13.28 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.52 0.728 . . . . 0.0 111.118 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -61.54 -18.87 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 114.0 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -19.72 52.04 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.352 0.661 . . . . 0.0 112.742 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.22 141.7 43.19 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.968 -1.083 . . . . 0.0 113.545 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -84.05 6.15 5.93 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.391 3.394 . . . . 0.0 114.984 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.3 23.69 32.45 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 127.237 2.351 . . . . 0.0 112.554 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.88 163.54 30.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 112.573 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -139.34 54.17 1.71 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.147 2.179 . . . . 0.0 108.602 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.72 106.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.481 1.512 . . . . 0.0 113.294 -174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -150.58 179.26 8.32 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 178.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.8 t -66.81 173.75 3.36 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.498 1.919 . . . . 0.0 115.907 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -131.35 -6.92 3.78 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.49 2.316 . . . . 0.0 112.603 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.3 mt -81.03 -64.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.122 0.969 . . . . 0.0 108.977 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.5 p -104.26 -11.75 17.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 129.916 3.287 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 62.33 18.74 10.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.762 2.825 . . . . 0.0 114.86 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 14.4 m-85 -74.17 142.77 79.36 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.834 -1.166 . . . . 0.0 113.234 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 32.1 Cg_exo -55.81 135.48 69.77 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.306 3.337 . . . . 0.0 111.316 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.67 126.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.363 1.065 . . . . 0.0 110.511 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.89 94.45 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.384 1.873 . . . . 0.0 110.38 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -57.27 132.45 53.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.118 1.367 . . . . 0.0 112.004 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 101' ' ' THR . 24.2 tptt 57.97 -169.02 0.12 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.522 1.929 . . . . 0.0 113.823 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.457 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 13.2 t . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.842 2.057 . . . . 0.0 111.223 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.1 169.12 23.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.973 1.309 . . . . 0.0 112.51 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -149.55 157.61 43.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.175 1.79 . . . . 0.0 110.479 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -141.38 162.21 36.04 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.508 1.123 . . . . 0.0 112.971 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.33 -28.98 0.19 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.721 1.609 . . . . 0.0 113.274 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 p -69.78 -173.09 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.835 2.454 . . . . 0.0 114.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.78 159.17 43.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.308 1.843 . . . . 0.0 111.838 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -148.42 -25.55 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.74 133.79 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.717 1.607 . . . . 0.0 113.342 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.6 m -145.21 136.75 25.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.898 2.079 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -159.06 165.36 34.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.93 1.292 . . . . 0.0 111.633 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -150.83 -70.35 0.18 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.511 1.524 . . . . 0.0 109.927 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -142.45 148.58 37.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.04 1.336 . . . . 0.0 111.93 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.75 161.5 16.75 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.19 86.31 4.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.606 2.362 . . . . 0.0 109.674 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.87 149.58 91.01 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.756 2.304 . . . . 0.0 115.136 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -64.27 69.11 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.55 -46.61 1.12 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.818 3.104 . . . . 0.0 109.728 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . 0.296 . . 69.77 179.4 0.24 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.825 2.05 . . . . 0.0 112.043 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -154.36 162.86 40.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.566 1.147 . . . . 0.0 112.601 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 t -83.21 125.85 32.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.103 0.961 . . . . 0.0 111.425 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -11.67 58.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.9 1.28 . . . . 0.0 113.744 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE ' ' A' ' 65' ' ' MET . 67.6 mt -102.47 -52.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.659 1.183 . . . . 0.0 109.666 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 9.4 m -98.61 -13.78 20.21 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.254 36.2 mmt180 48.35 69.02 0.59 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 123.675 1.702 . . . . 0.0 108.41 -171.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.03 139.56 10.81 Favored Glycine 0 N--CA 1.463 0.446 0 CA-C-N 110.931 -2.849 . . . . 0.0 110.206 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.19 154.58 31.0 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.498 1.119 . . . . 0.0 110.68 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.93 18.22 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.146 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -101.21 -150.84 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.378 0.671 . . . . 0.0 111.06 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.51 12.83 8.1 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.809 2.043 . . . . 0.0 111.671 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -142.6 -12.79 0.78 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.358 2.663 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -160.11 71.97 3.08 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.14 2.176 . . . . 0.0 107.82 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.57 -165.5 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.654 3.57 . . . . 0.0 110.371 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -131.6 154.14 49.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.971 1.308 . . . . 0.0 111.399 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -154.64 -179.03 7.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.297 1.439 . . . . 0.0 110.118 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 5.9 p80 -115.58 96.42 46.16 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.821 1.248 . . . . 0.0 111.601 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 54' ' ' HIS . 72.8 Cg_endo -76.14 -13.48 19.09 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.511 3.474 . . . . 0.0 113.556 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.1 t -148.61 166.98 26.65 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.858 2.863 . . . . 0.0 105.906 -171.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -75.45 -40.2 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.243 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.311 90.9 m 40.04 -17.75 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.548 1 C-N-CA 133.001 4.52 . . . . 0.0 119.719 -170.179 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.265 6.6 tpp180 45.87 58.86 4.04 Favored 'General case' 0 N--CA 1.471 0.6 1 C-N-CA 131.873 4.069 . . . . 0.0 115.99 -179.941 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.8 -178.48 48.44 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.36 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.9 p -53.49 -32.2 49.24 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.373 1.087 . . . . 0.0 112.182 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.62 -14.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 128.708 2.803 . . . . 0.0 114.642 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -62.91 -25.99 68.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.041 0.837 . . . . 0.0 112.519 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.6 136.37 36.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.388 1.089 . . . . 0.0 112.13 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.407 ' CE ' HD11 ' A' ' 41' ' ' ILE . 87.8 mtp -159.76 153.54 22.91 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.356 2.262 . . . . 0.0 108.278 -173.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -77.43 166.09 23.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.924 0.783 . . . . 0.0 109.283 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.48 -41.42 76.18 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.088 -1.632 . . . . 0.0 111.772 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 m -75.4 -29.08 59.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.878 1.671 . . . . 0.0 114.486 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 14.0 p -78.57 -42.48 29.03 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.355 1.074 . . . . 0.0 112.113 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' CG2' ' A' ' 97' ' ' ILE 0.274 44.6 tp -52.75 -48.78 66.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.585 1.154 . . . . 0.0 111.174 169.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.19 -23.87 62.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.282 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 3.9 pt-20 -97.83 -30.34 12.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.865 . . . . 0.0 111.585 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -65.41 -49.87 67.58 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.179 1.392 . . . . 0.0 110.802 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.27 -34.83 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.063 0.847 . . . . 0.0 111.228 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.83 79.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.25 0.548 . . . . 0.0 111.171 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 t -64.66 -16.28 62.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.55 1.14 . . . . 0.0 112.523 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -84.68 9.85 12.82 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 112.729 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 80.02 -0.71 2.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.16 2.584 . . . . 0.0 115.621 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.39 125.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.275 1.43 . . . . 0.0 112.327 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -84.48 102.54 12.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 112.787 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 pt -66.92 -15.59 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 113.798 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -69.41 -19.22 63.81 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -111.74 144.47 30.71 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.506 1.122 . . . . 0.0 112.596 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.92 10.32 2.38 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 124.197 3.265 . . . . 0.0 115.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.26 10.06 59.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.727 2.108 . . . . 0.0 113.08 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 167.47 6.3 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.564 1.546 . . . . 0.0 113.819 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -136.79 38.59 2.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.13 1.772 . . . . 0.0 110.506 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.79 78.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.471 1.909 . . . . 0.0 113.438 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -134.26 140.73 46.64 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.374 1.87 . . . . 0.0 110.677 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.39 172.78 0.79 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.493 2.317 . . . . 0.0 115.477 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.3 -9.28 6.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.351 2.26 . . . . 0.0 112.913 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.9 mt -85.3 -59.17 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p -109.35 -6.66 15.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.827 2.451 . . . . 0.0 111.829 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.0 m80 63.89 21.39 12.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.997 2.119 . . . . 0.0 114.905 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.47 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 26.9 m-85 -80.4 143.28 55.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.716 -1.24 . . . . 0.0 112.846 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.92 141.22 83.43 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.835 2.357 . . . . 0.0 110.358 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.481 ' CG2' HD11 ' A' ' 70' ' ' LEU . 5.4 mm -86.53 129.1 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.437 1.095 . . . . 0.0 109.598 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.23 117.74 27.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.379 1.472 . . . . 0.0 109.526 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.7 8.13 3.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -161.75 153.08 18.49 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.634 2.373 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.282 2.233 . . . . 0.0 111.592 178.13 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.3 19.55 1.38 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.415 1.086 . . . . 0.0 113.89 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -60.31 -36.73 78.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -144.97 156.81 44.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.66 8.08 5.32 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.31 -1.768 . . . . 0.0 114.064 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.6 p -140.52 175.38 9.65 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.759 1.623 . . . . 0.0 111.558 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.33 -4.65 0.67 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.716 2.406 . . . . 0.0 117.249 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -50.98 -32.43 21.04 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.635 1.574 . . . . 0.0 114.858 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.71 40.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.612 2.365 . . . . 0.0 113.223 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -142.53 55.73 1.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.866 2.066 . . . . 0.0 110.244 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -106.39 8.33 31.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.065 1.746 . . . . 0.0 114.767 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.92 154.54 34.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.248 1.419 . . . . 0.0 112.987 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.37 165.44 23.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.652 1.181 . . . . 0.0 111.599 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -148.87 26.28 0.91 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.193 2.197 . . . . 0.0 112.313 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 34' ' ' PRO . . . -124.11 172.22 6.06 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 127.741 2.416 . . . . 0.0 112.22 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 81.0 Cg_exo -51.18 -178.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 1 C-N-CA 125.363 4.042 . . . . 0.0 115.686 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.2 p -94.91 -2.33 50.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.472 1.509 . . . . 0.0 113.624 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.27 15.36 1.88 Allowed Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.774 1.654 . . . . 0.0 114.302 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.04 138.47 47.91 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.858 1.329 . . . . 0.0 108.873 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 p -140.78 148.91 41.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.924 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.7 t -60.3 123.62 17.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.267 1.827 . . . . 0.0 111.938 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -69.83 -8.02 44.88 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.787 -1.196 . . . . 0.0 112.114 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 77.6 mt -91.13 -51.66 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.75 13.67 5.87 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 61.81 8.98 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.458 2.703 . . . . 0.0 115.805 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.45 146.68 36.19 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.65 161.01 31.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.844 0.857 . . . . 0.0 111.92 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' A' ' 52' ' ' LEU . . . -68.72 120.74 15.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.58 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -96.52 -170.99 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.301 0.572 . . . . 0.0 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -84.48 -24.05 29.61 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 3.68 5.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 112.083 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.91 60.91 4.67 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 126.911 2.084 . . . . 0.0 109.953 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.56 -164.47 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 125.527 4.151 . . . . 0.0 111.926 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 46' ' ' ALA . 14.5 mt -126.65 163.04 24.35 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.703 2.001 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -165.39 -169.91 1.72 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.746 2.418 . . . . 0.0 108.177 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -126.68 101.11 27.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 119.052 0.842 . . . . 0.0 111.127 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.57 ' HG2' ' H ' ' A' ' 56' ' ' CYS . 83.3 Cg_endo -72.44 -54.44 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 N-CA-C 108.264 -1.476 . . . . 0.0 108.264 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.57 ' H ' ' HG2' ' A' ' 55' ' ' PRO . 12.5 p -102.64 169.75 8.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 131.411 3.884 . . . . 0.0 112.295 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -108.16 35.3 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.436 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 11.7 m -48.11 -12.69 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 62.24 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.841 3.256 . . . . 0.0 115.335 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.0 -159.75 31.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.842 0.734 . . . . 0.0 112.234 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -64.91 -30.6 71.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.269 2.4 pp -75.4 10.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 pttm -96.4 -20.05 18.74 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.728 -0.608 . . . . 0.0 110.598 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -63.5 135.7 57.06 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.263 1.025 . . . . 0.0 108.865 171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.6 mtp -150.89 141.36 22.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.909 1.284 . . . . 0.0 108.585 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 4.0 m170 -64.52 139.99 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.187 0.994 . . . . 0.0 110.491 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.2 19.21 0.08 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.512 1.525 . . . . 0.0 112.629 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.6 p -135.75 -46.63 0.67 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.352 2.661 . . . . 0.0 109.15 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 74.1 m -62.37 -37.38 85.5 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.555 1.542 . . . . 0.0 111.404 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.73 -46.94 80.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.62 1.1 . . . . 0.0 109.814 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.18 -32.2 70.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.462 1.105 . . . . 0.0 111.501 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.06 -36.45 30.47 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.254 2.622 . . . . 0.0 111.23 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -65.35 -51.9 57.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.471 1.108 . . . . 0.0 109.315 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.25 -30.34 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 119.619 1.1 . . . . 0.0 110.836 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.875 -0.516 . . . . 0.0 110.2 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 p -67.73 -8.49 35.85 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -88.95 -1.59 58.18 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.352 1.861 . . . . 0.0 113.47 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER 71.83 17.22 5.41 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.782 1.633 . . . . 0.0 114.89 178.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.69 167.91 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.429 1.892 . . . . 0.0 111.587 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -128.18 106.95 9.4 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.575 1.55 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -18.43 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 113.674 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -76.81 -8.55 57.53 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.07 143.94 78.29 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.773 -1.204 . . . . 0.0 111.586 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.17 7.07 3.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.813 3.009 . . . . 0.0 116.757 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.62 8.39 8.28 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 127.143 2.306 . . . . 0.0 112.056 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.7 142.83 57.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.896 0.848 . . . . 0.0 112.747 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -138.01 32.95 2.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.738 1.615 . . . . 0.0 110.368 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.56 118.07 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 112.741 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -146.79 176.47 9.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 176.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.01 162.29 1.97 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.025 2.53 . . . . 0.0 113.07 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -115.38 -12.0 11.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.23 -53.94 8.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 122.817 0.447 . . . . 0.0 109.811 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.3 p -106.72 -7.56 17.22 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 53.71 14.07 0.58 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.255 1.822 . . . . 0.0 115.276 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -82.5 136.34 45.75 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.118 -1.614 . . . . 0.0 110.584 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 54.5 Cg_exo -46.74 126.2 10.5 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.233 2.622 . . . . 0.0 112.276 171.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 55' ' ' PRO 0.262 0.6 OUTLIER -78.6 111.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.1 -1.864 . . . . 0.0 109.545 -173.521 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -80.74 73.29 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.721 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.03 143.16 3.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.161 1.784 . . . . 0.0 113.411 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.65 123.77 19.09 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.427 1.491 . . . . 0.0 109.44 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.501 1.521 . . . . 0.0 109.543 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.13 22.67 3.26 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.0 1.32 . . . . 0.0 113.272 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -140.58 156.7 46.21 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.776 1.63 . . . . 0.0 111.887 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.55 147.88 21.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.196 1.798 . . . . 0.0 113.904 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.35 56.33 3.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.427 1.891 . . . . 0.0 111.541 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p 51.28 -163.75 0.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.197 2.199 . . . . 0.0 115.357 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -152.37 139.28 19.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.842 1.657 . . . . 0.0 110.38 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.8 t -160.91 159.78 30.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.972 1.309 . . . . 0.0 111.653 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.92 161.21 41.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.23 1.412 . . . . 0.0 112.429 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 p -94.85 26.28 3.67 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.789 2.036 . . . . 0.0 112.761 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -139.55 144.0 37.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.889 2.475 . . . . 0.0 111.903 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.08 65.23 0.77 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.836 1.254 . . . . 0.0 112.496 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.86 36.94 0.79 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.8 1.24 . . . . 0.0 111.271 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 60.44 -58.23 0.08 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 130.892 3.677 . . . . 0.0 118.644 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 5.62 86.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 130.573 3.549 . . . . 0.0 115.964 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -57.07 146.98 78.0 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.33 2.02 . . . . 0.0 114.281 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 m -80.73 31.73 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.588 1.155 . . . . 0.0 112.667 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.38 38.23 0.04 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.013 2.244 . . . . 0.0 112.273 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.45 157.93 33.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.293 0.568 . . . . 0.0 110.625 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -156.34 165.68 35.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.793 1.237 . . . . 0.0 112.496 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.25 128.03 32.79 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 110.306 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -7.81 43.17 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.6 mt -94.05 -37.63 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.089 . . . . 0.0 110.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.43 4.17 3.66 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 61.24 19.33 10.0 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.702 2.001 . . . . 0.0 113.833 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.5 145.55 22.05 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.02 164.46 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.962 0.881 . . . . 0.0 111.472 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.83 144.43 56.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.9 p -135.27 156.65 48.61 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.42 1.105 . . . . 0.0 113.692 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.94 8.82 0.23 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.753 2.421 . . . . 0.0 115.452 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -133.65 -20.07 2.05 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.13 2.172 . . . . 0.0 111.221 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -155.71 71.45 5.37 Favored Pre-proline 0 N--CA 1.445 -0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 112.125 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.42 171.36 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 125.009 3.806 . . . . 0.0 116.354 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.84 148.83 35.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.726 173.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -157.75 179.2 9.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.89 2.076 . . . . 0.0 108.393 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -120.74 112.65 33.67 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.318 0.647 . . . . 0.0 110.603 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -12.19 14.39 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.784 2.989 . . . . 0.0 112.218 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.8 t -133.36 -153.39 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.424 1.489 . . . . 0.0 112.468 -167.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 5.4 tmtt? -135.89 14.07 3.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.193 2.197 . . . . 0.0 115.028 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.9 m -46.66 -23.52 0.42 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.869 2.468 . . . . 0.0 115.222 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp-105 65.39 162.92 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.18 2.992 . . . . 0.0 114.282 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 -164.9 29.5 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.508 -0.745 . . . . 0.0 113.029 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.3 m -61.08 -34.57 75.13 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.303 -1.116 . . . . 0.0 113.185 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.76 1.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -83.21 -21.69 33.37 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.218 -0.926 . . . . 0.0 112.515 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.48 150.66 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.022 0.915 . . . . 0.0 110.636 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mtp -158.21 141.46 15.07 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.35 1.46 . . . . 0.0 109.793 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -70.53 151.4 45.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -56.28 -49.56 73.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.114 -0.366 . . . . 0.0 110.276 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -64.27 -44.32 92.11 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.46 -46.68 87.41 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.312 -0.867 . . . . 0.0 112.243 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.83 -45.44 74.45 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.179 0.9 . . . . 0.0 109.728 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.22 -25.64 65.78 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -89.78 -32.25 17.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.323 0.965 . . . . 0.0 111.868 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.83 -57.92 10.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.969 1.308 . . . . 0.0 110.618 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.95 -23.98 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.872 1.269 . . . . 0.0 111.65 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.14 58.63 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 m -93.87 5.73 50.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.918 1.287 . . . . 0.0 111.817 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -108.18 9.13 28.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.728 2.411 . . . . 0.0 113.673 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.253 10.3 t30 63.69 42.62 6.18 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.713 1.205 . . . . 0.0 112.387 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.47 152.73 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.593 1.557 . . . . 0.0 110.102 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -123.74 111.55 16.29 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.974 1.309 . . . . 0.0 110.457 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.4 pt -60.88 -19.73 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.247 1.419 . . . . 0.0 113.827 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.9 t -78.67 -14.85 59.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -93.02 143.58 27.03 Favored Pre-proline 0 N--CA 1.478 0.942 0 O-C-N 121.177 -0.952 . . . . 0.0 112.629 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.11 5.09 6.47 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.849 3.033 . . . . 0.0 115.638 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.62 10.75 38.68 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.955 2.217 . . . . 0.0 112.727 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.37 156.47 29.11 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.034 0.934 . . . . 0.0 113.145 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.04 45.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.409 1.484 . . . . 0.0 110.746 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.93 102.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.743 1.217 . . . . 0.0 112.575 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.9 tttm -143.66 142.1 30.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.362 1.465 . . . . 0.0 112.378 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.82 178.33 0.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.447 2.699 . . . . 0.0 115.174 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -132.19 -12.08 3.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.755 2.422 . . . . 0.0 112.727 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -78.33 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 122.119 0.961 . . . . 0.0 109.213 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.75 -8.6 17.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.916 2.886 . . . . 0.0 111.264 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.448 ' O ' ' HE2' ' A' ' 89' ' ' LYS 0.364 0.0 OUTLIER 63.34 18.97 11.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.643 3.177 . . . . 0.0 115.366 -175.883 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 16.8 m-85 -75.7 145.8 79.05 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 120.477 -1.389 . . . . 0.0 114.329 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -61.74 141.61 91.12 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.214 1.943 . . . . 0.0 109.813 170.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -86.42 117.92 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 125.17 1.388 . . . . 0.0 108.143 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -114.38 94.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.427 1.491 . . . . 0.0 111.845 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.01 157.35 10.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.037 1.735 . . . . 0.0 112.807 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.9 158.74 18.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 113.258 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.288 1.835 . . . . 0.0 110.73 178.903 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.091 0.472 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.53 167.08 29.46 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.482 1.913 . . . . 0.0 110.205 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -37.72 -8.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 120.814 3.635 . . . . 0.0 120.814 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -110.82 -15.45 13.8 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 0.0 113.168 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.46 4.51 43.77 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.496 2.318 . . . . 0.0 113.265 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -82.06 60.02 4.67 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.182 1.793 . . . . 0.0 111.253 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.68 20.68 15.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.339 1.855 . . . . 0.0 113.97 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.4 p -79.05 49.05 0.9 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 127.213 2.205 . . . . 0.0 111.981 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.59 151.07 6.25 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -144.89 162.88 35.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.88 2.472 . . . . 0.0 110.972 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.32 154.94 44.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.513 1.525 . . . . 0.0 112.138 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -149.99 152.86 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.183 1.393 . . . . 0.0 113.529 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -73.74 47.2 0.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.834 2.054 . . . . 0.0 114.03 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -81.57 48.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.683 1.993 . . . . 0.0 112.258 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.85 92.44 34.06 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.196 2.198 . . . . 0.0 114.068 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.91 146.96 92.12 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.632 2.222 . . . . 0.0 112.333 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 m -78.04 -7.75 57.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.141 -0.974 . . . . 0.0 112.571 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.75 -1.38 49.38 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.291 1.901 . . . . 0.0 113.448 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 158.62 36.06 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.7 p -121.11 163.9 17.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.8 t -80.62 133.31 35.73 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 120.835 -1.166 . . . . 0.0 108.093 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -21.77 66.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.49 1.041 . . . . 0.0 113.021 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.72 -49.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.749 1.22 . . . . 0.0 110.216 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -88.23 -23.73 23.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 58.91 36.91 24.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.376 1.47 . . . . 0.0 108.893 -167.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.0 134.49 10.83 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.931 1.253 . . . . 0.0 112.974 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -71.58 142.62 50.01 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.18 148.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.625 1.57 . . . . 0.0 114.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -128.22 179.61 5.52 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.202 1.001 . . . . 0.0 111.214 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.84 -32.02 68.92 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.98 -31.37 13.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.644 1.978 . . . . 0.0 110.704 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -123.62 65.56 33.84 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.63 167.16 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.261 1.974 . . . . 0.0 112.186 162.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.9 mt -117.83 146.62 43.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.759 -2.019 . . . . 0.0 112.153 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -149.39 163.53 37.49 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.406 3.082 . . . . 0.0 105.712 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -114.02 104.33 54.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.54 -24.72 35.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.282 1.988 . . . . 0.0 113.174 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.436 ' HB2' HD13 ' A' ' 97' ' ' ILE 0.258 0.5 OUTLIER -139.96 150.53 44.6 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 127.262 2.225 . . . . 0.0 107.779 -168.876 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.22 -46.7 62.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 117.112 -1.423 . . . . 0.0 111.734 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 68.2 m 32.73 -12.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 1 C-N-CA 133.195 4.598 . . . . 0.0 120.901 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 72.14 149.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 131.002 3.721 . . . . 0.0 113.941 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.41 -142.55 48.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.74 1.162 . . . . 0.0 114.679 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -95.92 -7.05 37.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 112.891 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.0 24.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 111.931 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -105.82 -26.21 11.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.513 1.525 . . . . 0.0 112.374 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -77.48 152.45 34.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.139 1.376 . . . . 0.0 112.226 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 90.3 mtp -158.74 144.75 16.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.328 0.651 . . . . 0.0 112.294 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -70.8 152.45 43.74 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -56.16 -49.19 74.69 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.204 -0.935 . . . . 0.0 110.874 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -54.71 -50.04 69.27 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.411 1.084 . . . . 0.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.53 -44.16 93.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.72 -48.0 73.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.06 0.845 . . . . 0.0 111.44 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -55.7 -30.86 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.603 1.961 . . . . 0.0 112.949 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -91.99 -38.84 12.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.088 1.755 . . . . 0.0 112.156 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 80.2 t90 -58.62 -45.19 89.74 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 123.819 0.848 . . . . 0.0 111.015 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.36 -26.08 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.176 0.898 . . . . 0.0 112.213 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.63 62.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.788 -1.195 . . . . 0.0 111.43 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.7 p -84.5 11.18 9.14 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.527 -0.733 . . . . 0.0 112.502 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -115.03 8.39 15.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.701 1.6 . . . . 0.0 112.894 -174.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.32 0.0 OUTLIER 79.36 38.03 0.13 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.911 2.084 . . . . 0.0 112.67 178.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.58 145.28 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.437 1.095 . . . . 0.0 113.54 -171.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -139.54 102.84 4.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 110.024 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -12.26 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.258 1.423 . . . . 0.0 114.485 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -75.59 -16.34 60.25 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.726 -0.609 . . . . 0.0 111.972 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -106.56 142.21 24.46 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.103 1.361 . . . . 0.0 111.6 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.97 29.27 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.548 3.499 . . . . 0.0 114.626 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.15 20.19 6.32 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.882 2.182 . . . . 0.0 111.724 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.09 163.69 24.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 122.353 1.073 . . . . 0.0 113.637 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -143.92 41.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.85 2.06 . . . . 0.0 109.099 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.285 11.1 p -68.36 65.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.685 2.394 . . . . 0.0 115.447 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -133.53 144.88 49.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.401 2.281 . . . . 0.0 110.64 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -67.95 173.65 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.656 2.383 . . . . 0.0 115.256 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -129.12 -10.69 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.862 2.465 . . . . 0.0 112.978 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -78.76 -55.76 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.903 0.858 . . . . 0.0 109.434 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.9 p -115.45 -7.46 12.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 129.06 2.944 . . . . 0.0 111.85 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 66.9 20.7 10.51 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.078 2.551 . . . . 0.0 114.861 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.8 m-85 -85.14 145.81 43.91 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 113.487 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.24 135.96 49.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.53 2.154 . . . . 0.0 109.796 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 56' ' ' CYS . 11.4 mm -77.76 141.74 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.507 1.123 . . . . 0.0 109.817 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -133.56 120.58 20.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.243 1.417 . . . . 0.0 111.456 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -78.43 18.27 0.57 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -159.76 151.76 20.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.642 2.377 . . . . 0.0 110.448 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 126.416 1.886 . . . . 0.0 113.202 178.695 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.87 166.75 26.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 112.737 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.45 2.47 28.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.251 1.421 . . . . 0.0 113.612 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -146.09 157.73 43.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.273 1.829 . . . . 0.0 111.414 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 56.08 12.9 1.03 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.684 1.994 . . . . 0.0 116.222 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -156.24 175.16 14.36 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.417 -1.427 . . . . 0.0 112.176 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.94 147.85 27.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.922 1.689 . . . . 0.0 111.991 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.2 p -141.07 32.83 1.74 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.549 1.54 . . . . 0.0 113.08 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.92 50.93 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.028 -1.045 . . . . 0.0 113.776 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.2 p -74.31 154.97 38.68 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 113.015 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -48.68 159.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.181 2.192 . . . . 0.0 115.615 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.09 171.66 13.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.866 1.667 . . . . 0.0 112.112 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -140.47 172.86 12.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.274 1.83 . . . . 0.0 111.527 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -150.0 142.27 24.18 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.48 1.112 . . . . 0.0 113.618 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.04 159.89 60.12 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.87 2.068 . . . . 0.0 111.629 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.66 161.51 1.28 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.945 3.097 . . . . 0.0 114.72 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 m -76.71 -6.89 54.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.64 23.09 1.83 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 114.02 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.69 46.69 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.477 1.139 . . . . 0.0 109.749 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -143.36 149.34 37.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.125 1.37 . . . . 0.0 113.01 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -57.51 129.25 40.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.663 1.585 . . . . 0.0 112.214 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -7.97 53.51 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.455 -1.403 . . . . 0.0 113.827 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.6 mt -96.17 -44.09 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 117.724 -1.132 . . . . 0.0 109.627 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.3 p -128.07 9.67 6.3 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 55.17 19.58 2.94 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.652 2.381 . . . . 0.0 114.499 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.2 149.28 29.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.72 163.63 24.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.124 0.962 . . . . 0.0 111.175 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 129.44 41.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -99.02 -146.67 0.33 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.335 0.588 . . . . 0.0 112.046 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -130.7 13.49 5.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.561 2.344 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -145.25 -18.01 0.49 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.207 2.603 . . . . 0.0 111.591 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 66' ' ' HIS . 47.3 t30 -153.84 68.59 6.22 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 125.043 1.337 . . . . 0.0 111.883 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.67 179.51 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.43 1 C-N-CA 125.466 4.111 . . . . 0.0 116.263 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.52 154.01 32.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.459 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.17 -177.62 6.4 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.813 3.245 . . . . 0.0 106.311 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -128.96 117.62 19.3 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.585 0.63 . . . . 0.0 109.794 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 56' ' ' CYS . 33.0 Cg_endo -82.74 -9.93 10.82 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.815 3.01 . . . . 0.0 113.015 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 2.0 t -141.01 -162.87 1.43 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.769 1.228 . . . . 0.0 111.327 -166.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -129.21 24.38 5.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.258 1.823 . . . . 0.0 113.352 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -48.25 -21.53 0.52 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.849 2.06 . . . . 0.0 113.816 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 63.05 152.85 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 129.391 3.077 . . . . 0.0 115.549 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.4 -164.89 40.68 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.653 1.121 . . . . 0.0 114.752 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.7 m -59.02 6.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.88 7.15 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 126.491 1.916 . . . . 0.0 112.386 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -82.19 -23.09 35.68 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.894 . . . . 0.0 111.977 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -78.07 145.75 35.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.058 1.343 . . . . 0.0 111.289 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 91.6 mtp -155.9 139.22 15.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.47 1.108 . . . . 0.0 109.353 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.423 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.5 m80 -70.1 157.51 37.43 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.99 -50.59 72.78 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.391 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.3 t -58.69 -36.92 74.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.303 1.041 . . . . 0.0 113.074 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.51 -44.77 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.439 -0.788 . . . . 0.0 112.106 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.41 -41.75 85.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.712 1.596 . . . . 0.0 109.839 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.36 -33.52 72.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.906 1.682 . . . . 0.0 113.401 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.86 -27.4 26.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.533 0.733 . . . . 0.0 111.819 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.91 -57.58 4.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.687 1.595 . . . . 0.0 111.095 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 81' ' ' ILE . 33.3 m -55.47 -23.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.288 0.635 . . . . 0.0 111.105 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.51 30.77 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.812 0.445 . . . . 0.0 112.066 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -72.12 -23.85 61.38 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.356 -1.465 . . . . 0.0 111.399 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -77.61 -2.63 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.519 2.728 . . . . 0.0 112.389 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.42 47.11 7.0 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.363 1.465 . . . . 0.0 113.487 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.08 118.81 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.558 -1.339 . . . . 0.0 111.741 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -78.44 97.26 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.019 0.928 . . . . 0.0 111.477 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 74' ' ' VAL . 19.8 pt -63.66 -16.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.289 1.436 . . . . 0.0 113.68 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -75.97 -14.21 60.24 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -81.34 139.46 48.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 O-C-N 120.978 -1.076 . . . . 0.0 112.036 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.88 4.41 7.06 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.894 3.062 . . . . 0.0 115.949 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.39 18.27 5.79 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 127.789 2.614 . . . . 0.0 111.615 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.09 158.71 10.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.948 0.899 . . . . 0.0 113.31 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -120.23 37.17 4.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.5 1.52 . . . . 0.0 111.89 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.64 101.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.418 1.487 . . . . 0.0 110.734 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -147.95 143.73 27.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.673 1.189 . . . . 0.0 112.796 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.6 t -66.37 177.42 1.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.439 2.696 . . . . 0.0 115.169 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -131.32 -10.63 3.67 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.426 2.29 . . . . 0.0 112.65 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.36 -61.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.245 -0.909 . . . . 0.0 109.236 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.7 p -106.45 -9.7 16.58 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.348 2.659 . . . . 0.0 111.194 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.4 t60 63.74 23.53 13.5 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.939 2.495 . . . . 0.0 114.516 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 16.7 m-85 -79.41 145.04 62.92 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.413 -1.429 . . . . 0.0 113.132 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.28 135.86 56.56 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.012 2.475 . . . . 0.0 110.49 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.9 mm -79.29 113.77 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.892 2.077 . . . . 0.0 108.514 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -126.19 97.56 5.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.753 2.021 . . . . 0.0 110.924 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -59.11 29.26 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 130.317 3.447 . . . . 0.0 117.835 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.3 mttm 42.89 46.12 4.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 128.494 2.718 . . . . 0.0 114.284 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.254 1.312 0 C-N-CA 126.859 2.064 . . . . 0.0 113.718 178.803 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.64 39.11 0.12 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.688 1.995 . . . . 0.0 113.381 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.92 4.9 0.48 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.778 2.031 . . . . 0.0 112.005 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.53 -5.32 0.56 Allowed 'General case' 0 CA--C 1.554 1.134 0 O-C-N 120.402 -1.436 . . . . 0.0 113.067 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -129.16 21.87 5.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.322 2.649 . . . . 0.0 110.013 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 p -156.24 160.48 39.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.123 2.569 . . . . 0.0 110.929 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.24 125.3 19.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.631 1.172 . . . . 0.0 110.445 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -156.37 22.85 0.35 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.584 1.553 . . . . 0.0 112.518 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.79 143.3 13.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.122 1.369 . . . . 0.0 114.254 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.5 p -72.17 -3.69 24.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.434 1.894 . . . . 0.0 115.237 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -74.3 44.26 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.284 2.634 . . . . 0.0 112.776 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -135.04 -9.39 2.31 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.397 1.879 . . . . 0.0 113.185 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -149.26 166.14 29.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.044 2.138 . . . . 0.0 108.776 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -139.43 145.6 39.07 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.334 1.054 . . . . 0.0 112.349 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.46 162.19 27.17 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.648 2.779 . . . . 0.0 106.505 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -42.16 -36.61 4.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.81 3.674 . . . . 0.0 120.403 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 t 56.87 36.42 27.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.433 1.893 . . . . 0.0 111.31 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.14 41.62 0.02 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 128.675 3.036 . . . . 0.0 111.287 -176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.21 168.3 19.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.119 0.968 . . . . 0.0 110.959 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.7 p -150.81 153.53 35.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.755 1.222 . . . . 0.0 113.485 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.94 133.09 54.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.145 1.378 . . . . 0.0 110.084 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -71.09 -13.25 61.9 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.185 -0.947 . . . . 0.0 113.032 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 69' ' ' CYS . 73.5 mt -94.01 -41.57 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.296 1.039 . . . . 0.0 111.046 -175.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.26 13.01 4.22 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 55.15 17.46 1.98 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.932 2.093 . . . . 0.0 114.353 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.46 154.6 42.47 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.59 164.58 19.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.393 1.096 . . . . 0.0 110.111 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.82 25.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -92.01 -138.11 0.17 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.657 0.265 . . . . 0.0 111.49 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -130.71 5.38 4.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.776 2.03 . . . . 0.0 111.334 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.34 -10.01 0.96 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.694 3.198 . . . . 0.0 110.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -140.86 61.98 16.2 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 127.271 2.228 . . . . 0.0 114.162 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.1 159.97 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.893 2.395 . . . . 0.0 114.171 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.61 143.0 36.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 112.452 -2.158 . . . . 0.0 110.492 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -156.16 176.93 12.03 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.48 3.112 . . . . 0.0 106.612 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -124.04 117.85 26.96 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 118.253 0.479 . . . . 0.0 110.057 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -81.47 -7.58 12.71 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.72 3.614 . . . . 0.0 112.549 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 30.3 p -152.49 159.25 43.35 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.172 1.789 . . . . 0.0 113.055 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HB2' ' CD2' ' A' ' 95' ' ' TYR . 6.2 mtmm -77.12 30.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.264 1.826 . . . . 0.0 113.868 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.32 -14.9 1.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 27.09 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 130.559 3.544 . . . . 0.0 115.826 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.73 30.19 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.853 1.692 . . . . 0.0 112.147 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -62.61 6.43 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.75 6.07 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.549 2.34 . . . . 0.0 112.392 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -78.19 -22.5 48.51 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.081 -1.012 . . . . 0.0 112.002 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -80.29 145.99 31.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.172 1.389 . . . . 0.0 112.26 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.7 mtp -154.77 139.19 16.77 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.041 0.936 . . . . 0.0 110.485 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 15.7 m170 -66.2 148.07 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.76 -35.3 77.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 122.011 -0.431 . . . . 0.0 110.837 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -79.21 -28.83 42.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 88.0 m -81.07 -39.78 25.19 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.119 0.967 . . . . 0.0 111.219 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.21 -44.18 92.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.966 1.257 . . . . 0.0 109.277 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.16 -33.91 65.68 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.635 1.174 . . . . 0.0 113.597 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.5 pt-20 -88.99 -32.7 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.063 0.545 . . . . 0.0 112.244 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -62.24 -49.3 76.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.859 0.864 . . . . 0.0 110.097 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.62 -32.42 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.784 0.72 . . . . 0.0 112.199 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.98 -17.74 62.64 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.557 -0.714 . . . . 0.0 111.747 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -86.26 2.26 47.84 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.247 -0.908 . . . . 0.0 111.891 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -105.0 4.74 31.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.583 1.953 . . . . 0.0 114.046 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 62.98 44.85 5.71 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.566 1.146 . . . . 0.0 112.298 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.72 121.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.64 1.176 . . . . 0.0 110.697 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -80.13 106.91 12.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.283 0.633 . . . . 0.0 109.926 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.9 pt -60.85 -18.02 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.965 1.306 . . . . 0.0 113.907 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -82.09 -13.5 57.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -88.63 141.02 29.87 Favored Pre-proline 0 N--CA 1.481 1.083 0 O-C-N 121.027 -1.046 . . . . 0.0 112.682 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.08 0.83 9.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.03 3.153 . . . . 0.0 116.177 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.49 8.53 34.96 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.957 2.218 . . . . 0.0 112.736 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 168.3 15.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.775 1.23 . . . . 0.0 113.555 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -134.2 52.46 2.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.006 1.723 . . . . 0.0 109.979 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.36 76.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.135 1.774 . . . . 0.0 111.477 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . 0.269 18.5 ttmt -131.04 151.1 51.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.832 2.053 . . . . 0.0 111.631 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 15.3 t -63.98 165.78 8.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 0.0 113.731 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -120.7 3.58 10.63 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.396 1.878 . . . . 0.0 111.911 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -106.87 -55.58 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.513 1.525 . . . . 0.0 108.82 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 16.6 p -105.1 -4.82 21.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 60.77 10.43 2.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.326 2.25 . . . . 0.0 116.027 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 75.2 m-85 -92.44 146.32 32.23 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.464 -1.397 . . . . 0.0 111.611 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -45.33 142.98 5.81 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.853 3.036 . . . . 0.0 113.208 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -104.56 122.77 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.68 1.592 . . . . 0.0 110.596 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.72 122.87 44.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -66.24 175.42 2.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.235 1.814 . . . . 0.0 113.977 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -127.04 148.55 50.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.36 1.864 . . . . 0.0 111.244 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 128.348 2.659 . . . . 0.0 109.735 179.805 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 111.196 0.072 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.86 38.21 1.98 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.145 1.378 . . . . 0.0 111.994 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -55.61 140.1 42.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.21 1.404 . . . . 0.0 112.996 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.35 153.49 30.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.959 0.904 . . . . 0.0 113.373 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 60.3 -25.63 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.091 2.956 . . . . 0.0 117.467 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -97.68 15.03 24.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.255 1.822 . . . . 0.0 113.518 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -146.08 153.74 41.05 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.251 1.821 . . . . 0.0 111.494 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.19 135.4 32.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.467 1.507 . . . . 0.0 110.366 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.98 169.98 15.4 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.787 1.235 . . . . 0.0 113.086 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 p -148.65 149.58 31.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.893 2.077 . . . . 0.0 110.179 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -143.94 -4.68 0.82 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.584 1.554 . . . . 0.0 114.778 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -135.88 21.38 3.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.017 1.727 . . . . 0.0 113.244 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.26 40.37 0.1 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.51 1.924 . . . . 0.0 114.295 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -63.06 20.85 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.93 3.292 . . . . 0.0 117.048 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.09 150.75 73.83 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.339 1.856 . . . . 0.0 113.646 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -50.33 155.44 4.87 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.581 3.52 . . . . 0.0 115.782 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -62.09 -15.0 42.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.513 1.525 . . . . 0.0 114.551 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.29 11.64 7.2 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.453 1.978 . . . . 0.0 114.141 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.61 134.94 40.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.954 0.877 . . . . 0.0 110.059 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.4 p -144.16 153.53 42.21 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 111.488 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.0 t -63.72 127.1 29.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.504 1.122 . . . . 0.0 112.005 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -4.8 22.64 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.0 mt -103.57 -45.24 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.123 1.369 . . . . 0.0 110.226 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -123.69 5.08 8.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.32 31.5 mmt180 50.73 32.41 6.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.17 2.188 . . . . 0.0 115.632 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.3 148.1 18.86 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.29 168.4 18.4 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.834 1.653 . . . . 0.0 112.407 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.67 150.03 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.664 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.4 p -139.18 172.13 13.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.502 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -61.83 -21.93 65.05 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -119.63 -20.94 7.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.428 1.491 . . . . 0.0 112.281 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.97 66.51 47.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.193 1.797 . . . . 0.0 110.499 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.03 -167.93 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 1 C-N-CA 125.435 4.09 . . . . 0.0 111.113 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.7 mt -132.77 155.57 48.67 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.724 1.61 . . . . 0.0 111.868 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -153.92 -179.61 8.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.786 2.434 . . . . 0.0 108.122 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -129.24 110.42 18.03 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.579 0.752 . . . . 0.0 111.146 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.63 -17.42 12.61 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.577 2.851 . . . . 0.0 113.57 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 4.1 t -133.55 -161.55 1.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 112.067 -165.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 4.3 mptp? -123.14 12.79 9.62 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.734 1.614 . . . . 0.0 114.717 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -44.62 -25.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.222 2.609 . . . . 0.0 116.703 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 65.18 159.36 0.11 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.933 3.293 . . . . 0.0 115.599 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.47 -157.63 19.34 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.09 0.852 . . . . 0.0 113.599 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.1 p -59.48 -18.41 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.5 pt -84.79 -7.57 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.755 1.161 . . . . 0.0 113.601 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -76.06 -18.74 59.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.154 1.343 . . . . 0.0 113.535 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -84.53 143.34 29.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.359 1.064 . . . . 0.0 112.285 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 81.6 mtp -156.62 143.03 18.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.363 1.465 . . . . 0.0 109.793 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -76.35 154.51 34.92 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.14 -46.45 82.69 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.272 -0.892 . . . . 0.0 111.911 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -64.36 -42.97 95.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.002 0.921 . . . . 0.0 111.949 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.3 m -61.79 -43.88 97.97 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.173 -0.955 . . . . 0.0 111.751 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.71 -47.88 83.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.88 0.764 . . . . 0.0 109.811 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.08 -29.49 60.65 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.97 -38.33 18.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.415 1.086 . . . . 0.0 111.577 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.78 -48.19 77.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.199 1.0 . . . . 0.0 111.731 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.89 -28.96 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.656 -0.653 . . . . 0.0 111.691 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.52 71.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.013 0.525 . . . . 0.0 111.429 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 p -66.91 -14.24 62.57 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.744 -1.223 . . . . 0.0 113.305 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.31 3.66 20.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.689 1.596 . . . . 0.0 112.796 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.254 10.2 t30 64.47 42.73 4.88 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.35 147.48 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.069 1.348 . . . . 0.0 110.547 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -125.89 111.57 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.269 1.428 . . . . 0.0 111.083 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.98 -18.75 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.014 1.326 . . . . 0.0 113.777 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -77.28 -7.62 56.27 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.67 150.94 44.81 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.64 1.576 . . . . 0.0 112.397 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.9 14.96 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.128 3.219 . . . . 0.0 115.89 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.95 4.3 38.87 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.511 2.005 . . . . 0.0 112.757 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 145.45 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.352 1.061 . . . . 0.0 113.18 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.03 40.94 0.73 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.309 1.844 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -66.26 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.568 1.547 . . . . 0.0 113.169 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.5 tttm -145.74 146.62 31.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.292 1.837 . . . . 0.0 111.378 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -63.4 175.72 0.95 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.599 2.36 . . . . 0.0 115.903 -174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -130.42 -4.06 4.29 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.599 2.36 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.6 -66.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.011 -1.055 . . . . 0.0 108.437 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.27 -8.84 21.76 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.206 2.602 . . . . 0.0 110.947 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' O ' ' HE2' ' A' ' 89' ' ' LYS . 72.3 m80 64.07 24.0 13.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.162 2.185 . . . . 0.0 114.38 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 18.7 m-85 -79.72 145.75 63.17 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -61.03 142.28 96.9 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.853 2.369 . . . . 0.0 110.045 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 56' ' ' CYS . 6.9 mm -90.48 130.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 124.662 1.185 . . . . 0.0 111.306 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -119.05 107.92 14.09 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.024 1.729 . . . . 0.0 111.49 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -69.63 70.04 0.29 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.527 1.931 . . . . 0.0 113.611 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? 55.56 -154.49 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.896 2.078 . . . . 0.0 112.576 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.329 2.252 . . . . 0.0 112.447 -175.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.18 154.57 0.57 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.667 1.587 . . . . 0.0 114.166 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -51.46 -21.49 2.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -137.13 129.68 30.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.646 1.178 . . . . 0.0 111.354 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -89.88 0.68 56.91 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.166 1.386 . . . . 0.0 113.928 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -74.93 31.68 0.09 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.13 2.172 . . . . 0.0 114.617 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.02 162.4 29.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.988 1.715 . . . . 0.0 112.818 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.6 p -149.73 156.75 42.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.034 1.734 . . . . 0.0 112.237 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.74 156.62 36.68 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.391 1.477 . . . . 0.0 111.76 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -154.82 160.22 41.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.779 1.232 . . . . 0.0 112.013 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -45.85 111.69 0.38 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.639 1.976 . . . . 0.0 113.411 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -63.93 1.82 0.61 Allowed 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.4 t0 103.02 155.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 131.046 3.739 . . . . 0.0 111.378 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -73.44 120.17 18.68 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.74 159.06 20.36 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.54 2.336 . . . . 0.0 113.761 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.25 149.59 16.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.615 2.877 . . . . 0.0 111.829 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.3 m -74.58 38.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.04 -11.14 0.02 OUTLIER Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.735 2.112 . . . . 0.0 113.807 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.26 57.76 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.63 2.215 . . . . 0.0 111.18 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.9 p -145.42 152.31 39.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.395 0.678 . . . . 0.0 112.739 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.74 131.84 35.52 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.635 1.174 . . . . 0.0 110.62 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.11 64.7 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.739 -1.226 . . . . 0.0 111.503 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -92.49 -42.01 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.339 1.055 . . . . 0.0 110.57 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . 0.257 29.2 p -124.79 9.26 8.23 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 50.53 29.01 3.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.284 2.233 . . . . 0.0 112.888 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.43 140.22 14.88 Favored Glycine 0 N--CA 1.467 0.74 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.269 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.1 171.0 0.78 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.16 1.384 . . . . 0.0 114.718 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 141.15 57.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.69 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 p -130.08 155.36 46.3 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.065 0.936 . . . . 0.0 112.695 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.03 -11.79 0.1 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -128.28 -15.98 4.54 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.537 1.535 . . . . 0.0 112.921 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.532 HD21 ' HB3' ' A' ' 66' ' ' HIS . 36.3 t30 -150.69 74.62 8.66 Favored Pre-proline 0 N--CA 1.44 -0.93 0 C-N-CA 125.511 1.524 . . . . 0.0 109.483 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.22 -158.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.312 4.008 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mt -129.8 156.67 43.96 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 123.037 1.398 . . . . 0.0 111.532 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -154.04 177.14 11.39 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 129.463 3.105 . . . . 0.0 107.739 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -124.63 98.1 37.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.724 0.809 . . . . 0.0 108.86 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.25 -15.45 20.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.806 2.338 . . . . 0.0 112.732 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 0.4 OUTLIER -151.85 157.39 41.83 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 124.262 1.025 . . . . 0.0 112.433 -169.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -85.28 20.99 1.82 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.4 m -47.97 -14.39 0.05 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 126.582 1.953 . . . . 0.0 114.785 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttp-105 58.25 173.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.231 3.412 . . . . 0.0 115.26 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.63 -161.59 26.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.775 -1.203 . . . . 0.0 112.981 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.7 p -65.04 -24.15 67.4 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.494 -1.003 . . . . 0.0 113.194 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 pt -74.9 -3.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -74.17 -20.07 60.34 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.486 1.039 . . . . 0.0 112.684 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -90.3 139.93 30.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.433 1.093 . . . . 0.0 113.661 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 mtt -151.83 142.94 23.21 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.563 0.745 . . . . 0.0 111.973 -174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.532 ' HB3' HD21 ' A' ' 50' ' ' ASN . 23.5 m170 -70.1 149.5 47.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.177 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.53 -33.98 77.17 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.719 -0.613 . . . . 0.0 110.681 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.1 m -73.82 -42.94 60.17 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.758 -0.589 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 84.0 m -64.59 -43.5 93.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.916 1.287 . . . . 0.0 112.524 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.14 -44.05 97.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.386 0.994 . . . . 0.0 110.088 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.02 -28.84 59.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.257 1.023 . . . . 0.0 113.531 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -91.05 -37.0 13.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.281 1.432 . . . . 0.0 111.166 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.451 ' CE2' ' HE3' ' A' ' 77' ' ' LYS . 88.8 t90 -60.55 -51.74 68.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.49 -34.14 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.422 -0.799 . . . . 0.0 111.437 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.51 78.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.983 -0.448 . . . . 0.0 111.408 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -71.02 -30.87 67.21 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.967 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HE3' ' CE2' ' A' ' 73' ' ' TRP . 56.1 mmtt -81.05 8.38 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.496 2.718 . . . . 0.0 113.736 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER 75.68 16.51 2.48 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.4 2.28 . . . . 0.0 115.528 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.73 139.46 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.079 1.352 . . . . 0.0 111.41 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -130.08 112.97 13.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 0.0 112.998 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.2 pt -67.49 -17.87 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 113.94 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -71.77 -13.04 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.12 143.66 27.19 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.698 1.199 . . . . 0.0 111.53 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.68 16.77 1.23 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.049 3.166 . . . . 0.0 116.272 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.25 7.03 25.0 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.536 2.017 . . . . 0.0 112.805 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.8 55.81 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.286 1.034 . . . . 0.0 113.286 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.5 41.08 1.59 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.392 1.877 . . . . 0.0 110.141 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 88' ' ' VAL . 2.0 t -49.67 107.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.712 2.405 . . . . 0.0 114.13 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -148.38 144.95 27.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.147 1.779 . . . . 0.0 110.949 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 43.1 t -66.56 170.87 5.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.548 2.339 . . . . 0.0 114.715 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.79 -17.8 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.193 2.597 . . . . 0.0 111.808 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.2 -55.69 11.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.105 . . . . 0.0 109.578 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.9 p -115.85 -7.07 12.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.977 0.511 . . . . 0.0 111.894 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 68.89 18.03 8.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.518 2.327 . . . . 0.0 114.678 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.8 m-85 -82.75 145.31 50.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 120.817 -1.177 . . . . 0.0 111.966 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.37 132.19 39.86 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.577 2.185 . . . . 0.0 109.85 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -85.22 116.02 27.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 126.255 1.822 . . . . 0.0 108.854 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -114.26 111.94 22.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -170.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -73.47 48.37 0.25 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.994 2.118 . . . . 0.0 111.915 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.7 126.7 16.35 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.585 2.754 . . . . 0.0 113.451 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.251 1.155 0 C-N-CA 127.111 2.164 . . . . 0.0 111.188 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.48 166.68 10.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 113.499 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -149.18 -12.84 0.31 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -158.41 -24.91 0.08 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.336 1.454 . . . . 0.0 114.056 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -47.88 -45.58 30.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.182 2.193 . . . . 0.0 112.958 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -67.23 -0.06 3.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.863 2.065 . . . . 0.0 115.515 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.92 18.73 15.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.656 1.982 . . . . 0.0 112.711 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -71.2 164.08 26.37 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.197 1.399 . . . . 0.0 111.685 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.72 23.09 3.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.748 1.219 . . . . 0.0 114.032 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m 50.58 54.22 11.56 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.06 1.744 . . . . 0.0 111.854 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -50.5 153.24 1.65 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.4 2.28 . . . . 0.0 114.57 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -165.93 174.58 9.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.702 2.001 . . . . 0.0 111.074 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -132.81 144.34 50.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.994 1.318 . . . . 0.0 111.139 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -75.11 79.51 2.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.0 149.41 71.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.33 2.252 . . . . 0.0 110.67 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.18 155.85 8.55 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.921 3.081 . . . . 0.0 113.872 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.6 p -97.83 10.55 39.88 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.44 1.496 . . . . 0.0 113.185 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.97 7.45 0.56 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.4 147.93 30.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.309 1.555 . . . . 0.0 109.962 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 57.1 p -141.49 145.36 35.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.033 1.333 . . . . 0.0 112.652 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.8 t -58.33 140.17 53.95 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.941 1.296 . . . . 0.0 114.246 174.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.1 mt -99.22 -48.16 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 110.502 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.4 m -107.38 -4.64 18.37 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 49.34 31.23 3.67 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.234 2.214 . . . . 0.0 112.385 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.64 141.59 16.18 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.297 0.951 . . . . 0.0 112.627 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.76 160.43 11.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.922 1.289 . . . . 0.0 113.554 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.48 144.26 51.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.519 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.7 p -128.35 157.69 40.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.313 1.054 . . . . 0.0 112.636 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -57.72 -11.59 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.63 -21.77 5.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.432 1.493 . . . . 0.0 111.475 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.602 HD21 ' HB3' ' A' ' 66' ' ' HIS . 35.6 t30 -141.02 67.48 27.14 Favored Pre-proline 0 N--CA 1.444 -0.747 0 C-N-CA 124.118 0.967 . . . . 0.0 113.49 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -49.75 167.74 0.18 Allowed 'Trans proline' 0 C--O 1.235 0.371 1 C-N-CA 125.5 4.133 . . . . 0.0 116.928 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.62 142.33 44.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.177 173.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -152.75 -177.49 6.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.671 1.988 . . . . 0.0 108.765 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -114.99 108.23 48.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.841 0.856 . . . . 0.0 110.354 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 97' ' ' ILE . 87.4 Cg_endo -75.85 -18.82 16.67 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.622 2.881 . . . . 0.0 112.764 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.281 5.1 t -141.15 -161.33 1.2 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 129.678 3.191 . . . . 0.0 106.889 -167.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -95.11 -41.58 9.03 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.255 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.321 6.2 m 40.97 -5.47 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 1 C-N-CA 132.309 4.244 . . . . 0.0 119.298 -173.26 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 45.52 67.9 0.66 Allowed 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 131.78 4.032 . . . . 0.0 117.743 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.93 -174.19 31.01 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 125.942 1.734 . . . . 0.0 111.844 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -55.83 -23.92 33.34 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.215 1.008 . . . . 0.0 111.854 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -61.98 -14.62 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 113.498 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -70.36 -5.91 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.768 -1.207 . . . . 0.0 114.02 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -97.48 138.95 34.12 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.727 1.211 . . . . 0.0 110.724 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 83.3 mtp -158.35 145.89 18.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.606 1.562 . . . . 0.0 109.684 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.602 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.5 m80 -69.99 151.53 45.47 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.26 -38.88 77.81 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.749 -0.594 . . . . 0.0 110.712 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -81.32 -31.62 33.44 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -76.03 -41.05 52.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.411 1.101 . . . . 0.0 112.245 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.86 -49.85 74.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.708 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 mt -55.14 -35.39 64.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.423 1.089 . . . . 0.0 112.748 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.2 pt-20 -81.49 -37.67 27.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.216 0.462 . . . . 0.0 112.096 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -62.91 -51.02 68.56 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.681 -0.637 . . . . 0.0 110.715 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.78 -31.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.938 0.79 . . . . 0.0 112.331 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.66 -20.21 61.29 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.088 -0.382 . . . . 0.0 111.868 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -80.57 -5.02 56.16 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.804 -1.185 . . . . 0.0 111.867 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -92.11 9.85 31.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.611 1.964 . . . . 0.0 114.049 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 79.61 9.3 1.56 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.816 2.046 . . . . 0.0 113.844 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mt -109.89 124.22 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 111.342 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -87.4 82.33 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.174 0.988 . . . . 0.0 111.099 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -9.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 113.818 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.7 t -65.9 -25.77 67.32 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.15 -0.344 . . . . 0.0 110.977 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -92.52 143.55 27.4 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.521 1.128 . . . . 0.0 110.545 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.47 9.24 2.62 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.687 2.925 . . . . 0.0 116.624 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.3 -9.44 69.88 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.524 1.535 . . . . 0.0 113.32 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.59 150.2 49.1 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.203 1.001 . . . . 0.0 112.741 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.57 49.7 1.22 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.137 1.775 . . . . 0.0 109.839 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.01 131.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 126.234 1.814 . . . . 0.0 111.982 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -142.87 144.16 32.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.962 1.705 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 17.5 t -59.04 169.54 1.04 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.974 2.109 . . . . 0.0 115.743 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -127.76 -8.09 5.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.541 2.736 . . . . 0.0 112.041 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.3 mt -89.91 -56.28 5.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 124.022 0.929 . . . . 0.0 108.784 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.03 -1.76 11.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.017 0.927 . . . . 0.0 111.708 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 70.6 m80 61.31 16.74 7.64 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.896 2.078 . . . . 0.0 115.164 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.514 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.9 m-85 -77.03 144.24 71.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 120.848 -1.157 . . . . 0.0 111.297 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -57.67 148.82 71.8 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.402 2.068 . . . . 0.0 109.988 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 55' ' ' PRO . 2.4 mt -116.45 135.55 56.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 124.078 0.951 . . . . 0.0 110.78 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -121.96 125.59 46.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.216 1.006 . . . . 0.0 110.842 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -68.36 -1.37 6.25 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -160.87 161.98 32.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.601 2.36 . . . . 0.0 110.489 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.251 1.177 0 C-N-CA 127.012 2.125 . . . . 0.0 113.776 176.712 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.06 59.08 1.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.897 1.679 . . . . 0.0 110.258 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -133.25 22.4 4.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.854 1.661 . . . . 0.0 113.488 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -71.3 170.94 12.04 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 111.73 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.65 -4.6 4.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 p -142.78 137.65 29.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.805 1.242 . . . . 0.0 112.549 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -111.41 -135.17 0.36 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 0.0 110.115 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -138.38 138.17 38.0 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 109.881 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.02 173.17 14.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.81 1.244 . . . . 0.0 112.656 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -140.55 160.21 40.51 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.943 1.697 . . . . 0.0 111.072 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -125.98 169.93 12.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.706 1.202 . . . . 0.0 112.879 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.68 3.66 3.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.253 1.421 . . . . 0.0 113.523 -176.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -152.73 145.38 24.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.825 2.05 . . . . 0.0 108.505 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 67.94 -31.65 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.081 2.552 . . . . 0.0 116.486 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.56 153.94 32.71 Favored Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 128.979 2.912 . . . . 0.0 111.353 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -89.59 -137.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.867 3.711 . . . . 0.0 111.409 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.6 m -72.63 53.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.36 35.05 83.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.495 1.045 . . . . 0.0 112.855 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.13 162.93 27.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.482 0.713 . . . . 0.0 112.071 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -149.87 160.78 43.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.033 1.333 . . . . 0.0 113.55 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.1 t -69.12 125.16 25.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.18 1.792 . . . . 0.0 112.822 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -10.32 56.06 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.259 -0.901 . . . . 0.0 113.136 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 mt -91.77 -46.18 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 125.097 1.359 . . . . 0.0 109.668 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -125.73 3.22 7.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 59.25 31.27 21.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.736 2.015 . . . . 0.0 113.815 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 144.89 17.14 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.87 169.32 10.01 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.159 0.981 . . . . 0.0 111.685 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.74 53.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.8 p -114.94 168.56 9.8 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.112 0.958 . . . . 0.0 111.797 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.56 -19.31 37.0 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -121.49 -17.85 7.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 110.92 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.57 58.0 16.1 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.15 145.31 26.45 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.506 2.137 . . . . 0.0 111.919 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.38 175.58 9.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.136 -2.302 . . . . 0.0 109.92 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.4 175.47 2.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.215 2.206 . . . . 0.0 109.035 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -112.16 95.46 30.36 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.507 1.123 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.446 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.4 Cg_endo -71.08 -30.4 16.35 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.689 2.26 . . . . 0.0 111.688 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.9 t -135.37 -178.99 5.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.836 2.854 . . . . 0.0 110.446 -171.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.62 36.13 4.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.639 1.976 . . . . 0.0 113.419 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.5 m -51.6 -8.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.634 2.374 . . . . 0.0 116.519 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 65.64 175.5 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.875 2.07 . . . . 0.0 114.493 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.12 -150.5 1.01 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.478 1.513 . . . . 0.0 115.538 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -75.47 -1.79 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.788 1.235 . . . . 0.0 113.872 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.7 pt -97.78 -0.61 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.915 1.286 . . . . 0.0 113.91 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -83.61 5.57 23.86 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.47 143.24 45.26 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.673 1.589 . . . . 0.0 109.281 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.7 mtp -154.32 140.3 18.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.641 1.176 . . . . 0.0 111.084 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 7.2 m170 -70.22 144.57 51.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.049 0.94 . . . . 0.0 110.091 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.98 12.95 1.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 113.545 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -129.84 -40.38 1.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.129 1.372 . . . . 0.0 109.048 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 83.7 m -59.69 -47.85 83.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.641 1.176 . . . . 0.0 111.332 172.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -56.0 -44.33 78.54 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.275 0.63 . . . . 0.0 110.381 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.17 -22.62 61.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.856 1.262 . . . . 0.0 112.869 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.63 -39.89 8.87 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.828 1.651 . . . . 0.0 111.321 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.407 ' CZ2' ' HE2' ' A' ' 77' ' ' LYS . 91.9 t90 -56.38 -47.55 78.71 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.099 1.36 . . . . 0.0 111.416 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.9 m -66.7 -25.34 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 119.141 0.882 . . . . 0.0 111.817 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.77 -38.42 76.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.115 -0.366 . . . . 0.0 110.591 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 p -69.06 -18.64 64.03 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.068 -1.02 . . . . 0.0 113.605 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HE2' ' CZ2' ' A' ' 73' ' ' TRP . 35.7 mmtm -75.32 6.15 4.81 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.063 2.145 . . . . 0.0 113.619 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.262 9.3 t30 66.07 43.96 2.78 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.599 1.56 . . . . 0.0 111.601 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -138.48 140.79 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 109.312 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -117.9 99.58 7.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.411 1.085 . . . . 0.0 111.703 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.2 pt -63.51 -15.9 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.365 1.466 . . . . 0.0 113.881 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -68.75 -23.79 64.37 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.236 0.614 . . . . 0.0 112.084 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -107.18 148.78 37.71 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 125.333 1.453 . . . . 0.0 112.381 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.1 27.7 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.633 3.556 . . . . 0.0 114.673 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.83 -1.86 30.4 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.462 1.982 . . . . 0.0 112.314 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.79 43.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.172 0.989 . . . . 0.0 112.672 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -150.78 46.69 0.86 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.061 1.744 . . . . 0.0 109.741 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.72 109.34 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.999 1.32 . . . . 0.0 113.009 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -143.11 140.21 30.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.383 1.873 . . . . 0.0 110.003 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.6 168.11 2.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.058 2.143 . . . . 0.0 115.19 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -122.97 -7.99 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.543 2.337 . . . . 0.0 111.919 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -88.16 -57.29 4.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.659 1.184 . . . . 0.0 108.46 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.4 p -110.99 -6.88 14.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.104 0.562 . . . . 0.0 111.749 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.254 73.9 m80 64.44 19.25 11.73 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.706 2.002 . . . . 0.0 114.305 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.455 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.5 m-85 -82.11 145.02 51.87 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.056 -1.027 . . . . 0.0 111.413 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.53 153.0 69.64 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.811 1.674 . . . . 0.0 109.256 168.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -112.15 141.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.902 0.858 . . . . 0.0 110.092 -173.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -113.89 121.84 45.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.819 1.248 . . . . 0.0 111.101 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.3 -4.35 53.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -163.72 152.81 14.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.684 2.794 . . . . 0.0 109.685 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.006 1.722 . . . . 0.0 112.698 178.387 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 110.91 -0.033 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.63 18.93 1.67 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -145.89 151.83 38.49 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.785 1.634 . . . . 0.0 111.101 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.48 -42.47 99.51 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -48.74 2.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 130.429 3.491 . . . . 0.0 119.031 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.2 p -127.93 -3.62 5.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.345 1.458 . . . . 0.0 113.448 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.23 -11.94 8.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.14 1.776 . . . . 0.0 113.788 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 t -155.06 158.56 39.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.156 2.182 . . . . 0.0 110.493 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.87 43.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.236 1.015 . . . . 0.0 113.661 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.1 p -56.25 -7.42 0.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 118.281 2.697 . . . . 0.0 118.281 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.45 140.85 49.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.79 1.636 . . . . 0.0 112.566 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -141.6 123.12 15.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.754 2.021 . . . . 0.0 109.865 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.97 166.23 22.61 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.286 1.435 . . . . 0.0 114.155 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -63.74 179.66 0.47 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.65 160.52 53.15 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.622 2.369 . . . . 0.0 111.096 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 37' ' ' ALA . 1.3 Cg_exo -45.38 -2.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 2 C-N-CA 128.512 6.141 . . . . 0.0 125.202 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m 45.53 10.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.823 2.449 . . . . 0.0 117.48 -170.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.34 -2.2 0.34 Allowed Glycine 0 CA--C 1.54 1.601 0 C-N-CA 127.594 2.521 . . . . 0.0 114.293 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 34' ' ' PRO . . . -73.02 161.99 30.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.667 1.234 . . . . 0.0 108.481 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.7 p -148.3 148.7 30.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.073 0.949 . . . . 0.0 113.225 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.43 127.93 34.15 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.461 1.904 . . . . 0.0 110.751 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -14.85 62.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 69' ' ' CYS . 67.4 mt -96.64 -52.8 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.513 1.125 . . . . 0.0 110.346 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.53 -16.66 36.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 54.95 38.71 30.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.454 1.502 . . . . 0.0 110.445 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.36 156.25 22.31 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 122.802 1.223 . . . . 0.0 111.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -63.44 166.87 6.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 126.669 1.988 . . . . 0.0 115.932 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 158.41 28.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.721 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.6 p -137.27 160.09 40.03 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.281 1.039 . . . . 0.0 113.113 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.92 -9.27 3.95 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.85 -27.55 4.26 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.632 1.573 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 56.5 t30 -138.07 67.05 47.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.0 176.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 126.82 5.013 . . . . 0.0 117.75 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.01 145.49 43.64 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.92 172.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -156.39 -176.49 5.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.536 2.334 . . . . 0.0 109.632 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 8.6 m170 -119.49 102.4 47.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.302 1.041 . . . . 0.0 113.571 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.63 -33.52 1.25 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.102 1.201 . . . . 0.0 113.082 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.0 p -147.18 150.31 34.67 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.638 1.975 . . . . 0.0 110.165 -170.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 12.1 mptt -84.05 28.27 0.62 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.456 -1.247 . . . . 0.0 114.169 -174.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.46 87.91 5.06 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 161.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.81 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 3 C-N-CA 141.81 8.044 . . . . 0.0 112.122 1.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.6 -139.43 6.11 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.067 1.794 . . . . 0.0 109.624 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -54.01 -29.1 42.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 119.563 1.682 . . . . 0.0 111.775 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 pt -62.59 -9.1 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.121 1.768 . . . . 0.0 113.316 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HG3' ' CD2' ' A' ' 54' ' ' HIS . 16.5 pttt -82.13 0.33 41.3 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.339 -0.851 . . . . 0.0 112.012 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.61 139.18 31.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.36 1.464 . . . . 0.0 108.751 171.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.5 ttp -161.6 145.45 12.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.828 0.851 . . . . 0.0 110.438 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.8 m80 -67.84 154.89 40.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.372 0.533 . . . . 0.0 110.787 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.79 -45.42 92.38 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.277 -0.889 . . . . 0.0 109.638 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 p -54.98 -54.34 44.13 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.982 0.913 . . . . 0.0 112.375 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 41' ' ' ILE . 82.1 m -62.6 -36.99 84.53 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.376 1.47 . . . . 0.0 112.747 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.2 tp -66.3 -47.02 74.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.13 1.332 . . . . 0.0 110.723 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.57 -32.74 70.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.187 1.795 . . . . 0.0 111.92 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -79.6 -41.09 27.84 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 128.076 2.55 . . . . 0.0 111.199 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -62.28 -50.77 70.36 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.998 -1.064 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.46 -32.13 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.794 0.724 . . . . 0.0 110.605 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.09 93.13 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.593 -0.692 . . . . 0.0 109.983 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -61.65 -16.27 47.17 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.594 -1.316 . . . . 0.0 113.462 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.84 3.75 50.12 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.142 1.777 . . . . 0.0 112.586 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.252 10.1 t30 64.62 44.09 4.06 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.114 1.365 . . . . 0.0 112.375 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -135.61 142.22 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.762 1.225 . . . . 0.0 110.424 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -108.77 100.43 9.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.811 1.244 . . . . 0.0 109.422 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.27 -11.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 t -76.99 -21.42 54.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.179 0.592 . . . . 0.0 112.048 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.89 144.34 90.39 Favored Pre-proline 0 N--CA 1.475 0.821 0 O-C-N 120.985 -1.072 . . . . 0.0 111.558 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.38 7.03 3.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.642 2.894 . . . . 0.0 116.768 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.02 -3.08 34.02 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.451 1.977 . . . . 0.0 112.519 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.42 127.83 34.41 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.285 1.042 . . . . 0.0 111.755 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.36 40.92 1.61 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.219 1.808 . . . . 0.0 109.8 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.18 124.78 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.341 2.256 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -139.16 131.35 28.18 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.468 1.507 . . . . 0.0 110.625 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.9 t -66.47 126.91 30.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.49 -21.53 41.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.13 -66.69 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.625 1.17 . . . . 0.0 111.338 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.0 p -83.39 -18.99 36.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 111.423 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 21.7 t60 79.79 1.43 2.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.332 3.053 . . . . 0.0 112.609 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 57' ' ' LYS . 53.6 m-85 -83.89 131.2 52.36 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.402 -1.436 . . . . 0.0 112.098 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 95' ' ' TYR . 31.6 Cg_exo -55.46 145.83 66.31 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.314 3.343 . . . . 0.0 111.44 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 mm -74.12 107.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 122.233 1.016 . . . . 0.0 109.39 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -99.89 85.82 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 113.198 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -58.98 128.49 37.51 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.086 1.354 . . . . 0.0 111.019 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -69.55 145.81 52.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.442 1.097 . . . . 0.0 113.174 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 125.571 1.548 . . . . 0.0 109.312 173.397 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.8 161.29 34.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.72 1.208 . . . . 0.0 112.739 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -121.82 178.53 4.83 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.339 1.856 . . . . 0.0 112.826 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -145.77 165.06 29.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.637 1.975 . . . . 0.0 109.787 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.14 12.71 1.73 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.771 1.229 . . . . 0.0 114.025 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 p -76.57 163.93 26.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.626 1.57 . . . . 0.0 112.824 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.52 142.86 23.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.997 1.319 . . . . 0.0 111.417 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.1 p -137.59 9.37 2.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 113.704 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.22 145.73 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -146.01 151.42 37.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.661 2.385 . . . . 0.0 109.744 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -52.09 143.18 14.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.625 1.17 . . . . 0.0 113.34 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -141.61 170.65 15.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.636 1.974 . . . . 0.0 111.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.93 132.26 30.06 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.054 1.342 . . . . 0.0 111.886 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -76.3 166.67 23.12 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 40.62 68.3 2.41 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 127.519 2.328 . . . . 0.0 115.168 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.49 142.71 98.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.656 2.237 . . . . 0.0 114.426 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -92.92 54.96 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.437 1.113 . . . . 0.0 108.22 169.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.56 48.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.019 1.771 . . . . 0.0 112.412 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 38' ' ' THR . . . -65.94 -175.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 111.525 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 37' ' ' ALA . 11.5 p -160.53 172.96 16.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 112.016 174.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -84.89 127.25 34.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.769 1.228 . . . . 0.0 107.698 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -20.63 66.47 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.157 1.344 . . . . 0.0 112.945 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.2 mt -79.94 -43.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 117.542 -1.218 . . . . 0.0 109.503 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.36 -2.18 8.54 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.322 38.8 mmt180 52.3 45.86 27.7 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.2 1.8 . . . . 0.0 111.413 -173.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.43 134.23 12.04 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 111.643 -2.526 . . . . 0.0 110.422 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.36 155.07 41.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.874 0.845 . . . . 0.0 110.955 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.9 156.36 2.91 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -128.65 173.36 10.36 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.36 1.076 . . . . 0.0 113.042 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.42 5.01 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.853 1.798 . . . . 0.0 115.853 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -145.98 -28.85 0.42 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.367 1.467 . . . . 0.0 111.636 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -127.69 67.84 73.48 Favored Pre-proline 0 N--CA 1.44 -0.941 0 C-N-CA 125.657 1.583 . . . . 0.0 110.231 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.34 -171.42 1.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.074 3.849 . . . . 0.0 112.109 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.72 142.09 46.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 110.87 -2.877 . . . . 0.0 109.359 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -158.0 -166.65 2.02 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 128.359 2.664 . . . . 0.0 107.738 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.54 107.79 14.48 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.247 1.019 . . . . 0.0 112.5 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.15 -18.6 9.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.878 3.052 . . . . 0.0 113.743 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 9.8 t -143.43 171.68 13.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.269 2.228 . . . . 0.0 110.142 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -83.28 20.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 129.681 3.193 . . . . 0.0 113.784 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -12.26 0.18 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 55.23 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 130.534 3.534 . . . . 0.0 120.068 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.35 -175.91 49.69 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.342 1.428 . . . . 0.0 113.52 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -69.12 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.73 -28.1 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.748 2.419 . . . . 0.0 108.704 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -54.05 -29.11 42.74 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.263 1.392 . . . . 0.0 113.585 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.34 134.17 49.88 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.707 1.241 . . . . 0.0 111.839 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.4 mtt -157.69 143.81 17.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.214 1.405 . . . . 0.0 109.706 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -69.0 155.38 40.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.567 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.97 -52.27 66.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.483 -0.76 . . . . 0.0 110.564 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -60.31 -45.46 93.32 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.562 -0.711 . . . . 0.0 112.313 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.1 -44.77 91.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.731 0.696 . . . . 0.0 112.07 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.05 -47.06 87.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.964 0.802 . . . . 0.0 110.141 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.64 -28.03 66.87 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.965 0.906 . . . . 0.0 112.787 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -85.65 -34.02 21.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.865 0.866 . . . . 0.0 111.723 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -58.81 -59.05 6.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 109.951 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.84 -23.52 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 111.811 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.0 -0.44 55.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.2 m -113.5 -5.4 13.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.99 1.716 . . . . 0.0 111.811 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -80.28 6.0 13.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.701 2.8 . . . . 0.0 114.691 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.318 0.0 OUTLIER 76.34 32.15 0.59 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.684 1.593 . . . . 0.0 111.518 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -142.08 159.77 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.748 2.019 . . . . 0.0 109.795 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -132.83 112.98 12.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.534 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.8 pt -61.23 -17.68 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.231 1.412 . . . . 0.0 114.452 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -74.36 -26.78 60.34 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.204 0.456 . . . . 0.0 111.873 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.83 145.31 83.95 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 121.263 -0.898 . . . . 0.0 112.734 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -79.86 27.42 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.54 3.493 . . . . 0.0 114.948 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.47 20.99 3.66 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.167 2.318 . . . . 0.0 111.188 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.81 131.8 38.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.755 0.822 . . . . 0.0 112.743 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -145.62 55.78 1.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.575 1.95 . . . . 0.0 108.6 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -71.55 37.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.818 2.047 . . . . 0.0 116.024 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -58.44 141.91 50.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.699 2.8 . . . . 0.0 113.005 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 46.9 t -60.33 116.51 4.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.556 1.942 . . . . 0.0 110.759 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -78.11 13.97 1.3 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.65 -47.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.86 1.264 . . . . 0.0 110.502 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -116.44 -9.31 11.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.187 1.795 . . . . 0.0 111.816 -174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.277 78.4 m-70 65.4 31.31 10.45 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.972 2.109 . . . . 0.0 115.823 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.6 m-85 -106.96 138.19 19.74 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.868 1.267 . . . . 0.0 112.552 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.94 135.55 71.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.394 2.063 . . . . 0.0 110.31 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.1 mm -74.93 136.98 23.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.029 0.932 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -123.98 88.2 2.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.597 1.189 . . . . 0.0 113.503 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.56 64.14 7.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.223 1.809 . . . . 0.0 110.137 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.68 149.81 20.99 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.999 1.32 . . . . 0.0 113.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.489 1.916 . . . . 0.0 111.59 179.524 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.711 -0.185 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.54 11.9 2.97 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -52.53 156.46 1.82 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.628 1.571 . . . . 0.0 113.75 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.17 -34.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.036 2.934 . . . . 0.0 109.303 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -45.13 -32.18 1.71 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.054 2.541 . . . . 0.0 115.079 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -62.82 -12.87 27.43 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.99 144.1 54.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.925 1.29 . . . . 0.0 111.479 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -137.64 38.41 2.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.57 126.94 21.2 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.852 -1.155 . . . . 0.0 111.057 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.2 m -145.28 143.73 30.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.937 1.695 . . . . 0.0 110.133 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -134.59 145.03 48.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.434 1.494 . . . . 0.0 111.132 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -124.26 5.31 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.8 28.35 0.11 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -127.49 15.3 7.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.114 2.566 . . . . 0.0 112.528 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.6 161.34 71.38 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 127.507 2.323 . . . . 0.0 113.439 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -39.01 127.33 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 125.175 3.917 . . . . 0.0 117.826 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -142.66 42.12 1.59 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.957 2.503 . . . . 0.0 109.917 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.13 19.03 7.84 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.942 1.734 . . . . 0.0 111.556 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.86 152.67 45.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.884 1.274 . . . . 0.0 110.244 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 79.0 p -143.91 153.1 41.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.738 1.215 . . . . 0.0 112.333 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 t -59.91 127.19 30.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.482 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -14.0 61.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 112.899 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.08 -46.28 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.3 p -113.8 -7.33 13.24 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.315 31.2 mmt180 57.22 44.72 21.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.063 1.345 . . . . 0.0 112.552 -175.274 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.96 16.49 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 172.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.0 172.43 4.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.45 1.1 . . . . 0.0 111.764 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.84 161.81 23.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.538 0.685 . . . . 0.0 109.637 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.4 p -136.93 166.78 22.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.208 0.603 . . . . 0.0 111.108 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.43 -22.25 64.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.71 -27.77 10.1 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.078 1.751 . . . . 0.0 111.376 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -137.27 66.9 53.51 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.51 173.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.546 4.164 . . . . 0.0 116.364 172.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.3 mt -110.24 146.01 36.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.105 -1.861 . . . . 0.0 110.49 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.46 -177.9 6.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.074 2.149 . . . . 0.0 108.827 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -126.12 118.01 23.67 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.929 0.892 . . . . 0.0 109.201 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.68 -26.41 7.01 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.108 2.538 . . . . 0.0 111.575 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.58 -152.71 0.51 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 128.326 2.65 . . . . 0.0 110.962 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 6.1 mmtt -119.66 13.35 12.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.549 1.939 . . . . 0.0 113.69 -174.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 m -44.35 -17.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -174.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? 38.99 34.55 0.1 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 129.11 2.964 . . . . 0.0 118.435 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.33 28.36 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.602 1.096 . . . . 0.0 114.642 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.5 p -64.19 9.42 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.475 1.51 . . . . 0.0 114.437 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.02 12.33 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.559 2.343 . . . . 0.0 110.22 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -90.26 -21.87 21.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 113.214 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -79.85 140.36 36.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.967 1.307 . . . . 0.0 111.597 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.0 mtp -154.61 143.04 20.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.671 1.188 . . . . 0.0 110.527 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -76.11 158.45 31.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.2 -46.91 88.52 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.243 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 m -65.1 -48.55 73.28 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.654 0.782 . . . . 0.0 111.613 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.62 -39.44 88.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.955 -1.09 . . . . 0.0 111.603 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.03 -49.89 75.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.043 1.747 . . . . 0.0 109.815 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.9 -30.7 68.0 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 113.447 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.46 -34.65 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.001 2.52 . . . . 0.0 112.225 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -70.6 -52.84 18.7 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.449 1.1 . . . . 0.0 109.156 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.4 m -58.88 -30.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.989 0.813 . . . . 0.0 110.573 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.18 75.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.34 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 t -60.92 -30.96 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.709 -1.244 . . . . 0.0 111.591 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.63 8.67 7.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.721 2.808 . . . . 0.0 114.025 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.286 0.0 OUTLIER 74.7 18.99 2.65 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.907 2.083 . . . . 0.0 115.531 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.92 141.69 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -129.79 113.39 14.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.027 1.331 . . . . 0.0 111.533 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -21.07 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.592 1.557 . . . . 0.0 114.003 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -75.3 -16.98 60.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.795 0.838 . . . . 0.0 112.888 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.89 142.15 51.92 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 120.928 -1.108 . . . . 0.0 113.252 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.48 17.74 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.571 3.514 . . . . 0.0 115.314 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.98 16.15 5.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.369 2.414 . . . . 0.0 111.541 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.14 147.89 42.51 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.525 0.73 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.19 39.93 0.93 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.853 1.661 . . . . 0.0 110.366 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -53.77 116.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.284 1.834 . . . . 0.0 113.084 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -148.75 147.21 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.843 1.657 . . . . 0.0 111.473 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.8 t -64.03 172.18 2.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.53 1.532 . . . . 0.0 113.76 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -129.74 0.49 4.89 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.764 2.025 . . . . 0.0 112.673 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -105.04 -65.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.1 p -92.74 -9.37 40.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.612 1.965 . . . . 0.0 111.078 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.343 4.3 p-80 58.7 16.72 4.58 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.163 2.585 . . . . 0.0 115.905 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 28.7 m-85 -81.59 143.78 51.64 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 120.018 1.281 . . . . 0.0 113.232 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.02 136.03 29.49 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.895 3.063 . . . . 0.0 111.772 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -82.79 124.33 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.894 1.278 . . . . 0.0 109.988 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.86 93.22 4.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.323 1.449 . . . . 0.0 112.159 -175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -62.08 158.33 16.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.475 1.11 . . . . 0.0 111.226 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.5 162.79 14.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.397 1.079 . . . . 0.0 112.964 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.543 1.937 . . . . 0.0 112.858 -179.239 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.62 40.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.98 1.312 . . . . 0.0 111.702 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -102.11 158.14 16.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.122 1.369 . . . . 0.0 113.495 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -142.27 145.08 33.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.083 2.153 . . . . 0.0 109.879 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -165.58 -36.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.791 1.637 . . . . 0.0 113.055 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 p -60.74 -14.59 22.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 119.517 3.155 . . . . 0.0 119.517 -170.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -60.83 167.37 2.84 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.8 t -115.17 -136.63 0.36 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.378 1.871 . . . . 0.0 109.645 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.02 164.43 31.19 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.818 1.644 . . . . 0.0 112.074 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -141.6 148.71 39.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.754 1.622 . . . . 0.0 110.503 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -154.03 155.25 35.15 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.216 1.406 . . . . 0.0 111.218 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -141.39 152.87 44.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.825 1.65 . . . . 0.0 111.432 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.13 149.9 34.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.488 1.115 . . . . 0.0 113.288 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 68.88 -24.93 0.14 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 128.895 2.878 . . . . 0.0 115.237 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.86 80.04 67.73 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.379 2.672 . . . . 0.0 112.373 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -64.96 153.48 78.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.626 2.217 . . . . 0.0 113.171 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.0 m -97.8 18.24 16.21 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.859 1.264 . . . . 0.0 111.924 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.79 52.2 0.2 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 128.122 2.772 . . . . 0.0 109.989 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 170.85 6.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.665 1.186 . . . . 0.0 111.892 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.3 p -150.34 165.82 31.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.99 1.316 . . . . 0.0 112.135 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 39.1 t -75.62 120.97 21.75 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 114.336 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -9.17 13.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.57 1.148 . . . . 0.0 113.186 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 57.5 mt -99.26 -42.05 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.109 1.364 . . . . 0.0 110.831 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.77 12.42 4.03 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 53.75 19.39 1.84 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.681 2.793 . . . . 0.0 115.488 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.52 144.94 25.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.56 173.85 8.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 110.404 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.06 157.41 22.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.416 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.3 p -127.05 165.23 19.88 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.48 1.133 . . . . 0.0 112.407 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -61.51 -15.7 40.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.01 -24.28 2.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.129 0.972 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -136.59 71.72 58.09 Favored Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 124.753 1.221 . . . . 0.0 111.324 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.92 -160.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 124.499 3.466 . . . . 0.0 109.291 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mt -120.05 141.86 49.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.093 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -144.76 173.85 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 110.877 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -113.98 101.87 54.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.552 1.141 . . . . 0.0 112.381 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.68 -36.1 8.91 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.97 1.78 . . . . 0.0 111.443 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.9 t -119.7 -164.26 1.05 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 129.07 2.948 . . . . 0.0 112.294 -166.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -116.11 1.44 13.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.98 2.512 . . . . 0.0 115.247 -172.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 m -34.15 -48.69 0.33 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.598 2.359 . . . . 0.0 114.944 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 109.5 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 1 C-N-CA 132.925 4.49 . . . . 0.0 112.052 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 18.72 -109.98 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 129.213 3.292 . . . . 0.0 117.643 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -55.51 -5.26 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -174.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.94 19.41 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.85 1.659 . . . . 0.0 111.165 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -100.28 -53.56 3.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.705 1.202 . . . . 0.0 109.72 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -46.48 142.3 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.591 1.956 . . . . 0.0 112.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.1 mtt -159.64 150.57 19.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.474 1.51 . . . . 0.0 111.55 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -74.82 150.94 39.11 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -56.47 -42.32 78.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.822 1.192 . . . . 0.0 111.328 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.0 p -61.22 -46.29 91.05 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.372 1.469 . . . . 0.0 112.631 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.4 m -64.78 -40.13 94.75 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 112.292 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.58 -47.72 84.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.65 1.114 . . . . 0.0 110.289 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.45 -31.05 63.6 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.186 2.194 . . . . 0.0 113.268 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -92.46 -35.48 13.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.912 1.285 . . . . 0.0 112.143 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -62.97 -48.25 79.68 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.651 0.78 . . . . 0.0 111.04 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.87 -27.22 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.986 0.812 . . . . 0.0 111.585 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.39 90.25 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.76 -0.587 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.7 p -67.72 -1.66 5.68 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.92 8.63 44.8 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.037 1.29 . . . . 0.0 111.676 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 80.9 30.1 0.17 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.658 2.383 . . . . 0.0 113.296 178.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.25 145.94 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.494 1.118 . . . . 0.0 112.807 -170.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -139.43 111.31 7.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.093 1.357 . . . . 0.0 110.564 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 pt -63.91 -16.54 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.498 1.119 . . . . 0.0 113.321 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -82.11 0.18 41.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.462 1.105 . . . . 0.0 113.462 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -126.77 151.03 72.96 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.697 1.599 . . . . 0.0 112.418 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.38 27.69 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.75 3.633 . . . . 0.0 115.268 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.41 5.54 11.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.952 2.215 . . . . 0.0 112.084 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 144.7 53.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.432 1.093 . . . . 0.0 113.17 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.66 38.41 0.68 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.898 1.679 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.77 99.08 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 126.212 1.805 . . . . 0.0 114.246 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -150.88 142.84 23.94 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.399 2.279 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.5 t -67.15 177.78 1.68 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.231 2.612 . . . . 0.0 116.063 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -132.52 -3.8 3.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.762 2.425 . . . . 0.0 112.769 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mt -86.31 -71.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.788 -1.195 . . . . 0.0 107.854 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 7.9 p -88.03 -15.37 36.53 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.844 2.458 . . . . 0.0 110.574 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.4 m80 69.66 17.5 7.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.907 2.483 . . . . 0.0 113.11 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -76.19 146.65 78.65 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.46 149.21 76.28 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.228 2.619 . . . . 0.0 111.276 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 56' ' ' CYS . 5.2 mm -100.63 140.76 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.665 1.186 . . . . 0.0 109.906 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -135.64 137.2 41.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.144 0.974 . . . . 0.0 112.877 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -97.51 17.17 18.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.871 1.269 . . . . 0.0 113.287 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -152.98 139.46 18.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.304 2.242 . . . . 0.0 110.36 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.707 2.003 . . . . 0.0 113.975 -178.208 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.57 163.68 38.09 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.204 1.402 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -69.67 -8.36 47.01 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.86 17.13 2.66 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.032 1.733 . . . . 0.0 113.259 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -42.94 -43.65 4.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.475 1.91 . . . . 0.0 114.586 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.8 p -136.38 128.1 29.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.458 1.503 . . . . 0.0 111.167 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -156.71 154.58 30.28 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.568 1.547 . . . . 0.0 111.096 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.2 p -147.27 145.37 29.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.533 1.533 . . . . 0.0 111.288 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.33 22.53 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 p -111.79 122.93 49.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.514 1.525 . . . . 0.0 111.881 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -139.86 130.26 25.45 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.673 1.589 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -89.7 -15.09 33.34 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.647 1.179 . . . . 0.0 113.265 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -147.12 164.74 32.14 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.469 1.908 . . . . 0.0 110.359 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -147.58 10.88 0.97 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.161 1.385 . . . . 0.0 113.771 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.17 120.66 81.42 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.768 1.627 . . . . 0.0 112.81 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -61.25 -178.73 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.948 3.099 . . . . 0.0 113.716 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -71.72 32.64 0.05 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.977 2.511 . . . . 0.0 116.463 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.01 -38.06 1.92 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.961 2.696 . . . . 0.0 109.309 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 93.54 129.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 131.43 3.892 . . . . 0.0 112.854 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 45' ' ' GLU . 77.3 p -136.01 150.39 49.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.832 2.853 . . . . 0.0 114.393 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 51.2 t -61.88 132.62 53.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.66 1.584 . . . . 0.0 111.122 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -20.1 63.56 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.644 -1.285 . . . . 0.0 112.72 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 96.8 mt -83.25 -39.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 110.34 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.39 -10.87 12.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.253 22.0 mmt85 62.22 40.33 11.69 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.318 2.247 . . . . 0.0 112.567 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.76 152.83 21.12 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 125.325 1.44 . . . . 0.0 114.315 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.866 ' HA ' HG22 ' A' ' 38' ' ' THR . 3.4 mt-10 -156.0 -34.44 0.09 Allowed 'General case' 0 CA--C 1.481 -1.675 1 C-N-CA 133.324 4.65 . . . . 0.0 116.296 -1.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' H ' ' A' ' 45' ' ' GLU . . . -79.5 -176.01 5.06 Favored 'General case' 0 C--N 1.305 -1.355 1 C-N-CA 141.687 7.995 . . . . 0.0 112.174 -4.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 p -125.35 148.54 48.71 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.751 -1.218 . . . . 0.0 113.124 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.49 -7.07 1.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.04 -20.52 8.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.577 1.951 . . . . 0.0 111.052 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -145.75 72.8 13.86 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 125.284 1.434 . . . . 0.0 113.912 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -46.23 173.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.08 4.52 . . . . 0.0 117.014 173.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -116.71 155.58 28.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.512 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -157.04 -171.01 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.065 2.546 . . . . 0.0 107.74 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -125.4 115.56 25.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.926 0.89 . . . . 0.0 109.628 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -78.31 -19.41 11.88 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.833 3.022 . . . . 0.0 112.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.3 p -151.03 151.98 32.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.29 2.636 . . . . 0.0 110.969 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.2 39.86 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.467 1.507 . . . . 0.0 114.519 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.87 -3.73 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 175.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? 23.37 92.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 129.678 3.191 . . . . 0.0 115.867 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.4 23.16 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.924 1.726 . . . . 0.0 112.006 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.9 p -54.03 -37.13 63.78 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.28 1.69 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -80.75 -14.37 58.15 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.376 -0.827 . . . . 0.0 112.923 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.76 140.06 29.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.546 0.738 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.3 mtp -153.86 144.64 22.59 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.115 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 7.4 m170 -70.26 135.36 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -75.6 32.68 0.11 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.297 1.439 . . . . 0.0 113.4 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.3 t -145.66 -43.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.304 2.242 . . . . 0.0 108.469 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 86.0 m -59.19 -48.34 81.97 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.785 1.234 . . . . 0.0 112.948 174.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.0 tp -58.03 -46.94 84.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 123.853 0.861 . . . . 0.0 110.682 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -22.6 63.54 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.232 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -92.56 -40.16 10.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 110.353 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -56.69 -49.33 75.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.568 1.147 . . . . 0.0 112.172 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.23 -33.44 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.475 0.71 . . . . 0.0 111.956 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.9 81.87 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.741 -0.599 . . . . 0.0 111.24 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.2 m -63.82 -15.52 59.02 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.843 -1.16 . . . . 0.0 113.395 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -75.05 -7.84 54.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.808 1.243 . . . . 0.0 113.14 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 62.91 52.58 2.61 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.836 1.303 . . . . 0.0 112.368 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.4 150.51 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.872 -1.143 . . . . 0.0 111.246 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.16 117.45 9.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.041 0.536 . . . . 0.0 112.096 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.85 0.51 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -96.14 5.55 50.82 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 122.347 1.07 . . . . 0.0 110.249 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? 30.32 80.94 0.23 Allowed Pre-proline 0 CA--C 1.539 0.545 1 C-N-CA 133.049 4.54 . . . . 0.0 119.162 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -84.18 46.96 2.1 Favored 'Trans proline' 0 CA--C 1.544 0.995 1 C-N-CA 126.336 4.691 . . . . 0.0 109.902 172.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.98 -11.55 22.59 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.601 2.048 . . . . 0.0 112.015 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 162.87 13.88 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.019 0.909 . . . . 0.0 113.103 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.11 45.17 1.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.519 1.528 . . . . 0.0 110.619 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.9 t -52.65 114.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.817 1.647 . . . . 0.0 113.74 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -148.28 -177.82 5.97 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.3 t -62.79 164.54 7.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.861 2.064 . . . . 0.0 114.329 -174.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -125.51 13.08 8.12 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.679 1.992 . . . . 0.0 111.784 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 mt -113.43 -55.3 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.82 1.648 . . . . 0.0 108.297 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.48 -10.74 14.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 t60 55.42 19.56 3.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.016 1.726 . . . . 0.0 114.718 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -78.21 139.47 60.51 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.737 -1.227 . . . . 0.0 108.988 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 43.1 Cg_exo -49.68 129.16 23.0 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.058 3.172 . . . . 0.0 112.439 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -89.76 129.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.151 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -118.17 136.6 53.53 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.318 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.72 35.33 4.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.425 1.89 . . . . 0.0 111.26 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -154.35 159.77 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.627 3.171 . . . . 0.0 109.785 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.228 1.811 . . . . 0.0 110.594 178.75 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 111.269 0.1 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.11 163.59 18.69 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.129 0.972 . . . . 0.0 112.042 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -118.1 -8.59 10.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.552 1.141 . . . . 0.0 114.077 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.48 168.81 19.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.395 1.078 . . . . 0.0 112.684 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.96 150.7 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.383 1.873 . . . . 0.0 109.723 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -161.32 179.94 7.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.645 1.978 . . . . 0.0 110.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.97 136.59 58.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.374 1.07 . . . . 0.0 111.289 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 m -145.84 142.7 29.08 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.753 1.221 . . . . 0.0 110.93 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.94 -175.11 1.35 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.122 1.369 . . . . 0.0 112.63 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -140.8 140.92 34.8 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 111.255 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -158.95 162.81 36.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.426 1.891 . . . . 0.0 111.504 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -137.2 63.22 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.113 1.365 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -145.45 143.32 29.96 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.27 24.02 0.05 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.926 2.89 . . . . 0.0 114.374 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -162.86 79.19 1.76 Allowed Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.664 1.586 . . . . 0.0 113.499 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -63.92 151.07 86.82 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.15 1.9 . . . . 0.0 111.628 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -95.57 13.33 26.52 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.51 44.67 0.25 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.989 1.757 . . . . 0.0 112.225 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 168.85 2.56 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.976 1.31 . . . . 0.0 112.104 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.3 p -139.16 157.03 46.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -62.1 134.72 56.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.38 1.472 . . . . 0.0 113.162 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -5.67 43.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.27 -41.66 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.826 1.25 . . . . 0.0 110.112 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.48 6.49 5.24 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 54.45 27.83 8.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.608 1.563 . . . . 0.0 114.467 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.46 140.98 15.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -72.57 162.89 28.89 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.266 1.026 . . . . 0.0 112.681 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 51' ' ' PRO . . . -54.53 140.52 34.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.217 1.407 . . . . 0.0 113.094 173.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.2 p -114.98 -149.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.607 1.963 . . . . 0.0 110.217 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -109.88 -5.28 15.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.562 1.545 . . . . 0.0 112.284 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.68 -18.22 5.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.362 2.265 . . . . 0.0 110.939 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -141.53 69.79 26.06 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 128.33 2.652 . . . . 0.0 108.408 174.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 51.6 Cg_endo -77.15 4.21 6.02 Favored 'Trans proline' 0 N--CA 1.501 1.945 1 C-N-CA 129.397 6.732 . . . . 0.0 118.276 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt 60.08 144.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 1 C-N-CA 136.599 5.959 . . . . 0.0 113.636 -170.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.11 179.83 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.241 1.816 . . . . 0.0 109.483 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -122.65 103.48 37.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.922 1.289 . . . . 0.0 109.829 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.49 -17.92 20.53 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.464 2.109 . . . . 0.0 111.425 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.5 t -134.92 -168.11 2.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.703 2.401 . . . . 0.0 111.428 -168.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -125.14 33.25 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.455 1.502 . . . . 0.0 113.626 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 93' ' ' CYS . 2.3 m -53.72 -10.39 0.29 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.286 1.434 . . . . 0.0 114.091 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 30.36 69.55 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.851 2.86 . . . . 0.0 116.561 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.4 -169.8 42.83 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.44 -1.255 . . . . 0.0 114.013 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -64.04 8.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.822 1.649 . . . . 0.0 114.495 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.87 12.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 127.741 2.416 . . . . 0.0 111.442 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 pttt -90.86 -17.01 27.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.639 1.576 . . . . 0.0 113.08 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 63' ' ' LYS . 45.4 m-85 -90.15 144.32 25.98 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.116 1.766 . . . . 0.0 111.091 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.4 mtp -157.8 143.07 16.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.124 0.97 . . . . 0.0 110.956 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -75.97 144.53 40.92 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.31 -40.72 78.48 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.956 -1.09 . . . . 0.0 110.954 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -59.62 -47.02 87.23 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.525 1.93 . . . . 0.0 112.09 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.3 m -63.17 -46.37 87.45 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.857 1.263 . . . . 0.0 111.122 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.12 -48.85 80.08 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 122.911 0.485 . . . . 0.0 112.059 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.02 -20.85 60.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.635 1.574 . . . . 0.0 112.522 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -96.41 -31.89 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.959 1.704 . . . . 0.0 112.057 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.438 ' CZ2' ' HE3' ' A' ' 77' ' ' LYS . 15.8 t90 -64.05 -57.19 10.4 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.01 1.724 . . . . 0.0 111.746 178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 m -55.75 -22.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.456 1.502 . . . . 0.0 111.225 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.03 -33.94 22.42 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.036 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 t -70.55 -26.4 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.254 1.422 . . . . 0.0 110.817 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE3' ' CZ2' ' A' ' 73' ' ' TRP . 65.8 mmtt -74.35 7.31 2.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.875 2.87 . . . . 0.0 113.747 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 75.16 6.48 4.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.478 2.311 . . . . 0.0 115.531 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.81 152.05 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.37 1.468 . . . . 0.0 111.382 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -134.49 110.33 9.31 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.095 1.358 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -18.46 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.985 1.314 . . . . 0.0 113.702 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -82.59 -5.38 58.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.902 0.881 . . . . 0.0 113.266 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.97 150.06 44.4 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 112.924 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -77.94 23.27 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.494 3.463 . . . . 0.0 115.182 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.88 8.27 16.7 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.691 2.091 . . . . 0.0 112.182 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.61 145.5 51.95 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 113.224 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.16 44.1 0.71 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.335 1.854 . . . . 0.0 109.871 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.79 88.07 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.924 1.69 . . . . 0.0 113.566 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -141.42 139.55 33.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.712 1.605 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.3 t -64.58 176.49 1.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.121 2.568 . . . . 0.0 115.739 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.26 -10.24 4.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.518 2.327 . . . . 0.0 112.591 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -79.44 -64.59 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 122.576 1.179 . . . . 0.0 108.932 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 58' ' ' CYS . 26.5 p -101.4 -11.93 18.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 130.268 3.427 . . . . 0.0 111.222 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.0 m80 70.69 14.95 7.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.439 2.696 . . . . 0.0 114.064 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 17.9 m-85 -78.42 145.84 68.86 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.61 143.13 99.39 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.65 2.233 . . . . 0.0 109.631 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -91.85 132.83 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -127.72 120.34 27.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.285 1.034 . . . . 0.0 111.012 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -73.84 38.51 0.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.38 1.872 . . . . 0.0 114.573 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -157.61 136.04 11.19 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.244 2.218 . . . . 0.0 110.957 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.256 1.399 0 C-N-CA 126.062 1.745 . . . . 0.0 111.981 177.039 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.44 149.7 1.53 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.155 1.782 . . . . 0.0 111.563 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -134.9 151.15 50.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.9 t -46.22 160.27 0.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.634 1.974 . . . . 0.0 112.999 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.13 0.47 40.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.818 2.047 . . . . 0.0 114.678 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.36 -35.23 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.345 2.258 . . . . 0.0 113.223 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.1 p -143.12 23.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 39.15 30.26 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.012 2.125 . . . . 0.0 114.965 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.81 155.98 45.45 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.93 134.32 46.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.302 1.051 . . . . 0.0 108.801 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -35.44 139.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -111.51 -168.8 1.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.702 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -104.05 15.13 29.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.442 2.297 . . . . 0.0 112.421 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.29 -27.93 0.27 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.092 1.757 . . . . 0.0 111.486 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 65.2 t30 -146.35 80.58 9.98 Favored Pre-proline 0 N--CA 1.435 -1.189 0 C-N-CA 126.465 1.906 . . . . 0.0 108.629 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.27 -143.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 125.873 4.382 . . . . 0.0 112.159 -177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -141.42 159.23 42.64 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.101 2.16 . . . . 0.0 108.916 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -165.96 161.22 17.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.919 2.087 . . . . 0.0 108.58 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 8.3 p80 -105.38 109.78 63.6 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.06 0.544 . . . . 0.0 109.726 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 54' ' ' HIS 0.264 61.9 Cg_endo -78.05 -7.5 16.31 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.658 3.572 . . . . 0.0 112.994 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.435 ' HB2' HD13 ' A' ' 97' ' ' ILE . 2.2 t -150.06 176.13 11.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.937 1.695 . . . . 0.0 111.472 -167.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -110.6 36.66 3.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.382 2.273 . . . . 0.0 113.572 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.4 m -59.59 -36.71 76.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.399 0.68 . . . . 0.0 110.6 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 75.16 178.6 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.683 2.793 . . . . 0.0 113.528 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.21 -138.38 43.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.71 1.148 . . . . 0.0 113.973 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -99.6 14.7 29.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.647 1.579 . . . . 0.0 114.574 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 33.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 127.009 2.124 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -106.03 -40.49 5.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.043 1.737 . . . . 0.0 109.957 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -61.78 157.11 18.76 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.893 1.277 . . . . 0.0 112.228 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 ttm -172.48 145.88 1.68 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.127 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.2 m80 -71.28 154.92 41.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.95 -38.87 87.38 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.672 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.1 p -63.65 -55.31 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 111.546 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.24 -43.5 61.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.904 1.282 . . . . 0.0 112.224 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.05 -45.78 87.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.936 0.789 . . . . 0.0 111.55 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -58.88 -28.03 65.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.449 1.1 . . . . 0.0 113.161 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.99 -26.91 21.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.364 1.466 . . . . 0.0 111.919 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.68 -59.45 2.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.218 1.007 . . . . 0.0 110.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.41 -20.08 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.901 1.281 . . . . 0.0 111.604 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.42 -45.32 32.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -59.92 -29.17 68.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.008 1.323 . . . . 0.0 112.53 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.8 -3.39 12.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.669 1.988 . . . . 0.0 113.827 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.06 54.41 2.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.785 1.234 . . . . 0.0 111.948 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -140.05 132.18 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 110.812 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -88.08 97.67 11.11 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.684 0.793 . . . . 0.0 110.487 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 pt -64.7 -10.93 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.839 1.256 . . . . 0.0 113.612 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -93.53 5.61 51.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.231 . . . . 0.0 112.794 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -120.9 144.9 40.2 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.546 1.138 . . . . 0.0 113.983 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -86.12 21.53 1.07 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.798 3.665 . . . . 0.0 113.838 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.36 23.85 10.2 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.039 2.257 . . . . 0.0 111.906 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.93 166.69 20.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.298 1.439 . . . . 0.0 112.888 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.65 36.26 2.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.309 1.844 . . . . 0.0 110.405 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -36.72 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 127.36 2.264 . . . . 0.0 114.751 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 15.4 pttm -158.1 172.46 18.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.58 172.6 1.53 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.645 2.778 . . . . 0.0 116.046 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.32 -17.45 3.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.974 2.51 . . . . 0.0 112.605 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.4 -54.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.137 0.975 . . . . 0.0 109.506 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.2 p -116.2 -9.85 11.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.58 1.952 . . . . 0.0 111.45 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.307 7.3 p80 58.05 22.09 8.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.583 2.753 . . . . 0.0 116.342 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -78.92 137.48 57.6 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.733 -1.229 . . . . 0.0 112.915 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 24.5 Cg_exo -54.54 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.752 2.968 . . . . 0.0 112.303 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' A' ' 56' ' ' CYS . 10.5 mm -68.19 139.91 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.313 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.41 124.71 40.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 112.345 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.85 1.66 . . . . 0.0 114.309 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.474 0 N-CA-C 114.548 0.579 . . . . 0.0 114.548 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.72 128.64 37.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.879 0.872 . . . . 0.0 109.571 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 p -139.13 148.75 43.65 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.207 1.403 . . . . 0.0 112.103 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.48 126.65 17.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.999 1.319 . . . . 0.0 112.378 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -5.43 26.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.852 -1.155 . . . . 0.0 113.446 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.18 -43.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.004 1.321 . . . . 0.0 110.272 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.5 p -125.3 -1.58 7.59 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.318 33.9 mmt180 61.61 25.6 15.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.406 2.282 . . . . 0.0 115.455 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.24 139.64 15.75 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.97 165.28 15.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.109 0.963 . . . . 0.0 112.228 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 139.31 58.75 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.1 p -129.92 160.47 33.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.291 1.043 . . . . 0.0 112.85 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.9 13.54 0.51 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.842 1.657 . . . . 0.0 114.662 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.66 -20.74 2.01 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.293 2.237 . . . . 0.0 110.946 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.519 HD21 ' HB3' ' A' ' 66' ' ' HIS . 28.4 t30 -158.98 72.34 3.56 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.607 1.163 . . . . 0.0 112.82 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.16 167.36 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 125.274 3.982 . . . . 0.0 116.611 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.2 mt -109.82 142.97 40.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -154.55 177.53 11.1 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.47 2.708 . . . . 0.0 107.821 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CE1' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.74 110.16 37.21 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.29 -19.62 25.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.687 2.258 . . . . 0.0 111.209 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -145.3 154.74 42.67 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 130.38 3.472 . . . . 0.0 108.221 -173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -56.49 -39.87 73.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.672 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 28.83 10.87 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 131.182 3.793 . . . . 0.0 121.005 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 15.45 57.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 1 C-N-CA 134.514 5.126 . . . . 0.0 118.129 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.06 -174.05 44.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.525 0.583 . . . . 0.0 114.084 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -67.6 29.39 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 127.547 2.339 . . . . 0.0 114.024 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.26 -6.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 129.215 3.006 . . . . 0.0 112.039 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 54' ' ' HIS . 21.0 pttm -72.72 -23.02 60.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.682 1.128 . . . . 0.0 111.616 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -73.33 138.08 45.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.349 1.059 . . . . 0.0 112.067 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 84.0 mtp -157.3 140.24 15.2 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.385 1.474 . . . . 0.0 109.854 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.519 ' HB3' HD21 ' A' ' 50' ' ' ASN . 36.9 m80 -70.78 157.61 37.76 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.79 -48.13 82.03 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.75 -0.594 . . . . 0.0 109.827 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -62.22 -45.85 91.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.643 0.777 . . . . 0.0 112.127 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.13 -43.65 97.78 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.512 -0.742 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.4 -44.6 95.53 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.215 0.916 . . . . 0.0 110.198 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.62 -30.01 62.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.57 -38.71 18.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.483 1.113 . . . . 0.0 110.991 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -62.36 -48.0 81.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.427 1.091 . . . . 0.0 111.958 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -64.19 -32.87 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.569 0.748 . . . . 0.0 111.305 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.71 -35.56 79.02 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.389 0.675 . . . . 0.0 110.84 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.0 t -63.19 -19.0 64.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 0.0 112.567 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -82.55 2.99 30.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.125 1.37 . . . . 0.0 113.045 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 79.1 14.55 1.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.107 2.163 . . . . 0.0 113.715 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.94 127.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.921 1.289 . . . . 0.0 111.853 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.04 107.05 19.44 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.485 1.114 . . . . 0.0 110.062 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.0 -13.56 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.333 1.453 . . . . 0.0 114.342 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.46 -21.73 60.37 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.814 -0.554 . . . . 0.0 111.787 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -93.91 144.52 28.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.946 1.298 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.56 9.9 2.07 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.924 3.083 . . . . 0.0 115.837 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.19 -1.72 60.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.359 1.933 . . . . 0.0 113.094 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.15 141.99 57.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.115 0.958 . . . . 0.0 112.013 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.5 44.12 1.2 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.754 1.622 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.41 123.84 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.991 1.316 . . . . 0.0 111.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -145.04 143.07 30.27 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 0.0 110.647 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.4 t -62.42 163.56 8.49 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.66 -9.04 12.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.159 1.783 . . . . 0.0 111.736 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.2 -55.96 5.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 123.813 0.845 . . . . 0.0 108.793 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.0 p -109.44 -3.6 16.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.468 0.707 . . . . 0.0 112.792 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 60.78 11.44 3.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.152 1.781 . . . . 0.0 114.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -81.96 140.59 46.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 120.078 -1.639 . . . . 0.0 110.474 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.21 145.25 44.55 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.054 2.503 . . . . 0.0 111.114 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.5 mm -100.74 107.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.0 1.32 . . . . 0.0 111.045 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.52 116.06 24.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.384 1.474 . . . . 0.0 109.915 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.34 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 CA-C-O 119.321 -0.711 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.12 153.28 41.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.762 1.281 . . . . 0.0 109.67 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 p -146.87 149.15 32.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.49 128.99 38.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.379 1.472 . . . . 0.0 111.84 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -13.01 62.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.91 -43.74 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.554 1.142 . . . . 0.0 111.498 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.78 5.5 10.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 54.44 29.49 11.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.822 2.049 . . . . 0.0 113.647 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.64 147.6 16.69 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 122.726 1.181 . . . . 0.0 111.066 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.05 166.34 5.98 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.532 1.933 . . . . 0.0 114.146 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 147.04 54.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.427 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.5 p -129.39 155.65 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.577 1.18 . . . . 0.0 112.929 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.38 -10.81 1.0 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.67 1.988 . . . . 0.0 116.272 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.0 -20.7 4.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.667 1.587 . . . . 0.0 111.644 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 66' ' ' HIS . 45.5 t30 -143.76 66.54 15.24 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.31 169.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.429 1 C-N-CA 126.167 4.578 . . . . 0.0 118.059 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.9 mt -111.97 144.92 40.53 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.781 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -150.94 168.42 24.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.712 2.805 . . . . 0.0 106.618 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -111.73 107.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.81 -13.27 21.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.355 2.704 . . . . 0.0 112.455 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t -138.17 -161.99 1.25 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.138 1.375 . . . . 0.0 112.579 -166.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 55.6 mmtt -131.27 26.63 4.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.809 2.044 . . . . 0.0 113.388 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -8.5 0.59 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.673 1.589 . . . . 0.0 114.217 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 54.6 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.588 2.355 . . . . 0.0 115.626 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.41 -156.86 20.42 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.514 1.054 . . . . 0.0 114.635 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -82.69 5.08 22.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.018 1.327 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.73 9.2 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.563 1.545 . . . . 0.0 114.216 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -90.14 -4.7 57.13 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.181 0.993 . . . . 0.0 112.663 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -94.31 147.42 23.22 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.227 1.411 . . . . 0.0 111.201 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.1 mtp -158.85 139.89 12.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.993 0.917 . . . . 0.0 110.424 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HB3' HD21 ' A' ' 50' ' ' ASN . 41.6 m80 -68.31 158.39 33.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.02 -46.75 87.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.071 -1.018 . . . . 0.0 109.015 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -54.86 -57.22 12.48 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.02 1.328 . . . . 0.0 112.988 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.68 -36.81 84.1 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.873 1.269 . . . . 0.0 111.972 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.92 -47.29 75.23 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.494 1.497 . . . . 0.0 110.694 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.63 -33.52 72.9 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.231 1.812 . . . . 0.0 112.256 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.44 -36.08 39.45 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.519 2.728 . . . . 0.0 111.898 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.3 t90 -69.4 -52.88 22.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.003 0.921 . . . . 0.0 109.806 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -58.92 -29.98 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.473 1.033 . . . . 0.0 111.204 172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.96 -39.36 76.07 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.717 -0.614 . . . . 0.0 110.498 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 m -66.03 -24.26 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.77 -1.206 . . . . 0.0 112.917 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -73.69 -5.71 42.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.954 2.102 . . . . 0.0 112.561 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.256 8.8 t30 63.15 45.27 5.24 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.321 1.449 . . . . 0.0 112.478 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.84 126.56 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.052 -1.03 . . . . 0.0 111.105 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -81.13 106.64 13.28 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.52 0.728 . . . . 0.0 111.118 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -61.54 -18.87 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 114.0 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -19.72 52.04 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.352 0.661 . . . . 0.0 112.742 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.22 141.7 43.19 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.968 -1.083 . . . . 0.0 113.545 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -84.05 6.15 5.93 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.391 3.394 . . . . 0.0 114.984 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.3 23.69 32.45 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 127.237 2.351 . . . . 0.0 112.554 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.88 163.54 30.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 112.573 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -139.34 54.17 1.71 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.147 2.179 . . . . 0.0 108.602 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.72 106.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.481 1.512 . . . . 0.0 113.294 -174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -150.58 179.26 8.32 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 178.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.8 t -66.81 173.75 3.36 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.498 1.919 . . . . 0.0 115.907 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -131.35 -6.92 3.78 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.49 2.316 . . . . 0.0 112.603 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.3 mt -81.03 -64.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.122 0.969 . . . . 0.0 108.977 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.5 p -104.26 -11.75 17.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 129.916 3.287 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 62.33 18.74 10.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.762 2.825 . . . . 0.0 114.86 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 14.4 m-85 -74.17 142.77 79.36 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.834 -1.166 . . . . 0.0 113.234 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 32.1 Cg_exo -55.81 135.48 69.77 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.306 3.337 . . . . 0.0 111.316 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.67 126.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.363 1.065 . . . . 0.0 110.511 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.89 94.45 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.384 1.873 . . . . 0.0 110.38 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 CA--C 1.546 0.812 0 C-N-CA 125.118 1.367 . . . . 0.0 112.004 -179.371 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . 0.296 . . 69.77 179.4 0.24 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.825 2.05 . . . . 0.0 112.043 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -154.36 162.86 40.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.566 1.147 . . . . 0.0 112.601 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 t -83.21 125.85 32.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.103 0.961 . . . . 0.0 111.425 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -11.67 58.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.9 1.28 . . . . 0.0 113.744 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE ' ' A' ' 65' ' ' MET . 67.6 mt -102.47 -52.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.659 1.183 . . . . 0.0 109.666 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 9.4 m -98.61 -13.78 20.21 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.254 36.2 mmt180 48.35 69.02 0.59 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 123.675 1.702 . . . . 0.0 108.41 -171.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.03 139.56 10.81 Favored Glycine 0 N--CA 1.463 0.446 0 CA-C-N 110.931 -2.849 . . . . 0.0 110.206 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.19 154.58 31.0 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.498 1.119 . . . . 0.0 110.68 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.93 18.22 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.146 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -101.21 -150.84 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.378 0.671 . . . . 0.0 111.06 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.51 12.83 8.1 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.809 2.043 . . . . 0.0 111.671 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -142.6 -12.79 0.78 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.358 2.663 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -160.11 71.97 3.08 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.14 2.176 . . . . 0.0 107.82 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.57 -165.5 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.654 3.57 . . . . 0.0 110.371 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -131.6 154.14 49.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.971 1.308 . . . . 0.0 111.399 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -154.64 -179.03 7.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.297 1.439 . . . . 0.0 110.118 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 5.9 p80 -115.58 96.42 46.16 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.821 1.248 . . . . 0.0 111.601 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 54' ' ' HIS . 72.8 Cg_endo -76.14 -13.48 19.09 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.511 3.474 . . . . 0.0 113.556 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.1 t -148.61 166.98 26.65 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.858 2.863 . . . . 0.0 105.906 -171.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -75.45 -40.2 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.243 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.311 90.9 m 40.04 -17.75 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.548 1 C-N-CA 133.001 4.52 . . . . 0.0 119.719 -170.179 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.265 6.6 tpp180 45.87 58.86 4.04 Favored 'General case' 0 N--CA 1.471 0.6 1 C-N-CA 131.873 4.069 . . . . 0.0 115.99 -179.941 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.8 -178.48 48.44 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.36 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.9 p -53.49 -32.2 49.24 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.373 1.087 . . . . 0.0 112.182 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.62 -14.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 128.708 2.803 . . . . 0.0 114.642 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -62.91 -25.99 68.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.041 0.837 . . . . 0.0 112.519 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.6 136.37 36.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.388 1.089 . . . . 0.0 112.13 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.407 ' CE ' HD11 ' A' ' 41' ' ' ILE . 87.8 mtp -159.76 153.54 22.91 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.356 2.262 . . . . 0.0 108.278 -173.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -77.43 166.09 23.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.924 0.783 . . . . 0.0 109.283 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.48 -41.42 76.18 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.088 -1.632 . . . . 0.0 111.772 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 m -75.4 -29.08 59.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.878 1.671 . . . . 0.0 114.486 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 14.0 p -78.57 -42.48 29.03 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.355 1.074 . . . . 0.0 112.113 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' CG2' ' A' ' 97' ' ' ILE 0.274 44.6 tp -52.75 -48.78 66.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.585 1.154 . . . . 0.0 111.174 169.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.19 -23.87 62.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.282 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 3.9 pt-20 -97.83 -30.34 12.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.865 . . . . 0.0 111.585 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -65.41 -49.87 67.58 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.179 1.392 . . . . 0.0 110.802 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.27 -34.83 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.063 0.847 . . . . 0.0 111.228 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.83 79.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.25 0.548 . . . . 0.0 111.171 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 t -64.66 -16.28 62.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.55 1.14 . . . . 0.0 112.523 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -84.68 9.85 12.82 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 112.729 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 80.02 -0.71 2.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.16 2.584 . . . . 0.0 115.621 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.39 125.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.275 1.43 . . . . 0.0 112.327 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -84.48 102.54 12.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 112.787 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 pt -66.92 -15.59 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 113.798 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -69.41 -19.22 63.81 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -111.74 144.47 30.71 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.506 1.122 . . . . 0.0 112.596 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.92 10.32 2.38 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 124.197 3.265 . . . . 0.0 115.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.26 10.06 59.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.727 2.108 . . . . 0.0 113.08 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 167.47 6.3 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.564 1.546 . . . . 0.0 113.819 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -136.79 38.59 2.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.13 1.772 . . . . 0.0 110.506 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.79 78.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.471 1.909 . . . . 0.0 113.438 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -134.26 140.73 46.64 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.374 1.87 . . . . 0.0 110.677 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.39 172.78 0.79 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.493 2.317 . . . . 0.0 115.477 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.3 -9.28 6.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.351 2.26 . . . . 0.0 112.913 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.9 mt -85.3 -59.17 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p -109.35 -6.66 15.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.827 2.451 . . . . 0.0 111.829 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.0 m80 63.89 21.39 12.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.997 2.119 . . . . 0.0 114.905 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.47 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 26.9 m-85 -80.4 143.28 55.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.716 -1.24 . . . . 0.0 112.846 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.92 141.22 83.43 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.835 2.357 . . . . 0.0 110.358 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.481 ' CG2' HD11 ' A' ' 70' ' ' LEU . 5.4 mm -86.53 129.1 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.437 1.095 . . . . 0.0 109.598 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.23 117.74 27.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.379 1.472 . . . . 0.0 109.526 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -176.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.386 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.04 138.47 47.91 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.858 1.329 . . . . 0.0 108.873 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 p -140.78 148.91 41.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.924 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.7 t -60.3 123.62 17.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.267 1.827 . . . . 0.0 111.938 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -69.83 -8.02 44.88 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.787 -1.196 . . . . 0.0 112.114 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 77.6 mt -91.13 -51.66 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.75 13.67 5.87 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 61.81 8.98 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.458 2.703 . . . . 0.0 115.805 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.45 146.68 36.19 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.65 161.01 31.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.844 0.857 . . . . 0.0 111.92 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' A' ' 52' ' ' LEU . . . -68.72 120.74 15.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.58 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -96.52 -170.99 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.301 0.572 . . . . 0.0 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -84.48 -24.05 29.61 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 3.68 5.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 112.083 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.91 60.91 4.67 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 126.911 2.084 . . . . 0.0 109.953 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.56 -164.47 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 125.527 4.151 . . . . 0.0 111.926 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 46' ' ' ALA . 14.5 mt -126.65 163.04 24.35 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.703 2.001 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -165.39 -169.91 1.72 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.746 2.418 . . . . 0.0 108.177 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -126.68 101.11 27.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 119.052 0.842 . . . . 0.0 111.127 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.57 ' HG2' ' H ' ' A' ' 56' ' ' CYS . 83.3 Cg_endo -72.44 -54.44 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 N-CA-C 108.264 -1.476 . . . . 0.0 108.264 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.57 ' H ' ' HG2' ' A' ' 55' ' ' PRO . 12.5 p -102.64 169.75 8.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 131.411 3.884 . . . . 0.0 112.295 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -108.16 35.3 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.436 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 11.7 m -48.11 -12.69 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 62.24 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.841 3.256 . . . . 0.0 115.335 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.0 -159.75 31.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.842 0.734 . . . . 0.0 112.234 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -64.91 -30.6 71.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.269 2.4 pp -75.4 10.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 pttm -96.4 -20.05 18.74 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.728 -0.608 . . . . 0.0 110.598 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -63.5 135.7 57.06 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.263 1.025 . . . . 0.0 108.865 171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.6 mtp -150.89 141.36 22.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.909 1.284 . . . . 0.0 108.585 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 4.0 m170 -64.52 139.99 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.187 0.994 . . . . 0.0 110.491 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.2 19.21 0.08 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.512 1.525 . . . . 0.0 112.629 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.6 p -135.75 -46.63 0.67 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.352 2.661 . . . . 0.0 109.15 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 74.1 m -62.37 -37.38 85.5 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.555 1.542 . . . . 0.0 111.404 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.73 -46.94 80.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.62 1.1 . . . . 0.0 109.814 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.18 -32.2 70.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.462 1.105 . . . . 0.0 111.501 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.06 -36.45 30.47 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.254 2.622 . . . . 0.0 111.23 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -65.35 -51.9 57.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.471 1.108 . . . . 0.0 109.315 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.25 -30.34 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 119.619 1.1 . . . . 0.0 110.836 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.875 -0.516 . . . . 0.0 110.2 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 p -67.73 -8.49 35.85 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -88.95 -1.59 58.18 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.352 1.861 . . . . 0.0 113.47 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER 71.83 17.22 5.41 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.782 1.633 . . . . 0.0 114.89 178.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.69 167.91 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.429 1.892 . . . . 0.0 111.587 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -128.18 106.95 9.4 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.575 1.55 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -18.43 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 113.674 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -76.81 -8.55 57.53 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.07 143.94 78.29 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.773 -1.204 . . . . 0.0 111.586 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.17 7.07 3.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.813 3.009 . . . . 0.0 116.757 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.62 8.39 8.28 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 127.143 2.306 . . . . 0.0 112.056 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.7 142.83 57.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.896 0.848 . . . . 0.0 112.747 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -138.01 32.95 2.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.738 1.615 . . . . 0.0 110.368 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.56 118.07 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 112.741 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -146.79 176.47 9.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 176.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.01 162.29 1.97 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.025 2.53 . . . . 0.0 113.07 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -115.38 -12.0 11.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.23 -53.94 8.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 122.817 0.447 . . . . 0.0 109.811 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.3 p -106.72 -7.56 17.22 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 53.71 14.07 0.58 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.255 1.822 . . . . 0.0 115.276 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -82.5 136.34 45.75 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.118 -1.614 . . . . 0.0 110.584 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 54.5 Cg_exo -46.74 126.2 10.5 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.233 2.622 . . . . 0.0 112.276 171.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 55' ' ' PRO 0.262 0.6 OUTLIER -78.6 111.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.1 -1.864 . . . . 0.0 109.545 -173.521 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -80.74 73.29 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.721 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 126.161 1.784 . . . . 0.0 113.411 179.461 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.45 157.93 33.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.293 0.568 . . . . 0.0 110.625 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -156.34 165.68 35.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.793 1.237 . . . . 0.0 112.496 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.25 128.03 32.79 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 110.306 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -7.81 43.17 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.6 mt -94.05 -37.63 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.089 . . . . 0.0 110.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.43 4.17 3.66 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 61.24 19.33 10.0 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.702 2.001 . . . . 0.0 113.833 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.5 145.55 22.05 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.02 164.46 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.962 0.881 . . . . 0.0 111.472 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.83 144.43 56.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.9 p -135.27 156.65 48.61 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.42 1.105 . . . . 0.0 113.692 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.94 8.82 0.23 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.753 2.421 . . . . 0.0 115.452 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -133.65 -20.07 2.05 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.13 2.172 . . . . 0.0 111.221 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -155.71 71.45 5.37 Favored Pre-proline 0 N--CA 1.445 -0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 112.125 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.42 171.36 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 125.009 3.806 . . . . 0.0 116.354 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.84 148.83 35.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.726 173.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -157.75 179.2 9.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.89 2.076 . . . . 0.0 108.393 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -120.74 112.65 33.67 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.318 0.647 . . . . 0.0 110.603 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -12.19 14.39 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.784 2.989 . . . . 0.0 112.218 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.8 t -133.36 -153.39 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.424 1.489 . . . . 0.0 112.468 -167.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 5.4 tmtt? -135.89 14.07 3.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.193 2.197 . . . . 0.0 115.028 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.9 m -46.66 -23.52 0.42 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.869 2.468 . . . . 0.0 115.222 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp-105 65.39 162.92 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.18 2.992 . . . . 0.0 114.282 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 -164.9 29.5 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.508 -0.745 . . . . 0.0 113.029 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.3 m -61.08 -34.57 75.13 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.303 -1.116 . . . . 0.0 113.185 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.76 1.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -83.21 -21.69 33.37 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.218 -0.926 . . . . 0.0 112.515 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.48 150.66 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.022 0.915 . . . . 0.0 110.636 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mtp -158.21 141.46 15.07 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.35 1.46 . . . . 0.0 109.793 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -70.53 151.4 45.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -56.28 -49.56 73.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.114 -0.366 . . . . 0.0 110.276 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -64.27 -44.32 92.11 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.46 -46.68 87.41 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.312 -0.867 . . . . 0.0 112.243 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.83 -45.44 74.45 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.179 0.9 . . . . 0.0 109.728 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.22 -25.64 65.78 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -89.78 -32.25 17.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.323 0.965 . . . . 0.0 111.868 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.83 -57.92 10.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.969 1.308 . . . . 0.0 110.618 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.95 -23.98 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.872 1.269 . . . . 0.0 111.65 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.14 58.63 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 m -93.87 5.73 50.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.918 1.287 . . . . 0.0 111.817 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -108.18 9.13 28.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.728 2.411 . . . . 0.0 113.673 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.253 10.3 t30 63.69 42.62 6.18 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.713 1.205 . . . . 0.0 112.387 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.47 152.73 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.593 1.557 . . . . 0.0 110.102 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -123.74 111.55 16.29 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.974 1.309 . . . . 0.0 110.457 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.4 pt -60.88 -19.73 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.247 1.419 . . . . 0.0 113.827 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.9 t -78.67 -14.85 59.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -93.02 143.58 27.03 Favored Pre-proline 0 N--CA 1.478 0.942 0 O-C-N 121.177 -0.952 . . . . 0.0 112.629 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.11 5.09 6.47 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.849 3.033 . . . . 0.0 115.638 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.62 10.75 38.68 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.955 2.217 . . . . 0.0 112.727 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.37 156.47 29.11 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.034 0.934 . . . . 0.0 113.145 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.04 45.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.409 1.484 . . . . 0.0 110.746 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.93 102.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.743 1.217 . . . . 0.0 112.575 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.9 tttm -143.66 142.1 30.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.362 1.465 . . . . 0.0 112.378 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.82 178.33 0.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.447 2.699 . . . . 0.0 115.174 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -132.19 -12.08 3.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.755 2.422 . . . . 0.0 112.727 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -78.33 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 122.119 0.961 . . . . 0.0 109.213 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.75 -8.6 17.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.916 2.886 . . . . 0.0 111.264 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.448 ' O ' ' HE2' ' A' ' 89' ' ' LYS 0.364 0.0 OUTLIER 63.34 18.97 11.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.643 3.177 . . . . 0.0 115.366 -175.883 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 16.8 m-85 -75.7 145.8 79.05 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 120.477 -1.389 . . . . 0.0 114.329 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -61.74 141.61 91.12 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.214 1.943 . . . . 0.0 109.813 170.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -86.42 117.92 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 125.17 1.388 . . . . 0.0 108.143 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -114.38 94.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.427 1.491 . . . . 0.0 111.845 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 126.037 1.735 . . . . 0.0 112.807 178.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.528 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 158.62 36.06 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.7 p -121.11 163.9 17.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.8 t -80.62 133.31 35.73 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 120.835 -1.166 . . . . 0.0 108.093 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -21.77 66.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.49 1.041 . . . . 0.0 113.021 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.72 -49.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.749 1.22 . . . . 0.0 110.216 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -88.23 -23.73 23.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 58.91 36.91 24.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.376 1.47 . . . . 0.0 108.893 -167.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.0 134.49 10.83 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.931 1.253 . . . . 0.0 112.974 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -71.58 142.62 50.01 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.18 148.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.625 1.57 . . . . 0.0 114.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -128.22 179.61 5.52 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.202 1.001 . . . . 0.0 111.214 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.84 -32.02 68.92 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.98 -31.37 13.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.644 1.978 . . . . 0.0 110.704 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -123.62 65.56 33.84 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.63 167.16 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.261 1.974 . . . . 0.0 112.186 162.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.9 mt -117.83 146.62 43.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.759 -2.019 . . . . 0.0 112.153 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -149.39 163.53 37.49 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.406 3.082 . . . . 0.0 105.712 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -114.02 104.33 54.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.54 -24.72 35.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.282 1.988 . . . . 0.0 113.174 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' HB2' HD13 ' A' ' 97' ' ' ILE 0.258 0.5 OUTLIER -139.96 150.53 44.6 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 127.262 2.225 . . . . 0.0 107.779 -168.876 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.22 -46.7 62.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 117.112 -1.423 . . . . 0.0 111.734 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 68.2 m 32.73 -12.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 1 C-N-CA 133.195 4.598 . . . . 0.0 120.901 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 72.14 149.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 131.002 3.721 . . . . 0.0 113.941 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.41 -142.55 48.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.74 1.162 . . . . 0.0 114.679 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -95.92 -7.05 37.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 112.891 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.0 24.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 111.931 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -105.82 -26.21 11.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.513 1.525 . . . . 0.0 112.374 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -77.48 152.45 34.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.139 1.376 . . . . 0.0 112.226 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 90.3 mtp -158.74 144.75 16.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.328 0.651 . . . . 0.0 112.294 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -70.8 152.45 43.74 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -56.16 -49.19 74.69 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.204 -0.935 . . . . 0.0 110.874 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -54.71 -50.04 69.27 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.411 1.084 . . . . 0.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.53 -44.16 93.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.72 -48.0 73.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.06 0.845 . . . . 0.0 111.44 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -55.7 -30.86 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.603 1.961 . . . . 0.0 112.949 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -91.99 -38.84 12.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.088 1.755 . . . . 0.0 112.156 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 80.2 t90 -58.62 -45.19 89.74 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 123.819 0.848 . . . . 0.0 111.015 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.36 -26.08 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.176 0.898 . . . . 0.0 112.213 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.63 62.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.788 -1.195 . . . . 0.0 111.43 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.7 p -84.5 11.18 9.14 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.527 -0.733 . . . . 0.0 112.502 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -115.03 8.39 15.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.701 1.6 . . . . 0.0 112.894 -174.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.32 0.0 OUTLIER 79.36 38.03 0.13 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.911 2.084 . . . . 0.0 112.67 178.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.58 145.28 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.437 1.095 . . . . 0.0 113.54 -171.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -139.54 102.84 4.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 110.024 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -12.26 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.258 1.423 . . . . 0.0 114.485 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -75.59 -16.34 60.25 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.726 -0.609 . . . . 0.0 111.972 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -106.56 142.21 24.46 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.103 1.361 . . . . 0.0 111.6 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.97 29.27 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.548 3.499 . . . . 0.0 114.626 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.15 20.19 6.32 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.882 2.182 . . . . 0.0 111.724 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.09 163.69 24.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 122.353 1.073 . . . . 0.0 113.637 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -143.92 41.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.85 2.06 . . . . 0.0 109.099 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.285 11.1 p -68.36 65.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.685 2.394 . . . . 0.0 115.447 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -133.53 144.88 49.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.401 2.281 . . . . 0.0 110.64 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -67.95 173.65 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.656 2.383 . . . . 0.0 115.256 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -129.12 -10.69 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.862 2.465 . . . . 0.0 112.978 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -78.76 -55.76 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.903 0.858 . . . . 0.0 109.434 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.9 p -115.45 -7.46 12.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 129.06 2.944 . . . . 0.0 111.85 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 66.9 20.7 10.51 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.078 2.551 . . . . 0.0 114.861 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.8 m-85 -85.14 145.81 43.91 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 113.487 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.24 135.96 49.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.53 2.154 . . . . 0.0 109.796 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 56' ' ' CYS . 11.4 mm -77.76 141.74 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.507 1.123 . . . . 0.0 109.817 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -133.56 120.58 20.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.243 1.417 . . . . 0.0 111.456 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -178.824 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 CA-C-O 119.452 -0.638 . . . . 0.0 114.02 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.69 46.69 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.477 1.139 . . . . 0.0 109.749 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -143.36 149.34 37.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.125 1.37 . . . . 0.0 113.01 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -57.51 129.25 40.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.663 1.585 . . . . 0.0 112.214 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -7.97 53.51 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.455 -1.403 . . . . 0.0 113.827 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.6 mt -96.17 -44.09 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 117.724 -1.132 . . . . 0.0 109.627 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.3 p -128.07 9.67 6.3 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 55.17 19.58 2.94 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.652 2.381 . . . . 0.0 114.499 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.2 149.28 29.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.72 163.63 24.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.124 0.962 . . . . 0.0 111.175 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 129.44 41.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -99.02 -146.67 0.33 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.335 0.588 . . . . 0.0 112.046 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -130.7 13.49 5.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.561 2.344 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -145.25 -18.01 0.49 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.207 2.603 . . . . 0.0 111.591 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 66' ' ' HIS . 47.3 t30 -153.84 68.59 6.22 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 125.043 1.337 . . . . 0.0 111.883 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.67 179.51 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.43 1 C-N-CA 125.466 4.111 . . . . 0.0 116.263 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.52 154.01 32.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.459 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.17 -177.62 6.4 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.813 3.245 . . . . 0.0 106.311 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -128.96 117.62 19.3 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.585 0.63 . . . . 0.0 109.794 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 56' ' ' CYS . 33.0 Cg_endo -82.74 -9.93 10.82 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.815 3.01 . . . . 0.0 113.015 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 2.0 t -141.01 -162.87 1.43 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.769 1.228 . . . . 0.0 111.327 -166.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -129.21 24.38 5.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.258 1.823 . . . . 0.0 113.352 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -48.25 -21.53 0.52 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.849 2.06 . . . . 0.0 113.816 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 63.05 152.85 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 129.391 3.077 . . . . 0.0 115.549 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.4 -164.89 40.68 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.653 1.121 . . . . 0.0 114.752 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.7 m -59.02 6.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.88 7.15 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 126.491 1.916 . . . . 0.0 112.386 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -82.19 -23.09 35.68 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.894 . . . . 0.0 111.977 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -78.07 145.75 35.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.058 1.343 . . . . 0.0 111.289 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 91.6 mtp -155.9 139.22 15.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.47 1.108 . . . . 0.0 109.353 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.423 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.5 m80 -70.1 157.51 37.43 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.99 -50.59 72.78 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.391 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.3 t -58.69 -36.92 74.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.303 1.041 . . . . 0.0 113.074 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.51 -44.77 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.439 -0.788 . . . . 0.0 112.106 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.41 -41.75 85.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.712 1.596 . . . . 0.0 109.839 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.36 -33.52 72.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.906 1.682 . . . . 0.0 113.401 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.86 -27.4 26.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.533 0.733 . . . . 0.0 111.819 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.91 -57.58 4.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.687 1.595 . . . . 0.0 111.095 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 81' ' ' ILE . 33.3 m -55.47 -23.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.288 0.635 . . . . 0.0 111.105 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.51 30.77 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.812 0.445 . . . . 0.0 112.066 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -72.12 -23.85 61.38 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.356 -1.465 . . . . 0.0 111.399 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -77.61 -2.63 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.519 2.728 . . . . 0.0 112.389 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.42 47.11 7.0 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.363 1.465 . . . . 0.0 113.487 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.08 118.81 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.558 -1.339 . . . . 0.0 111.741 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -78.44 97.26 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.019 0.928 . . . . 0.0 111.477 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 74' ' ' VAL . 19.8 pt -63.66 -16.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.289 1.436 . . . . 0.0 113.68 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -75.97 -14.21 60.24 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -81.34 139.46 48.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 O-C-N 120.978 -1.076 . . . . 0.0 112.036 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.88 4.41 7.06 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.894 3.062 . . . . 0.0 115.949 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.39 18.27 5.79 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 127.789 2.614 . . . . 0.0 111.615 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.09 158.71 10.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.948 0.899 . . . . 0.0 113.31 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -120.23 37.17 4.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.5 1.52 . . . . 0.0 111.89 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.64 101.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.418 1.487 . . . . 0.0 110.734 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -147.95 143.73 27.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.673 1.189 . . . . 0.0 112.796 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.6 t -66.37 177.42 1.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.439 2.696 . . . . 0.0 115.169 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -131.32 -10.63 3.67 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.426 2.29 . . . . 0.0 112.65 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.36 -61.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.245 -0.909 . . . . 0.0 109.236 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.7 p -106.45 -9.7 16.58 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.348 2.659 . . . . 0.0 111.194 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.4 t60 63.74 23.53 13.5 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.939 2.495 . . . . 0.0 114.516 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 16.7 m-85 -79.41 145.04 62.92 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.413 -1.429 . . . . 0.0 113.132 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.28 135.86 56.56 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.012 2.475 . . . . 0.0 110.49 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.9 mm -79.29 113.77 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.892 2.077 . . . . 0.0 108.514 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -126.19 97.56 5.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.753 2.021 . . . . 0.0 110.924 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 CA--C 1.557 1.215 0 C-N-CA 130.317 3.447 . . . . 0.0 117.835 -177.051 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.272 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.21 168.3 19.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.119 0.968 . . . . 0.0 110.959 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.7 p -150.81 153.53 35.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.755 1.222 . . . . 0.0 113.485 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.94 133.09 54.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.145 1.378 . . . . 0.0 110.084 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -71.09 -13.25 61.9 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.185 -0.947 . . . . 0.0 113.032 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 69' ' ' CYS . 73.5 mt -94.01 -41.57 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.296 1.039 . . . . 0.0 111.046 -175.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.26 13.01 4.22 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 55.15 17.46 1.98 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.932 2.093 . . . . 0.0 114.353 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.46 154.6 42.47 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.59 164.58 19.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.393 1.096 . . . . 0.0 110.111 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.82 25.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -92.01 -138.11 0.17 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.657 0.265 . . . . 0.0 111.49 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -130.71 5.38 4.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.776 2.03 . . . . 0.0 111.334 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.34 -10.01 0.96 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.694 3.198 . . . . 0.0 110.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -140.86 61.98 16.2 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 127.271 2.228 . . . . 0.0 114.162 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.1 159.97 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.893 2.395 . . . . 0.0 114.171 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.61 143.0 36.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 112.452 -2.158 . . . . 0.0 110.492 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -156.16 176.93 12.03 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.48 3.112 . . . . 0.0 106.612 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -124.04 117.85 26.96 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 118.253 0.479 . . . . 0.0 110.057 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -81.47 -7.58 12.71 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.72 3.614 . . . . 0.0 112.549 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 30.3 p -152.49 159.25 43.35 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.172 1.789 . . . . 0.0 113.055 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HB2' ' CD2' ' A' ' 95' ' ' TYR . 6.2 mtmm -77.12 30.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.264 1.826 . . . . 0.0 113.868 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.32 -14.9 1.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 27.09 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 130.559 3.544 . . . . 0.0 115.826 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.73 30.19 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.853 1.692 . . . . 0.0 112.147 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -62.61 6.43 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.75 6.07 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.549 2.34 . . . . 0.0 112.392 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -78.19 -22.5 48.51 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.081 -1.012 . . . . 0.0 112.002 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -80.29 145.99 31.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.172 1.389 . . . . 0.0 112.26 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.7 mtp -154.77 139.19 16.77 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.041 0.936 . . . . 0.0 110.485 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 15.7 m170 -66.2 148.07 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.76 -35.3 77.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 122.011 -0.431 . . . . 0.0 110.837 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -79.21 -28.83 42.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 88.0 m -81.07 -39.78 25.19 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.119 0.967 . . . . 0.0 111.219 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.21 -44.18 92.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.966 1.257 . . . . 0.0 109.277 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.16 -33.91 65.68 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.635 1.174 . . . . 0.0 113.597 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.5 pt-20 -88.99 -32.7 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.063 0.545 . . . . 0.0 112.244 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -62.24 -49.3 76.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.859 0.864 . . . . 0.0 110.097 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.62 -32.42 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.784 0.72 . . . . 0.0 112.199 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.98 -17.74 62.64 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.557 -0.714 . . . . 0.0 111.747 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -86.26 2.26 47.84 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.247 -0.908 . . . . 0.0 111.891 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -105.0 4.74 31.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.583 1.953 . . . . 0.0 114.046 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 62.98 44.85 5.71 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.566 1.146 . . . . 0.0 112.298 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.72 121.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.64 1.176 . . . . 0.0 110.697 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -80.13 106.91 12.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.283 0.633 . . . . 0.0 109.926 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.9 pt -60.85 -18.02 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.965 1.306 . . . . 0.0 113.907 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -82.09 -13.5 57.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -88.63 141.02 29.87 Favored Pre-proline 0 N--CA 1.481 1.083 0 O-C-N 121.027 -1.046 . . . . 0.0 112.682 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.08 0.83 9.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.03 3.153 . . . . 0.0 116.177 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.49 8.53 34.96 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.957 2.218 . . . . 0.0 112.736 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 168.3 15.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.775 1.23 . . . . 0.0 113.555 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -134.2 52.46 2.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.006 1.723 . . . . 0.0 109.979 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.36 76.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.135 1.774 . . . . 0.0 111.477 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . 0.269 18.5 ttmt -131.04 151.1 51.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.832 2.053 . . . . 0.0 111.631 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 15.3 t -63.98 165.78 8.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 0.0 113.731 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -120.7 3.58 10.63 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.396 1.878 . . . . 0.0 111.911 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -106.87 -55.58 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.513 1.525 . . . . 0.0 108.82 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 16.6 p -105.1 -4.82 21.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 60.77 10.43 2.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.326 2.25 . . . . 0.0 116.027 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 75.2 m-85 -92.44 146.32 32.23 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.464 -1.397 . . . . 0.0 111.611 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -45.33 142.98 5.81 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.853 3.036 . . . . 0.0 113.208 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -104.56 122.77 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.68 1.592 . . . . 0.0 110.596 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.72 122.87 44.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 126.235 1.814 . . . . 0.0 113.977 179.848 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.489 0 N-CA-C 114.141 0.416 . . . . 0.0 114.141 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.61 134.94 40.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.954 0.877 . . . . 0.0 110.059 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.4 p -144.16 153.53 42.21 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 111.488 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.0 t -63.72 127.1 29.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.504 1.122 . . . . 0.0 112.005 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -4.8 22.64 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.0 mt -103.57 -45.24 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.123 1.369 . . . . 0.0 110.226 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -123.69 5.08 8.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.32 31.5 mmt180 50.73 32.41 6.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.17 2.188 . . . . 0.0 115.632 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.3 148.1 18.86 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.29 168.4 18.4 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.834 1.653 . . . . 0.0 112.407 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.67 150.03 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.664 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.4 p -139.18 172.13 13.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.502 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -61.83 -21.93 65.05 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -119.63 -20.94 7.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.428 1.491 . . . . 0.0 112.281 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.97 66.51 47.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.193 1.797 . . . . 0.0 110.499 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.03 -167.93 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 1 C-N-CA 125.435 4.09 . . . . 0.0 111.113 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.7 mt -132.77 155.57 48.67 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.724 1.61 . . . . 0.0 111.868 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -153.92 -179.61 8.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.786 2.434 . . . . 0.0 108.122 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -129.24 110.42 18.03 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.579 0.752 . . . . 0.0 111.146 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.63 -17.42 12.61 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.577 2.851 . . . . 0.0 113.57 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 4.1 t -133.55 -161.55 1.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 112.067 -165.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 4.3 mptp? -123.14 12.79 9.62 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.734 1.614 . . . . 0.0 114.717 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -44.62 -25.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.222 2.609 . . . . 0.0 116.703 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 65.18 159.36 0.11 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.933 3.293 . . . . 0.0 115.599 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.47 -157.63 19.34 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.09 0.852 . . . . 0.0 113.599 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.1 p -59.48 -18.41 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.5 pt -84.79 -7.57 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.755 1.161 . . . . 0.0 113.601 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -76.06 -18.74 59.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.154 1.343 . . . . 0.0 113.535 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -84.53 143.34 29.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.359 1.064 . . . . 0.0 112.285 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 81.6 mtp -156.62 143.03 18.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.363 1.465 . . . . 0.0 109.793 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -76.35 154.51 34.92 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.14 -46.45 82.69 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.272 -0.892 . . . . 0.0 111.911 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -64.36 -42.97 95.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.002 0.921 . . . . 0.0 111.949 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.3 m -61.79 -43.88 97.97 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.173 -0.955 . . . . 0.0 111.751 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.71 -47.88 83.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.88 0.764 . . . . 0.0 109.811 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.08 -29.49 60.65 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.97 -38.33 18.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.415 1.086 . . . . 0.0 111.577 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.78 -48.19 77.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.199 1.0 . . . . 0.0 111.731 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.89 -28.96 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.656 -0.653 . . . . 0.0 111.691 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.52 71.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.013 0.525 . . . . 0.0 111.429 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 p -66.91 -14.24 62.57 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.744 -1.223 . . . . 0.0 113.305 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.31 3.66 20.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.689 1.596 . . . . 0.0 112.796 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.254 10.2 t30 64.47 42.73 4.88 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.35 147.48 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.069 1.348 . . . . 0.0 110.547 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -125.89 111.57 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.269 1.428 . . . . 0.0 111.083 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.98 -18.75 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.014 1.326 . . . . 0.0 113.777 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -77.28 -7.62 56.27 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.67 150.94 44.81 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.64 1.576 . . . . 0.0 112.397 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.9 14.96 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.128 3.219 . . . . 0.0 115.89 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.95 4.3 38.87 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.511 2.005 . . . . 0.0 112.757 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 145.45 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.352 1.061 . . . . 0.0 113.18 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.03 40.94 0.73 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.309 1.844 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -66.26 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.568 1.547 . . . . 0.0 113.169 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.5 tttm -145.74 146.62 31.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.292 1.837 . . . . 0.0 111.378 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -63.4 175.72 0.95 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.599 2.36 . . . . 0.0 115.903 -174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -130.42 -4.06 4.29 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.599 2.36 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.6 -66.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.011 -1.055 . . . . 0.0 108.437 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.27 -8.84 21.76 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.206 2.602 . . . . 0.0 110.947 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.456 ' O ' ' HE2' ' A' ' 89' ' ' LYS . 72.3 m80 64.07 24.0 13.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.162 2.185 . . . . 0.0 114.38 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 18.7 m-85 -79.72 145.75 63.17 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -61.03 142.28 96.9 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.853 2.369 . . . . 0.0 110.045 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 56' ' ' CYS . 6.9 mm -90.48 130.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 124.662 1.185 . . . . 0.0 111.306 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -119.05 107.92 14.09 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.024 1.729 . . . . 0.0 111.49 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.548 0.895 0 C-N-CA 126.527 1.931 . . . . 0.0 113.611 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.015 0 CA-C-O 118.229 -1.317 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.26 57.76 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.63 2.215 . . . . 0.0 111.18 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.9 p -145.42 152.31 39.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.395 0.678 . . . . 0.0 112.739 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.74 131.84 35.52 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.635 1.174 . . . . 0.0 110.62 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.11 64.7 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.739 -1.226 . . . . 0.0 111.503 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -92.49 -42.01 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.339 1.055 . . . . 0.0 110.57 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . 0.257 29.2 p -124.79 9.26 8.23 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 50.53 29.01 3.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.284 2.233 . . . . 0.0 112.888 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.43 140.22 14.88 Favored Glycine 0 N--CA 1.467 0.74 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.269 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.1 171.0 0.78 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.16 1.384 . . . . 0.0 114.718 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 141.15 57.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.69 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 p -130.08 155.36 46.3 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.065 0.936 . . . . 0.0 112.695 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.03 -11.79 0.1 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -128.28 -15.98 4.54 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.537 1.535 . . . . 0.0 112.921 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.532 HD21 ' HB3' ' A' ' 66' ' ' HIS . 36.3 t30 -150.69 74.62 8.66 Favored Pre-proline 0 N--CA 1.44 -0.93 0 C-N-CA 125.511 1.524 . . . . 0.0 109.483 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.22 -158.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.312 4.008 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mt -129.8 156.67 43.96 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 123.037 1.398 . . . . 0.0 111.532 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -154.04 177.14 11.39 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 129.463 3.105 . . . . 0.0 107.739 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -124.63 98.1 37.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.724 0.809 . . . . 0.0 108.86 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.25 -15.45 20.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.806 2.338 . . . . 0.0 112.732 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 0.4 OUTLIER -151.85 157.39 41.83 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 124.262 1.025 . . . . 0.0 112.433 -169.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -85.28 20.99 1.82 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.4 m -47.97 -14.39 0.05 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 126.582 1.953 . . . . 0.0 114.785 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttp-105 58.25 173.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.231 3.412 . . . . 0.0 115.26 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.63 -161.59 26.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.775 -1.203 . . . . 0.0 112.981 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.7 p -65.04 -24.15 67.4 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.494 -1.003 . . . . 0.0 113.194 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 pt -74.9 -3.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -74.17 -20.07 60.34 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.486 1.039 . . . . 0.0 112.684 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -90.3 139.93 30.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.433 1.093 . . . . 0.0 113.661 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 mtt -151.83 142.94 23.21 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.563 0.745 . . . . 0.0 111.973 -174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.532 ' HB3' HD21 ' A' ' 50' ' ' ASN . 23.5 m170 -70.1 149.5 47.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.177 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.53 -33.98 77.17 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.719 -0.613 . . . . 0.0 110.681 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.1 m -73.82 -42.94 60.17 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.758 -0.589 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 84.0 m -64.59 -43.5 93.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.916 1.287 . . . . 0.0 112.524 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.14 -44.05 97.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.386 0.994 . . . . 0.0 110.088 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.02 -28.84 59.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.257 1.023 . . . . 0.0 113.531 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -91.05 -37.0 13.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.281 1.432 . . . . 0.0 111.166 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.451 ' CE2' ' HE3' ' A' ' 77' ' ' LYS . 88.8 t90 -60.55 -51.74 68.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.49 -34.14 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.422 -0.799 . . . . 0.0 111.437 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.51 78.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.983 -0.448 . . . . 0.0 111.408 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -71.02 -30.87 67.21 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.967 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HE3' ' CE2' ' A' ' 73' ' ' TRP . 56.1 mmtt -81.05 8.38 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.496 2.718 . . . . 0.0 113.736 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER 75.68 16.51 2.48 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.4 2.28 . . . . 0.0 115.528 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.73 139.46 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.079 1.352 . . . . 0.0 111.41 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -130.08 112.97 13.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 0.0 112.998 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.2 pt -67.49 -17.87 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 113.94 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -71.77 -13.04 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.12 143.66 27.19 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.698 1.199 . . . . 0.0 111.53 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.68 16.77 1.23 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.049 3.166 . . . . 0.0 116.272 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.25 7.03 25.0 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.536 2.017 . . . . 0.0 112.805 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.8 55.81 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.286 1.034 . . . . 0.0 113.286 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.5 41.08 1.59 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.392 1.877 . . . . 0.0 110.141 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 88' ' ' VAL . 2.0 t -49.67 107.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.712 2.405 . . . . 0.0 114.13 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -148.38 144.95 27.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.147 1.779 . . . . 0.0 110.949 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 43.1 t -66.56 170.87 5.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.548 2.339 . . . . 0.0 114.715 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.79 -17.8 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.193 2.597 . . . . 0.0 111.808 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.2 -55.69 11.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.105 . . . . 0.0 109.578 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.9 p -115.85 -7.07 12.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.977 0.511 . . . . 0.0 111.894 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 68.89 18.03 8.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.518 2.327 . . . . 0.0 114.678 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.8 m-85 -82.75 145.31 50.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 120.817 -1.177 . . . . 0.0 111.966 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.37 132.19 39.86 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.577 2.185 . . . . 0.0 109.85 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -85.22 116.02 27.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 126.255 1.822 . . . . 0.0 108.854 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -114.26 111.94 22.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -170.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 126.994 2.118 . . . . 0.0 111.915 176.047 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.494 0 CA-C-O 119.001 -0.888 . . . . 0.0 114.92 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.4 147.93 30.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.309 1.555 . . . . 0.0 109.962 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 57.1 p -141.49 145.36 35.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.033 1.333 . . . . 0.0 112.652 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.551 ' HG ' ' HG ' ' A' ' 69' ' ' CYS . 18.8 t -58.33 140.17 53.95 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.941 1.296 . . . . 0.0 114.246 174.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.1 mt -99.22 -48.16 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 110.502 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.4 m -107.38 -4.64 18.37 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 49.34 31.23 3.67 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.234 2.214 . . . . 0.0 112.385 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.64 141.59 16.18 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.297 0.951 . . . . 0.0 112.627 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.76 160.43 11.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.922 1.289 . . . . 0.0 113.554 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.48 144.26 51.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.519 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.7 p -128.35 157.69 40.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.313 1.054 . . . . 0.0 112.636 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -57.72 -11.59 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.63 -21.77 5.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.432 1.493 . . . . 0.0 111.475 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.602 HD21 ' HB3' ' A' ' 66' ' ' HIS . 35.6 t30 -141.02 67.48 27.14 Favored Pre-proline 0 N--CA 1.444 -0.747 0 C-N-CA 124.118 0.967 . . . . 0.0 113.49 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -49.75 167.74 0.18 Allowed 'Trans proline' 0 C--O 1.235 0.371 1 C-N-CA 125.5 4.133 . . . . 0.0 116.928 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.62 142.33 44.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.177 173.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -152.75 -177.49 6.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.671 1.988 . . . . 0.0 108.765 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -114.99 108.23 48.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.841 0.856 . . . . 0.0 110.354 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 97' ' ' ILE . 87.4 Cg_endo -75.85 -18.82 16.67 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.622 2.881 . . . . 0.0 112.764 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.281 5.1 t -141.15 -161.33 1.2 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 129.678 3.191 . . . . 0.0 106.889 -167.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -95.11 -41.58 9.03 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.255 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.321 6.2 m 40.97 -5.47 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 1 C-N-CA 132.309 4.244 . . . . 0.0 119.298 -173.26 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 45.52 67.9 0.66 Allowed 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 131.78 4.032 . . . . 0.0 117.743 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.93 -174.19 31.01 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 125.942 1.734 . . . . 0.0 111.844 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -55.83 -23.92 33.34 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.215 1.008 . . . . 0.0 111.854 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -61.98 -14.62 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 113.498 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -70.36 -5.91 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.768 -1.207 . . . . 0.0 114.02 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -97.48 138.95 34.12 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.727 1.211 . . . . 0.0 110.724 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 83.3 mtp -158.35 145.89 18.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.606 1.562 . . . . 0.0 109.684 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.602 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.5 m80 -69.99 151.53 45.47 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.26 -38.88 77.81 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.749 -0.594 . . . . 0.0 110.712 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -81.32 -31.62 33.44 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.551 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -76.03 -41.05 52.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.411 1.101 . . . . 0.0 112.245 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.86 -49.85 74.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.708 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 mt -55.14 -35.39 64.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.423 1.089 . . . . 0.0 112.748 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.2 pt-20 -81.49 -37.67 27.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.216 0.462 . . . . 0.0 112.096 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -62.91 -51.02 68.56 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.681 -0.637 . . . . 0.0 110.715 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.78 -31.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.938 0.79 . . . . 0.0 112.331 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.66 -20.21 61.29 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.088 -0.382 . . . . 0.0 111.868 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -80.57 -5.02 56.16 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.804 -1.185 . . . . 0.0 111.867 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -92.11 9.85 31.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.611 1.964 . . . . 0.0 114.049 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 79.61 9.3 1.56 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.816 2.046 . . . . 0.0 113.844 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mt -109.89 124.22 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 111.342 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -87.4 82.33 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.174 0.988 . . . . 0.0 111.099 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -9.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 113.818 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.7 t -65.9 -25.77 67.32 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.15 -0.344 . . . . 0.0 110.977 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -92.52 143.55 27.4 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.521 1.128 . . . . 0.0 110.545 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.47 9.24 2.62 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.687 2.925 . . . . 0.0 116.624 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.3 -9.44 69.88 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.524 1.535 . . . . 0.0 113.32 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.59 150.2 49.1 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.203 1.001 . . . . 0.0 112.741 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.57 49.7 1.22 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.137 1.775 . . . . 0.0 109.839 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.01 131.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 126.234 1.814 . . . . 0.0 111.982 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -142.87 144.16 32.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.962 1.705 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 17.5 t -59.04 169.54 1.04 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.974 2.109 . . . . 0.0 115.743 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -127.76 -8.09 5.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.541 2.736 . . . . 0.0 112.041 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.3 mt -89.91 -56.28 5.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 124.022 0.929 . . . . 0.0 108.784 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.03 -1.76 11.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.017 0.927 . . . . 0.0 111.708 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 70.6 m80 61.31 16.74 7.64 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.896 2.078 . . . . 0.0 115.164 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.514 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.9 m-85 -77.03 144.24 71.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 120.848 -1.157 . . . . 0.0 111.297 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -57.67 148.82 71.8 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.402 2.068 . . . . 0.0 109.988 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 55' ' ' PRO . 2.4 mt -116.45 135.55 56.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 124.078 0.951 . . . . 0.0 110.78 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -121.96 125.59 46.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.216 1.006 . . . . 0.0 110.842 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -173.032 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 112.855 -0.098 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.13 162.93 27.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.482 0.713 . . . . 0.0 112.071 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -149.87 160.78 43.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.033 1.333 . . . . 0.0 113.55 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.1 t -69.12 125.16 25.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.18 1.792 . . . . 0.0 112.822 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -10.32 56.06 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.259 -0.901 . . . . 0.0 113.136 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 mt -91.77 -46.18 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 125.097 1.359 . . . . 0.0 109.668 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -125.73 3.22 7.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 59.25 31.27 21.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.736 2.015 . . . . 0.0 113.815 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 144.89 17.14 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.87 169.32 10.01 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.159 0.981 . . . . 0.0 111.685 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.74 53.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.8 p -114.94 168.56 9.8 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.112 0.958 . . . . 0.0 111.797 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.56 -19.31 37.0 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -121.49 -17.85 7.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 110.92 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.57 58.0 16.1 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.15 145.31 26.45 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.506 2.137 . . . . 0.0 111.919 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.38 175.58 9.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.136 -2.302 . . . . 0.0 109.92 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.4 175.47 2.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.215 2.206 . . . . 0.0 109.035 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -112.16 95.46 30.36 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.507 1.123 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.446 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.4 Cg_endo -71.08 -30.4 16.35 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.689 2.26 . . . . 0.0 111.688 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.9 t -135.37 -178.99 5.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.836 2.854 . . . . 0.0 110.446 -171.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.62 36.13 4.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.639 1.976 . . . . 0.0 113.419 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.5 m -51.6 -8.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.634 2.374 . . . . 0.0 116.519 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 65.64 175.5 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.875 2.07 . . . . 0.0 114.493 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.12 -150.5 1.01 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.478 1.513 . . . . 0.0 115.538 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -75.47 -1.79 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.788 1.235 . . . . 0.0 113.872 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.7 pt -97.78 -0.61 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.915 1.286 . . . . 0.0 113.91 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -83.61 5.57 23.86 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.47 143.24 45.26 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.673 1.589 . . . . 0.0 109.281 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.7 mtp -154.32 140.3 18.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.641 1.176 . . . . 0.0 111.084 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 7.2 m170 -70.22 144.57 51.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.049 0.94 . . . . 0.0 110.091 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.98 12.95 1.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 113.545 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -129.84 -40.38 1.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.129 1.372 . . . . 0.0 109.048 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 83.7 m -59.69 -47.85 83.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.641 1.176 . . . . 0.0 111.332 172.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -56.0 -44.33 78.54 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.275 0.63 . . . . 0.0 110.381 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.17 -22.62 61.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.856 1.262 . . . . 0.0 112.869 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.63 -39.89 8.87 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.828 1.651 . . . . 0.0 111.321 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.407 ' CZ2' ' HE2' ' A' ' 77' ' ' LYS . 91.9 t90 -56.38 -47.55 78.71 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.099 1.36 . . . . 0.0 111.416 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.9 m -66.7 -25.34 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 119.141 0.882 . . . . 0.0 111.817 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.77 -38.42 76.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.115 -0.366 . . . . 0.0 110.591 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 p -69.06 -18.64 64.03 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.068 -1.02 . . . . 0.0 113.605 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HE2' ' CZ2' ' A' ' 73' ' ' TRP . 35.7 mmtm -75.32 6.15 4.81 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.063 2.145 . . . . 0.0 113.619 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.262 9.3 t30 66.07 43.96 2.78 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.599 1.56 . . . . 0.0 111.601 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -138.48 140.79 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 109.312 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -117.9 99.58 7.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.411 1.085 . . . . 0.0 111.703 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.2 pt -63.51 -15.9 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.365 1.466 . . . . 0.0 113.881 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -68.75 -23.79 64.37 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.236 0.614 . . . . 0.0 112.084 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -107.18 148.78 37.71 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 125.333 1.453 . . . . 0.0 112.381 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.1 27.7 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.633 3.556 . . . . 0.0 114.673 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.83 -1.86 30.4 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.462 1.982 . . . . 0.0 112.314 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.79 43.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.172 0.989 . . . . 0.0 112.672 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -150.78 46.69 0.86 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.061 1.744 . . . . 0.0 109.741 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.72 109.34 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.999 1.32 . . . . 0.0 113.009 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -143.11 140.21 30.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.383 1.873 . . . . 0.0 110.003 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.6 168.11 2.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.058 2.143 . . . . 0.0 115.19 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -122.97 -7.99 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.543 2.337 . . . . 0.0 111.919 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -88.16 -57.29 4.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.659 1.184 . . . . 0.0 108.46 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.4 p -110.99 -6.88 14.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.104 0.562 . . . . 0.0 111.749 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.254 73.9 m80 64.44 19.25 11.73 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.706 2.002 . . . . 0.0 114.305 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.455 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.5 m-85 -82.11 145.02 51.87 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.056 -1.027 . . . . 0.0 111.413 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.53 153.0 69.64 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.811 1.674 . . . . 0.0 109.256 168.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -112.15 141.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.902 0.858 . . . . 0.0 110.092 -173.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -113.89 121.84 45.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.819 1.248 . . . . 0.0 111.101 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -176.296 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.601 0 CA-C-O 119.607 -0.552 . . . . 0.0 114.293 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.02 161.99 30.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.667 1.234 . . . . 0.0 108.481 172.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.7 p -148.3 148.7 30.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.073 0.949 . . . . 0.0 113.225 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.43 127.93 34.15 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.461 1.904 . . . . 0.0 110.751 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -14.85 62.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 69' ' ' CYS . 67.4 mt -96.64 -52.8 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.513 1.125 . . . . 0.0 110.346 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.53 -16.66 36.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 54.95 38.71 30.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.454 1.502 . . . . 0.0 110.445 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.36 156.25 22.31 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 122.802 1.223 . . . . 0.0 111.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -63.44 166.87 6.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 126.669 1.988 . . . . 0.0 115.932 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 158.41 28.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.721 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.6 p -137.27 160.09 40.03 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.281 1.039 . . . . 0.0 113.113 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.92 -9.27 3.95 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.85 -27.55 4.26 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.632 1.573 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 56.5 t30 -138.07 67.05 47.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.0 176.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 126.82 5.013 . . . . 0.0 117.75 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.01 145.49 43.64 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.92 172.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -156.39 -176.49 5.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.536 2.334 . . . . 0.0 109.632 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -119.49 102.4 47.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.302 1.041 . . . . 0.0 113.571 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.63 -33.52 1.25 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.102 1.201 . . . . 0.0 113.082 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.0 p -147.18 150.31 34.67 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.638 1.975 . . . . 0.0 110.165 -170.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 12.1 mptt -84.05 28.27 0.62 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.456 -1.247 . . . . 0.0 114.169 -174.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.46 87.91 5.06 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 161.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.81 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 3 C-N-CA 141.81 8.044 . . . . 0.0 112.122 1.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.6 -139.43 6.11 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.067 1.794 . . . . 0.0 109.624 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -54.01 -29.1 42.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 119.563 1.682 . . . . 0.0 111.775 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 pt -62.59 -9.1 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.121 1.768 . . . . 0.0 113.316 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -82.13 0.33 41.3 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.339 -0.851 . . . . 0.0 112.012 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.61 139.18 31.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.36 1.464 . . . . 0.0 108.751 171.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.5 ttp -161.6 145.45 12.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.828 0.851 . . . . 0.0 110.438 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.8 m80 -67.84 154.89 40.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.372 0.533 . . . . 0.0 110.787 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.79 -45.42 92.38 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.277 -0.889 . . . . 0.0 109.638 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 p -54.98 -54.34 44.13 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.982 0.913 . . . . 0.0 112.375 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 41' ' ' ILE . 82.1 m -62.6 -36.99 84.53 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.376 1.47 . . . . 0.0 112.747 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.2 tp -66.3 -47.02 74.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.13 1.332 . . . . 0.0 110.723 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.57 -32.74 70.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.187 1.795 . . . . 0.0 111.92 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -79.6 -41.09 27.84 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 128.076 2.55 . . . . 0.0 111.199 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -62.28 -50.77 70.36 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.998 -1.064 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.46 -32.13 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.794 0.724 . . . . 0.0 110.605 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.09 93.13 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.593 -0.692 . . . . 0.0 109.983 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -61.65 -16.27 47.17 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.594 -1.316 . . . . 0.0 113.462 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.84 3.75 50.12 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.142 1.777 . . . . 0.0 112.586 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.252 10.1 t30 64.62 44.09 4.06 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.114 1.365 . . . . 0.0 112.375 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -135.61 142.22 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.762 1.225 . . . . 0.0 110.424 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -108.77 100.43 9.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.811 1.244 . . . . 0.0 109.422 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.27 -11.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 t -76.99 -21.42 54.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.179 0.592 . . . . 0.0 112.048 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.89 144.34 90.39 Favored Pre-proline 0 N--CA 1.475 0.821 0 O-C-N 120.985 -1.072 . . . . 0.0 111.558 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.38 7.03 3.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.642 2.894 . . . . 0.0 116.768 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.02 -3.08 34.02 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.451 1.977 . . . . 0.0 112.519 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.42 127.83 34.41 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.285 1.042 . . . . 0.0 111.755 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.36 40.92 1.61 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.219 1.808 . . . . 0.0 109.8 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.18 124.78 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.341 2.256 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -139.16 131.35 28.18 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.468 1.507 . . . . 0.0 110.625 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.9 t -66.47 126.91 30.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.49 -21.53 41.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.13 -66.69 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.625 1.17 . . . . 0.0 111.338 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.0 p -83.39 -18.99 36.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 111.423 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 21.7 t60 79.79 1.43 2.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.332 3.053 . . . . 0.0 112.609 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 57' ' ' LYS . 53.6 m-85 -83.89 131.2 52.36 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.402 -1.436 . . . . 0.0 112.098 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 95' ' ' TYR . 31.6 Cg_exo -55.46 145.83 66.31 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.314 3.343 . . . . 0.0 111.44 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 mm -74.12 107.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 122.233 1.016 . . . . 0.0 109.39 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -99.89 85.82 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 113.198 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 125.086 1.354 . . . . 0.0 111.019 176.89 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 CA-C-O 119.946 -0.363 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 38' ' ' THR . . . -65.94 -175.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 111.525 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 37' ' ' ALA . 11.5 p -160.53 172.96 16.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 112.016 174.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -84.89 127.25 34.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.769 1.228 . . . . 0.0 107.698 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -20.63 66.47 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.157 1.344 . . . . 0.0 112.945 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.2 mt -79.94 -43.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 117.542 -1.218 . . . . 0.0 109.503 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.36 -2.18 8.54 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.322 38.8 mmt180 52.3 45.86 27.7 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.2 1.8 . . . . 0.0 111.413 -173.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.43 134.23 12.04 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 111.643 -2.526 . . . . 0.0 110.422 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.36 155.07 41.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.874 0.845 . . . . 0.0 110.955 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.9 156.36 2.91 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -128.65 173.36 10.36 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.36 1.076 . . . . 0.0 113.042 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.42 5.01 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.853 1.798 . . . . 0.0 115.853 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -145.98 -28.85 0.42 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.367 1.467 . . . . 0.0 111.636 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -127.69 67.84 73.48 Favored Pre-proline 0 N--CA 1.44 -0.941 0 C-N-CA 125.657 1.583 . . . . 0.0 110.231 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.34 -171.42 1.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.074 3.849 . . . . 0.0 112.109 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.72 142.09 46.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 110.87 -2.877 . . . . 0.0 109.359 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -158.0 -166.65 2.02 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 128.359 2.664 . . . . 0.0 107.738 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.54 107.79 14.48 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.247 1.019 . . . . 0.0 112.5 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.15 -18.6 9.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.878 3.052 . . . . 0.0 113.743 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 9.8 t -143.43 171.68 13.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.269 2.228 . . . . 0.0 110.142 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -83.28 20.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 129.681 3.193 . . . . 0.0 113.784 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -12.26 0.18 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 55.23 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 130.534 3.534 . . . . 0.0 120.068 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.35 -175.91 49.69 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.342 1.428 . . . . 0.0 113.52 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -69.12 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.73 -28.1 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.748 2.419 . . . . 0.0 108.704 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -54.05 -29.11 42.74 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.263 1.392 . . . . 0.0 113.585 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.34 134.17 49.88 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.707 1.241 . . . . 0.0 111.839 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.4 mtt -157.69 143.81 17.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.214 1.405 . . . . 0.0 109.706 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -69.0 155.38 40.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.567 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.97 -52.27 66.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.483 -0.76 . . . . 0.0 110.564 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -60.31 -45.46 93.32 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.562 -0.711 . . . . 0.0 112.313 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.1 -44.77 91.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.731 0.696 . . . . 0.0 112.07 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.05 -47.06 87.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.964 0.802 . . . . 0.0 110.141 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.64 -28.03 66.87 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.965 0.906 . . . . 0.0 112.787 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -85.65 -34.02 21.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.865 0.866 . . . . 0.0 111.723 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -58.81 -59.05 6.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 109.951 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.84 -23.52 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 111.811 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.0 -0.44 55.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.2 m -113.5 -5.4 13.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.99 1.716 . . . . 0.0 111.811 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -80.28 6.0 13.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.701 2.8 . . . . 0.0 114.691 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.318 0.0 OUTLIER 76.34 32.15 0.59 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.684 1.593 . . . . 0.0 111.518 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -142.08 159.77 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.748 2.019 . . . . 0.0 109.795 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -132.83 112.98 12.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.534 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.8 pt -61.23 -17.68 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.231 1.412 . . . . 0.0 114.452 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -74.36 -26.78 60.34 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.204 0.456 . . . . 0.0 111.873 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.83 145.31 83.95 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 121.263 -0.898 . . . . 0.0 112.734 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -79.86 27.42 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.54 3.493 . . . . 0.0 114.948 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.47 20.99 3.66 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.167 2.318 . . . . 0.0 111.188 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.81 131.8 38.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.755 0.822 . . . . 0.0 112.743 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -145.62 55.78 1.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.575 1.95 . . . . 0.0 108.6 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -71.55 37.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.818 2.047 . . . . 0.0 116.024 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -58.44 141.91 50.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.699 2.8 . . . . 0.0 113.005 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 46.9 t -60.33 116.51 4.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.556 1.942 . . . . 0.0 110.759 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -78.11 13.97 1.3 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.65 -47.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.86 1.264 . . . . 0.0 110.502 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -116.44 -9.31 11.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.187 1.795 . . . . 0.0 111.816 -174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.277 78.4 m-70 65.4 31.31 10.45 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.972 2.109 . . . . 0.0 115.823 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.6 m-85 -106.96 138.19 19.74 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.868 1.267 . . . . 0.0 112.552 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.94 135.55 71.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.394 2.063 . . . . 0.0 110.31 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.1 mm -74.93 136.98 23.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.029 0.932 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -123.98 88.2 2.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.597 1.189 . . . . 0.0 113.503 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 C-N-CA 126.223 1.809 . . . . 0.0 110.137 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.558 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.86 152.67 45.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.884 1.274 . . . . 0.0 110.244 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 79.0 p -143.91 153.1 41.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.738 1.215 . . . . 0.0 112.333 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 t -59.91 127.19 30.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.482 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -14.0 61.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 112.899 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.08 -46.28 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.3 p -113.8 -7.33 13.24 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.315 31.2 mmt180 57.22 44.72 21.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.063 1.345 . . . . 0.0 112.552 -175.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.96 16.49 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 172.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.0 172.43 4.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.45 1.1 . . . . 0.0 111.764 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.84 161.81 23.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.538 0.685 . . . . 0.0 109.637 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.4 p -136.93 166.78 22.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.208 0.603 . . . . 0.0 111.108 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.43 -22.25 64.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.71 -27.77 10.1 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.078 1.751 . . . . 0.0 111.376 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 66' ' ' HIS . 58.1 t30 -137.27 66.9 53.51 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.51 173.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.546 4.164 . . . . 0.0 116.364 172.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.3 mt -110.24 146.01 36.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.105 -1.861 . . . . 0.0 110.49 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.46 -177.9 6.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.074 2.149 . . . . 0.0 108.827 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -126.12 118.01 23.67 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.929 0.892 . . . . 0.0 109.201 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.68 -26.41 7.01 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.108 2.538 . . . . 0.0 111.575 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.58 -152.71 0.51 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 128.326 2.65 . . . . 0.0 110.962 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 6.1 mmtt -119.66 13.35 12.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.549 1.939 . . . . 0.0 113.69 -174.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 m -44.35 -17.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -174.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? 38.99 34.55 0.1 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 129.11 2.964 . . . . 0.0 118.435 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.33 28.36 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.602 1.096 . . . . 0.0 114.642 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.5 p -64.19 9.42 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.475 1.51 . . . . 0.0 114.437 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.02 12.33 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.559 2.343 . . . . 0.0 110.22 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -90.26 -21.87 21.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 113.214 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -79.85 140.36 36.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.967 1.307 . . . . 0.0 111.597 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.0 mtp -154.61 143.04 20.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.671 1.188 . . . . 0.0 110.527 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.517 ' HB3' HD21 ' A' ' 50' ' ' ASN . 42.8 m80 -76.11 158.45 31.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.2 -46.91 88.52 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.243 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 m -65.1 -48.55 73.28 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.654 0.782 . . . . 0.0 111.613 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.62 -39.44 88.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.955 -1.09 . . . . 0.0 111.603 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.03 -49.89 75.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.043 1.747 . . . . 0.0 109.815 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.9 -30.7 68.0 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 113.447 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.46 -34.65 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.001 2.52 . . . . 0.0 112.225 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -70.6 -52.84 18.7 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.449 1.1 . . . . 0.0 109.156 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.4 m -58.88 -30.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.989 0.813 . . . . 0.0 110.573 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.18 75.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.34 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 t -60.92 -30.96 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.709 -1.244 . . . . 0.0 111.591 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.63 8.67 7.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.721 2.808 . . . . 0.0 114.025 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.286 0.0 OUTLIER 74.7 18.99 2.65 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.907 2.083 . . . . 0.0 115.531 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.92 141.69 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -129.79 113.39 14.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.027 1.331 . . . . 0.0 111.533 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -21.07 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.592 1.557 . . . . 0.0 114.003 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -75.3 -16.98 60.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.795 0.838 . . . . 0.0 112.888 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.89 142.15 51.92 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 120.928 -1.108 . . . . 0.0 113.252 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.48 17.74 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.571 3.514 . . . . 0.0 115.314 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.98 16.15 5.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.369 2.414 . . . . 0.0 111.541 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.14 147.89 42.51 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.525 0.73 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.19 39.93 0.93 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.853 1.661 . . . . 0.0 110.366 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -53.77 116.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.284 1.834 . . . . 0.0 113.084 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -148.75 147.21 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.843 1.657 . . . . 0.0 111.473 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.8 t -64.03 172.18 2.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.53 1.532 . . . . 0.0 113.76 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -129.74 0.49 4.89 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.764 2.025 . . . . 0.0 112.673 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -105.04 -65.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.1 p -92.74 -9.37 40.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.612 1.965 . . . . 0.0 111.078 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.343 4.3 p-80 58.7 16.72 4.58 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.163 2.585 . . . . 0.0 115.905 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 28.7 m-85 -81.59 143.78 51.64 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 120.018 1.281 . . . . 0.0 113.232 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.02 136.03 29.49 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.895 3.063 . . . . 0.0 111.772 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -82.79 124.33 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.894 1.278 . . . . 0.0 109.988 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.86 93.22 4.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.323 1.449 . . . . 0.0 112.159 -175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.475 1.11 . . . . 0.0 111.226 176.203 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 170.85 6.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.665 1.186 . . . . 0.0 111.892 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.3 p -150.34 165.82 31.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.99 1.316 . . . . 0.0 112.135 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 39.1 t -75.62 120.97 21.75 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 114.336 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -9.17 13.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.57 1.148 . . . . 0.0 113.186 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.424 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 57.5 mt -99.26 -42.05 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.109 1.364 . . . . 0.0 110.831 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.77 12.42 4.03 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 53.75 19.39 1.84 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.681 2.793 . . . . 0.0 115.488 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.52 144.94 25.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.56 173.85 8.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 110.404 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.06 157.41 22.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.416 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.3 p -127.05 165.23 19.88 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.48 1.133 . . . . 0.0 112.407 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -61.51 -15.7 40.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.01 -24.28 2.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.129 0.972 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -136.59 71.72 58.09 Favored Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 124.753 1.221 . . . . 0.0 111.324 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.92 -160.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 124.499 3.466 . . . . 0.0 109.291 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mt -120.05 141.86 49.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.093 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -144.76 173.85 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 110.877 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -113.98 101.87 54.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.552 1.141 . . . . 0.0 112.381 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.68 -36.1 8.91 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.97 1.78 . . . . 0.0 111.443 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.9 t -119.7 -164.26 1.05 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 129.07 2.948 . . . . 0.0 112.294 -166.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -116.11 1.44 13.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.98 2.512 . . . . 0.0 115.247 -172.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 m -34.15 -48.69 0.33 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.598 2.359 . . . . 0.0 114.944 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 109.5 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 1 C-N-CA 132.925 4.49 . . . . 0.0 112.052 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 18.72 -109.98 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 129.213 3.292 . . . . 0.0 117.643 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -55.51 -5.26 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -174.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.94 19.41 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.85 1.659 . . . . 0.0 111.165 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -100.28 -53.56 3.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.705 1.202 . . . . 0.0 109.72 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -46.48 142.3 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.591 1.956 . . . . 0.0 112.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.1 mtt -159.64 150.57 19.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.474 1.51 . . . . 0.0 111.55 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -74.82 150.94 39.11 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -56.47 -42.32 78.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.822 1.192 . . . . 0.0 111.328 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.0 p -61.22 -46.29 91.05 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.372 1.469 . . . . 0.0 112.631 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.4 m -64.78 -40.13 94.75 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 112.292 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.58 -47.72 84.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.65 1.114 . . . . 0.0 110.289 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.45 -31.05 63.6 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.186 2.194 . . . . 0.0 113.268 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -92.46 -35.48 13.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.912 1.285 . . . . 0.0 112.143 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -62.97 -48.25 79.68 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.651 0.78 . . . . 0.0 111.04 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.87 -27.22 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.986 0.812 . . . . 0.0 111.585 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.39 90.25 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.76 -0.587 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.7 p -67.72 -1.66 5.68 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.92 8.63 44.8 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.037 1.29 . . . . 0.0 111.676 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 80.9 30.1 0.17 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.658 2.383 . . . . 0.0 113.296 178.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.25 145.94 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.494 1.118 . . . . 0.0 112.807 -170.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -139.43 111.31 7.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.093 1.357 . . . . 0.0 110.564 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 pt -63.91 -16.54 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.498 1.119 . . . . 0.0 113.321 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -82.11 0.18 41.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.462 1.105 . . . . 0.0 113.462 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -126.77 151.03 72.96 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.697 1.599 . . . . 0.0 112.418 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.38 27.69 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.75 3.633 . . . . 0.0 115.268 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.41 5.54 11.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.952 2.215 . . . . 0.0 112.084 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 144.7 53.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.432 1.093 . . . . 0.0 113.17 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.66 38.41 0.68 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.898 1.679 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.77 99.08 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 126.212 1.805 . . . . 0.0 114.246 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -150.88 142.84 23.94 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.399 2.279 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.5 t -67.15 177.78 1.68 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.231 2.612 . . . . 0.0 116.063 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -132.52 -3.8 3.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.762 2.425 . . . . 0.0 112.769 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mt -86.31 -71.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.788 -1.195 . . . . 0.0 107.854 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 7.9 p -88.03 -15.37 36.53 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.844 2.458 . . . . 0.0 110.574 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.4 m80 69.66 17.5 7.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.907 2.483 . . . . 0.0 113.11 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -76.19 146.65 78.65 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.46 149.21 76.28 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.228 2.619 . . . . 0.0 111.276 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 56' ' ' CYS . 5.2 mm -100.63 140.76 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.665 1.186 . . . . 0.0 109.906 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -135.64 137.2 41.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.144 0.974 . . . . 0.0 112.877 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.871 1.269 . . . . 0.0 113.287 179.829 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 93.54 129.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 131.43 3.892 . . . . 0.0 112.854 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 45' ' ' GLU . 77.3 p -136.01 150.39 49.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.832 2.853 . . . . 0.0 114.393 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 51.2 t -61.88 132.62 53.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.66 1.584 . . . . 0.0 111.122 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -20.1 63.56 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.644 -1.285 . . . . 0.0 112.72 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 96.8 mt -83.25 -39.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 110.34 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.39 -10.87 12.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.253 22.0 mmt85 62.22 40.33 11.69 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.318 2.247 . . . . 0.0 112.567 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.76 152.83 21.12 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 125.325 1.44 . . . . 0.0 114.315 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.866 ' HA ' HG22 ' A' ' 38' ' ' THR . 3.4 mt-10 -156.0 -34.44 0.09 Allowed 'General case' 0 CA--C 1.481 -1.675 1 C-N-CA 133.324 4.65 . . . . 0.0 116.296 -1.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' H ' ' A' ' 45' ' ' GLU . . . -79.5 -176.01 5.06 Favored 'General case' 0 C--N 1.305 -1.355 1 C-N-CA 141.687 7.995 . . . . 0.0 112.174 -4.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 p -125.35 148.54 48.71 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.751 -1.218 . . . . 0.0 113.124 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.49 -7.07 1.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.04 -20.52 8.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.577 1.951 . . . . 0.0 111.052 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.627 HD21 ' HB3' ' A' ' 66' ' ' HIS . 44.0 t30 -145.75 72.8 13.86 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 125.284 1.434 . . . . 0.0 113.912 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -46.23 173.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.08 4.52 . . . . 0.0 117.014 173.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -116.71 155.58 28.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.512 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -157.04 -171.01 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.065 2.546 . . . . 0.0 107.74 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -125.4 115.56 25.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.926 0.89 . . . . 0.0 109.628 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -78.31 -19.41 11.88 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.833 3.022 . . . . 0.0 112.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.3 p -151.03 151.98 32.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.29 2.636 . . . . 0.0 110.969 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.2 39.86 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.467 1.507 . . . . 0.0 114.519 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.87 -3.73 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 175.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? 23.37 92.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 129.678 3.191 . . . . 0.0 115.867 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.4 23.16 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.924 1.726 . . . . 0.0 112.006 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.9 p -54.03 -37.13 63.78 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.28 1.69 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -80.75 -14.37 58.15 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.376 -0.827 . . . . 0.0 112.923 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.76 140.06 29.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.546 0.738 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.3 mtp -153.86 144.64 22.59 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.115 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.627 ' HB3' HD21 ' A' ' 50' ' ' ASN . 7.4 m170 -70.26 135.36 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -75.6 32.68 0.11 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.297 1.439 . . . . 0.0 113.4 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.3 t -145.66 -43.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.304 2.242 . . . . 0.0 108.469 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 86.0 m -59.19 -48.34 81.97 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.785 1.234 . . . . 0.0 112.948 174.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.0 tp -58.03 -46.94 84.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 123.853 0.861 . . . . 0.0 110.682 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -22.6 63.54 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.232 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -92.56 -40.16 10.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 110.353 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -56.69 -49.33 75.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.568 1.147 . . . . 0.0 112.172 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.23 -33.44 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.475 0.71 . . . . 0.0 111.956 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.9 81.87 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.741 -0.599 . . . . 0.0 111.24 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.2 m -63.82 -15.52 59.02 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.843 -1.16 . . . . 0.0 113.395 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -75.05 -7.84 54.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.808 1.243 . . . . 0.0 113.14 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 62.91 52.58 2.61 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.836 1.303 . . . . 0.0 112.368 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.4 150.51 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.872 -1.143 . . . . 0.0 111.246 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.16 117.45 9.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.041 0.536 . . . . 0.0 112.096 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.85 0.51 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -96.14 5.55 50.82 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 122.347 1.07 . . . . 0.0 110.249 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? 30.32 80.94 0.23 Allowed Pre-proline 0 CA--C 1.539 0.545 1 C-N-CA 133.049 4.54 . . . . 0.0 119.162 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -84.18 46.96 2.1 Favored 'Trans proline' 0 CA--C 1.544 0.995 1 C-N-CA 126.336 4.691 . . . . 0.0 109.902 172.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.98 -11.55 22.59 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.601 2.048 . . . . 0.0 112.015 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 162.87 13.88 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.019 0.909 . . . . 0.0 113.103 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.11 45.17 1.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.519 1.528 . . . . 0.0 110.619 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.9 t -52.65 114.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.817 1.647 . . . . 0.0 113.74 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -148.28 -177.82 5.97 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.3 t -62.79 164.54 7.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.861 2.064 . . . . 0.0 114.329 -174.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -125.51 13.08 8.12 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.679 1.992 . . . . 0.0 111.784 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 mt -113.43 -55.3 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.82 1.648 . . . . 0.0 108.297 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.48 -10.74 14.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 t60 55.42 19.56 3.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.016 1.726 . . . . 0.0 114.718 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -78.21 139.47 60.51 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.737 -1.227 . . . . 0.0 108.988 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 43.1 Cg_exo -49.68 129.16 23.0 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.058 3.172 . . . . 0.0 112.439 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -89.76 129.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.151 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -118.17 136.6 53.53 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.318 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 126.425 1.89 . . . . 0.0 111.26 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 168.85 2.56 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.976 1.31 . . . . 0.0 112.104 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.3 p -139.16 157.03 46.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -62.1 134.72 56.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.38 1.472 . . . . 0.0 113.162 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -5.67 43.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.27 -41.66 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.826 1.25 . . . . 0.0 110.112 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.48 6.49 5.24 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 54.45 27.83 8.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.608 1.563 . . . . 0.0 114.467 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.46 140.98 15.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -72.57 162.89 28.89 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.266 1.026 . . . . 0.0 112.681 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 51' ' ' PRO . . . -54.53 140.52 34.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.217 1.407 . . . . 0.0 113.094 173.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.2 p -114.98 -149.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.607 1.963 . . . . 0.0 110.217 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -109.88 -5.28 15.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.562 1.545 . . . . 0.0 112.284 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.68 -18.22 5.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.362 2.265 . . . . 0.0 110.939 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -141.53 69.79 26.06 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 128.33 2.652 . . . . 0.0 108.408 174.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 51.6 Cg_endo -77.15 4.21 6.02 Favored 'Trans proline' 0 N--CA 1.501 1.945 1 C-N-CA 129.397 6.732 . . . . 0.0 118.276 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt 60.08 144.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 1 C-N-CA 136.599 5.959 . . . . 0.0 113.636 -170.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.11 179.83 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.241 1.816 . . . . 0.0 109.483 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -122.65 103.48 37.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.922 1.289 . . . . 0.0 109.829 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.49 -17.92 20.53 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.464 2.109 . . . . 0.0 111.425 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.5 t -134.92 -168.11 2.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.703 2.401 . . . . 0.0 111.428 -168.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -125.14 33.25 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.455 1.502 . . . . 0.0 113.626 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 93' ' ' CYS . 2.3 m -53.72 -10.39 0.29 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.286 1.434 . . . . 0.0 114.091 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 30.36 69.55 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.851 2.86 . . . . 0.0 116.561 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.4 -169.8 42.83 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.44 -1.255 . . . . 0.0 114.013 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -64.04 8.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.822 1.649 . . . . 0.0 114.495 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.87 12.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 127.741 2.416 . . . . 0.0 111.442 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 pttt -90.86 -17.01 27.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.639 1.576 . . . . 0.0 113.08 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 63' ' ' LYS . 45.4 m-85 -90.15 144.32 25.98 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.116 1.766 . . . . 0.0 111.091 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.4 mtp -157.8 143.07 16.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.124 0.97 . . . . 0.0 110.956 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -75.97 144.53 40.92 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.31 -40.72 78.48 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.956 -1.09 . . . . 0.0 110.954 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -59.62 -47.02 87.23 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.525 1.93 . . . . 0.0 112.09 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.3 m -63.17 -46.37 87.45 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.857 1.263 . . . . 0.0 111.122 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.12 -48.85 80.08 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 122.911 0.485 . . . . 0.0 112.059 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.02 -20.85 60.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.635 1.574 . . . . 0.0 112.522 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -96.41 -31.89 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.959 1.704 . . . . 0.0 112.057 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.438 ' CZ2' ' HE3' ' A' ' 77' ' ' LYS . 15.8 t90 -64.05 -57.19 10.4 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.01 1.724 . . . . 0.0 111.746 178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 m -55.75 -22.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.456 1.502 . . . . 0.0 111.225 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.03 -33.94 22.42 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.036 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 t -70.55 -26.4 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.254 1.422 . . . . 0.0 110.817 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE3' ' CZ2' ' A' ' 73' ' ' TRP . 65.8 mmtt -74.35 7.31 2.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.875 2.87 . . . . 0.0 113.747 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 75.16 6.48 4.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.478 2.311 . . . . 0.0 115.531 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.81 152.05 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.37 1.468 . . . . 0.0 111.382 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -134.49 110.33 9.31 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.095 1.358 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -18.46 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.985 1.314 . . . . 0.0 113.702 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -82.59 -5.38 58.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.902 0.881 . . . . 0.0 113.266 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.97 150.06 44.4 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 112.924 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -77.94 23.27 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.494 3.463 . . . . 0.0 115.182 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.88 8.27 16.7 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.691 2.091 . . . . 0.0 112.182 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.61 145.5 51.95 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 113.224 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.16 44.1 0.71 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.335 1.854 . . . . 0.0 109.871 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.79 88.07 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.924 1.69 . . . . 0.0 113.566 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -141.42 139.55 33.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.712 1.605 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.3 t -64.58 176.49 1.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.121 2.568 . . . . 0.0 115.739 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.26 -10.24 4.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.518 2.327 . . . . 0.0 112.591 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -79.44 -64.59 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 122.576 1.179 . . . . 0.0 108.932 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 58' ' ' CYS . 26.5 p -101.4 -11.93 18.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 130.268 3.427 . . . . 0.0 111.222 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.0 m80 70.69 14.95 7.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.439 2.696 . . . . 0.0 114.064 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 17.9 m-85 -78.42 145.84 68.86 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.61 143.13 99.39 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.65 2.233 . . . . 0.0 109.631 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -91.85 132.83 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -127.72 120.34 27.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.285 1.034 . . . . 0.0 111.012 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 126.38 1.872 . . . . 0.0 114.573 -177.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.81 18.62 1.64 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -81.25 -24.25 37.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.185 0.994 . . . . 0.0 113.304 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.0 174.43 3.79 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.495 1.518 . . . . 0.0 113.319 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.47 11.21 6.81 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.382 1.473 . . . . 0.0 113.542 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 t -159.14 161.71 36.32 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.176 1.791 . . . . 0.0 110.502 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -161.52 160.84 29.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.62 1.568 . . . . 0.0 111.106 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.8 m -57.68 140.44 51.29 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.297 1.439 . . . . 0.0 111.825 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.61 173.05 14.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.538 1.535 . . . . 0.0 111.874 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.0 m -135.48 138.71 43.42 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.991 1.316 . . . . 0.0 110.16 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -143.32 131.55 21.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.311 1.445 . . . . 0.0 110.25 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -156.25 171.65 19.83 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.298 1.439 . . . . 0.0 112.913 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -116.07 23.96 11.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.434 1.493 . . . . 0.0 113.192 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -160.95 170.32 20.83 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.495 3.118 . . . . 0.0 108.365 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -46.94 102.75 0.32 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 127.079 2.152 . . . . 0.0 113.324 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -65.3 148.58 88.6 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.628 2.218 . . . . 0.0 113.889 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.1 m -81.54 -13.34 58.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.47 46.14 0.82 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 126.43 1.967 . . . . 0.0 112.045 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.44 149.7 1.53 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.155 1.782 . . . . 0.0 111.563 -175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -134.9 151.15 50.63 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.9 t -46.22 160.27 0.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.634 1.974 . . . . 0.0 112.999 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.13 0.47 40.68 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.818 2.047 . . . . 0.0 114.678 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.36 -35.23 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 127.345 2.258 . . . . 0.0 113.223 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.1 p -143.12 23.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 39.15 30.26 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.012 2.125 . . . . 0.0 114.965 175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.81 155.98 45.45 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -102.93 134.32 46.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.302 1.051 . . . . 0.0 108.801 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -35.44 139.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -111.51 -168.8 1.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.702 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -104.05 15.13 29.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.442 2.297 . . . . 0.0 112.421 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.29 -27.93 0.27 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.092 1.757 . . . . 0.0 111.486 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 65.2 t30 -146.35 80.58 9.98 Favored Pre-proline 0 N--CA 1.435 -1.189 0 C-N-CA 126.465 1.906 . . . . 0.0 108.629 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -66.27 -143.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 125.873 4.382 . . . . 0.0 112.159 -177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -141.42 159.23 42.64 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.101 2.16 . . . . 0.0 108.916 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -165.96 161.22 17.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.919 2.087 . . . . 0.0 108.58 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 8.3 p80 -105.38 109.78 63.6 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.06 0.544 . . . . 0.0 109.726 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 54' ' ' HIS 0.264 61.9 Cg_endo -78.05 -7.5 16.31 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.658 3.572 . . . . 0.0 112.994 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.435 ' HB2' HD13 ' A' ' 97' ' ' ILE . 2.2 t -150.06 176.13 11.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.937 1.695 . . . . 0.0 111.472 -167.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -110.6 36.66 3.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.382 2.273 . . . . 0.0 113.572 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.4 m -59.59 -36.71 76.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.399 0.68 . . . . 0.0 110.6 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 75.16 178.6 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.683 2.793 . . . . 0.0 113.528 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.21 -138.38 43.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.71 1.148 . . . . 0.0 113.973 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 m -99.6 14.7 29.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.647 1.579 . . . . 0.0 114.574 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 33.33 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 127.009 2.124 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -106.03 -40.49 5.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.043 1.737 . . . . 0.0 109.957 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -61.78 157.11 18.76 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.893 1.277 . . . . 0.0 112.228 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.4 ttm -172.48 145.88 1.68 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.127 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.2 m80 -71.28 154.92 41.26 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.95 -38.87 87.38 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.672 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.1 p -63.65 -55.31 24.54 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.415 1.486 . . . . 0.0 111.546 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.24 -43.5 61.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.904 1.282 . . . . 0.0 112.224 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.05 -45.78 87.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.936 0.789 . . . . 0.0 111.55 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -58.88 -28.03 65.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.449 1.1 . . . . 0.0 113.161 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.99 -26.91 21.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.364 1.466 . . . . 0.0 111.919 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.68 -59.45 2.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.218 1.007 . . . . 0.0 110.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.41 -20.08 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.901 1.281 . . . . 0.0 111.604 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.42 -45.32 32.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -59.92 -29.17 68.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.008 1.323 . . . . 0.0 112.53 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.8 -3.39 12.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.669 1.988 . . . . 0.0 113.827 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.06 54.41 2.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.785 1.234 . . . . 0.0 111.948 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -140.05 132.18 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 110.812 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -88.08 97.67 11.11 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.684 0.793 . . . . 0.0 110.487 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.1 pt -64.7 -10.93 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.839 1.256 . . . . 0.0 113.612 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -93.53 5.61 51.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.779 1.231 . . . . 0.0 112.794 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -120.9 144.9 40.2 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.546 1.138 . . . . 0.0 113.983 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -86.12 21.53 1.07 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.798 3.665 . . . . 0.0 113.838 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.36 23.85 10.2 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 127.039 2.257 . . . . 0.0 111.906 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.93 166.69 20.39 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.298 1.439 . . . . 0.0 112.888 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -137.65 36.26 2.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.309 1.844 . . . . 0.0 110.405 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -36.72 104.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 127.36 2.264 . . . . 0.0 114.751 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 15.4 pttm -158.1 172.46 18.37 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.58 172.6 1.53 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.645 2.778 . . . . 0.0 116.046 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.32 -17.45 3.38 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.974 2.51 . . . . 0.0 112.605 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.7 mt -78.4 -54.06 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.137 0.975 . . . . 0.0 109.506 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.2 p -116.2 -9.85 11.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.58 1.952 . . . . 0.0 111.45 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.307 7.3 p80 58.05 22.09 8.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 128.583 2.753 . . . . 0.0 116.342 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -78.92 137.48 57.6 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.733 -1.229 . . . . 0.0 112.915 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 24.5 Cg_exo -54.54 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.752 2.968 . . . . 0.0 112.303 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' A' ' 56' ' ' CYS . 10.5 mm -68.19 139.91 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.313 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.41 124.71 40.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 112.345 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.08 11.33 4.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.85 1.66 . . . . 0.0 114.309 -177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -160.56 151.91 19.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.065 2.146 . . . . 0.0 110.932 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.115 1.766 . . . . 0.0 111.637 179.274 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 110.715 -0.106 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.03 26.71 1.84 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.863 1.265 . . . . 0.0 113.086 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.99 153.16 39.73 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.976 1.71 . . . . 0.0 111.433 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.86 -1.34 2.01 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -120.71 0.17 10.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.62 1.568 . . . . 0.0 113.117 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -75.68 -7.32 54.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 t0 73.23 154.8 0.15 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 128.356 2.662 . . . . 0.0 113.664 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.0 p -138.57 13.65 2.75 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.652 1.981 . . . . 0.0 113.414 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.91 164.62 32.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -107.86 2.72 23.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.45 1.5 . . . . 0.0 114.658 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 t80 48.06 58.1 5.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.997 2.119 . . . . 0.0 112.146 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -82.46 -174.92 5.45 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.111 1.765 . . . . 0.0 112.997 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.9 -173.39 3.79 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.305 2.242 . . . . 0.0 108.113 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.75 -38.11 79.88 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.754 -1.216 . . . . 0.0 112.129 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.31 144.16 36.18 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.798 2.439 . . . . 0.0 113.11 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.76 165.34 0.78 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 125.162 3.908 . . . . 0.0 115.061 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -102.62 19.78 18.43 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.398 1.879 . . . . 0.0 110.837 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.24 28.46 0.29 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 126.479 1.99 . . . . 0.0 114.548 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.72 128.64 37.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.879 0.872 . . . . 0.0 109.571 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.4 p -139.13 148.75 43.65 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.207 1.403 . . . . 0.0 112.103 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.0 t -51.48 126.65 17.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.999 1.319 . . . . 0.0 112.378 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -5.43 26.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.852 -1.155 . . . . 0.0 113.446 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -101.18 -43.11 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.004 1.321 . . . . 0.0 110.272 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.5 p -125.3 -1.58 7.59 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.318 33.9 mmt180 61.61 25.6 15.47 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.406 2.282 . . . . 0.0 115.455 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.24 139.64 15.75 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.97 165.28 15.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.109 0.963 . . . . 0.0 112.228 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 139.31 58.75 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.228 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.1 p -129.92 160.47 33.48 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.291 1.043 . . . . 0.0 112.85 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.9 13.54 0.51 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.842 1.657 . . . . 0.0 114.662 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -133.66 -20.74 2.01 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.293 2.237 . . . . 0.0 110.946 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.519 HD21 ' HB3' ' A' ' 66' ' ' HIS . 28.4 t30 -158.98 72.34 3.56 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.607 1.163 . . . . 0.0 112.82 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.16 167.36 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 125.274 3.982 . . . . 0.0 116.611 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.2 mt -109.82 142.97 40.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.7 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -154.55 177.53 11.1 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 128.47 2.708 . . . . 0.0 107.821 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CE1' ' HE2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.74 110.16 37.21 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.29 -19.62 25.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.687 2.258 . . . . 0.0 111.209 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -145.3 154.74 42.67 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 130.38 3.472 . . . . 0.0 108.221 -173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -56.49 -39.87 73.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.672 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 28.83 10.87 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 131.182 3.793 . . . . 0.0 121.005 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 15.45 57.67 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 1 C-N-CA 134.514 5.126 . . . . 0.0 118.129 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.06 -174.05 44.16 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.525 0.583 . . . . 0.0 114.084 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.4 m -67.6 29.39 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 127.547 2.339 . . . . 0.0 114.024 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.26 -6.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 129.215 3.006 . . . . 0.0 112.039 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 54' ' ' HIS . 21.0 pttm -72.72 -23.02 60.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.682 1.128 . . . . 0.0 111.616 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -73.33 138.08 45.17 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.349 1.059 . . . . 0.0 112.067 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 84.0 mtp -157.3 140.24 15.2 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.385 1.474 . . . . 0.0 109.854 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.519 ' HB3' HD21 ' A' ' 50' ' ' ASN . 36.9 m80 -70.78 157.61 37.76 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.79 -48.13 82.03 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.75 -0.594 . . . . 0.0 109.827 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.5 m -62.22 -45.85 91.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.643 0.777 . . . . 0.0 112.127 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -63.13 -43.65 97.78 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.512 -0.742 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.4 -44.6 95.53 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.215 0.916 . . . . 0.0 110.198 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.62 -30.01 62.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.57 -38.71 18.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.483 1.113 . . . . 0.0 110.991 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -62.36 -48.0 81.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.427 1.091 . . . . 0.0 111.958 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -64.19 -32.87 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.569 0.748 . . . . 0.0 111.305 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.71 -35.56 79.02 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.389 0.675 . . . . 0.0 110.84 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.0 t -63.19 -19.0 64.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.637 1.175 . . . . 0.0 112.567 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -82.55 2.99 30.36 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.125 1.37 . . . . 0.0 113.045 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER 79.1 14.55 1.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.107 2.163 . . . . 0.0 113.715 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.94 127.37 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.921 1.289 . . . . 0.0 111.853 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -98.04 107.05 19.44 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.485 1.114 . . . . 0.0 110.062 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.0 -13.56 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.333 1.453 . . . . 0.0 114.342 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.46 -21.73 60.37 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.814 -0.554 . . . . 0.0 111.787 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -93.91 144.52 28.26 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 124.946 1.298 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.56 9.9 2.07 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.924 3.083 . . . . 0.0 115.837 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.19 -1.72 60.95 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.359 1.933 . . . . 0.0 113.094 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.15 141.99 57.19 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.115 0.958 . . . . 0.0 112.013 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -146.5 44.12 1.2 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.754 1.622 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.41 123.84 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.991 1.316 . . . . 0.0 111.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -145.04 143.07 30.27 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.024 1.73 . . . . 0.0 110.647 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.4 t -62.42 163.56 8.49 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.66 -9.04 12.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.159 1.783 . . . . 0.0 111.736 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.2 -55.96 5.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 123.813 0.845 . . . . 0.0 108.793 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.0 p -109.44 -3.6 16.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.468 0.707 . . . . 0.0 112.792 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 60.78 11.44 3.2 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.152 1.781 . . . . 0.0 114.78 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -81.96 140.59 46.67 Favored Pre-proline 0 CA--C 1.539 0.548 0 O-C-N 120.078 -1.639 . . . . 0.0 110.474 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.21 145.25 44.55 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.054 2.503 . . . . 0.0 111.114 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.5 mm -100.74 107.2 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.0 1.32 . . . . 0.0 111.045 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.52 116.06 24.4 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.384 1.474 . . . . 0.0 109.915 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -64.26 4.48 0.34 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -159.89 160.42 33.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.13 2.172 . . . . 0.0 111.163 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 128.561 2.744 . . . . 0.0 113.917 178.3 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 110.714 -0.106 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.03 -171.13 3.39 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.732 1.213 . . . . 0.0 111.921 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -131.8 7.13 4.38 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.029 1.732 . . . . 0.0 113.192 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -149.72 150.95 32.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.048 2.939 . . . . 0.0 109.622 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -151.33 26.29 0.69 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.02 0.928 . . . . 0.0 112.598 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.0 p -129.86 6.03 5.05 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.39 169.49 0.43 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.648 1.979 . . . . 0.0 115.616 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.7 m -142.66 143.2 32.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.158 2.183 . . . . 0.0 109.241 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.71 162.1 40.61 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.3 m -147.8 142.37 26.53 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.811 2.044 . . . . 0.0 108.836 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -143.08 148.7 37.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.548 1.139 . . . . 0.0 113.247 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -153.94 140.82 19.19 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.69 1.596 . . . . 0.0 111.012 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -156.21 175.19 14.31 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.096 1.758 . . . . 0.0 110.503 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -68.23 -3.3 10.28 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.05 132.87 10.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 127.192 2.197 . . . . 0.0 110.888 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -50.85 151.63 10.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.851 3.034 . . . . 0.0 114.552 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -58.76 -25.86 63.44 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.189 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.59 26.98 6.12 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 126.224 1.869 . . . . 0.0 114.401 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.12 153.28 41.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.762 1.281 . . . . 0.0 109.67 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.9 p -146.87 149.15 32.7 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.6 t -56.49 128.99 38.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.379 1.472 . . . . 0.0 111.84 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -13.01 62.11 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.91 -43.74 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.554 1.142 . . . . 0.0 111.498 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.78 5.5 10.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 54.44 29.49 11.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.822 2.049 . . . . 0.0 113.647 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.64 147.6 16.69 Favored Glycine 0 N--CA 1.467 0.727 0 CA-C-O 122.726 1.181 . . . . 0.0 111.066 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.05 166.34 5.98 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.532 1.933 . . . . 0.0 114.146 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.26 147.04 54.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.427 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.5 p -129.39 155.65 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.577 1.18 . . . . 0.0 112.929 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.38 -10.81 1.0 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.67 1.988 . . . . 0.0 116.272 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.0 -20.7 4.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.667 1.587 . . . . 0.0 111.644 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 66' ' ' HIS . 45.5 t30 -143.76 66.54 15.24 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.31 169.45 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.429 1 C-N-CA 126.167 4.578 . . . . 0.0 118.059 176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.9 mt -111.97 144.92 40.53 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.781 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -150.94 168.42 24.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.712 2.805 . . . . 0.0 106.618 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -111.73 107.62 56.39 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.81 -13.27 21.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.355 2.704 . . . . 0.0 112.455 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.6 t -138.17 -161.99 1.25 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.138 1.375 . . . . 0.0 112.579 -166.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 55.6 mmtt -131.27 26.63 4.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.809 2.044 . . . . 0.0 113.388 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -8.5 0.59 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.673 1.589 . . . . 0.0 114.217 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 54.6 -178.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 127.588 2.355 . . . . 0.0 115.626 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.41 -156.86 20.42 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.514 1.054 . . . . 0.0 114.635 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -82.69 5.08 22.43 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.018 1.327 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.73 9.2 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.563 1.545 . . . . 0.0 114.216 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -90.14 -4.7 57.13 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.181 0.993 . . . . 0.0 112.663 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -94.31 147.42 23.22 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.227 1.411 . . . . 0.0 111.201 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.1 mtp -158.85 139.89 12.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.993 0.917 . . . . 0.0 110.424 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.466 ' HB3' HD21 ' A' ' 50' ' ' ASN . 41.6 m80 -68.31 158.39 33.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.02 -46.75 87.42 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.071 -1.018 . . . . 0.0 109.015 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -54.86 -57.22 12.48 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.02 1.328 . . . . 0.0 112.988 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.1 m -62.68 -36.81 84.1 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.873 1.269 . . . . 0.0 111.972 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.92 -47.29 75.23 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.494 1.497 . . . . 0.0 110.694 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.63 -33.52 72.9 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.231 1.812 . . . . 0.0 112.256 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.44 -36.08 39.45 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.519 2.728 . . . . 0.0 111.898 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.3 t90 -69.4 -52.88 22.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.003 0.921 . . . . 0.0 109.806 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -58.92 -29.98 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.473 1.033 . . . . 0.0 111.204 172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.96 -39.36 76.07 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.717 -0.614 . . . . 0.0 110.498 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 m -66.03 -24.26 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.77 -1.206 . . . . 0.0 112.917 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -73.69 -5.71 42.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.954 2.102 . . . . 0.0 112.561 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.256 8.8 t30 63.15 45.27 5.24 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.321 1.449 . . . . 0.0 112.478 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.84 126.56 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.052 -1.03 . . . . 0.0 111.105 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -81.13 106.64 13.28 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.52 0.728 . . . . 0.0 111.118 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -61.54 -18.87 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 114.0 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -19.72 52.04 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.352 0.661 . . . . 0.0 112.742 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.22 141.7 43.19 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.968 -1.083 . . . . 0.0 113.545 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -84.05 6.15 5.93 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.391 3.394 . . . . 0.0 114.984 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.3 23.69 32.45 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 127.237 2.351 . . . . 0.0 112.554 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.88 163.54 30.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.09 1.356 . . . . 0.0 112.573 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -139.34 54.17 1.71 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.147 2.179 . . . . 0.0 108.602 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.72 106.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.481 1.512 . . . . 0.0 113.294 -174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -150.58 179.26 8.32 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 178.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 11.8 t -66.81 173.75 3.36 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.498 1.919 . . . . 0.0 115.907 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -131.35 -6.92 3.78 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.49 2.316 . . . . 0.0 112.603 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.3 mt -81.03 -64.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.122 0.969 . . . . 0.0 108.977 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.5 p -104.26 -11.75 17.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 129.916 3.287 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 62.33 18.74 10.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.762 2.825 . . . . 0.0 114.86 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 14.4 m-85 -74.17 142.77 79.36 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.834 -1.166 . . . . 0.0 113.234 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 32.1 Cg_exo -55.81 135.48 69.77 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.306 3.337 . . . . 0.0 111.316 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.67 126.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.363 1.065 . . . . 0.0 110.511 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.89 94.45 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.384 1.873 . . . . 0.0 110.38 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -57.27 132.45 53.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.118 1.367 . . . . 0.0 112.004 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 101' ' ' THR . 24.2 tptt 57.97 -169.02 0.12 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.522 1.929 . . . . 0.0 113.823 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.457 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 13.2 t . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.842 2.057 . . . . 0.0 111.223 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.1 169.12 23.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.973 1.309 . . . . 0.0 112.51 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -149.55 157.61 43.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.175 1.79 . . . . 0.0 110.479 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -141.38 162.21 36.04 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.508 1.123 . . . . 0.0 112.971 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -151.33 -28.98 0.19 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.721 1.609 . . . . 0.0 113.274 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 p -69.78 -173.09 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.835 2.454 . . . . 0.0 114.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.78 159.17 43.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.308 1.843 . . . . 0.0 111.838 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 p -148.42 -25.55 0.33 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.74 133.79 44.7 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.717 1.607 . . . . 0.0 113.342 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.6 m -145.21 136.75 25.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.898 2.079 . . . . 0.0 109.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -159.06 165.36 34.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.93 1.292 . . . . 0.0 111.633 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -150.83 -70.35 0.18 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.511 1.524 . . . . 0.0 109.927 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -142.45 148.58 37.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.04 1.336 . . . . 0.0 111.93 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.75 161.5 16.75 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.19 86.31 4.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 127.606 2.362 . . . . 0.0 109.674 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.87 149.58 91.01 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.756 2.304 . . . . 0.0 115.136 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -64.27 69.11 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.55 -46.61 1.12 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.818 3.104 . . . . 0.0 109.728 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . 0.296 . . 69.77 179.4 0.24 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.825 2.05 . . . . 0.0 112.043 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -154.36 162.86 40.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.566 1.147 . . . . 0.0 112.601 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 t -83.21 125.85 32.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.103 0.961 . . . . 0.0 111.425 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -11.67 58.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.9 1.28 . . . . 0.0 113.744 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE ' ' A' ' 65' ' ' MET . 67.6 mt -102.47 -52.72 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.659 1.183 . . . . 0.0 109.666 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 9.4 m -98.61 -13.78 20.21 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.254 36.2 mmt180 48.35 69.02 0.59 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 123.675 1.702 . . . . 0.0 108.41 -171.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.03 139.56 10.81 Favored Glycine 0 N--CA 1.463 0.446 0 CA-C-N 110.931 -2.849 . . . . 0.0 110.206 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.19 154.58 31.0 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.498 1.119 . . . . 0.0 110.68 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.93 18.22 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.146 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.9 p -101.21 -150.84 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.378 0.671 . . . . 0.0 111.06 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.51 12.83 8.1 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 126.809 2.043 . . . . 0.0 111.671 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -142.6 -12.79 0.78 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.358 2.663 . . . . 0.0 111.626 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -160.11 71.97 3.08 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.14 2.176 . . . . 0.0 107.82 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.57 -165.5 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.654 3.57 . . . . 0.0 110.371 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -131.6 154.14 49.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.971 1.308 . . . . 0.0 111.399 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -154.64 -179.03 7.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.297 1.439 . . . . 0.0 110.118 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 5.9 p80 -115.58 96.42 46.16 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.821 1.248 . . . . 0.0 111.601 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 54' ' ' HIS . 72.8 Cg_endo -76.14 -13.48 19.09 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.511 3.474 . . . . 0.0 113.556 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 3.1 t -148.61 166.98 26.65 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 128.858 2.863 . . . . 0.0 105.906 -171.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -75.45 -40.2 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 117.957 -1.021 . . . . 0.0 113.243 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.311 90.9 m 40.04 -17.75 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.548 1 C-N-CA 133.001 4.52 . . . . 0.0 119.719 -170.179 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.265 6.6 tpp180 45.87 58.86 4.04 Favored 'General case' 0 N--CA 1.471 0.6 1 C-N-CA 131.873 4.069 . . . . 0.0 115.99 -179.941 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.8 -178.48 48.44 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.36 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.9 p -53.49 -32.2 49.24 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.373 1.087 . . . . 0.0 112.182 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.62 -14.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 128.708 2.803 . . . . 0.0 114.642 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -62.91 -25.99 68.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.041 0.837 . . . . 0.0 112.519 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.6 136.37 36.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.388 1.089 . . . . 0.0 112.13 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.407 ' CE ' HD11 ' A' ' 41' ' ' ILE . 87.8 mtp -159.76 153.54 22.91 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.356 2.262 . . . . 0.0 108.278 -173.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -77.43 166.09 23.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.924 0.783 . . . . 0.0 109.283 171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.48 -41.42 76.18 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.088 -1.632 . . . . 0.0 111.772 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 m -75.4 -29.08 59.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.878 1.671 . . . . 0.0 114.486 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 14.0 p -78.57 -42.48 29.03 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.355 1.074 . . . . 0.0 112.113 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' CG2' ' A' ' 97' ' ' ILE 0.274 44.6 tp -52.75 -48.78 66.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.585 1.154 . . . . 0.0 111.174 169.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.19 -23.87 62.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.282 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 3.9 pt-20 -97.83 -30.34 12.83 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.865 . . . . 0.0 111.585 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -65.41 -49.87 67.58 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.179 1.392 . . . . 0.0 110.802 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.27 -34.83 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.063 0.847 . . . . 0.0 111.228 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.58 -34.83 79.17 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.25 0.548 . . . . 0.0 111.171 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 t -64.66 -16.28 62.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.55 1.14 . . . . 0.0 112.523 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -84.68 9.85 12.82 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 112.729 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 80.02 -0.71 2.06 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.16 2.584 . . . . 0.0 115.621 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.39 125.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.275 1.43 . . . . 0.0 112.327 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -84.48 102.54 12.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.114 0.966 . . . . 0.0 112.787 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.8 pt -66.92 -15.59 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.423 1.489 . . . . 0.0 113.798 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -69.41 -19.22 63.81 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -111.74 144.47 30.71 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.506 1.122 . . . . 0.0 112.596 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.92 10.32 2.38 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 124.197 3.265 . . . . 0.0 115.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.26 10.06 59.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.727 2.108 . . . . 0.0 113.08 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.02 167.47 6.3 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.564 1.546 . . . . 0.0 113.819 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -136.79 38.59 2.6 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.13 1.772 . . . . 0.0 110.506 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.79 78.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.471 1.909 . . . . 0.0 113.438 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -134.26 140.73 46.64 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.374 1.87 . . . . 0.0 110.677 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.39 172.78 0.79 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.493 2.317 . . . . 0.0 115.477 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -126.3 -9.28 6.39 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.351 2.26 . . . . 0.0 112.913 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.9 mt -85.3 -59.17 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 26.2 p -109.35 -6.66 15.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.827 2.451 . . . . 0.0 111.829 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.0 m80 63.89 21.39 12.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.997 2.119 . . . . 0.0 114.905 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.47 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 26.9 m-85 -80.4 143.28 55.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 120.716 -1.24 . . . . 0.0 112.846 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.92 141.22 83.43 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.835 2.357 . . . . 0.0 110.358 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.481 ' CG2' HD11 ' A' ' 70' ' ' LEU . 5.4 mm -86.53 129.1 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.437 1.095 . . . . 0.0 109.598 -178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.23 117.74 27.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.379 1.472 . . . . 0.0 109.526 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.7 8.13 3.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -161.75 153.08 18.49 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.634 2.373 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.282 2.233 . . . . 0.0 111.592 178.13 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 111.215 0.08 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.3 19.55 1.38 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.415 1.086 . . . . 0.0 113.89 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -60.31 -36.73 78.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -144.97 156.81 44.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -129.66 8.08 5.32 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.31 -1.768 . . . . 0.0 114.064 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.6 p -140.52 175.38 9.65 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.759 1.623 . . . . 0.0 111.558 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 66.33 -4.65 0.67 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.716 2.406 . . . . 0.0 117.249 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.8 p -50.98 -32.43 21.04 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.635 1.574 . . . . 0.0 114.858 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.71 40.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.612 2.365 . . . . 0.0 113.223 176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -142.53 55.73 1.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.866 2.066 . . . . 0.0 110.244 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -106.39 8.33 31.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.065 1.746 . . . . 0.0 114.767 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.92 154.54 34.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.248 1.419 . . . . 0.0 112.987 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -78.37 165.44 23.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.652 1.181 . . . . 0.0 111.599 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -148.87 26.28 0.91 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.193 2.197 . . . . 0.0 112.313 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 34' ' ' PRO . . . -124.11 172.22 6.06 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 127.741 2.416 . . . . 0.0 112.22 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 33' ' ' ALA . 81.0 Cg_exo -51.18 -178.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 1 C-N-CA 125.363 4.042 . . . . 0.0 115.686 174.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.2 p -94.91 -2.33 50.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.472 1.509 . . . . 0.0 113.624 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.27 15.36 1.88 Allowed Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.774 1.654 . . . . 0.0 114.302 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.04 138.47 47.91 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.858 1.329 . . . . 0.0 108.873 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.7 p -140.78 148.91 41.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.946 1.298 . . . . 0.0 111.924 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.7 t -60.3 123.62 17.8 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.267 1.827 . . . . 0.0 111.938 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -69.83 -8.02 44.88 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.787 -1.196 . . . . 0.0 112.114 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 77.6 mt -91.13 -51.66 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.75 13.67 5.87 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 61.81 8.98 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.458 2.703 . . . . 0.0 115.805 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.45 146.68 36.19 Favored Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.65 161.01 31.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.844 0.857 . . . . 0.0 111.92 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' HD12 ' A' ' 52' ' ' LEU . . . -68.72 120.74 15.17 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.58 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 p -96.52 -170.99 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.301 0.572 . . . . 0.0 110.212 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -84.48 -24.05 29.61 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 3.68 5.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 112.083 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.91 60.91 4.67 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 126.911 2.084 . . . . 0.0 109.953 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.56 -164.47 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 125.527 4.151 . . . . 0.0 111.926 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 46' ' ' ALA . 14.5 mt -126.65 163.04 24.35 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 126.703 2.001 . . . . 0.0 110.625 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -165.39 -169.91 1.72 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.746 2.418 . . . . 0.0 108.177 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -126.68 101.11 27.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 119.052 0.842 . . . . 0.0 111.127 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.57 ' HG2' ' H ' ' A' ' 56' ' ' CYS . 83.3 Cg_endo -72.44 -54.44 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 N-CA-C 108.264 -1.476 . . . . 0.0 108.264 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.57 ' H ' ' HG2' ' A' ' 55' ' ' PRO . 12.5 p -102.64 169.75 8.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 131.411 3.884 . . . . 0.0 112.295 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -108.16 35.3 3.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.436 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 11.7 m -48.11 -12.69 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 62.24 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.841 3.256 . . . . 0.0 115.335 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.0 -159.75 31.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.842 0.734 . . . . 0.0 112.234 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.6 p -64.91 -30.6 71.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.269 2.4 pp -75.4 10.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.0 pttm -96.4 -20.05 18.74 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.728 -0.608 . . . . 0.0 110.598 170.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -63.5 135.7 57.06 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.263 1.025 . . . . 0.0 108.865 171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.6 mtp -150.89 141.36 22.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.909 1.284 . . . . 0.0 108.585 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 4.0 m170 -64.52 139.99 58.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.187 0.994 . . . . 0.0 110.491 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -72.2 19.21 0.08 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.512 1.525 . . . . 0.0 112.629 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.6 p -135.75 -46.63 0.67 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 128.352 2.661 . . . . 0.0 109.15 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 74.1 m -62.37 -37.38 85.5 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.555 1.542 . . . . 0.0 111.404 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.73 -46.94 80.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.62 1.1 . . . . 0.0 109.814 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.18 -32.2 70.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.462 1.105 . . . . 0.0 111.501 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.06 -36.45 30.47 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.254 2.622 . . . . 0.0 111.23 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -65.35 -51.9 57.38 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.471 1.108 . . . . 0.0 109.315 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.25 -30.34 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 119.619 1.1 . . . . 0.0 110.836 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.875 -0.516 . . . . 0.0 110.2 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 p -67.73 -8.49 35.85 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -88.95 -1.59 58.18 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 126.352 1.861 . . . . 0.0 113.47 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER 71.83 17.22 5.41 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.782 1.633 . . . . 0.0 114.89 178.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.69 167.91 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.429 1.892 . . . . 0.0 111.587 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -128.18 106.95 9.4 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.575 1.55 . . . . 0.0 110.472 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -18.43 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.871 1.268 . . . . 0.0 113.674 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -76.81 -8.55 57.53 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.07 143.94 78.29 Favored Pre-proline 0 N--CA 1.479 0.976 0 O-C-N 120.773 -1.204 . . . . 0.0 111.586 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.17 7.07 3.87 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.813 3.009 . . . . 0.0 116.757 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.62 8.39 8.28 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 127.143 2.306 . . . . 0.0 112.056 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.7 142.83 57.28 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.896 0.848 . . . . 0.0 112.747 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -138.01 32.95 2.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.738 1.615 . . . . 0.0 110.368 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.56 118.07 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 112.741 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -146.79 176.47 9.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 176.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 4.3 t -56.01 162.29 1.97 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.025 2.53 . . . . 0.0 113.07 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -115.38 -12.0 11.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.23 -53.94 8.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 122.817 0.447 . . . . 0.0 109.811 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.3 p -106.72 -7.56 17.22 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 53.71 14.07 0.58 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.255 1.822 . . . . 0.0 115.276 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -82.5 136.34 45.75 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.118 -1.614 . . . . 0.0 110.584 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 54.5 Cg_exo -46.74 126.2 10.5 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.233 2.622 . . . . 0.0 112.276 171.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 55' ' ' PRO 0.262 0.6 OUTLIER -78.6 111.27 15.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 113.1 -1.864 . . . . 0.0 109.545 -173.521 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -80.74 73.29 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.721 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.03 143.16 3.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.161 1.784 . . . . 0.0 113.411 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.65 123.77 19.09 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.427 1.491 . . . . 0.0 109.44 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.501 1.521 . . . . 0.0 109.543 179.092 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.13 22.67 3.26 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.0 1.32 . . . . 0.0 113.272 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -140.58 156.7 46.21 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.776 1.63 . . . . 0.0 111.887 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.55 147.88 21.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.196 1.798 . . . . 0.0 113.904 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.35 56.33 3.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.427 1.891 . . . . 0.0 111.541 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p 51.28 -163.75 0.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 127.197 2.199 . . . . 0.0 115.357 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -152.37 139.28 19.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.842 1.657 . . . . 0.0 110.38 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.8 t -160.91 159.78 30.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.972 1.309 . . . . 0.0 111.653 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.92 161.21 41.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.23 1.412 . . . . 0.0 112.429 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 p -94.85 26.28 3.67 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.789 2.036 . . . . 0.0 112.761 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -139.55 144.0 37.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.889 2.475 . . . . 0.0 111.903 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.08 65.23 0.77 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.836 1.254 . . . . 0.0 112.496 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -148.86 36.94 0.79 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.8 1.24 . . . . 0.0 111.271 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.0 t70 60.44 -58.23 0.08 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 130.892 3.677 . . . . 0.0 118.644 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 5.62 86.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 130.573 3.549 . . . . 0.0 115.964 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -57.07 146.98 78.0 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.33 2.02 . . . . 0.0 114.281 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 m -80.73 31.73 0.3 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.588 1.155 . . . . 0.0 112.667 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.38 38.23 0.04 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 127.013 2.244 . . . . 0.0 112.273 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.45 157.93 33.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.293 0.568 . . . . 0.0 110.625 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -156.34 165.68 35.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.793 1.237 . . . . 0.0 112.496 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.25 128.03 32.79 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.176 1.39 . . . . 0.0 110.306 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -7.81 43.17 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.6 mt -94.05 -37.63 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.421 1.089 . . . . 0.0 110.956 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.8 p -133.43 4.17 3.66 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 61.24 19.33 10.0 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.702 2.001 . . . . 0.0 113.833 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.5 145.55 22.05 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.02 164.46 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.962 0.881 . . . . 0.0 111.472 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.83 144.43 56.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.9 p -135.27 156.65 48.61 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.42 1.105 . . . . 0.0 113.692 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.94 8.82 0.23 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.753 2.421 . . . . 0.0 115.452 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -133.65 -20.07 2.05 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.13 2.172 . . . . 0.0 111.221 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -155.71 71.45 5.37 Favored Pre-proline 0 N--CA 1.445 -0.711 0 C-N-CA 124.667 1.187 . . . . 0.0 112.125 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.42 171.36 0.42 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 125.009 3.806 . . . . 0.0 116.354 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.84 148.83 35.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.726 173.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -157.75 179.2 9.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.89 2.076 . . . . 0.0 108.393 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -120.74 112.65 33.67 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.318 0.647 . . . . 0.0 110.603 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -79.22 -12.19 14.39 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.784 2.989 . . . . 0.0 112.218 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.8 t -133.36 -153.39 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.424 1.489 . . . . 0.0 112.468 -167.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 5.4 tmtt? -135.89 14.07 3.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.193 2.197 . . . . 0.0 115.028 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.9 m -46.66 -23.52 0.42 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.869 2.468 . . . . 0.0 115.222 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 ttp-105 65.39 162.92 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.18 2.992 . . . . 0.0 114.282 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.58 -164.9 29.5 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.508 -0.745 . . . . 0.0 113.029 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.3 m -61.08 -34.57 75.13 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.303 -1.116 . . . . 0.0 113.185 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.76 1.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -83.21 -21.69 33.37 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.218 -0.926 . . . . 0.0 112.515 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.48 150.66 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.022 0.915 . . . . 0.0 110.636 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.8 mtp -158.21 141.46 15.07 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.35 1.46 . . . . 0.0 109.793 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -70.53 151.4 45.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -56.28 -49.56 73.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.114 -0.366 . . . . 0.0 110.276 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.2 t -64.27 -44.32 92.11 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.46 -46.68 87.41 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.312 -0.867 . . . . 0.0 112.243 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 tp -54.83 -45.44 74.45 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.179 0.9 . . . . 0.0 109.728 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.22 -25.64 65.78 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -89.78 -32.25 17.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.323 0.965 . . . . 0.0 111.868 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -60.83 -57.92 10.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.969 1.308 . . . . 0.0 110.618 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.95 -23.98 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.872 1.269 . . . . 0.0 111.65 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.14 58.63 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 m -93.87 5.73 50.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.918 1.287 . . . . 0.0 111.817 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -108.18 9.13 28.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.728 2.411 . . . . 0.0 113.673 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.253 10.3 t30 63.69 42.62 6.18 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.713 1.205 . . . . 0.0 112.387 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.47 152.73 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.593 1.557 . . . . 0.0 110.102 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -123.74 111.55 16.29 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.974 1.309 . . . . 0.0 110.457 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.4 pt -60.88 -19.73 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.247 1.419 . . . . 0.0 113.827 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.9 t -78.67 -14.85 59.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -93.02 143.58 27.03 Favored Pre-proline 0 N--CA 1.478 0.942 0 O-C-N 121.177 -0.952 . . . . 0.0 112.629 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.11 5.09 6.47 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.849 3.033 . . . . 0.0 115.638 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.62 10.75 38.68 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.955 2.217 . . . . 0.0 112.727 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.37 156.47 29.11 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.034 0.934 . . . . 0.0 113.145 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.04 45.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.409 1.484 . . . . 0.0 110.746 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.93 102.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.743 1.217 . . . . 0.0 112.575 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.9 tttm -143.66 142.1 30.86 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.362 1.465 . . . . 0.0 112.378 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.82 178.33 0.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.447 2.699 . . . . 0.0 115.174 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -132.19 -12.08 3.22 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.755 2.422 . . . . 0.0 112.727 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -78.33 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 122.119 0.961 . . . . 0.0 109.213 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.75 -8.6 17.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.916 2.886 . . . . 0.0 111.264 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.448 ' O ' ' HE2' ' A' ' 89' ' ' LYS 0.364 0.0 OUTLIER 63.34 18.97 11.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.643 3.177 . . . . 0.0 115.366 -175.883 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 16.8 m-85 -75.7 145.8 79.05 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 120.477 -1.389 . . . . 0.0 114.329 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -61.74 141.61 91.12 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.214 1.943 . . . . 0.0 109.813 170.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -86.42 117.92 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 125.17 1.388 . . . . 0.0 108.143 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -114.38 94.63 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.427 1.491 . . . . 0.0 111.845 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -59.01 157.35 10.18 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.037 1.735 . . . . 0.0 112.807 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -62.9 158.74 18.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 113.258 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.288 1.835 . . . . 0.0 110.73 178.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.091 0.472 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.53 167.08 29.46 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.482 1.913 . . . . 0.0 110.205 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -37.72 -8.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 120.814 3.635 . . . . 0.0 120.814 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -110.82 -15.45 13.8 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 0.0 113.168 176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.46 4.51 43.77 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.496 2.318 . . . . 0.0 113.265 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -82.06 60.02 4.67 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.182 1.793 . . . . 0.0 111.253 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.68 20.68 15.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.339 1.855 . . . . 0.0 113.97 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.4 p -79.05 49.05 0.9 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 127.213 2.205 . . . . 0.0 111.981 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.59 151.07 6.25 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -144.89 162.88 35.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.88 2.472 . . . . 0.0 110.972 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.32 154.94 44.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.513 1.525 . . . . 0.0 112.138 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -149.99 152.86 35.6 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.183 1.393 . . . . 0.0 113.529 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -73.74 47.2 0.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.834 2.054 . . . . 0.0 114.03 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -81.57 48.67 1.21 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.683 1.993 . . . . 0.0 112.258 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.85 92.44 34.06 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.196 2.198 . . . . 0.0 114.068 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.91 146.96 92.12 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.632 2.222 . . . . 0.0 112.333 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.6 m -78.04 -7.75 57.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.141 -0.974 . . . . 0.0 112.571 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.75 -1.38 49.38 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.291 1.901 . . . . 0.0 113.448 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.83 158.62 36.06 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 52.7 p -121.11 163.9 17.68 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.8 t -80.62 133.31 35.73 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 120.835 -1.166 . . . . 0.0 108.093 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.56 -21.77 66.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.49 1.041 . . . . 0.0 113.021 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.72 -49.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.749 1.22 . . . . 0.0 110.216 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -88.23 -23.73 23.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 58.91 36.91 24.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.376 1.47 . . . . 0.0 108.893 -167.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.0 134.49 10.83 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.931 1.253 . . . . 0.0 112.974 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -71.58 142.62 50.01 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -39.18 148.97 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.625 1.57 . . . . 0.0 114.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -128.22 179.61 5.52 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.202 1.001 . . . . 0.0 111.214 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.84 -32.02 68.92 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.98 -31.37 13.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.644 1.978 . . . . 0.0 110.704 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -123.62 65.56 33.84 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.63 167.16 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.261 1.974 . . . . 0.0 112.186 162.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.9 mt -117.83 146.62 43.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.759 -2.019 . . . . 0.0 112.153 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -149.39 163.53 37.49 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.406 3.082 . . . . 0.0 105.712 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -114.02 104.33 54.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.54 -24.72 35.64 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.282 1.988 . . . . 0.0 113.174 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.436 ' HB2' HD13 ' A' ' 97' ' ' ILE 0.258 0.5 OUTLIER -139.96 150.53 44.6 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 127.262 2.225 . . . . 0.0 107.779 -168.876 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.22 -46.7 62.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 117.112 -1.423 . . . . 0.0 111.734 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 68.2 m 32.73 -12.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.357 1 C-N-CA 133.195 4.598 . . . . 0.0 120.901 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 72.14 149.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 131.002 3.721 . . . . 0.0 113.941 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.41 -142.55 48.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.74 1.162 . . . . 0.0 114.679 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -95.92 -7.05 37.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 112.891 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.0 24.87 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 111.931 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -105.82 -26.21 11.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.513 1.525 . . . . 0.0 112.374 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -77.48 152.45 34.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.139 1.376 . . . . 0.0 112.226 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 90.3 mtp -158.74 144.75 16.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.328 0.651 . . . . 0.0 112.294 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -70.8 152.45 43.74 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -56.16 -49.19 74.69 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.204 -0.935 . . . . 0.0 110.874 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -54.71 -50.04 69.27 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.411 1.084 . . . . 0.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.53 -44.16 93.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.72 -48.0 73.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.06 0.845 . . . . 0.0 111.44 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -55.7 -30.86 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.603 1.961 . . . . 0.0 112.949 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -91.99 -38.84 12.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.088 1.755 . . . . 0.0 112.156 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 80.2 t90 -58.62 -45.19 89.74 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 123.819 0.848 . . . . 0.0 111.015 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.36 -26.08 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.176 0.898 . . . . 0.0 112.213 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.63 62.49 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.788 -1.195 . . . . 0.0 111.43 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.7 p -84.5 11.18 9.14 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.527 -0.733 . . . . 0.0 112.502 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -115.03 8.39 15.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.701 1.6 . . . . 0.0 112.894 -174.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.32 0.0 OUTLIER 79.36 38.03 0.13 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.911 2.084 . . . . 0.0 112.67 178.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.58 145.28 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.437 1.095 . . . . 0.0 113.54 -171.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -139.54 102.84 4.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.662 1.585 . . . . 0.0 110.024 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -12.26 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.258 1.423 . . . . 0.0 114.485 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -75.59 -16.34 60.25 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.726 -0.609 . . . . 0.0 111.972 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -106.56 142.21 24.46 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.103 1.361 . . . . 0.0 111.6 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.97 29.27 0.44 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.548 3.499 . . . . 0.0 114.626 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.15 20.19 6.32 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.882 2.182 . . . . 0.0 111.724 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.09 163.69 24.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 122.353 1.073 . . . . 0.0 113.637 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -143.92 41.47 1.42 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.85 2.06 . . . . 0.0 109.099 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.285 11.1 p -68.36 65.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.685 2.394 . . . . 0.0 115.447 -173.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -133.53 144.88 49.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.401 2.281 . . . . 0.0 110.64 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -67.95 173.65 4.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.656 2.383 . . . . 0.0 115.256 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -129.12 -10.69 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.862 2.465 . . . . 0.0 112.978 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.0 mt -78.76 -55.76 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.903 0.858 . . . . 0.0 109.434 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.9 p -115.45 -7.46 12.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 129.06 2.944 . . . . 0.0 111.85 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 66.9 20.7 10.51 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.078 2.551 . . . . 0.0 114.861 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.8 m-85 -85.14 145.81 43.91 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 113.487 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.24 135.96 49.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.53 2.154 . . . . 0.0 109.796 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 56' ' ' CYS . 11.4 mm -77.76 141.74 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.507 1.123 . . . . 0.0 109.817 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -133.56 120.58 20.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.243 1.417 . . . . 0.0 111.456 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -78.43 18.27 0.57 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -159.76 151.76 20.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.642 2.377 . . . . 0.0 110.448 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 126.416 1.886 . . . . 0.0 113.202 178.695 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.87 166.75 26.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.733 1.213 . . . . 0.0 112.737 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -81.45 2.47 28.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.251 1.421 . . . . 0.0 113.612 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -146.09 157.73 43.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.273 1.829 . . . . 0.0 111.414 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 56.08 12.9 1.03 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.684 1.994 . . . . 0.0 116.222 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -156.24 175.16 14.36 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 120.417 -1.427 . . . . 0.0 112.176 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.94 147.85 27.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.922 1.689 . . . . 0.0 111.991 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.2 p -141.07 32.83 1.74 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.549 1.54 . . . . 0.0 113.08 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.92 50.93 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.028 -1.045 . . . . 0.0 113.776 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.2 p -74.31 154.97 38.68 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 113.015 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -48.68 159.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.181 2.192 . . . . 0.0 115.615 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.09 171.66 13.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.866 1.667 . . . . 0.0 112.112 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -140.47 172.86 12.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.274 1.83 . . . . 0.0 111.527 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -150.0 142.27 24.18 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.48 1.112 . . . . 0.0 113.618 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.04 159.89 60.12 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.87 2.068 . . . . 0.0 111.629 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -50.66 161.51 1.28 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.945 3.097 . . . . 0.0 114.72 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 m -76.71 -6.89 54.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.64 23.09 1.83 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 114.02 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.69 46.69 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.477 1.139 . . . . 0.0 109.749 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -143.36 149.34 37.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.125 1.37 . . . . 0.0 113.01 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -57.51 129.25 40.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.663 1.585 . . . . 0.0 112.214 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.96 -7.97 53.51 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.455 -1.403 . . . . 0.0 113.827 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.6 mt -96.17 -44.09 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 117.724 -1.132 . . . . 0.0 109.627 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 21.3 p -128.07 9.67 6.3 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 55.17 19.58 2.94 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.652 2.381 . . . . 0.0 114.499 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.2 149.28 29.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.72 163.63 24.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.124 0.962 . . . . 0.0 111.175 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.82 129.44 41.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -99.02 -146.67 0.33 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.335 0.588 . . . . 0.0 112.046 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -130.7 13.49 5.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.561 2.344 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -145.25 -18.01 0.49 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.207 2.603 . . . . 0.0 111.591 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 66' ' ' HIS . 47.3 t30 -153.84 68.59 6.22 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 125.043 1.337 . . . . 0.0 111.883 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -56.67 179.51 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.43 1 C-N-CA 125.466 4.111 . . . . 0.0 116.263 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.52 154.01 32.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 113.017 -1.901 . . . . 0.0 111.459 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -160.17 -177.62 6.4 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.813 3.245 . . . . 0.0 106.311 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -128.96 117.62 19.3 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 118.585 0.63 . . . . 0.0 109.794 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 56' ' ' CYS . 33.0 Cg_endo -82.74 -9.93 10.82 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 123.815 3.01 . . . . 0.0 113.015 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 2.0 t -141.01 -162.87 1.43 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.769 1.228 . . . . 0.0 111.327 -166.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -129.21 24.38 5.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.258 1.823 . . . . 0.0 113.352 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -48.25 -21.53 0.52 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.849 2.06 . . . . 0.0 113.816 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 63.05 152.85 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 129.391 3.077 . . . . 0.0 115.549 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.4 -164.89 40.68 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.653 1.121 . . . . 0.0 114.752 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.7 m -59.02 6.89 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.88 7.15 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 126.491 1.916 . . . . 0.0 112.386 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -82.19 -23.09 35.68 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.894 . . . . 0.0 111.977 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -78.07 145.75 35.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.058 1.343 . . . . 0.0 111.289 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 91.6 mtp -155.9 139.22 15.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.47 1.108 . . . . 0.0 109.353 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.423 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.5 m80 -70.1 157.51 37.43 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.99 -50.59 72.78 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.391 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.3 t -58.69 -36.92 74.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.303 1.041 . . . . 0.0 113.074 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.51 -44.77 33.79 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.439 -0.788 . . . . 0.0 112.106 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.41 -41.75 85.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.712 1.596 . . . . 0.0 109.839 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.36 -33.52 72.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.906 1.682 . . . . 0.0 113.401 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.86 -27.4 26.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.533 0.733 . . . . 0.0 111.819 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.91 -57.58 4.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.687 1.595 . . . . 0.0 111.095 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 81' ' ' ILE . 33.3 m -55.47 -23.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.288 0.635 . . . . 0.0 111.105 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.51 30.77 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.812 0.445 . . . . 0.0 112.066 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -72.12 -23.85 61.38 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.356 -1.465 . . . . 0.0 111.399 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -77.61 -2.63 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.519 2.728 . . . . 0.0 112.389 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 t30 61.42 47.11 7.0 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.363 1.465 . . . . 0.0 113.487 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.08 118.81 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 120.558 -1.339 . . . . 0.0 111.741 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -78.44 97.26 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.019 0.928 . . . . 0.0 111.477 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 74' ' ' VAL . 19.8 pt -63.66 -16.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.289 1.436 . . . . 0.0 113.68 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -75.97 -14.21 60.24 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -81.34 139.46 48.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 O-C-N 120.978 -1.076 . . . . 0.0 112.036 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.88 4.41 7.06 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.894 3.062 . . . . 0.0 115.949 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.39 18.27 5.79 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 127.789 2.614 . . . . 0.0 111.615 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.09 158.71 10.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.948 0.899 . . . . 0.0 113.31 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -120.23 37.17 4.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.5 1.52 . . . . 0.0 111.89 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.64 101.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.418 1.487 . . . . 0.0 110.734 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -147.95 143.73 27.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.673 1.189 . . . . 0.0 112.796 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.6 t -66.37 177.42 1.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.439 2.696 . . . . 0.0 115.169 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -131.32 -10.63 3.67 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.426 2.29 . . . . 0.0 112.65 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.36 -61.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 121.245 -0.909 . . . . 0.0 109.236 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.7 p -106.45 -9.7 16.58 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.348 2.659 . . . . 0.0 111.194 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.4 t60 63.74 23.53 13.5 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.939 2.495 . . . . 0.0 114.516 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.495 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 16.7 m-85 -79.41 145.04 62.92 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 120.413 -1.429 . . . . 0.0 113.132 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.28 135.86 56.56 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.012 2.475 . . . . 0.0 110.49 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.9 mm -79.29 113.77 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.892 2.077 . . . . 0.0 108.514 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -126.19 97.56 5.13 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.753 2.021 . . . . 0.0 110.924 -172.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -59.11 29.26 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 130.317 3.447 . . . . 0.0 117.835 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.3 mttm 42.89 46.12 4.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 128.494 2.718 . . . . 0.0 114.284 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.254 1.312 0 C-N-CA 126.859 2.064 . . . . 0.0 113.718 178.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.64 39.11 0.12 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.688 1.995 . . . . 0.0 113.381 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.92 4.9 0.48 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.778 2.031 . . . . 0.0 112.005 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.53 -5.32 0.56 Allowed 'General case' 0 CA--C 1.554 1.134 0 O-C-N 120.402 -1.436 . . . . 0.0 113.067 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -129.16 21.87 5.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.322 2.649 . . . . 0.0 110.013 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 p -156.24 160.48 39.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.123 2.569 . . . . 0.0 110.929 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.24 125.3 19.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.631 1.172 . . . . 0.0 110.445 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -156.37 22.85 0.35 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.584 1.553 . . . . 0.0 112.518 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.79 143.3 13.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.122 1.369 . . . . 0.0 114.254 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.5 p -72.17 -3.69 24.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.434 1.894 . . . . 0.0 115.237 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -74.3 44.26 0.19 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.284 2.634 . . . . 0.0 112.776 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -135.04 -9.39 2.31 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.397 1.879 . . . . 0.0 113.185 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -149.26 166.14 29.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.044 2.138 . . . . 0.0 108.776 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -139.43 145.6 39.07 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.334 1.054 . . . . 0.0 112.349 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.46 162.19 27.17 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.648 2.779 . . . . 0.0 106.505 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -42.16 -36.61 4.14 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.81 3.674 . . . . 0.0 120.403 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 t 56.87 36.42 27.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.433 1.893 . . . . 0.0 111.31 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.14 41.62 0.02 OUTLIER Glycine 0 CA--C 1.534 1.272 0 C-N-CA 128.675 3.036 . . . . 0.0 111.287 -176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.21 168.3 19.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.119 0.968 . . . . 0.0 110.959 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.7 p -150.81 153.53 35.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.755 1.222 . . . . 0.0 113.485 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.94 133.09 54.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.145 1.378 . . . . 0.0 110.084 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -71.09 -13.25 61.9 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.185 -0.947 . . . . 0.0 113.032 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 69' ' ' CYS . 73.5 mt -94.01 -41.57 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.296 1.039 . . . . 0.0 111.046 -175.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.2 p -133.26 13.01 4.22 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 55.15 17.46 1.98 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.932 2.093 . . . . 0.0 114.353 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.46 154.6 42.47 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -83.59 164.58 19.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.393 1.096 . . . . 0.0 110.111 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.82 25.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -92.01 -138.11 0.17 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 120.657 0.265 . . . . 0.0 111.49 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -130.71 5.38 4.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.776 2.03 . . . . 0.0 111.334 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -141.34 -10.01 0.96 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.694 3.198 . . . . 0.0 110.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -140.86 61.98 16.2 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 127.271 2.228 . . . . 0.0 114.162 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.1 159.97 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.893 2.395 . . . . 0.0 114.171 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -107.61 143.0 36.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 112.452 -2.158 . . . . 0.0 110.492 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -156.16 176.93 12.03 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.48 3.112 . . . . 0.0 106.612 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -124.04 117.85 26.96 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 118.253 0.479 . . . . 0.0 110.057 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -81.47 -7.58 12.71 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.72 3.614 . . . . 0.0 112.549 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 93' ' ' CYS . 30.3 p -152.49 159.25 43.35 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.172 1.789 . . . . 0.0 113.055 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HB2' ' CD2' ' A' ' 95' ' ' TYR . 6.2 mtmm -77.12 30.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.264 1.826 . . . . 0.0 113.868 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.32 -14.9 1.33 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 27.09 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 130.559 3.544 . . . . 0.0 115.826 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.98 -174.73 30.19 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.853 1.692 . . . . 0.0 112.147 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -62.61 6.43 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.75 6.07 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.549 2.34 . . . . 0.0 112.392 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -78.19 -22.5 48.51 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.081 -1.012 . . . . 0.0 112.002 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -80.29 145.99 31.86 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.172 1.389 . . . . 0.0 112.26 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 88.7 mtp -154.77 139.19 16.77 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.041 0.936 . . . . 0.0 110.485 -174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 15.7 m170 -66.2 148.07 52.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -61.76 -35.3 77.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 122.011 -0.431 . . . . 0.0 110.837 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.4 m -79.21 -28.83 42.59 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 88.0 m -81.07 -39.78 25.19 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.119 0.967 . . . . 0.0 111.219 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.21 -44.18 92.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.966 1.257 . . . . 0.0 109.277 172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.16 -33.91 65.68 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.635 1.174 . . . . 0.0 113.597 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.5 pt-20 -88.99 -32.7 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.063 0.545 . . . . 0.0 112.244 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -62.24 -49.3 76.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.859 0.864 . . . . 0.0 110.097 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.62 -32.42 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.784 0.72 . . . . 0.0 112.199 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.98 -17.74 62.64 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.557 -0.714 . . . . 0.0 111.747 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -86.26 2.26 47.84 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.247 -0.908 . . . . 0.0 111.891 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -105.0 4.74 31.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.583 1.953 . . . . 0.0 114.046 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 62.98 44.85 5.71 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.566 1.146 . . . . 0.0 112.298 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.72 121.36 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.64 1.176 . . . . 0.0 110.697 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -80.13 106.91 12.51 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.283 0.633 . . . . 0.0 109.926 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.9 pt -60.85 -18.02 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.965 1.306 . . . . 0.0 113.907 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 t -82.09 -13.5 57.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -88.63 141.02 29.87 Favored Pre-proline 0 N--CA 1.481 1.083 0 O-C-N 121.027 -1.046 . . . . 0.0 112.682 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.08 0.83 9.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.03 3.153 . . . . 0.0 116.177 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.49 8.53 34.96 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.957 2.218 . . . . 0.0 112.736 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.93 168.3 15.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.775 1.23 . . . . 0.0 113.555 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -134.2 52.46 2.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.006 1.723 . . . . 0.0 109.979 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.36 76.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.135 1.774 . . . . 0.0 111.477 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . 0.269 18.5 ttmt -131.04 151.1 51.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.832 2.053 . . . . 0.0 111.631 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 15.3 t -63.98 165.78 8.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 0.0 113.731 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -120.7 3.58 10.63 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.396 1.878 . . . . 0.0 111.911 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -106.87 -55.58 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.513 1.525 . . . . 0.0 108.82 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 56' ' ' CYS . 16.6 p -105.1 -4.82 21.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.272 0.629 . . . . 0.0 112.16 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 60.77 10.43 2.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.326 2.25 . . . . 0.0 116.027 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 75.2 m-85 -92.44 146.32 32.23 Favored Pre-proline 0 N--CA 1.47 0.555 0 O-C-N 120.464 -1.397 . . . . 0.0 111.611 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -45.33 142.98 5.81 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.853 3.036 . . . . 0.0 113.208 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -104.56 122.77 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.68 1.592 . . . . 0.0 110.596 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.72 122.87 44.64 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -66.24 175.42 2.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.235 1.814 . . . . 0.0 113.977 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -127.04 148.55 50.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.36 1.864 . . . . 0.0 111.244 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 128.348 2.659 . . . . 0.0 109.735 179.805 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 111.196 0.072 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.86 38.21 1.98 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.145 1.378 . . . . 0.0 111.994 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -55.61 140.1 42.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.21 1.404 . . . . 0.0 112.996 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.35 153.49 30.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.959 0.904 . . . . 0.0 113.373 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 60.3 -25.63 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 129.091 2.956 . . . . 0.0 117.467 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.3 p -97.68 15.03 24.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.255 1.822 . . . . 0.0 113.518 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -146.08 153.74 41.05 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.251 1.821 . . . . 0.0 111.494 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.19 135.4 32.38 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.467 1.507 . . . . 0.0 110.366 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.98 169.98 15.4 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.787 1.235 . . . . 0.0 113.086 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 p -148.65 149.58 31.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.893 2.077 . . . . 0.0 110.179 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -143.94 -4.68 0.82 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.584 1.554 . . . . 0.0 114.778 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -135.88 21.38 3.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.017 1.727 . . . . 0.0 113.244 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -73.26 40.37 0.1 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.51 1.924 . . . . 0.0 114.295 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -63.06 20.85 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.93 3.292 . . . . 0.0 117.048 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.09 150.75 73.83 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.339 1.856 . . . . 0.0 113.646 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -50.33 155.44 4.87 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.581 3.52 . . . . 0.0 115.782 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -62.09 -15.0 42.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.513 1.525 . . . . 0.0 114.551 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.29 11.64 7.2 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.453 1.978 . . . . 0.0 114.141 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.61 134.94 40.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.954 0.877 . . . . 0.0 110.059 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.4 p -144.16 153.53 42.21 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.343 1.457 . . . . 0.0 111.488 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.0 t -63.72 127.1 29.84 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.504 1.122 . . . . 0.0 112.005 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -4.8 22.64 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.0 mt -103.57 -45.24 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.123 1.369 . . . . 0.0 110.226 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -123.69 5.08 8.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.32 31.5 mmt180 50.73 32.41 6.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.17 2.188 . . . . 0.0 115.632 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.3 148.1 18.86 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.29 168.4 18.4 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.834 1.653 . . . . 0.0 112.407 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.67 150.03 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.664 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.4 p -139.18 172.13 13.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.502 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -61.83 -21.93 65.05 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -119.63 -20.94 7.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.428 1.491 . . . . 0.0 112.281 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -137.97 66.51 47.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.193 1.797 . . . . 0.0 110.499 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.03 -167.93 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 1 C-N-CA 125.435 4.09 . . . . 0.0 111.113 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.7 mt -132.77 155.57 48.67 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.724 1.61 . . . . 0.0 111.868 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -153.92 -179.61 8.01 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.786 2.434 . . . . 0.0 108.122 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -129.24 110.42 18.03 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.579 0.752 . . . . 0.0 111.146 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.63 -17.42 12.61 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.577 2.851 . . . . 0.0 113.57 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 4.1 t -133.55 -161.55 1.15 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.312 1.845 . . . . 0.0 112.067 -165.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 4.3 mptp? -123.14 12.79 9.62 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.734 1.614 . . . . 0.0 114.717 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.7 m -44.62 -25.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.222 2.609 . . . . 0.0 116.703 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 65.18 159.36 0.11 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.933 3.293 . . . . 0.0 115.599 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.47 -157.63 19.34 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.09 0.852 . . . . 0.0 113.599 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.1 p -59.48 -18.41 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.5 pt -84.79 -7.57 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.755 1.161 . . . . 0.0 113.601 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -76.06 -18.74 59.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.154 1.343 . . . . 0.0 113.535 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -84.53 143.34 29.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.359 1.064 . . . . 0.0 112.285 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 81.6 mtp -156.62 143.03 18.33 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.363 1.465 . . . . 0.0 109.793 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -76.35 154.51 34.92 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -57.14 -46.45 82.69 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.272 -0.892 . . . . 0.0 111.911 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -64.36 -42.97 95.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.002 0.921 . . . . 0.0 111.949 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.3 m -61.79 -43.88 97.97 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.173 -0.955 . . . . 0.0 111.751 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.71 -47.88 83.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.88 0.764 . . . . 0.0 109.811 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.08 -29.49 60.65 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -85.97 -38.33 18.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.415 1.086 . . . . 0.0 111.577 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -63.78 -48.19 77.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.199 1.0 . . . . 0.0 111.731 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 m -61.89 -28.96 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.656 -0.653 . . . . 0.0 111.691 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.52 71.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.013 0.525 . . . . 0.0 111.429 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 p -66.91 -14.24 62.57 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.744 -1.223 . . . . 0.0 113.305 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.31 3.66 20.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.689 1.596 . . . . 0.0 112.796 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.254 10.2 t30 64.47 42.73 4.88 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.35 147.48 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.069 1.348 . . . . 0.0 110.547 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -125.89 111.57 14.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.269 1.428 . . . . 0.0 111.083 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.5 pt -62.98 -18.75 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 125.014 1.326 . . . . 0.0 113.777 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.8 t -77.28 -7.62 56.27 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.67 150.94 44.81 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.64 1.576 . . . . 0.0 112.397 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.9 14.96 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.128 3.219 . . . . 0.0 115.89 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.95 4.3 38.87 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 126.511 2.005 . . . . 0.0 112.757 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.96 145.45 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.352 1.061 . . . . 0.0 113.18 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.03 40.94 0.73 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.309 1.844 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -66.26 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.568 1.547 . . . . 0.0 113.169 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 94' ' ' HIS . 14.5 tttm -145.74 146.62 31.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.292 1.837 . . . . 0.0 111.378 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 35.8 t -63.4 175.72 0.95 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.599 2.36 . . . . 0.0 115.903 -174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -130.42 -4.06 4.29 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.599 2.36 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.6 mt -88.6 -66.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.011 -1.055 . . . . 0.0 108.437 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.27 -8.84 21.76 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.206 2.602 . . . . 0.0 110.947 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' O ' ' HE2' ' A' ' 89' ' ' LYS . 72.3 m80 64.07 24.0 13.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.162 2.185 . . . . 0.0 114.38 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.438 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 18.7 m-85 -79.72 145.75 63.17 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -61.03 142.28 96.9 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.853 2.369 . . . . 0.0 110.045 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 56' ' ' CYS . 6.9 mm -90.48 130.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 124.662 1.185 . . . . 0.0 111.306 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -119.05 107.92 14.09 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.024 1.729 . . . . 0.0 111.49 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -69.63 70.04 0.29 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.527 1.931 . . . . 0.0 113.611 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? 55.56 -154.49 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.896 2.078 . . . . 0.0 112.576 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.253 1.268 0 C-N-CA 127.329 2.252 . . . . 0.0 112.447 -175.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.18 154.57 0.57 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.667 1.587 . . . . 0.0 114.166 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -51.46 -21.49 2.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -137.13 129.68 30.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.646 1.178 . . . . 0.0 111.354 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -89.88 0.68 56.91 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.166 1.386 . . . . 0.0 113.928 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 p -74.93 31.68 0.09 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.13 2.172 . . . . 0.0 114.617 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.02 162.4 29.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.988 1.715 . . . . 0.0 112.818 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.6 p -149.73 156.75 42.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.034 1.734 . . . . 0.0 112.237 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.74 156.62 36.68 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.391 1.477 . . . . 0.0 111.76 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -154.82 160.22 41.11 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.779 1.232 . . . . 0.0 112.013 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -45.85 111.69 0.38 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.639 1.976 . . . . 0.0 113.411 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -63.93 1.82 0.61 Allowed 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.4 t0 103.02 155.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 131.046 3.739 . . . . 0.0 111.378 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -73.44 120.17 18.68 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.74 159.06 20.36 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.54 2.336 . . . . 0.0 113.761 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.25 149.59 16.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.615 2.877 . . . . 0.0 111.829 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.3 m -74.58 38.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 176.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.04 -11.14 0.02 OUTLIER Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.735 2.112 . . . . 0.0 113.807 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.26 57.76 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.63 2.215 . . . . 0.0 111.18 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.9 p -145.42 152.31 39.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.395 0.678 . . . . 0.0 112.739 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -52.74 131.84 35.52 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.635 1.174 . . . . 0.0 110.62 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.11 64.7 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.739 -1.226 . . . . 0.0 111.503 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mt -92.49 -42.01 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.339 1.055 . . . . 0.0 110.57 -173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . 0.257 29.2 p -124.79 9.26 8.23 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 50.53 29.01 3.71 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.284 2.233 . . . . 0.0 112.888 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.43 140.22 14.88 Favored Glycine 0 N--CA 1.467 0.74 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.269 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.1 171.0 0.78 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.16 1.384 . . . . 0.0 114.718 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 141.15 57.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.69 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 p -130.08 155.36 46.3 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.065 0.936 . . . . 0.0 112.695 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.03 -11.79 0.1 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -128.28 -15.98 4.54 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.537 1.535 . . . . 0.0 112.921 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.532 HD21 ' HB3' ' A' ' 66' ' ' HIS . 36.3 t30 -150.69 74.62 8.66 Favored Pre-proline 0 N--CA 1.44 -0.93 0 C-N-CA 125.511 1.524 . . . . 0.0 109.483 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.22 -158.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.312 4.008 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mt -129.8 156.67 43.96 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 123.037 1.398 . . . . 0.0 111.532 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -154.04 177.14 11.39 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 129.463 3.105 . . . . 0.0 107.739 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -124.63 98.1 37.97 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.724 0.809 . . . . 0.0 108.86 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.25 -15.45 20.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.806 2.338 . . . . 0.0 112.732 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 0.4 OUTLIER -151.85 157.39 41.83 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 124.262 1.025 . . . . 0.0 112.433 -169.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -85.28 20.99 1.82 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.4 m -47.97 -14.39 0.05 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 126.582 1.953 . . . . 0.0 114.785 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttp-105 58.25 173.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 130.231 3.412 . . . . 0.0 115.26 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.63 -161.59 26.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.775 -1.203 . . . . 0.0 112.981 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.7 p -65.04 -24.15 67.4 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.494 -1.003 . . . . 0.0 113.194 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 pt -74.9 -3.55 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -74.17 -20.07 60.34 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.486 1.039 . . . . 0.0 112.684 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -90.3 139.93 30.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.433 1.093 . . . . 0.0 113.661 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 mtt -151.83 142.94 23.21 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.563 0.745 . . . . 0.0 111.973 -174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.532 ' HB3' HD21 ' A' ' 50' ' ' ASN . 23.5 m170 -70.1 149.5 47.55 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.177 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.53 -33.98 77.17 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.719 -0.613 . . . . 0.0 110.681 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.1 m -73.82 -42.94 60.17 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.758 -0.589 . . . . 0.0 110.537 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 84.0 m -64.59 -43.5 93.61 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.916 1.287 . . . . 0.0 112.524 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.14 -44.05 97.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.386 0.994 . . . . 0.0 110.088 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.02 -28.84 59.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.257 1.023 . . . . 0.0 113.531 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -91.05 -37.0 13.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.281 1.432 . . . . 0.0 111.166 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.451 ' CE2' ' HE3' ' A' ' 77' ' ' LYS . 88.8 t90 -60.55 -51.74 68.15 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.49 -34.14 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.422 -0.799 . . . . 0.0 111.437 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -34.51 78.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.983 -0.448 . . . . 0.0 111.408 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -71.02 -30.87 67.21 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.967 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HE3' ' CE2' ' A' ' 73' ' ' TRP . 56.1 mmtt -81.05 8.38 8.7 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 128.496 2.718 . . . . 0.0 113.736 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER 75.68 16.51 2.48 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.4 2.28 . . . . 0.0 115.528 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.73 139.46 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.079 1.352 . . . . 0.0 111.41 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -130.08 112.97 13.95 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 0.0 112.998 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.2 pt -67.49 -17.87 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 113.94 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -71.77 -13.04 61.59 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.12 143.66 27.19 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.698 1.199 . . . . 0.0 111.53 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -78.68 16.77 1.23 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 124.049 3.166 . . . . 0.0 116.272 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -113.25 7.03 25.0 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.536 2.017 . . . . 0.0 112.805 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.12 138.8 55.81 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.286 1.034 . . . . 0.0 113.286 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.5 41.08 1.59 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.392 1.877 . . . . 0.0 110.141 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 88' ' ' VAL . 2.0 t -49.67 107.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.712 2.405 . . . . 0.0 114.13 -174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -148.38 144.95 27.84 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.147 1.779 . . . . 0.0 110.949 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 43.1 t -66.56 170.87 5.65 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.548 2.339 . . . . 0.0 114.715 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.79 -17.8 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.193 2.597 . . . . 0.0 111.808 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.2 -55.69 11.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.464 1.105 . . . . 0.0 109.578 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.9 p -115.85 -7.07 12.06 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.977 0.511 . . . . 0.0 111.894 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 68.89 18.03 8.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.518 2.327 . . . . 0.0 114.678 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.8 m-85 -82.75 145.31 50.18 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 120.817 -1.177 . . . . 0.0 111.966 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.37 132.19 39.86 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.577 2.185 . . . . 0.0 109.85 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 mm -85.22 116.02 27.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 126.255 1.822 . . . . 0.0 108.854 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -114.26 111.94 22.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -170.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -73.47 48.37 0.25 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.994 2.118 . . . . 0.0 111.915 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.7 126.7 16.35 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.585 2.754 . . . . 0.0 113.451 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.251 1.155 0 C-N-CA 127.111 2.164 . . . . 0.0 111.188 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.48 166.68 10.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 113.499 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -149.18 -12.84 0.31 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -158.41 -24.91 0.08 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.336 1.454 . . . . 0.0 114.056 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -47.88 -45.58 30.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.182 2.193 . . . . 0.0 112.958 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.6 p -67.23 -0.06 3.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.863 2.065 . . . . 0.0 115.515 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -115.92 18.73 15.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.656 1.982 . . . . 0.0 112.711 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -71.2 164.08 26.37 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.197 1.399 . . . . 0.0 111.685 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.72 23.09 3.95 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.748 1.219 . . . . 0.0 114.032 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m 50.58 54.22 11.56 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.06 1.744 . . . . 0.0 111.854 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -50.5 153.24 1.65 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.4 2.28 . . . . 0.0 114.57 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -165.93 174.58 9.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.702 2.001 . . . . 0.0 111.074 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -132.81 144.34 50.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.994 1.318 . . . . 0.0 111.139 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -75.11 79.51 2.26 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.0 149.41 71.55 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.33 2.252 . . . . 0.0 110.67 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.18 155.85 8.55 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.921 3.081 . . . . 0.0 113.872 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 77.6 p -97.83 10.55 39.88 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.44 1.496 . . . . 0.0 113.185 174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.97 7.45 0.56 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.445 1.498 . . . . 0.0 114.92 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.4 147.93 30.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.309 1.555 . . . . 0.0 109.962 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 57.1 p -141.49 145.36 35.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.033 1.333 . . . . 0.0 112.652 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.8 t -58.33 140.17 53.95 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.941 1.296 . . . . 0.0 114.246 174.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.1 mt -99.22 -48.16 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.23 1.812 . . . . 0.0 110.502 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.4 m -107.38 -4.64 18.37 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 49.34 31.23 3.67 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.234 2.214 . . . . 0.0 112.385 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.64 141.59 16.18 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.297 0.951 . . . . 0.0 112.627 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.76 160.43 11.82 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.922 1.289 . . . . 0.0 113.554 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.48 144.26 51.63 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.519 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.7 p -128.35 157.69 40.31 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.313 1.054 . . . . 0.0 112.636 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -57.72 -11.59 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.63 -21.77 5.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.432 1.493 . . . . 0.0 111.475 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.602 HD21 ' HB3' ' A' ' 66' ' ' HIS . 35.6 t30 -141.02 67.48 27.14 Favored Pre-proline 0 N--CA 1.444 -0.747 0 C-N-CA 124.118 0.967 . . . . 0.0 113.49 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -49.75 167.74 0.18 Allowed 'Trans proline' 0 C--O 1.235 0.371 1 C-N-CA 125.5 4.133 . . . . 0.0 116.928 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -111.62 142.33 44.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.177 173.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -152.75 -177.49 6.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.671 1.988 . . . . 0.0 108.765 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -114.99 108.23 48.79 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.841 0.856 . . . . 0.0 110.354 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 97' ' ' ILE . 87.4 Cg_endo -75.85 -18.82 16.67 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.622 2.881 . . . . 0.0 112.764 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 95' ' ' TYR 0.281 5.1 t -141.15 -161.33 1.2 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 129.678 3.191 . . . . 0.0 106.889 -167.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -95.11 -41.58 9.03 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.255 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.321 6.2 m 40.97 -5.47 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.521 1 C-N-CA 132.309 4.244 . . . . 0.0 119.298 -173.26 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 45.52 67.9 0.66 Allowed 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 131.78 4.032 . . . . 0.0 117.743 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.93 -174.19 31.01 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 125.942 1.734 . . . . 0.0 111.844 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.9 m -55.83 -23.92 33.34 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.215 1.008 . . . . 0.0 111.854 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -61.98 -14.62 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 113.498 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -70.36 -5.91 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.768 -1.207 . . . . 0.0 114.02 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -97.48 138.95 34.12 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.727 1.211 . . . . 0.0 110.724 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 83.3 mtp -158.35 145.89 18.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.606 1.562 . . . . 0.0 109.684 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.602 ' HB3' HD21 ' A' ' 50' ' ' ASN . 44.5 m80 -69.99 151.53 45.47 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -58.26 -38.88 77.81 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.749 -0.594 . . . . 0.0 110.712 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -81.32 -31.62 33.44 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -76.03 -41.05 52.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.411 1.101 . . . . 0.0 112.245 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.86 -49.85 74.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.708 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.1 mt -55.14 -35.39 64.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.423 1.089 . . . . 0.0 112.748 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 69' ' ' CYS . 8.2 pt-20 -81.49 -37.67 27.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.216 0.462 . . . . 0.0 112.096 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -62.91 -51.02 68.56 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.681 -0.637 . . . . 0.0 110.715 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.78 -31.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.938 0.79 . . . . 0.0 112.331 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.66 -20.21 61.29 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.088 -0.382 . . . . 0.0 111.868 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -80.57 -5.02 56.16 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.804 -1.185 . . . . 0.0 111.867 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -92.11 9.85 31.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.611 1.964 . . . . 0.0 114.049 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 79.61 9.3 1.56 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.816 2.046 . . . . 0.0 113.844 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mt -109.89 124.22 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.256 1.422 . . . . 0.0 111.342 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -87.4 82.33 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.174 0.988 . . . . 0.0 111.099 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -9.76 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.558 1.143 . . . . 0.0 113.818 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.7 t -65.9 -25.77 67.32 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.15 -0.344 . . . . 0.0 110.977 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -92.52 143.55 27.4 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.521 1.128 . . . . 0.0 110.545 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.47 9.24 2.62 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.687 2.925 . . . . 0.0 116.624 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.3 -9.44 69.88 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.524 1.535 . . . . 0.0 113.32 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.59 150.2 49.1 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.203 1.001 . . . . 0.0 112.741 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.57 49.7 1.22 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.137 1.775 . . . . 0.0 109.839 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.01 131.38 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 126.234 1.814 . . . . 0.0 111.982 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -142.87 144.16 32.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.962 1.705 . . . . 0.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 17.5 t -59.04 169.54 1.04 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.974 2.109 . . . . 0.0 115.743 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -127.76 -8.09 5.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.541 2.736 . . . . 0.0 112.041 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.3 mt -89.91 -56.28 5.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 124.022 0.929 . . . . 0.0 108.784 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.03 -1.76 11.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.017 0.927 . . . . 0.0 111.708 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 70.6 m80 61.31 16.74 7.64 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.896 2.078 . . . . 0.0 115.164 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.514 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 30.9 m-85 -77.03 144.24 71.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 120.848 -1.157 . . . . 0.0 111.297 174.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -57.67 148.82 71.8 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.402 2.068 . . . . 0.0 109.988 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 55' ' ' PRO . 2.4 mt -116.45 135.55 56.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 124.078 0.951 . . . . 0.0 110.78 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -121.96 125.59 46.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.216 1.006 . . . . 0.0 110.842 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -68.36 -1.37 6.25 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -173.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -160.87 161.98 32.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.601 2.36 . . . . 0.0 110.489 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.251 1.177 0 C-N-CA 127.012 2.125 . . . . 0.0 113.776 176.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.06 59.08 1.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.897 1.679 . . . . 0.0 110.258 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -133.25 22.4 4.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.854 1.661 . . . . 0.0 113.488 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -71.3 170.94 12.04 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.668 1.187 . . . . 0.0 111.73 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.65 -4.6 4.15 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 p -142.78 137.65 29.87 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.805 1.242 . . . . 0.0 112.549 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -111.41 -135.17 0.36 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 0.0 110.115 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.0 m -138.38 138.17 38.0 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 109.881 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.02 173.17 14.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.81 1.244 . . . . 0.0 112.656 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.7 p -140.55 160.21 40.51 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.943 1.697 . . . . 0.0 111.072 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -125.98 169.93 12.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.706 1.202 . . . . 0.0 112.879 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.68 3.66 3.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.253 1.421 . . . . 0.0 113.523 -176.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -152.73 145.38 24.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.825 2.05 . . . . 0.0 108.505 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 67.94 -31.65 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.081 2.552 . . . . 0.0 116.486 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.56 153.94 32.71 Favored Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 128.979 2.912 . . . . 0.0 111.353 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -89.59 -137.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 124.867 3.711 . . . . 0.0 111.409 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.6 m -72.63 53.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.36 35.05 83.41 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.495 1.045 . . . . 0.0 112.855 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.13 162.93 27.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.482 0.713 . . . . 0.0 112.071 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -149.87 160.78 43.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.033 1.333 . . . . 0.0 113.55 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 42.1 t -69.12 125.16 25.79 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.18 1.792 . . . . 0.0 112.822 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -10.32 56.06 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.259 -0.901 . . . . 0.0 113.136 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.9 mt -91.77 -46.18 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 125.097 1.359 . . . . 0.0 109.668 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.1 p -125.73 3.22 7.48 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 59.25 31.27 21.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.736 2.015 . . . . 0.0 113.815 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 144.89 17.14 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.87 169.32 10.01 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.159 0.981 . . . . 0.0 111.685 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.74 53.91 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.8 p -114.94 168.56 9.8 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 122.112 0.958 . . . . 0.0 111.797 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.56 -19.31 37.0 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -121.49 -17.85 7.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 110.92 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.57 58.0 16.1 Favored Pre-proline 0 N--CA 1.441 -0.903 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.15 145.31 26.45 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.506 2.137 . . . . 0.0 111.919 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.38 175.58 9.26 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.136 -2.302 . . . . 0.0 109.92 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.4 175.47 2.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.215 2.206 . . . . 0.0 109.035 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -112.16 95.46 30.36 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.507 1.123 . . . . 0.0 111.121 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.446 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.4 Cg_endo -71.08 -30.4 16.35 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.689 2.26 . . . . 0.0 111.688 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.9 t -135.37 -178.99 5.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.836 2.854 . . . . 0.0 110.446 -171.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.62 36.13 4.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.639 1.976 . . . . 0.0 113.419 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.5 m -51.6 -8.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.634 2.374 . . . . 0.0 116.519 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 65.64 175.5 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.875 2.07 . . . . 0.0 114.493 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.12 -150.5 1.01 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.478 1.513 . . . . 0.0 115.538 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -75.47 -1.79 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.788 1.235 . . . . 0.0 113.872 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.7 pt -97.78 -0.61 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.915 1.286 . . . . 0.0 113.91 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -83.61 5.57 23.86 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.47 143.24 45.26 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.673 1.589 . . . . 0.0 109.281 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.7 mtp -154.32 140.3 18.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.641 1.176 . . . . 0.0 111.084 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 69' ' ' CYS . 7.2 m170 -70.22 144.57 51.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.049 0.94 . . . . 0.0 110.091 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -76.98 12.95 1.17 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 113.545 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -129.84 -40.38 1.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.129 1.372 . . . . 0.0 109.048 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 66' ' ' HIS . 83.7 m -59.69 -47.85 83.98 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.641 1.176 . . . . 0.0 111.332 172.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -56.0 -44.33 78.54 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.275 0.63 . . . . 0.0 110.381 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.17 -22.62 61.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.856 1.262 . . . . 0.0 112.869 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.63 -39.89 8.87 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.828 1.651 . . . . 0.0 111.321 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.407 ' CZ2' ' HE2' ' A' ' 77' ' ' LYS . 91.9 t90 -56.38 -47.55 78.71 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.099 1.36 . . . . 0.0 111.416 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.9 m -66.7 -25.34 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 119.141 0.882 . . . . 0.0 111.817 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.77 -38.42 76.74 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.115 -0.366 . . . . 0.0 110.591 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.3 p -69.06 -18.64 64.03 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.068 -1.02 . . . . 0.0 113.605 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HE2' ' CZ2' ' A' ' 73' ' ' TRP . 35.7 mmtm -75.32 6.15 4.81 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.063 2.145 . . . . 0.0 113.619 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.262 9.3 t30 66.07 43.96 2.78 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.599 1.56 . . . . 0.0 111.601 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -138.48 140.79 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 109.312 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -117.9 99.58 7.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.411 1.085 . . . . 0.0 111.703 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.2 pt -63.51 -15.9 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.365 1.466 . . . . 0.0 113.881 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.6 t -68.75 -23.79 64.37 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.236 0.614 . . . . 0.0 112.084 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -107.18 148.78 37.71 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 125.333 1.453 . . . . 0.0 112.381 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.1 27.7 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.633 3.556 . . . . 0.0 114.673 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.83 -1.86 30.4 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.462 1.982 . . . . 0.0 112.314 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.43 153.79 43.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.172 0.989 . . . . 0.0 112.672 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -150.78 46.69 0.86 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.061 1.744 . . . . 0.0 109.741 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.9 t -66.72 109.34 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.999 1.32 . . . . 0.0 113.009 -174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -143.11 140.21 30.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.383 1.873 . . . . 0.0 110.003 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.6 168.11 2.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.058 2.143 . . . . 0.0 115.19 -174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -122.97 -7.99 8.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.543 2.337 . . . . 0.0 111.919 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -88.16 -57.29 4.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.659 1.184 . . . . 0.0 108.46 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.4 p -110.99 -6.88 14.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.104 0.562 . . . . 0.0 111.749 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.254 73.9 m80 64.44 19.25 11.73 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.706 2.002 . . . . 0.0 114.305 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.455 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 23.5 m-85 -82.11 145.02 51.87 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 121.056 -1.027 . . . . 0.0 111.413 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -61.53 153.0 69.64 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.811 1.674 . . . . 0.0 109.256 168.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.446 HG23 ' HB2' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -112.15 141.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.902 0.858 . . . . 0.0 110.092 -173.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -113.89 121.84 45.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.819 1.248 . . . . 0.0 111.101 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -80.3 -4.35 53.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -163.72 152.81 14.16 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.684 2.794 . . . . 0.0 109.685 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.006 1.722 . . . . 0.0 112.698 178.387 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 110.91 -0.033 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.63 18.93 1.67 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -145.89 151.83 38.49 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.785 1.634 . . . . 0.0 111.101 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.48 -42.47 99.51 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -48.74 2.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 130.429 3.491 . . . . 0.0 119.031 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.2 p -127.93 -3.62 5.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.345 1.458 . . . . 0.0 113.448 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.23 -11.94 8.34 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.14 1.776 . . . . 0.0 113.788 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 t -155.06 158.56 39.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.156 2.182 . . . . 0.0 110.493 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.87 43.3 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.236 1.015 . . . . 0.0 113.661 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.1 p -56.25 -7.42 0.36 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 118.281 2.697 . . . . 0.0 118.281 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -131.45 140.85 49.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.79 1.636 . . . . 0.0 112.566 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -141.6 123.12 15.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.754 2.021 . . . . 0.0 109.865 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -71.97 166.23 22.61 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.286 1.435 . . . . 0.0 114.155 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -63.74 179.66 0.47 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.65 160.52 53.15 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 127.622 2.369 . . . . 0.0 111.096 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 37' ' ' ALA . 1.3 Cg_exo -45.38 -2.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 2 C-N-CA 128.512 6.141 . . . . 0.0 125.202 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m 45.53 10.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.823 2.449 . . . . 0.0 117.48 -170.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.34 -2.2 0.34 Allowed Glycine 0 CA--C 1.54 1.601 0 C-N-CA 127.594 2.521 . . . . 0.0 114.293 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 34' ' ' PRO . . . -73.02 161.99 30.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.667 1.234 . . . . 0.0 108.481 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.7 p -148.3 148.7 30.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.073 0.949 . . . . 0.0 113.225 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.43 127.93 34.15 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.461 1.904 . . . . 0.0 110.751 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -14.85 62.76 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 69' ' ' CYS . 67.4 mt -96.64 -52.8 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.513 1.125 . . . . 0.0 110.346 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.53 -16.66 36.25 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 54.95 38.71 30.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.454 1.502 . . . . 0.0 110.445 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.36 156.25 22.31 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 122.802 1.223 . . . . 0.0 111.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -63.44 166.87 6.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 126.669 1.988 . . . . 0.0 115.932 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 158.41 28.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.721 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.6 p -137.27 160.09 40.03 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.281 1.039 . . . . 0.0 113.113 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.92 -9.27 3.95 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.85 -27.55 4.26 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.632 1.573 . . . . 0.0 111.046 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 66' ' ' HIS . 56.5 t30 -138.07 67.05 47.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -48.0 176.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 1 C-N-CA 126.82 5.013 . . . . 0.0 117.75 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.2 mt -117.01 145.49 43.64 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 112.931 -1.94 . . . . 0.0 110.92 172.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -156.39 -176.49 5.99 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.536 2.334 . . . . 0.0 109.632 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -119.49 102.4 47.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.302 1.041 . . . . 0.0 113.571 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.63 -33.52 1.25 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.102 1.201 . . . . 0.0 113.082 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.0 p -147.18 150.31 34.67 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.638 1.975 . . . . 0.0 110.165 -170.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 12.1 mptt -84.05 28.27 0.62 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.456 -1.247 . . . . 0.0 114.169 -174.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.46 87.91 5.06 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 161.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.81 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 3 C-N-CA 141.81 8.044 . . . . 0.0 112.122 1.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.6 -139.43 6.11 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.067 1.794 . . . . 0.0 109.624 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -54.01 -29.1 42.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 119.563 1.682 . . . . 0.0 111.775 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.2 pt -62.59 -9.1 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.121 1.768 . . . . 0.0 113.316 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -82.13 0.33 41.3 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.339 -0.851 . . . . 0.0 112.012 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.61 139.18 31.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.36 1.464 . . . . 0.0 108.751 171.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.5 ttp -161.6 145.45 12.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.828 0.851 . . . . 0.0 110.438 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB3' HD21 ' A' ' 50' ' ' ASN . 37.8 m80 -67.84 154.89 40.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.372 0.533 . . . . 0.0 110.787 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -59.79 -45.42 92.38 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.277 -0.889 . . . . 0.0 109.638 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 p -54.98 -54.34 44.13 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.982 0.913 . . . . 0.0 112.375 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 41' ' ' ILE . 82.1 m -62.6 -36.99 84.53 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.376 1.47 . . . . 0.0 112.747 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.2 tp -66.3 -47.02 74.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 120.13 1.332 . . . . 0.0 110.723 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.57 -32.74 70.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.187 1.795 . . . . 0.0 111.92 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -79.6 -41.09 27.84 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 128.076 2.55 . . . . 0.0 111.199 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -62.28 -50.77 70.36 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 120.998 -1.064 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.46 -32.13 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.794 0.724 . . . . 0.0 110.605 173.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.09 93.13 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.593 -0.692 . . . . 0.0 109.983 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -61.65 -16.27 47.17 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.594 -1.316 . . . . 0.0 113.462 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.84 3.75 50.12 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.142 1.777 . . . . 0.0 112.586 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.252 10.1 t30 64.62 44.09 4.06 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.114 1.365 . . . . 0.0 112.375 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -135.61 142.22 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.762 1.225 . . . . 0.0 110.424 -178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -108.77 100.43 9.66 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.811 1.244 . . . . 0.0 109.422 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.27 -11.88 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 t -76.99 -21.42 54.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.179 0.592 . . . . 0.0 112.048 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.89 144.34 90.39 Favored Pre-proline 0 N--CA 1.475 0.821 0 O-C-N 120.985 -1.072 . . . . 0.0 111.558 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.38 7.03 3.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.642 2.894 . . . . 0.0 116.768 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.02 -3.08 34.02 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.451 1.977 . . . . 0.0 112.519 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.42 127.83 34.41 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.285 1.042 . . . . 0.0 111.755 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -142.36 40.92 1.61 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.219 1.808 . . . . 0.0 109.8 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.18 124.78 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.341 2.256 . . . . 0.0 111.404 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -139.16 131.35 28.18 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.468 1.507 . . . . 0.0 110.625 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.9 t -66.47 126.91 30.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -80.49 -21.53 41.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -66.13 -66.69 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.625 1.17 . . . . 0.0 111.338 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.0 p -83.39 -18.99 36.85 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.121 1.368 . . . . 0.0 111.423 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 21.7 t60 79.79 1.43 2.14 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 129.332 3.053 . . . . 0.0 112.609 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 57' ' ' LYS . 53.6 m-85 -83.89 131.2 52.36 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.402 -1.436 . . . . 0.0 112.098 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 95' ' ' TYR . 31.6 Cg_exo -55.46 145.83 66.31 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.314 3.343 . . . . 0.0 111.44 176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.2 mm -74.12 107.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 122.233 1.016 . . . . 0.0 109.39 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -99.89 85.82 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 113.198 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -58.98 128.49 37.51 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.086 1.354 . . . . 0.0 111.019 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -69.55 145.81 52.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.442 1.097 . . . . 0.0 113.174 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 125.571 1.548 . . . . 0.0 109.312 173.397 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.8 161.29 34.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.72 1.208 . . . . 0.0 112.739 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -121.82 178.53 4.83 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.339 1.856 . . . . 0.0 112.826 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -145.77 165.06 29.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.637 1.975 . . . . 0.0 109.787 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.14 12.71 1.73 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.771 1.229 . . . . 0.0 114.025 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 p -76.57 163.93 26.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.626 1.57 . . . . 0.0 112.824 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.52 142.86 23.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.997 1.319 . . . . 0.0 111.417 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.1 p -137.59 9.37 2.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.095 1.758 . . . . 0.0 113.704 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -38.22 145.73 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -146.01 151.42 37.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 127.661 2.385 . . . . 0.0 109.744 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -52.09 143.18 14.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.625 1.17 . . . . 0.0 113.34 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -141.61 170.65 15.31 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.636 1.974 . . . . 0.0 111.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.93 132.26 30.06 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.054 1.342 . . . . 0.0 111.886 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -76.3 166.67 23.12 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 40.62 68.3 2.41 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 127.519 2.328 . . . . 0.0 115.168 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.49 142.71 98.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.656 2.237 . . . . 0.0 114.426 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -92.92 54.96 2.28 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.437 1.113 . . . . 0.0 108.22 169.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.56 48.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.019 1.771 . . . . 0.0 112.412 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 38' ' ' THR . . . -65.94 -175.68 0.33 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 111.525 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 37' ' ' ALA . 11.5 p -160.53 172.96 16.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 112.016 174.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -84.89 127.25 34.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.769 1.228 . . . . 0.0 107.698 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -20.63 66.47 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.157 1.344 . . . . 0.0 112.945 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.2 mt -79.94 -43.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 117.542 -1.218 . . . . 0.0 109.503 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.36 -2.18 8.54 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.322 38.8 mmt180 52.3 45.86 27.7 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.2 1.8 . . . . 0.0 111.413 -173.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.43 134.23 12.04 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 111.643 -2.526 . . . . 0.0 110.422 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.36 155.07 41.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.874 0.845 . . . . 0.0 110.955 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.9 156.36 2.91 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.9 p -128.65 173.36 10.36 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.36 1.076 . . . . 0.0 113.042 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.42 5.01 5.05 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.853 1.798 . . . . 0.0 115.853 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -145.98 -28.85 0.42 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.367 1.467 . . . . 0.0 111.636 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -127.69 67.84 73.48 Favored Pre-proline 0 N--CA 1.44 -0.941 0 C-N-CA 125.657 1.583 . . . . 0.0 110.231 -177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.34 -171.42 1.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.074 3.849 . . . . 0.0 112.109 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.72 142.09 46.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 110.87 -2.877 . . . . 0.0 109.359 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -158.0 -166.65 2.02 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 128.359 2.664 . . . . 0.0 107.738 -174.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.54 107.79 14.48 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.247 1.019 . . . . 0.0 112.5 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -80.15 -18.6 9.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.878 3.052 . . . . 0.0 113.743 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 9.8 t -143.43 171.68 13.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.269 2.228 . . . . 0.0 110.142 -174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -83.28 20.6 1.27 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 129.681 3.193 . . . . 0.0 113.784 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 -12.26 0.18 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 55.23 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 130.534 3.534 . . . . 0.0 120.068 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.35 -175.91 49.69 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.342 1.428 . . . . 0.0 113.52 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -69.12 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.73 -28.1 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.748 2.419 . . . . 0.0 108.704 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -54.05 -29.11 42.74 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.263 1.392 . . . . 0.0 113.585 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.34 134.17 49.88 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.707 1.241 . . . . 0.0 111.839 176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.4 mtt -157.69 143.81 17.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.214 1.405 . . . . 0.0 109.706 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -69.0 155.38 40.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.567 173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.97 -52.27 66.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.483 -0.76 . . . . 0.0 110.564 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -60.31 -45.46 93.32 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.562 -0.711 . . . . 0.0 112.313 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.1 -44.77 91.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.731 0.696 . . . . 0.0 112.07 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.05 -47.06 87.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.964 0.802 . . . . 0.0 110.141 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.64 -28.03 66.87 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.965 0.906 . . . . 0.0 112.787 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -85.65 -34.02 21.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.865 0.866 . . . . 0.0 111.723 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -58.81 -59.05 6.04 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 109.951 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.84 -23.52 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.557 0.743 . . . . 0.0 111.811 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.0 -0.44 55.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.2 m -113.5 -5.4 13.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.99 1.716 . . . . 0.0 111.811 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -80.28 6.0 13.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.701 2.8 . . . . 0.0 114.691 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.318 0.0 OUTLIER 76.34 32.15 0.59 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.684 1.593 . . . . 0.0 111.518 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mt -142.08 159.77 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.748 2.019 . . . . 0.0 109.795 -176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -132.83 112.98 12.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.536 1.534 . . . . 0.0 110.858 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.8 pt -61.23 -17.68 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.231 1.412 . . . . 0.0 114.452 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -74.36 -26.78 60.34 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 118.204 0.456 . . . . 0.0 111.873 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.83 145.31 83.95 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 121.263 -0.898 . . . . 0.0 112.734 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -79.86 27.42 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.54 3.493 . . . . 0.0 114.948 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.47 20.99 3.66 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 127.167 2.318 . . . . 0.0 111.188 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.81 131.8 38.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.755 0.822 . . . . 0.0 112.743 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -145.62 55.78 1.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.575 1.95 . . . . 0.0 108.6 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.0 m -71.55 37.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.818 2.047 . . . . 0.0 116.024 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -58.44 141.91 50.17 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.699 2.8 . . . . 0.0 113.005 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 46.9 t -60.33 116.51 4.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.556 1.942 . . . . 0.0 110.759 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -78.11 13.97 1.3 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.65 -47.0 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.86 1.264 . . . . 0.0 110.502 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -116.44 -9.31 11.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.187 1.795 . . . . 0.0 111.816 -174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.277 78.4 m-70 65.4 31.31 10.45 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.972 2.109 . . . . 0.0 115.823 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 47.6 m-85 -106.96 138.19 19.74 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.868 1.267 . . . . 0.0 112.552 175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.94 135.55 71.45 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.394 2.063 . . . . 0.0 110.31 172.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.1 mm -74.93 136.98 23.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.029 0.932 . . . . 0.0 109.948 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -123.98 88.2 2.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.597 1.189 . . . . 0.0 113.503 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.56 64.14 7.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.223 1.809 . . . . 0.0 110.137 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.68 149.81 20.99 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.999 1.32 . . . . 0.0 113.155 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.489 1.916 . . . . 0.0 111.59 179.524 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.711 -0.185 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.54 11.9 2.97 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -52.53 156.46 1.82 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.628 1.571 . . . . 0.0 113.75 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.17 -34.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.036 2.934 . . . . 0.0 109.303 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -45.13 -32.18 1.71 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.054 2.541 . . . . 0.0 115.079 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -62.82 -12.87 27.43 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.99 144.1 54.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.925 1.29 . . . . 0.0 111.479 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.3 t -137.64 38.41 2.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.57 126.94 21.2 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.852 -1.155 . . . . 0.0 111.057 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.2 m -145.28 143.73 30.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.937 1.695 . . . . 0.0 110.133 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -134.59 145.03 48.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.434 1.494 . . . . 0.0 111.132 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -124.26 5.31 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.8 28.35 0.11 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -127.49 15.3 7.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.114 2.566 . . . . 0.0 112.528 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.6 161.34 71.38 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 127.507 2.323 . . . . 0.0 113.439 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -39.01 127.33 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 125.175 3.917 . . . . 0.0 117.826 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.1 m -142.66 42.12 1.59 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.957 2.503 . . . . 0.0 109.917 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.13 19.03 7.84 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.942 1.734 . . . . 0.0 111.556 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.86 152.67 45.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.884 1.274 . . . . 0.0 110.244 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 79.0 p -143.91 153.1 41.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.738 1.215 . . . . 0.0 112.333 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 t -59.91 127.19 30.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.482 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -14.0 61.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 112.899 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.08 -46.28 12.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.524 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.3 p -113.8 -7.33 13.24 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 43' ' ' ARG 0.315 31.2 mmt180 57.22 44.72 21.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.063 1.345 . . . . 0.0 112.552 -175.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.96 16.49 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 172.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.0 172.43 4.51 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.45 1.1 . . . . 0.0 111.764 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.84 161.81 23.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.538 0.685 . . . . 0.0 109.637 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.4 p -136.93 166.78 22.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.208 0.603 . . . . 0.0 111.108 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.43 -22.25 64.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.71 -27.77 10.1 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.078 1.751 . . . . 0.0 111.376 -176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 66' ' ' HIS . 58.1 t30 -137.27 66.9 53.51 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -46.51 173.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 1 C-N-CA 125.546 4.164 . . . . 0.0 116.364 172.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.3 mt -110.24 146.01 36.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.105 -1.861 . . . . 0.0 110.49 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -151.46 -177.9 6.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.074 2.149 . . . . 0.0 108.827 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -126.12 118.01 23.67 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.929 0.892 . . . . 0.0 109.201 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -77.68 -26.41 7.01 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.108 2.538 . . . . 0.0 111.575 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.58 -152.71 0.51 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 128.326 2.65 . . . . 0.0 110.962 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HB2' ' CG ' ' A' ' 95' ' ' TYR . 6.1 mmtt -119.66 13.35 12.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.549 1.939 . . . . 0.0 113.69 -174.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 m -44.35 -17.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -174.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? 38.99 34.55 0.1 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 129.11 2.964 . . . . 0.0 118.435 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.56 -175.33 28.36 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 124.602 1.096 . . . . 0.0 114.642 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.5 p -64.19 9.42 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.475 1.51 . . . . 0.0 114.437 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.02 12.33 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.559 2.343 . . . . 0.0 110.22 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -90.26 -21.87 21.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.15 1.38 . . . . 0.0 113.214 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -79.85 140.36 36.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.967 1.307 . . . . 0.0 111.597 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.0 mtp -154.61 143.04 20.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.671 1.188 . . . . 0.0 110.527 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.517 ' HB3' HD21 ' A' ' 50' ' ' ASN . 42.8 m80 -76.11 158.45 31.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.2 -46.91 88.52 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.068 -1.02 . . . . 0.0 111.243 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.6 m -65.1 -48.55 73.28 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.654 0.782 . . . . 0.0 111.613 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.62 -39.44 88.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.955 -1.09 . . . . 0.0 111.603 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.03 -49.89 75.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.043 1.747 . . . . 0.0 109.815 173.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.9 -30.7 68.0 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 113.447 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.46 -34.65 23.39 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.001 2.52 . . . . 0.0 112.225 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -70.6 -52.84 18.7 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.449 1.1 . . . . 0.0 109.156 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.4 m -58.88 -30.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.989 0.813 . . . . 0.0 110.573 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.18 75.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.34 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.8 t -60.92 -30.96 70.51 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.709 -1.244 . . . . 0.0 111.591 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.63 8.67 7.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.721 2.808 . . . . 0.0 114.025 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.286 0.0 OUTLIER 74.7 18.99 2.65 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.907 2.083 . . . . 0.0 115.531 176.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.92 141.69 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.77 1.228 . . . . 0.0 111.367 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -129.79 113.39 14.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.027 1.331 . . . . 0.0 111.533 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -21.07 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.592 1.557 . . . . 0.0 114.003 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -75.3 -16.98 60.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.795 0.838 . . . . 0.0 112.888 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.89 142.15 51.92 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 120.928 -1.108 . . . . 0.0 113.252 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.48 17.74 1.55 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.571 3.514 . . . . 0.0 115.314 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.98 16.15 5.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.369 2.414 . . . . 0.0 111.541 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.14 147.89 42.51 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.525 0.73 . . . . 0.0 112.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.19 39.93 0.93 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.853 1.661 . . . . 0.0 110.366 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -53.77 116.06 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.284 1.834 . . . . 0.0 113.084 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -148.75 147.21 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.843 1.657 . . . . 0.0 111.473 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 19.8 t -64.03 172.18 2.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.53 1.532 . . . . 0.0 113.76 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -129.74 0.49 4.89 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.764 2.025 . . . . 0.0 112.673 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -105.04 -65.08 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.1 p -92.74 -9.37 40.91 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.612 1.965 . . . . 0.0 111.078 177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . 0.343 4.3 p-80 58.7 16.72 4.58 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.163 2.585 . . . . 0.0 115.905 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' LYS . 28.7 m-85 -81.59 143.78 51.64 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 120.018 1.281 . . . . 0.0 113.232 177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.02 136.03 29.49 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.895 3.063 . . . . 0.0 111.772 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -82.79 124.33 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.894 1.278 . . . . 0.0 109.988 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -114.86 93.22 4.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.323 1.449 . . . . 0.0 112.159 -175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -62.08 158.33 16.91 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.475 1.11 . . . . 0.0 111.226 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -111.5 162.79 14.73 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.397 1.079 . . . . 0.0 112.964 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.543 1.937 . . . . 0.0 112.858 -179.239 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.62 40.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.98 1.312 . . . . 0.0 111.702 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -102.11 158.14 16.37 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.122 1.369 . . . . 0.0 113.495 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -142.27 145.08 33.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.083 2.153 . . . . 0.0 109.879 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -165.58 -36.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.791 1.637 . . . . 0.0 113.055 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.3 p -60.74 -14.59 22.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 119.517 3.155 . . . . 0.0 119.517 -170.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -60.83 167.37 2.84 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.8 t -115.17 -136.63 0.36 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.378 1.871 . . . . 0.0 109.645 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.02 164.43 31.19 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.818 1.644 . . . . 0.0 112.074 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.6 m -141.6 148.71 39.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.754 1.622 . . . . 0.0 110.503 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -154.03 155.25 35.15 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.216 1.406 . . . . 0.0 111.218 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -141.39 152.87 44.7 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.825 1.65 . . . . 0.0 111.432 179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.13 149.9 34.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.488 1.115 . . . . 0.0 113.288 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t0 68.88 -24.93 0.14 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 128.895 2.878 . . . . 0.0 115.237 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.86 80.04 67.73 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.379 2.672 . . . . 0.0 112.373 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -64.96 153.48 78.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.626 2.217 . . . . 0.0 113.171 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.0 m -97.8 18.24 16.21 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.859 1.264 . . . . 0.0 111.924 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.79 52.2 0.2 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 128.122 2.772 . . . . 0.0 109.989 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 170.85 6.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.665 1.186 . . . . 0.0 111.892 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.3 p -150.34 165.82 31.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.99 1.316 . . . . 0.0 112.135 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 39.1 t -75.62 120.97 21.75 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 114.336 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -9.17 13.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.57 1.148 . . . . 0.0 113.186 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 57.5 mt -99.26 -42.05 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.109 1.364 . . . . 0.0 110.831 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.77 12.42 4.03 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? 53.75 19.39 1.84 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 128.681 2.793 . . . . 0.0 115.488 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.52 144.94 25.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.56 173.85 8.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.257 1.023 . . . . 0.0 110.404 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.06 157.41 22.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.416 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.3 p -127.05 165.23 19.88 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.48 1.133 . . . . 0.0 112.407 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -61.51 -15.7 40.56 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.01 -24.28 2.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.129 0.972 . . . . 0.0 111.79 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -136.59 71.72 58.09 Favored Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 124.753 1.221 . . . . 0.0 111.324 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.92 -160.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 124.499 3.466 . . . . 0.0 109.291 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mt -120.05 141.86 49.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.093 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -144.76 173.85 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.418 1.887 . . . . 0.0 110.877 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -113.98 101.87 54.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.552 1.141 . . . . 0.0 112.381 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.68 -36.1 8.91 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.97 1.78 . . . . 0.0 111.443 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.9 t -119.7 -164.26 1.05 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 129.07 2.948 . . . . 0.0 112.294 -166.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -116.11 1.44 13.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.98 2.512 . . . . 0.0 115.247 -172.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 m -34.15 -48.69 0.33 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.598 2.359 . . . . 0.0 114.944 -173.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 109.5 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 1 C-N-CA 132.925 4.49 . . . . 0.0 112.052 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 18.72 -109.98 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 129.213 3.292 . . . . 0.0 117.643 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -55.51 -5.26 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -174.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.94 19.41 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.85 1.659 . . . . 0.0 111.165 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -100.28 -53.56 3.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.705 1.202 . . . . 0.0 109.72 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -46.48 142.3 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.591 1.956 . . . . 0.0 112.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 63.1 mtt -159.64 150.57 19.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.474 1.51 . . . . 0.0 111.55 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -74.82 150.94 39.11 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 169.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -56.47 -42.32 78.04 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.822 1.192 . . . . 0.0 111.328 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.0 p -61.22 -46.29 91.05 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.372 1.469 . . . . 0.0 112.631 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.4 m -64.78 -40.13 94.75 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 112.292 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.58 -47.72 84.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.65 1.114 . . . . 0.0 110.289 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -56.45 -31.05 63.6 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.186 2.194 . . . . 0.0 113.268 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -92.46 -35.48 13.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.912 1.285 . . . . 0.0 112.143 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -62.97 -48.25 79.68 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.651 0.78 . . . . 0.0 111.04 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.87 -27.22 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.986 0.812 . . . . 0.0 111.585 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.39 90.25 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.76 -0.587 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.7 p -67.72 -1.66 5.68 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.92 8.63 44.8 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.037 1.29 . . . . 0.0 111.676 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 80.9 30.1 0.17 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.658 2.383 . . . . 0.0 113.296 178.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.25 145.94 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.494 1.118 . . . . 0.0 112.807 -170.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -139.43 111.31 7.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.093 1.357 . . . . 0.0 110.564 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 pt -63.91 -16.54 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.498 1.119 . . . . 0.0 113.321 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -82.11 0.18 41.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.462 1.105 . . . . 0.0 113.462 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -126.77 151.03 72.96 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.697 1.599 . . . . 0.0 112.418 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.38 27.69 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.75 3.633 . . . . 0.0 115.268 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.41 5.54 11.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.952 2.215 . . . . 0.0 112.084 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 144.7 53.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.432 1.093 . . . . 0.0 113.17 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.66 38.41 0.68 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.898 1.679 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.77 99.08 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 126.212 1.805 . . . . 0.0 114.246 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -150.88 142.84 23.94 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.399 2.279 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.5 t -67.15 177.78 1.68 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.231 2.612 . . . . 0.0 116.063 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -132.52 -3.8 3.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.762 2.425 . . . . 0.0 112.769 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.9 mt -86.31 -71.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.788 -1.195 . . . . 0.0 107.854 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 7.9 p -88.03 -15.37 36.53 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.844 2.458 . . . . 0.0 110.574 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.4 m80 69.66 17.5 7.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.907 2.483 . . . . 0.0 113.11 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -76.19 146.65 78.65 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -58.46 149.21 76.28 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.228 2.619 . . . . 0.0 111.276 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 56' ' ' CYS . 5.2 mm -100.63 140.76 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.665 1.186 . . . . 0.0 109.906 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -135.64 137.2 41.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.144 0.974 . . . . 0.0 112.877 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -97.51 17.17 18.26 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.871 1.269 . . . . 0.0 113.287 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -152.98 139.46 18.66 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.304 2.242 . . . . 0.0 110.36 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.707 2.003 . . . . 0.0 113.975 -178.208 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.57 163.68 38.09 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.204 1.402 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -69.67 -8.36 47.01 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.86 17.13 2.66 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.032 1.733 . . . . 0.0 113.259 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -42.94 -43.65 4.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.475 1.91 . . . . 0.0 114.586 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.8 p -136.38 128.1 29.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.458 1.503 . . . . 0.0 111.167 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -156.71 154.58 30.28 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.568 1.547 . . . . 0.0 111.096 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.2 p -147.27 145.37 29.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.533 1.533 . . . . 0.0 111.288 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.33 22.53 0.36 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 p -111.79 122.93 49.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.514 1.525 . . . . 0.0 111.881 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -139.86 130.26 25.45 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.673 1.589 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -89.7 -15.09 33.34 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.647 1.179 . . . . 0.0 113.265 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -147.12 164.74 32.14 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.469 1.908 . . . . 0.0 110.359 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -147.58 10.88 0.97 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.161 1.385 . . . . 0.0 113.771 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.17 120.66 81.42 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.768 1.627 . . . . 0.0 112.81 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -61.25 -178.73 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.948 3.099 . . . . 0.0 113.716 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -71.72 32.64 0.05 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.977 2.511 . . . . 0.0 116.463 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.01 -38.06 1.92 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 127.961 2.696 . . . . 0.0 109.309 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 93.54 129.01 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 131.43 3.892 . . . . 0.0 112.854 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 45' ' ' GLU . 77.3 p -136.01 150.39 49.2 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.832 2.853 . . . . 0.0 114.393 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 41' ' ' ILE . 51.2 t -61.88 132.62 53.65 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.66 1.584 . . . . 0.0 111.122 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -20.1 63.56 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.644 -1.285 . . . . 0.0 112.72 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 96.8 mt -83.25 -39.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 110.34 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.39 -10.87 12.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . 0.253 22.0 mmt85 62.22 40.33 11.69 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.318 2.247 . . . . 0.0 112.567 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.76 152.83 21.12 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 125.325 1.44 . . . . 0.0 114.315 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.866 ' HA ' HG22 ' A' ' 38' ' ' THR . 3.4 mt-10 -156.0 -34.44 0.09 Allowed 'General case' 0 CA--C 1.481 -1.675 1 C-N-CA 133.324 4.65 . . . . 0.0 116.296 -1.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' H ' ' A' ' 45' ' ' GLU . . . -79.5 -176.01 5.06 Favored 'General case' 0 C--N 1.305 -1.355 1 C-N-CA 141.687 7.995 . . . . 0.0 112.174 -4.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 p -125.35 148.54 48.71 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.751 -1.218 . . . . 0.0 113.124 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.49 -7.07 1.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.32 1.971 . . . . 0.0 116.32 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.04 -20.52 8.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.577 1.951 . . . . 0.0 111.052 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.627 HD21 ' HB3' ' A' ' 66' ' ' HIS . 44.0 t30 -145.75 72.8 13.86 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 125.284 1.434 . . . . 0.0 113.912 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -46.23 173.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 1 C-N-CA 126.08 4.52 . . . . 0.0 117.014 173.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -116.71 155.58 28.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.512 172.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -157.04 -171.01 3.48 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.065 2.546 . . . . 0.0 107.74 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -125.4 115.56 25.39 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.926 0.89 . . . . 0.0 109.628 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -78.31 -19.41 11.88 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.833 3.022 . . . . 0.0 112.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.3 p -151.03 151.98 32.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.29 2.636 . . . . 0.0 110.969 -170.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.2 39.86 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.467 1.507 . . . . 0.0 114.519 -176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.87 -3.73 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 175.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? 23.37 92.92 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 129.678 3.191 . . . . 0.0 115.867 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.4 23.16 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.924 1.726 . . . . 0.0 112.006 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.9 p -54.03 -37.13 63.78 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.28 1.69 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -80.75 -14.37 58.15 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.376 -0.827 . . . . 0.0 112.923 175.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -89.76 140.06 29.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.546 0.738 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 89.3 mtp -153.86 144.64 22.59 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.115 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' HB3' HD21 ' A' ' 50' ' ' ASN . 7.4 m170 -70.26 135.36 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -75.6 32.68 0.11 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.297 1.439 . . . . 0.0 113.4 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.3 t -145.66 -43.1 0.21 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.304 2.242 . . . . 0.0 108.469 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 86.0 m -59.19 -48.34 81.97 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.785 1.234 . . . . 0.0 112.948 174.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.0 tp -58.03 -46.94 84.51 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 123.853 0.861 . . . . 0.0 110.682 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -22.6 63.54 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.232 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -92.56 -40.16 10.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.177 1.391 . . . . 0.0 110.353 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.2 t90 -56.69 -49.33 75.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.568 1.147 . . . . 0.0 112.172 177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.23 -33.44 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.475 0.71 . . . . 0.0 111.956 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.9 81.87 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.741 -0.599 . . . . 0.0 111.24 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.2 m -63.82 -15.52 59.02 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.843 -1.16 . . . . 0.0 113.395 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -75.05 -7.84 54.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.808 1.243 . . . . 0.0 113.14 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 t30 62.91 52.58 2.61 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.836 1.303 . . . . 0.0 112.368 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.4 150.51 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.872 -1.143 . . . . 0.0 111.246 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.16 117.45 9.21 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.041 0.536 . . . . 0.0 112.096 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.6 pt -91.85 0.51 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -96.14 5.55 50.82 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 122.347 1.07 . . . . 0.0 110.249 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? 30.32 80.94 0.23 Allowed Pre-proline 0 CA--C 1.539 0.545 1 C-N-CA 133.049 4.54 . . . . 0.0 119.162 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -84.18 46.96 2.1 Favored 'Trans proline' 0 CA--C 1.544 0.995 1 C-N-CA 126.336 4.691 . . . . 0.0 109.902 172.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.98 -11.55 22.59 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.601 2.048 . . . . 0.0 112.015 -173.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 162.87 13.88 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 118.019 0.909 . . . . 0.0 113.103 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.11 45.17 1.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.519 1.528 . . . . 0.0 110.619 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.9 t -52.65 114.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.817 1.647 . . . . 0.0 113.74 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -148.28 -177.82 5.97 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.3 t -62.79 164.54 7.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.861 2.064 . . . . 0.0 114.329 -174.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -125.51 13.08 8.12 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.679 1.992 . . . . 0.0 111.784 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.4 mt -113.43 -55.3 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.82 1.648 . . . . 0.0 108.297 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.48 -10.74 14.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.6 t60 55.42 19.56 3.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.016 1.726 . . . . 0.0 114.718 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -78.21 139.47 60.51 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.737 -1.227 . . . . 0.0 108.988 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 43.1 Cg_exo -49.68 129.16 23.0 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.058 3.172 . . . . 0.0 112.439 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -89.76 129.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 113.693 -1.594 . . . . 0.0 110.151 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -118.17 136.6 53.53 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.245 0.618 . . . . 0.0 111.318 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -126.72 35.33 4.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.425 1.89 . . . . 0.0 111.26 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -154.35 159.77 41.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.627 3.171 . . . . 0.0 109.785 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.228 1.811 . . . . 0.0 110.594 178.75 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 111.269 0.1 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.11 163.59 18.69 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.129 0.972 . . . . 0.0 112.042 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -118.1 -8.59 10.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.552 1.141 . . . . 0.0 114.077 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.48 168.81 19.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.395 1.078 . . . . 0.0 112.684 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.96 150.7 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.383 1.873 . . . . 0.0 109.723 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -161.32 179.94 7.91 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.645 1.978 . . . . 0.0 110.875 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.97 136.59 58.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.374 1.07 . . . . 0.0 111.289 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.5 m -145.84 142.7 29.08 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.753 1.221 . . . . 0.0 110.93 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.94 -175.11 1.35 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.122 1.369 . . . . 0.0 112.63 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -140.8 140.92 34.8 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 111.255 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -158.95 162.81 36.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.426 1.891 . . . . 0.0 111.504 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -137.2 63.22 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.113 1.365 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -145.45 143.32 29.96 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -72.27 24.02 0.05 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.926 2.89 . . . . 0.0 114.374 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -162.86 79.19 1.76 Allowed Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.664 1.586 . . . . 0.0 113.499 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -63.92 151.07 86.82 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.15 1.9 . . . . 0.0 111.628 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 m -95.57 13.33 26.52 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.51 44.67 0.25 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.989 1.757 . . . . 0.0 112.225 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.45 168.85 2.56 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.976 1.31 . . . . 0.0 112.104 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.3 p -139.16 157.03 46.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -62.1 134.72 56.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.38 1.472 . . . . 0.0 113.162 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -5.67 43.14 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.27 -41.66 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.826 1.25 . . . . 0.0 110.112 177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.48 6.49 5.24 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 -176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 54.45 27.83 8.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.608 1.563 . . . . 0.0 114.467 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.46 140.98 15.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -72.57 162.89 28.89 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.266 1.026 . . . . 0.0 112.681 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 51' ' ' PRO . . . -54.53 140.52 34.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.217 1.407 . . . . 0.0 113.094 173.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.2 p -114.98 -149.23 0.44 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.607 1.963 . . . . 0.0 110.217 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -109.88 -5.28 15.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.562 1.545 . . . . 0.0 112.284 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.68 -18.22 5.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.362 2.265 . . . . 0.0 110.939 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -141.53 69.79 26.06 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 128.33 2.652 . . . . 0.0 108.408 174.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 51.6 Cg_endo -77.15 4.21 6.02 Favored 'Trans proline' 0 N--CA 1.501 1.945 1 C-N-CA 129.397 6.732 . . . . 0.0 118.276 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt 60.08 144.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 1 C-N-CA 136.599 5.959 . . . . 0.0 113.636 -170.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.11 179.83 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.241 1.816 . . . . 0.0 109.483 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -122.65 103.48 37.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.922 1.289 . . . . 0.0 109.829 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.49 -17.92 20.53 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.464 2.109 . . . . 0.0 111.425 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 95' ' ' TYR . 1.5 t -134.92 -168.11 2.11 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.703 2.401 . . . . 0.0 111.428 -168.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -125.14 33.25 5.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.455 1.502 . . . . 0.0 113.626 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 93' ' ' CYS . 2.3 m -53.72 -10.39 0.29 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.286 1.434 . . . . 0.0 114.091 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 30.36 69.55 0.09 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.851 2.86 . . . . 0.0 116.561 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.4 -169.8 42.83 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.44 -1.255 . . . . 0.0 114.013 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -64.04 8.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.822 1.649 . . . . 0.0 114.495 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.87 12.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 127.741 2.416 . . . . 0.0 111.442 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 64' ' ' TYR . 12.9 pttt -90.86 -17.01 27.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.639 1.576 . . . . 0.0 113.08 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 63' ' ' LYS . 45.4 m-85 -90.15 144.32 25.98 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.116 1.766 . . . . 0.0 111.091 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 86.4 mtp -157.8 143.07 16.91 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.124 0.97 . . . . 0.0 110.956 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -75.97 144.53 40.92 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.31 -40.72 78.48 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.956 -1.09 . . . . 0.0 110.954 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -59.62 -47.02 87.23 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.525 1.93 . . . . 0.0 112.09 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.3 m -63.17 -46.37 87.45 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.857 1.263 . . . . 0.0 111.122 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.12 -48.85 80.08 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 122.911 0.485 . . . . 0.0 112.059 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.02 -20.85 60.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.635 1.574 . . . . 0.0 112.522 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -96.41 -31.89 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.959 1.704 . . . . 0.0 112.057 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.438 ' CZ2' ' HE3' ' A' ' 77' ' ' LYS . 15.8 t90 -64.05 -57.19 10.4 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.01 1.724 . . . . 0.0 111.746 178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 m -55.75 -22.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.456 1.502 . . . . 0.0 111.225 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.03 -33.94 22.42 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.036 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.1 t -70.55 -26.4 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.254 1.422 . . . . 0.0 110.817 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE3' ' CZ2' ' A' ' 73' ' ' TRP . 65.8 mmtt -74.35 7.31 2.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.875 2.87 . . . . 0.0 113.747 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 75.16 6.48 4.2 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.478 2.311 . . . . 0.0 115.531 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.81 152.05 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.37 1.468 . . . . 0.0 111.382 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -134.49 110.33 9.31 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.095 1.358 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -18.46 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.985 1.314 . . . . 0.0 113.702 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 t -82.59 -5.38 58.76 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.902 0.881 . . . . 0.0 113.266 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.97 150.06 44.4 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.396 1.478 . . . . 0.0 112.924 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -77.94 23.27 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.494 3.463 . . . . 0.0 115.182 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.88 8.27 16.7 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.691 2.091 . . . . 0.0 112.182 176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.61 145.5 51.95 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 113.224 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -152.16 44.1 0.71 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.335 1.854 . . . . 0.0 109.871 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.79 88.07 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.924 1.69 . . . . 0.0 113.566 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -141.42 139.55 33.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.712 1.605 . . . . 0.0 111.642 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.3 t -64.58 176.49 1.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.121 2.568 . . . . 0.0 115.739 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -129.26 -10.24 4.69 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.518 2.327 . . . . 0.0 112.591 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.8 mt -79.44 -64.59 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 122.576 1.179 . . . . 0.0 108.932 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 58' ' ' CYS . 26.5 p -101.4 -11.93 18.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 130.268 3.427 . . . . 0.0 111.222 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.0 m80 70.69 14.95 7.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.439 2.696 . . . . 0.0 114.064 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 17.9 m-85 -78.42 145.84 68.86 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.61 143.13 99.39 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.65 2.233 . . . . 0.0 109.631 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -91.85 132.83 35.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -127.72 120.34 27.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.285 1.034 . . . . 0.0 111.012 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -73.84 38.51 0.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.38 1.872 . . . . 0.0 114.573 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -157.61 136.04 11.19 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.244 2.218 . . . . 0.0 110.957 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.256 1.399 0 C-N-CA 126.062 1.745 . . . . 0.0 111.981 177.039 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_